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Abstract  
Superhydrophobic (SH) surfaces have been greatly explored in the biomedical field. Such surfaces are 
inspired by the repellent properties of natural structures. The most well known example is the lotus leaf, 
which has the capacity to repeal the water droplets due to the presence of micro/nano topographical 
features and the low surface energy. One particular application of artificial SH surfaces is their 
employment as supports where liquid droplets of aqueous-based polymeric solutions are dispensed, 
acquiring an almost spherical shape. Through application of one or multiple hardening steps solid particles 
are obtained in a fast way. Using this methodology, a variety of functional natural-based hydrogel spherical 
systems encapsulating cells and/or drugs are proposed in this thesis. The strategy of the first proposed 
system is the incorporation of cyclodextrins (CDs) in the dextran-methacrylate (Dex-MA) microgels 
networks in order to improve their loading efficiency for hydrophobic drugs. The formation of inclusion 
complexes between CDs and dexamethasone, when the CDs were copolymerized, increased significantly 
the amount of drug in the Dex-MA particles, when compared with formulations without or with freely 
dispersed CDs. Chitosan (Chi), unless it has been modified, is soluble in acidic media, which turn it 
incompatible with encapsulation of cells or pH sensitive molecules. The second system proposed 
envisaged a mild Chi-based system with two sequential hardening steps, where dexamethasone or 
fibroblast-like cells were successfully entrapped. SH surfaces methodology was also used to co-
encapsulate cells and proteins into hydrogel particles without compromise the cell viability and protein 
activity. Collagen combined with platelet lysates were used to obtain easy-to-handle spherical formulations 
being capable to act as in situ growth factors release system as well as reservoirs of human adipose 
derived stem cells, for applications in skin regeneration. Mesenchymal stem cells derived from bone 
marrow and fibronectin were also encapsulated inside alginate spheres and the system was studied for 
bone regeneration. The control of the release of bioactive agents may be achieved by adjusting the 
chemistry and physical parameters such as particles architecture. Multicompartmentalized systems have 
emerged and are envisioned to be the next area of development due to the possibility to confines various 
bioactive agents exhibiting a variety of release kinetics. Taking advantage of the simplicity of the SH 
surfaces methodology, core/shell and multilayered particles composed by Dex-MA and alginate were 
efficiently prepared, with cells or drugs encapsulated into individual compartments. The developed work 
shows that a wide variety of particles useful for biomedical application, ranging from homogeneous 
spherical matrices to compartmentalized systems, could be obtained under mild conditions and in a fast 
way, using SH surfaces.  !
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Resumo  
Superfícies superhidrofóbicas (SH) têm vindo a ser exploradas no campo biomédico. Estas superfícies são 
inspiradas nas propriedades repelentes de estruturas naturais. O exemplo mais conhecido é a folha de lotus, 
com a sua capacidade de repelir gotas de água devido à presença de micro/nano estruturas e baixa energia 
de superfície. Uma aplicação particular das superfícies SH artificiais é a sua utilização como suportes onde 
gotas de soluções poliméricas de base aquosa são dispensadas, adquirindo uma forma quase esférica. 
Através da aplicação de um ou múltiplos passos de solidificação, partículas sólidas são obtidas de uma forma 
rápida. Usando esta metodologia, uma variedade de hidrogéis funcionais de base natural, encapsulando 
células e/ou fármacos, são propostos nesta tese. A estratégia do primeiro sistema proposto é a incorporação 
de ciclodextrinas (CDs) em microgéis de dextrano-metacrilatado (Dex-MA), com o intuito de melhorar a sua 
capacidade de carga para fármacos hidrofóbicos. A formação de complexos de inclusão entre CDs e 
dexametasona, quando as CDS estavam co-polimerizadas, aumentou significativamente a quantidade de 
fármaco no interior das partículas, quando comparadas com formulações sem, ou com CDs livres. O 
quitosano, a não ser que esteja modificado, é solúvel em meios ácidos, o que o torna  incompatível com o 
encapsulamento de células ou moléculas sensíveis ao pH. O segundo sistema proposto teve como objectivo a 
produção de sistemas não agressivos, através de dois passos sequenciais de gelificação do quitosano, onde 
dexametasona e/ou fibroblastos foram encapsuladas com sucesso. A metodologia das superfícies SH foi 
também usada para o co-encapsulamento de células e proteínas em hidrogéis sem comprometer a viabilidade 
das células nem a atividade das proteínas. Colagénio combinado com lisados de plaquetas foram usados para 
obter formulações fáceis de manusear, sendo estas capazes de atuar como sistema de libertação de factores 
de crescimento in situ e também como reservatório de células estaminais derivadas do tecido adiposo, para a 
regeneração de pele. Em outro sistema apresentado, células estaminais mesenquimais e fibronectina foram 
encapsulados em esferas de alginato e o sistema foi estudado para regeneração óssea. O controlo da 
libertação de agentes bioativos pode ser conseguido através do ajuste da química e de parâmetros físicos tal 
como a arquitetura das partículas. O potencial dos sistemas multi-compartimentalizados tem emergido devido 
à possibilidade de encapsulamento de vários agentes bioativos exibindo diferentes cinéticas de libertação. 
Aproveitando a simplicidade da metodologia das superfícies SH, partículas com uma ou mais camadas, 
compostas por Dex-MA e alginato foram eficientemente preparadas, encapsulando células e fármacos em 
compartimentos individuais. Os trabalhos desenvolvidos mostram que uma grande variedade de partículas 
úteis para aplicações biomédicas, desde matrizes esféricas homogéneas até sistemas compartimentalizados, 
podem ser obtidos em condições não agressivas e de uma forma rápida, usando superfícies SH. 
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  Figure 1.2. Examples of isotropic and anisotopic micro/nano structured surfaces found in Nature. 
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high adhesive (II) structures. Low adhesive superhydrophobic surfaces exhibiting self-cleaning effect (A) 
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spider silk (K, K.1-3); repel oil products (V) when surrounded by liquids (L) as it is the case of shark skin (M, 
M.1); or even have self-cleaning properties where the droplets slip without rolling off (VI; O) being the most 
well-known case the Nepenthes pitcher plant (P, P.1-3). The scanning electron microscopy images of each 
natural system show that independently of the general behavior of the surfaces, they are composed by a 
hierarchical arrangement of micro and nano topographic structures. 
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  Figure 1.3. Examples of micro/nano structured artificial surfaces produced by inspiration from natural 
systems. I) Examples of superhydrophobic surfaces with low adhesion where the liquid droplets are 
suspended on the top of the nano structures (A): polystyrene (B), copper (C) and a micropatterned Si replica 
(D). Examples of high adhesive superhydrophobic surfaces, where the water enters through the micro 
exposed elements but air pockets prevent the penetration into the nano roughness (E), are: micro patterned 
epoxy resin coated with nanostructures of n-hexatriacontane (F) and hierarchical hairy carbonaceous ﬁbers 
deposited on micro patterned Si (G). II) Superoleophobic surfaces of Cu(OH)2 nanoneedle arrays capable to 
control the oil adhesion depending on the nanostructures at the surface and the preloads on the oil droplet 
(A, A.1) and aluminum coated with a polyelectrolyte multilayer treated with perfluorooctanoate which repels 
oil in dry and wet environments (B, B.1-2). III) Surfaces capable to repel both water and organic liquids are 
named superamphiphobic or superomniophobic. Examples are coralline-like structured surfaces obtained by 
spraying nanocomposites of fluorinated multi-walled carbon nanotubes and fluorinated polyurethane (A); 
surfaces obtained by carbon nanospheres deposition, coated with a silica shell (B), in which the carbon core 
was removed by calcination (B.1), revealing a structured silica coating with holes (B.2); cotton textiles coated 
with micro and nano silica particles (C); and etched and fluorinated aluminum (D). IV) Smart surfaces 
capable to change their behavior when subjected to a certain stimulus have also been developed:  textile 
surfaces capable to switch from superoleophilic to superoleophobic when immersed in a certain aqueous 
medium (A, A.1-3); hierarchical structured surfaces coated with poly(N-isopropylacrylamide-co-acrylic acid) 
(PNIPAAm-co-AAc) (B) which are adhesive or non-adhesive depending on the temperature (B.1) and on the 
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are superhydrophilic or superhydrophobic (C.1) 
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Applications Overview 
 
    
  Figure 2.1. Superhydrophobic electrospun strip (A) and the microstructure of the meshes composed by PCL 
complemented with 10% PGC-C18 (B). The CA of the electrospun meshes varies in function of the amount of 
PGC-C18 used (C) and a transition between the Wenzel and Cassie state occurred for higher content of PGC-
C18. (D) Schematic representation of the release mechanism from the superhydrophobic meshes. (E) 
Release profiles of SN-38 from PCL solely and PCL+PGC-C18 meshes.  
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  Figure 2.2. Aqueous dispersions containing polymers, cells or bioactive agents may be dispensed onto the 
non-adhesive superhydrophobic surfaces (A) with controlled sizes (B) and hardened (C) through different 
processes depending on the polymers used. Alginate particles ionically cross-linked by dispensing CaCl2 (D) 
were used to encapsulate cells (D.1) and co-encapsulate fibronectin and mesenchymal stem cells (D.2, I and 
II, respectively). Using photocrosslinkable polymers, such as dextran-methacrylate, spherical hydrogels may 
be obtained by UV light exposure (E). Multilayer particles were produced (E.1, I) for sequential drug release 
(E.1, II) and cell encapsulation (E.3, III). Responsive particles (E.2, I and II) composed by dextran-
methacrylate and poly(N-isopropylacrylamide) controlled the release profile of insulin and BSA according to 
the temperature. Simply by solvent evaporation (F) hierarchical particles composed by bioactive glass 
nanoparticles (F.1) were obtained. Initially the nanoparticles are randomly dispersed (I) in the aqueous 
medium and when the solvent evaporates they become organized (II) in a spherical-shape (III). Responsive 
chitosan microgels crosslinked under glutaraldehyde atmospheric environment (G, G.1) and coated with 
pectin layers were produced to release an anti-tumor agent, preferentially in sites with specific pH, such as 
gastro-intestinal tract.  
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  Figure 2.3. Spraying systems proposed to dispense droplets onto superhydrophobic surfaces. A generic 
spraying device was proposed to decrease the size of the particles produced using the solid-air interface 
between the superhydrophobic surfaces and the atmosphere (A). Photocrosslinkable chitosan 
(methacrylamide chitosan) was used and particles with diameters lower than 320 µm, in a hydrated state, 
were obtained. A similar spraying system was also used to produce hydrogel particles in a solid-liquid 
interface (B). Superhydrophobic surfaces (from PTFE) were immersed into an organic liquid (TMP); then the 
polymeric solution containing the monomer, co-monomer, crosslinker and initiator was sprayed onto the 
organic liquid. Micro scale particles were obtained (B.1). The typical shape of the precursor solution at air-
PTFE and TPM-PTFE interfaces are shown in B.3 and B.3, respectively. A precise dispensing system based 
on an acoustic wave nebulizer which delivers a spray aerosol droplets onto a superhydrophobic surface (C) 
was also proposed. By an accurate measurement of the weight of the dispensed droplets, the exact volume is 
determined. The gentle shaking of the superhydrohobic surface joint the small droplets into a single one.  
 
44 
  Figure 2.4. Examples of screening systems using superhydrophobic surfaces. (A) Blood type screening test 
obtained by colorimetric analysis of the droplets dispensed on the superhydrophobic surfaces, and where 
blood agglutination occurred after a mixture with antibodies (Anti-A, Anti-B and Anti-D). The red stars indicate 
where blood aggregation was triggered. (B) Square patterned superhydrophobic surfaces to analyze the 
bioactivity of different inorganic nanoparticles dispensed onto the hydrophilic areas (I). The nanoparticles 
were confined in such areas after solvent evaporation. The apatite deposition in each spot was analyzed by 
EDS after immersion the chip in simulated body fluid medium (II). (C) Patterned chips for the study of 
proteins-cell-materials interactions: (I) proteins and subsequent cell adhesion; (II) viability of cells 
encapsulated in hydrogels with different compositions and (III) cell proliferation and viability on scaffolds also 
with different compositions. (D) Micro patterned superhydrophobic surfaces used to study cell-cell 
communications.  Cells adhered on the superhydrophilic areas, however depending on the distance (I), cells 
could establish cell-cell direct contact. Different designs of the patterned areas may be produced and used to 
study more than one type of cells (II). (E) Ring-shaped patterned chip (II) to follow the release of fluorescent 
molecules from each spherical shaped particle fixed on the center of each ring (III). The quantification was 
obtained by imaging analysis of captured fluorescent microscopy images over time. 
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  Figure 2.5. General microfluidic systems proposed using different superhydrophobic and highly water 
repellent surfaces: (A) polystyrene superhydrophobic platform patterned by argon plasma treatment or 
UV/Ozone exposure was proposed as a microfluidic platform for continuous liquids flowing and; (B) PDMS 
microfluidic platform where the flow of the droplets was controlled along the desired path. (C) Process to 
fabricate a glass-based hydrophobic platform to produce microbead gradients (C.1) by dispensing a 
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suspension of green fluorescein microparticles. The same surface modification strategy was implemented in 
a microwell system (D). Cells were seeded inside the microweels and a gradient of doxorubicin concentration 
was created. The viability of the cells in contact with different amounts of drug was accessed by Live/Dead 
assay (live cells were green and dead cells were red) (D.1). (E) Superhydrophobic glass coated with 
diatomaceous earth, where a channel-like pattern was obtained by argon plasma treatment, showed to be a 
suitable device to produce gradients of concentrations of materials/molecules. 
 
  Figure 2.6. (A) Structure of the fibers of superhydrophobic cotton. The structure of the fibers became rough, 
due to the presence of the nanoparticles. The antibacterial activity of the superhydrophobic cotton was 
verified against Staphylococcus aureus (B) and Escherichia coli (C).  
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  Figure 2.7. Platelets adhesion onto PDMS smooth (A.1), micro patterned with different distances between 
the pillars (A.2-A.4) and sub micro grooved (A.5) surfaces. The quantification of platelets demonstrates that 
submicra structures and lower pitches in micropatterned PDMS inhibited platelet adhesion (A.6). 
Poly(carbonate urethane) (PCU) was also studied to averiguate the effect of superhydrophobicity. Smooth 
surfaces (B.1, CA!≈109.1°±1.58) were coated with aligned carbon nanotubes (B.2, CA!≈163.6°±1.18). 
Higher number of platelets with a spread morphology was observed on smooth PCUs (B.3 and B.4) when 
compared with superhydrophobic ones (B.5). The superhydrophobic PCU surface was clean and just a very 
few round shape platelets (B.6) were found. The blood compatibility of polypropylene (PP) was studied when 
films were in contact with platelet rich plasma and fresh human blood. The original PP films exhibited higher 
platelet adhesion (C.1) as well as blood cells (C.2). In contrast, the superhydrophobic surfaces exhibited an 
opposite effect, where almost no platelets (C.3) or blood cells (C.4) were visualized. 
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 Chapter 3. Advances in Particulate Systems for Biomedical Applications: Non-Spherical and 
Compartmentalized Approaches 
 
    
  Figure 3.1. The chemistry at surface and bulk level as well as the physical features such as mechanical 
properties, size, porosity, surface topography/texture, shape and compartmentalization should be carefully 
considered during the design/engineering of particulate systems for biomedical applications.  
 
72 
  Figure 3.2. Strategies to encapsulate single bioactive agents in a matrix: A. adsorption/immobilization onto 
the surface of the particles; B. physical dispersion inside the matrix: homogeneous arrangement or exhibiting 
some special organization (e.g. gradients); C. establishment of links between the particle matrix and the 
bioactive agent (e.g. covalent bonds, electrostatic interactions, among others); D. encapsulation in a 
multiscale system where the bioactive agents are encapsulated into small matrices which in turn are 
encapsulated in higher scale structures (e.g. nanoparticles inside microparticles).  
 
74 
  Figure 3.3. General architecture of theranostic particles and key components: targeting entities, therapeutic 
molecules, detection components and a coating or a polymeric matrix to support the previous enumerated 
entities. Image from the reference [21].  
 
75 
  Figure 3.4. Main requirements of particles for cell encapsulation: protection against immune cells and 
antibodies, adequate diffusion properties to allow the entrance of nutrients and O2, and the expelling of 
metabolites and growth factors.  
 
77 
  Figure 3.5. I. Internalization of HEMA particles exhibiting soft and stiff characteristics by HepG2 cells. The 
cells internalized higher amounts of soft particles. No particles (soft or stiff) were observed colonizing the cell 
nuclei. In both cases the particles were distributed in the cell cytoplasm (inside lysosomes) and no 
differences between both types of particles were observed. II. Effect of stiffness of the particles in cell 
cytoplasm after 24 h. The F-actin organization changed after particles internalization. Independently of the 
mechanical properties of the particles a reduction of the oriented stress fibers was observed. Image adapted 
from [74].  
 
83 
  Figure 3.6. Variety particles shapes produced by heating and stretching polystyrene spheres in one and two 
dimensions: A) Spheres; B) Rectangular disks; C) Rods; D) Worms; E) Oblate ellipses; F) Elliptical disks; G) 
UFOs; H) Circular disks; I) Ribbons with curled ends; J) Bicones; K) Diamond disks; L) Emarginate disks; M) 
Flat pills; N) Elongated hexagonal disks; O) Ravioli; P) Tacos; Q) Wrinkled prolate ellipsoids; R) Wrinkled 
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oblate ellipses; S) Porous elliptical disks; T) Barrels; U) Bullets; V) Pills; X) Pulleys; Y) Biconvex lenses. 
Adapted from [79].  
 
  Figure 3.7. I. Interaction of macrophages with polystyrene particles with non-spherical (A, B D and E) and 
spherical (C and F) shapes. II. The plot indicates the first point of contact between the macrophages and the 
particles as well as the velocity of internalization. The images were adapted from [84]. 
 
88 
  Figure 3.8. PLGA particles internalized by HUVECs by endocytosis accumuled around the cells nuclei. In 
images i, ii and iii it is possible visualize the spherical shaped particles and in images  iv, v and vi the elliptical 
disks. Image adapted from [90].  
 
89 
  Figure 3.9. Based on the organized structure of the human body which is composed by macro scaled 
compartments (organs) as well as on the micro/submicro arrangement of the organelles inside the cells, 
compartmentalized particles with a wide range of structures have been developed to be applied in the 
biomedical field with the aim to simulate some complex natural biological processes. Images obtained from 
[94]. 
 
91 
  Figure 3.10. General formulation of aAPC: an antibody (anti-CD28) and a dimer (MHC-IgG) were 
immobilized on the surface of PLGA particles (A). The T-cells will recognize such molecules on the particle 
surface and will interact with particles (B and C). The particles with different aspect ratios (D) induced 
different cell proliferation (E). Higher aspect ratio seemed to increase significantly the T-cell expansion. When 
T-Cells were administered with ellipsoidal aAPCs the increase of the tumor size was lower than in the same 
conditions with spherical aAPCs (F), showing the potential of elongated particles in those types of treatments. 
Adapted from [97] .  
 
93 
  Figure 3.11. Using a PRINT technique (A), HEA hydrogel particles were obtained with erythrocyte-like 
structure (B). Such particles were capable to pass through very small fenestrations simulating blood 
capillaries (C). The accumulation of the particles in different tissues 2h after administration in mice 
demonstrated that those particles could accumulate in certain organs and such accumulation depended on 
the particles rigidity (D). Scale bar 20 µm. Image adapted from [104]. 
 
95 
  Figure 3.12. A. Filomicelles, in the nanometer scale, resulted from the self-assembly of amphiphilic di-block 
copolymers. B. Fluorescent filomicelles injected in vivo remained in the blood circulation up to one week. C. 
Longer degradable filomicelles circulate longer up to a limiting length. D. Filomicelles with two different 
lengths and loaded with paclitaxel were administered in mice. The filomicelles caused higher tumor cell 
apoptosis one week after when compared with free drug administration. Larger micelles were more effective 
E. The decrease of the tumor size was more visible in the mice treated with longest filomicelles and high drug 
dose. Adapted from [80].  
 
97 
  Figure 3.13. Micelles containing a DNA in the hydrophilic part of the polymer that compose the structure 
formed a spherical shape. In the presence of a DNAzyme the particles switch to an elongated shape due to 
the absence of DNA in the polymer structure. The particles have the capity to recover the spherical shape 
upon adding a DNA sequence. TEM images of the particles are represented in A and the explanation scheme 
in B. C represents the evolution of the particles length after adding DNAzyme: a) 0 min, b) 2 min, c) 2 h, d) 1 
day and e) 2 days. Adapted from [122].  
 
99 
  Figure 3.14. Multilayer system capable to fold preferentially in the small intestine (due to their pH-sensitive 
composition) protecting and controlling the release of a drug in this site. I. Schematic representation of the 
self-folding system. II. Optical images of the system before (a) and after folding (C) when immersed in a buffer 
solution simulating the conditions in the small intestine. III. Comparison of the performance of the self-folding 
device with other administration strategies, namely a patch and a solution. Adapted from [130].  
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  Figure 3.15. Compartmentalized particles were obtained using a biomimetic methodology that involved 
successive steps of dispensing liquid polymeric solutions and crosslinking strategies (I). Concentric multilayer 
(II) or core/shell (III) particles were prepared encapsulating model drugs or cells in individual compartments. 
Depending on the layer where the drug is immobilized, the release kinetic could be controlled (IV). A specific 
application was studied with 5-fluoraracil encapsulated in a chitosan core coated with pectin layers.  
Depending on the pH, a controlled release of such chemotherapeutic agent was achieved (V). Images 
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adapted from [108,109]. 
 
  Figure 3.16. Core/Shell particles encapsulating lysozyme were obtained as structural elements of a fibrous 
scaffold (I and II). The particles allowed the control of lysozyme release, avoiding the typical initial burst (III). 
Image adapted [137].  
 
104 
  Figure 3.17. Schematic representation of the main strategies to encapsulate bioactive agents into LbL 
multilayered particles: a) use the bioactive agent to construct the multilayer shell; b) load the template with 
bioactive agent that will be retained inside the multilayer shell after core removal and c) bioactive agents 
entrapment through altering the permeability of the multilayered shell. Image obtained from [144]. 
 
106 
  Figure 3.18. Schematic representation of hierarchical systems composed by nanoparticles and/or drugs 
inside LbL microcapsules, which in turn were encapsulated inside macro-scale LbL capsules. Image from 
[176].   
 
111 
  Figure 3.19. Hierarchical system composed by LbL capsules where PLLA microparticles were encapsulated 
and acted as supports for adherent cells expansion. Capsules without (A) and containing (B) solid PLLA 
microparticles inside the liquid liquefied core. Image from [146].  
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  Figure 3.20. Representative scheme of preparation of hollow mesoporous particles. Using a soft-template, 
two routes may be followed: 1) heterogenerous and 2) self-generated. In the first case nucleation of the 
precursor/surfactant mixture occurs at the interface between the core and the liquid medium containing 
surfactants and precursor molecules. Then, the shell grows due to the precursor hydrolysis around the core 
template and the self-assembly of the surfactants. In the second process the precursor is integrated in the 
core. The core template is gradually consumed and the shell is formed by self-assembly of surfactants 
present in the liquid medium. In both strategies the final stem is the core and mesoporous templates 
removal. Image from [177].  
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  Figure 3.21. Architectures of the hollow mesoporous silica spheres with single (a1) and double (a2 and a3) 
mesoporous shells. Rattle-type mesoporous silica particles having a single (b1) and double (b2 and b3) 
mesoporous shells. Non-spherical hollow mesoporous silica (ellipsoids) with single (c1 and c2) and double 
(c3) mesoporous shells. Fe2O3 ellipsoidal particles (d1) coated with a single (d2) and double (d3) mesoporous 
shells. Finally, rattle-type Fe2O3 rattle-type particles exhibiting a single (e1) and double (e2 and e3) 
mesoporous shells. The set of images with number 4 are the schematic representations of the double-shelled 
structures. Image from [193].  
 
116 
  Figure 3.22. Self-assembled compartmentalized structures with stratified spherical (a); segmented worm-
like (b) and raspberry-like spherical (c) architectures. The correspondent cryo-TEM images are labelled with d, 
e, and f, respectively. Image adapted from [213]. 
 
119 
  Figure 3.23. Schematic representation of possible Janus structures. Image from [218]. 
 
120 
  Figure 3.24. When magnetic nanoparticles are in embedded the ECM and mixed with the cells of a 
spheroid (A), the particles are internalized by the cells causing a significant decrease in the viability (C). Janus 
spheroids, where the particles are separated from the cells (A and B), seemed to be advantageous, not 
affecting the cell viability (C). Applying a magnetic force it was possible to control the position of the Janus 
spheroids (D). After a certain time, the spheroids found and formed continuous tissues (E). Image from 
[266]. 
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SECTION II. Materials and Methods   
  
 Chapter 4. Detailed Description of Experimental Testing and Materials  
    
  Figure 4.1. I. Schematic representation of the procedure to obtain PS superhydrophobic surfaces. II. 
Smooth PS exhibiting a contact angle (CA) of ca. 77° (before modification) and the topographical structures 
of the superhydrophobic PS surface (after modification). The water CA achieved was higher than 150° and 
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the surfaces exhibited aggregates of nanostructures onto microstructures recreating the hierarchical structure 
of the natural water repellent systems. Images adapted from [7]. 
 
  Figure 4.2. I. Schematic representation of the procedure to obtain Cu superhydrophobic surfaces. II. Cu 
substrate before film deposition, exhibiting CA around 56° and after immersion in ammonia and PFDTS 
solution. On the surface of the Cu grew up micro and nano structures of Cu(OH)2  which combined with a 
PFDTS increased the water contact angle to ca. 164°. Image adapted from [7].  
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  Figure 4.3. Structure of Dextran.  
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  Figure 4.4. Structure of the glycidyl methacrylate used to modify the dextran. After the reaction, two 
isomers may be obtained: 3-methacryloyl-1-glyceryl ether or 2-methacryloyl-1-glyceryl ether.  
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  Figure 4.5. Chemical structure of chitin and chitosan.  
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  Figure 4.6. Assembly of collagen type I. The peptide chains form triple helices with approximately 100-200 
nm in length and then are assembled via the staggered lateral packing into nanofibers which form a hydrogel. 
Image adapted from [42]. 
 
161 
  Figure 4.7. Alginate-based hydrogels could be prepared by ionic crosslinking following an egg-box model. 
The Ca2+ ions are placed in the interstices of guluronate blocks of one polymer chain and junctions with the 
guluronate blocks of adjacent polymer chains are formed. Image adapted from [44].  
 
162 
  Figure 4.8. Structure of the γ-CD. 
 
164 
  Figure 4.9. Structure of the γ-CD-NMA.  
 
165 
  Figure 4.10. Molecules secreted by platelets: signaling proteins (growth factors, chemokines and other 
cytokines), adhesive proteins and proteases, and small molecules. The table describes the approximate 
contents of GFs in human PL. Image adapted from [55] and table from [57].  
 
167 
  Figure 4.11. Fibronectin structure with its binding sites. FN contains cell binding sites (RGD28 on FNIII10 
and the synergy site PHSRN on FNIII9) and protein-protein interaction sites. Image from [64].  
 
168 
  Figure 4.12. Schematic representation of the procedures to prepare the different homogeneous matrices 
proposed in this thesis.  
 
172 
  Figure 4.13. Schematic representation of the procedure to prepare multicompartmentalized spherical 
particles (core/shell and multilayered) using the superhydrophobic surfaces methodology.  
 
173 
  Figure 4.14. Reaction of bromine with unsatured compounds.  
 
175 
  Figure 4.15. Schematic representation of the ELISA method.  
 
180 
  Figure 4.16. 1) Silicon inserts and micro-dishes used in the scratch wound assay; 2) the cells were seeded 
in each compartment of the silicon insert; 3) the inserts were removed when the cells reach confluence; 4) 
cell culture medium was added to the micro-dish and then the particles were immersed in the culture 
medium. Image adapted from [85]. 
 !
185 
  Figure 4.17. Localization of the CAM inside the egg and the detailed description of the CAM. 1: chorionic 
epithelium; 2: mesoderm with blood vessels depicted in red; 3: allantoic epithelium. Image adapted from 
[97].  
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SECTION III. Natural-Based Spherical Systems, Prepared on Superhydrophobic Surfaces, for 
Applications in the Biomedical Field 
 
  
 Chapter 5. Free and Copolymerized γ-Cyclodextrins Regulate the Performance of Dexamethasone-
Loaded Dextran Microspheres for Bone Regeneration 
 
    
  Scheme 5.1. Reaction of dextran with GMA in the presence of DMSO and DMAP. The glycidyl group may 
interact with any of the hydroxyl groups present in the dextran structure, and two region isomers could be 
created: 2-methacryloyl-1-glyceryl ether and 3-methacryloyl-1-glyceryl ether. 
 
214 
  Scheme 5.2. Scheme of the γ -CD monomer (γ -CD–NMA) after reaction with one N-
(hydroxymethyl)acrylamide (NMA). The molecular weight of the monomer was estimated assuming that each 
γ -CD has one NMA group. 
 
216 
  Scheme 5.3. Photocrosslinking of the dextran-MA solution drops may result in three distinct covalent bonds: 
(A) dextran-MA–dextran-MA; (B) dextran-MA–γ-CD–NMA; (C) γ -CD–NMA–γ -CD–NMA. 
 
218 
  Figure 5.1. 1H NMR spectra of dextran as supplied (gray line) and after reaction with GMA (black line) 
dissolved in deutered water. 
 
215 
  Figure 5.2. (A) FT-IR and (B) 1H NMR spectra of γ -CD (black lines) and γ - CD–NMA (blue lines). 
 
216 
  Figure 5.3. Color of bromine aqueous solutions 5 min after pouring 40 µL of precursor solutions used for 
particle production or 8 particles of each formulation. 
 
219 
  Figure 5.4. Stereomicroscope images of the dried particles. The scale bar is 500 µm. 
 
220 
  Figure 5.5. SEM micrographs of swollen freeze-dried particles and their respective cross-sections. 
 
220 
  Figure 5.6. SEM micrographs of the air-dried particles, cross-sections and respective magnifications. 
 
221 
  Figure 5.7. Dexamethasone loaded by 10 particles of dextran-MA particles immersed in 30 µg/mL drug 
solution at room temperature. 
 
222 
  Figure 5.8. Dexamethasone release profiles in water referred to the particle mass (A) and to the total 
amount of dexamethasone loaded (B). Arrows indicate the moment at which an additional volume (1 mL) of 
release medium was added. 
 
224 
  Figure 5.9. Viability of SaOs-2 cells after being in direct contact with dexamethasone loaded and non-loaded 
particles for 24 and 72 h (n=4, error bars represent standard deviations). 
 
225 
  Figure 5.10. Proliferation of hASCs cultured in direct contact with dexamethasone loaded and non-loaded 
particles and in the respective controls up to day 12. Cell number per well was calculated using a calibration 
curve of known cell numbers (n =3, bars represent standard deviations). 
 
226 
  Figure 5.11. ALP activity in hASCs induced by dexamethasone loaded and non-loaded particles and the 
respective positive and negative controls after 3, 7 and 12 days in culture. The results are expressed in 
mean±standard deviation with n=3 for aech bar. 
 
 
227 
  Figure 5.12. ALP staining of hASCs in direct contact with non-loaded and loaded particles, and their 
respective controls at 12 days. The scale bar is 100 µm. 
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 Chapter 6. Sequential Ionic Thermogelation of Chitosan Spherical Hydrogels Prepared Using 
Superhydrophobic Surfaces to Immobilize Cells and Drugs.  
 
    
  Figure 6.1. PS SH surfaces were used as platforms to support aqueous-based droplets (a) for the 
preparation of CHI/β-GP:TPP spherical particles immobilizing (b) dexamethasone or (c) L929 cells. In any 
case, stable hydrogel beads were obtained upon ionic (d) crosslinking. 
 
242 
  Figure 6.2. Schematic representation of CHI/β-GP:TPP hydrogel networks derived from physical 
associations formed by ionic interactions (first crosslinking) and other attractive forces (second crosslinking). 
 
243 
  Figure 6.3. (a) Storage modulus (E’), (b) loss modulus (E’’), and (c) loss factor (tan δ) of CHI/β-GP:TPP gels 
at 20 °C and 37 °C, within the frequency range of 0.1–15 Hz. 
 
244 
  Figure 6.4. Swelling of the CHI/β-GP:TPP particles after 2, 5, 7, and 14 days of immersion in pH 2, 7.4, 
and 9 media at 37°C. 
 
245 
  Figure 6.5. Stereomicroscope images of CHI/β-GP:TPP particles immediately after preparation (5 min) and 
after immersion in pH 2, 7.4, and 9 media for 5 and 7 days at 37 °C (scale bar: 1 mm). 
 
246 
  Figure 6.6. Dexamethasone release profiles from CHI/β-GP:TPP particles immersed in media with pH 2, 
7.4, and 9 at 37 °C. 
 
247 
  Figure 6.7. Fluorescent microscopy images of Live/Dead assay at 1, 3, and 7 days of culture. ALG particles 
(control) and CHI/ β -GP:TPP particles were analyzed. Living cells were stained in green by calcein-AM, and 
dead cells were stained in red by propidium iodide (scale bar: 500 µm). 
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 Chapter 7. Fast and Mild Strategy, Using Superhydrophobic Surfaces, to Produce 
Collagen/Platelet Lysate Gel Beads for Skin Regeneration 
 
    
  Figure 7.1. Flow chart of the preparation and evaluation of Coll+PL gel particles. (A) A mixture of Coll and 
PL was dispensed onto PS superhydrophobic surfaces, as droplets of controlled volume. (B) The platform 
with liquid droplets was incubated at 37 °C for 10–15 minutes and almost spherical gels in a hydrated state 
were obtained. Two main strategies were hypothesized in this work: (C.1) spherical particles encapsulating 
hASCs to be directly applied (I) or stored by cryopreservation and later thawing and use (II), (C.2) gels without 
cells which could act as bioactive agents release systems, also applied immediately after production 
(hydrated form) (I) or later, after being freeze-dried and stored (II). Each formulation could be then ingraft in a 
skin lesion (e.g. ulcer) (D) which in turn could be coated or not by a dressing (E and F). 
 
263 
  Figure 7.2. I) Stereomicroscope images of Coll and Coll+PL (1, 2, and 3×) spherical gels prepared 
dispensing 10 µL of precursor solutions onto PS superhydrophobic surfaces and hardening at 37 °C for 10–
15 min. Particles without cells were evaluated as hydrated gels obtained immediately after incubation (A, D, 
G and J), as freeze-dried particles (B, E, H and K) and as re-hydrated gels obtained after hydration of freeze-
dried particles through immersion in PBS at pH 7.4 (C, F, I and L). Scale bar represents 1 mm. II) Diameter 
of hydrated, freeze-dried and re-hydrated gel beads (n = 5). III) SEM images of the surface of freeze-dried 
spherical particles (M, N, O, P) and of the surface of the gels with PL without cells, fixed and dehydrated (Q, 
R, S). Two images with different magnifications of each gel formulation are shown. 
 
264 
  Figure 7.3. Total protein (A), VEGF and PDGF (B, C) released from Coll+PL2× particles over 72 h. Data are 
shown as percentage (A, B) and as amount released per bead (C). 
 
265 
  Figure 7.4. A) hASCs growth within Coll and Coll+PL gel beads for 7 days. Gels without PL cultured in 
medium with and without FBS were used as controls. The effect of PL concentration on hASCs proliferation 
capability was evaluated. *p<0.05, significantly different from Coll with FBS. #p<0.05, significantly different 
from Coll without FBS. $p<0.05, significantly different from Coll+PL1×. &p<0.05, significantly different from 
Coll+PL2×. The comparisons were performed between data collected in the same time point. B) hASCS 
proliferation within Coll+PL1× prepared using freeze-dried or non freeze-dried (fresh) PL. The influence of 
freeze drying process on effect of PL was evaluated. *p<0.05, significantly different from Coll+PL1× when non 
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freeze-dried PL was used, at day 7. 
 
  Figure 7.5. Live/dead fluorescent assay at 1, 3 and 7 days of culture. Coll (cultured in medium with or 
without FBS, controls) and Coll+PL particles with three different PL concentrations were tested. Living cells 
were stained green (calcein-AM) and dead cells were stained red (propidium iodide). Scale bar represents 
100 µm. 
 
267 
  Figure 7.6. Phalloidin/DAPI fluorescence assay at 1, 3 and 7 days of culture. Coll (cultured in medium with 
or without FBS, controls) and Coll+PL particles with three different PL concentrations were tested. Cells F-
actin filaments in cytoplasm were stained red by Phalloidin, and nuclei were stained in blue by DAPI. Scale 
bar represents 100 µm. 
 
268 
  Figure 7.7. Optical microscope images of gel beads encapsulating hASCs and cultured for 3 and 7 days 
and the respective scheme representing the state of the cells when encapsulated in Coll+PL gels. 
Immediately after gels hardening, cells exhibited a round shape typical of non-adhered cells (I), over time, the 
cells started to extend their cytoplasmatic elongations (II), proliferated and established connections between 
adjacent particles (III). Finally, a membrane composed by gels unified by hASCs and gelified released PL was 
obtained (IV). Image V is the stereomicroscope image of a membrane composed by Coll+PL2× encapsulating 
hASCs and cultured for 7 days in a 12-well cell culture plate. Scale bar represents 1 mm. Coll formulations 
did not exhibit a significant hASCs proliferation neither cell established connections between adjacent 
particles after 3 (A.D3 and B.D3) and 7 (A.D7 and B.D7) days. Only in the formulations where PL was 
present the bond of adjacent particles was observed after 3 (C.D3, D.D3 and E.D3) and 7 days (C.D7, D.D7 
and E.D7). Scale bar represents 100 µm. 
 
269 
  Figure 7.8. Live/dead assay of the gels in culture for 3 and 7 days after being cryopreserved for 1 month. 
Sale bar represents 100 µm. 
 
270 
  Figure 7.9. Stereomicroscopeimages monitoring the enzymatic degradation of Coll and Coll+PL gel beads 
over time. High collagenase concentration (50 µg/ mL, in tricine buffer pH 7.5) was used in order to mimic 
exudates of untreatable skin ulcers. Particles immersed in tricine buffer pH 7.5 were used as controls. Scale 
bar represents 3 mm. 
 
271 
  Figure 7.10. A) Effect of released PL from hydrated and re-hydrated particles on hASCs proliferation. hASCs 
cultured in the presence of PL without being encapsulated (PL1, PL2 and PL3×) and in medium with or 
without FBS were used as controls. *p < 0.05, significantly different from Coll hydrated, re-hydrated and 
control (without FBS) at day 1, 3 and 5. #p < 0.05, significantly different from Coll+PL1× re-hydrated (day 5). 
&p<0.05, significantly different from PL1× (day 5). $p<0.05, significant- ly different from control with FBS (day 
5). B) Effect of PL released from Coll+PL1× hydrated particles prepared with freeze-dried or non freeze- dried 
(fresh) PL on hASCs proliferation. 
 
272 
  Figure 7.11. Scratch test: hASCs were cultured physically separated by a distance of 500 µm. The 
presence of PL significantly accelerated cell migration and the filling of the scratch area. Scale bar represents 
100 µm. 
 
273 
  Figure 7.12. Interaction of hydrated and re-hydrated gels with a monolayer of hASCs (cells adhered onto 
the bottom of cell culture plates). The particles were cultured in direct contact with a cell monolayer (I). After 
some days in culture, hASCs migrate to the particles surface (II). In the case of Coll gels (A, E), cells were not 
found on the gels surface, neither extending elongations to connect adjacent gels. Oppositely, hASCs adhered 
to the surface of Coll+PL gels (B-D and F-H) and tried to establish connections between the gel particles after 
7 days in culture. Scale bar represents 100 µm. 
 
 
273 
  Figure 7.13. Representative stereomicroscope images of the excised chick CAMs after implantation of 2 
particles of Coll (A), Coll+PL1x (B), Coll+PL2x (C), 10 µL of PL1x (D) and 10 µL of PL2× (E). (F) is a 
representative image of a normal CAM. Direct blood vessels growth was observed towards the Coll+PL 
formulations 3 days post-implantation, but no direct blood vessels growth was observed towards Coll solely. 
The Coll+PL beads were integrated in the chick CAM. Scale bar represents 1 mm. (G) Number of converging 
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vessels at 3 days post- implantation. *p<0.05, significantly different from the Coll. #p<0.05, significantly 
different from Coll+PL1×. &p<0.05, significantly different from PL1×. 
 
    
 Chapter 8. Novel Methodology Based on Biomimetic Superhydrophobic Substrates to Immobilize 
Cells and Proteins in Hydrogel Spheres for Applications in Bone Regeneration 
 
    
  Figure 8.1. Schematic representation of cell and protein immobilization in alginate hydrogels using 
polystyrene (PS) super- hydrophobic substrates: 5 µL drops of mesenchymal stem cells isolated from Wistar rats 
bone marrow (rMSCs) + fibronectin (FN) suspension in a sodium alginate (ALG) solution were dispensed on PS 
superhydrophobic substrates (A). After, 2 µL of CaCl
2 was dispensed on the top of each drop to crosslink 
alginate (B). After 5 min the spheres with rMSCs + FN immobilized were collected (C) and in vitro (D) and in 
vivo (E) tests were performed. A bone defect was created in calvarial bone (E1) and filled in with  particles  
(E2) in order  to  evaluate  the  regeneration of the  bone. 
 
294 
  Figure 8.2. Fluorescent microscopy images of FN (250 µg/mL) labeled with Alexa Fluor 555 (A) and rMCSs 
labeled with Phalloidin/ DAPI (B) inside 2% ALG beads.  
 
296 
  Figure 8.3. Cellular activity quantified by MTS assay: (K-), negative control where cells were cultivated in 
wells; (K+), positive control where the cells were dead and rMSCs immobilized in three different alginate 
concentrations with and without FN. Each result is the mean and respective standard error of at least three 
independent experiments. 
 
297 
  Figure 8.4. LDH quantification of rMSCs immobilized in alginate beads with FN in culture after 24, 48, and 
72 h: (K-) is the negative control where cells were cultivated in wells; (K+) is the positive control where the cells 
were dead.  
 
297 
  Figure 8.5. Live/dead staining of rMSCs immobilized into 2% ALG + FN beads over 21 days in culture. 
 
298 
  Figure 8.6. Optical microscopy images of alginate particles loaded with rMSCs. Group A were beads 
composed by 1% ALG after 72 h in culture in presence (A1) and absence (A2) of FN. The same order of 
images disposition was followed for the other alginate beads concentration: in group B was 1.5% ALG and 
group C 2% ALG. The white arrows show the cells released due to the slight particle disintegration. 
 
299 
  Figure 8.7. Part I. The alginate particles with rMSCs+FN were cultured in a well plate for 9 days and the 
rMSC morphology was accessed by optical microscopy: (A) correspond to 1% ALG, (B) to 1.5% ALG, and (C) 
to 2% ALG after 5 days (A1, B1, C1) and 7 days (A2, B2, C2) in culture. Part II. When the released rMSCs 
reach the confluence in the surface of the well plate, the particles were transferred for a new plate. 1% ALG 
beads were not transferred because were completely disintegrated before day 9. The other alginate 
formulations were cultured for more days and the continuous rMSC release was observed at day 14 (B3, C3) 
and 21 (B4, C4). Scale bar 20 µm. 
 
299 
  Figure 8.8. Cumulative release of calcium ions from alginate beads (1%, 1.5%, and 2% ALG) crosslinked 
with CaCl2 after immersion in cell culture medium. The calcium at 0h corresponds to the amount content in 
cell culture medium. 
 
300 
  Figure 8.9.  Scanning electron microscopy micrographs of 2% ALG+FN without rMSCs (A) and with rMSCs 
immobilized (B), after 48 h in culture. (C) Corresponds to fluorescent microscopy images of rMSCs stained 
with Hoechst 33342 immediately after immobilization in 2% ALG+FN. 
 
 
301 
  Figure 8.10. Alizarin red staining of 2% ALG+FN+rMSCs after 1 (A1, A2), 7 (B1, B2), 14 (C1, C2), and 21 
days (D1, D2) in culture under basal and osteogenic conditions. 
 
302 
  Figure 8.11. MicroComputed Tomography analysis of calvaria defects in Wistar rats. Images show the 
endpoint result after 4 weeks of bone regeneration of empty defects (I) and upon implantation of 2% ALG 
beads (II) loaded with FN and (III) loaded with FN and rMSCs. 
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  Figure 8.12. Hematoxylin and eosin stained histological images of calvaria defects at 4 weeks: empty 
control group (I), defects filled with beads loaded with FN (II), and beads loaded with FN and rMSCs (III). The 
black arrows represent the deposition of osteoblasts and formation of circular bone pieces. CB, compact 
bone; NB, new bone; P, periosteum. Scale bar 200 µm. 
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 Chapter 9. Biomimetic Methodology to Produce Polymeric Multilayered Particles for 
Biotechnological and Biomedical Applications 
 
    
  Figure 9.1. Biomimetic approach using copper superhydrophobic surfaces to produce multilayered 
particles: (A1) the core (Layer 1) is produced dispensing 2 µL of DEX-MA+DAPI solution onto the 
superhydrophobic surface and then crosslinking by UV light exposure; (B1) the follow layer (Layer 2) is 
obtained dispensing µL of DEX-MA+Rhodamine B solution around the previous obtained particle and again 
crosslinking by UV light exposure; and (C1) the third layer (Layer 3) is obtained following the same procedure 
but using 6 µL DEX-MA+FITC solution. Fluorescent microscopic images (A2, B2, B3, B4 and C2) of the 
particles obtained in each step of the procedure; and (B5) thickness of the particle layers that where obtained 
by dispensing different volumes of polymeric precursor solutions in the second layer: 2 µL (B2), 4 µL (B3) 
and 6 µL (B4). 
 
317 
  Figure 9.2. (A1 and A2) Bi-layered DEX-MA particles with red and green dyes immobilized in opposite 
positions; (B) In vitro release of Rhodamine B from 15% (w/v) bi-layered DEX-MA particles, where Rhodamine B 
was encapsulated on the external layer (triangles) and in the internal layer/core (squares). 
 
318 
  Figure 9.3. Bi-layered particles where cells were immobilized in the external layer: (A1) 2 µL of DEX-MA 
solution containing a photoinitiator and CaCl2 was dispensed onto the superhydrophobic surface and then 
crosslinked under UV light; (A2) the external layer was obtained dispensing a L929 cell suspension in sodium 
alginate over the previously obtained particles. The release of the calcium immobilized in the cores allowed 
the crosslinking of the alginate layer; (B) MTS viability assay of bi-layered particles where the core was 
crosslinked with two different photoinitiators (Irgacure 2959 and VA-086) after 4 h, 24 h and 72 h of cell 
culture (mean values with standard deviations, n = 3; *** indicate significant differences between testing 
conditions as a function of time); (C) Fluorescent microscopy image of loaded particles where cells were 
stained with Calcein-AM and propidium iodide and cultured for 4 h; (D) confocal microscopy image of a 
quarter-circle of a bi-layered particles where cells were stained with DAPI (nucleus) and phalloidin 
(cytoskeletons) cultured for 4 h; (E1) and (E2) stereo microscope images of core particles stained with 
Alizarin red immediately after being produced and after being immersed in water for 20 min, respectively. 
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Introduction to the Thesis Format 
This thesis is divided into 4 main sections containing a total of 10 chapters. Section I correspond to the 
general introduction to the thesis. The second section provides a detailed overview of the experimental 
methods and materials used. The experimental results obtained and their discussion are showed in the 
section III. The last section compiles the final remarks and the future perspectives in the context of this 
work. The chapters of this thesis are all based on peer-reviewed papers published or submitted for 
publication and contain: abstract, introduction, experimental section, results and discussion, conclusions 
and acknowledgements. A list of references is also provided in each chapter. The follow paragraphs 
summarize the content of each chapter.  
 
Section I. General Introduction 
 
Chapter 1. Micro/Nano Structured Superhydrophobic Surfaces in the Biomedical Field. Part 
I: Basic Concepts and Biomimetic Approaches 
This chapter is focused on the description of the characteristics of extreme wettable surfaces, as well as 
the main examples found in Nature, which inspired the production of artificial superhydrophobic surfaces. 
This chapter also describes the interactions of substrates with extreme wettabilities with proteins and cells.  
 
Chapter 2. Micro/Nano Structured Superhydrophobic Surfaces in the Biomedical Field. Part 
II: Applications Overview.  
In the sequence of the previous chapter, the second one intends to demonstrate that biomimetic 
superhydrophobic surfaces may be used in a wide range of applications in the biomedical field. In this 
chapter are compiled the applications of superhydrophobic surfaces explored until the current date. In 
addition, it is analyzed and discussed the main fragilities as well as hypothesis about the potential and the 
future directions that superhydrophobic surfaces should taken to improve the results in this area.  
 
Chapter 3. Advances in Particulate Systems for Biomedical Applications: Non-spherical and 
Compartmentalized Approaches 
This chapter reports the importance of the physical characteristics of the particles, namely shape and 
compartmentalization, in their performance when used in therapeutic strategies (e.g. drug 
release/delivery, cell carriers), or as diagnosis tools. Special attention is given to non-spherical systems 
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and multicompartmented particles. Representative examples demonstrate the importance of physical 
design parameters when the particles are used in biomedical applications.  
 
Section II. Materials and Methods 
 
Chapter 4. Detailed Description of Experimental Testing and Materials  
Detailed description of the materials properties and explanation of the techniques used to obtain the 
results described in this thesis.  
 
Section III. Natural-Based Spherical Systems, Prepared on Superhydrophic 
Surfaces, for Applications in the Biomedical Field 
 
Chapter 5. Free and copolymerized γ-cyclodextrins regulate the performance of 
dexamethasone-loaded dextran microspheres for bone regeneration 
This chapter aims to demonstrate that hydrogel-based particles may be efficiently loaded with hydrophobic 
drugs and be capable to control the release of such molecules. Dextran-MA particles incorporating CDs in 
a free form or copolymerized may be obtained using the superhydrophobic surfaces methodology and may 
be loaded with dexamethasone. The presence of the CDs as structural monomers is crucial to control the 
fixation and the release of this molecule.  
 
Chapter 6. Sequential Ionic and Thermogelation of Chitosan Spherical Hydrogels Prepared 
Using Superhydrophobic Surfaces to Immobilize Cells and Drugs 
 In this chapter, a strategy was proposed to harden chitosan particles for cells or drugs encapsulation in 
mild conditions, starting from an acidic chitosan solution. The neutralization of the solution with β-
glycerophosphate and the subsequent ionic crosslinking were effective in the production of easy-to-handle 
gel particles without jeopardize the cell viability. In addition, the β-glycerophosphate allowed the 
improvement of the mechanical properties of the system under physiological conditions. The system was 
also studied as a drug container.  
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Chapter 7. Fast and Mild Strategy, Using Superhydrophobic Surfaces, to Produce 
Collagen/Platelet Lysate Gel Beads for Skin Regeneration 
This chapter presents a system capable to harden in 10-15 min when submitted to physiological 
temperatures, co-encapsulating cells and a cocktail of bioactive agents. Particles composed by collageb 
and platelet lysates were studied as potential systems to supply skin damaged regions with cells (adipose-
derived stem cells) and growth factors.  
 
Chapter 8. Novel Methodology Based on Biomimetic Superhydrophobic Substrates to 
Immobilize Cells and Proteins in Hydrogel Spheres for Applications in Bone Regeneration 
Similarly to chapter 7, this chapter presents another system encapsulating a protein and cells. Fibronectin 
and autologous mesenchymal stem cells were encapsulated in calcium crosslinked alginate particles. The 
obtained system was firstly studied in vitro, and then applied in the regeneration of a cranial bone lesion in 
a rat model.  
 
Chapter 9. Biomimetic Methodology to Produce Polymeric Multilayered Particles for 
Biotechnological and Biomedical Applications 
This chapter demonstrates that the superhydrophobic surfaces methodology is a versatile technique where 
multicompartmented (core/shell and multilayered particles) may be produced in fast way and under dry 
conditions. Two different approaches were proposed: cells encapsulated in the external layer of core/shell 
particles composed by Dex-MA/alginate, respectively; and model drugs encapsulated in Dex-MA core/shell 
and multilayered particles. The characteristics of both complex structured spherical systems were studied 
in order to evaluate their potential for biomedical and biotechnological applications.  
 
Section IV. Concluding Remarks 
Chapter 10. Conclusions and Future Perspectives  
The last chapter of this thesis describes the main conclusions of the work developed. To complement this 
information, a reflection about the current limitations and the future perspectives are also reported.  
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Chapter 1 
Micro/Nano Structured Superhydrophobic Surfaces in the 
Biomedical Field. Part I: Basic Concepts and Biomimetic Approaches  
 
1.1. Abstract 
Inspired by natural structures, great attention has been devoted on the study and development of surfaces 
with extreme wettable properties. The meticulous study of such natural systems revealed that the 
micro/nano topography of the surface is critical to obtain unique wettability features, including 
superhydrophobicity. However, the surface chemistry also has an important role in such surface 
characteristics. As the interaction of biomaterials with the biological milieu occurs at the surface of the 
materials it is expected that synthetic substrates with extreme and controllable wettability ranging from the 
superhydrophilic to the superhydrophobic regimes could bring new possibilities of new investigations of 
cell-materials interactions on non-conventional surfaces and development of alternative devices with 
biomedical utility. This chapter will describe in detail how proteins and cells interact with micro/nano 
structured surfaces exhibiting extreme wettabilities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication:  
Lima A. C. and Mano J. F., Micro/Nano Structured Superhydrophobic Surfaces in the Biomedical Field. Part I: Basic Concepts and Biomimetic 
Approaches, Nanomedicine (Lond.), 10(1), DOI: 10.2217/NNM.14.174 (In press). 
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1.2. Introduction  
The surface of the biomaterials plays a relevant role in determining the outcome of the interactions 
between the materials and the biological environment. The properties of the surfaces manage the 
deposition of biomolecules and microorganisms, as well as adhesion, spreading, growth, migration and 
position of cells [1]. Significant properties of the surfaces of biomaterials include chemistry, elasticity, 
morphology and wettability. The manipulation of these characteristics has been emerged as an important 
point of research in materials science in order to achieve the set of the properties more appropriate for 
specific biological functions. In this chapter we will focus our attention on the pertinence of surfaces 
wettability in the biomedical field, specifically at the level of the interactions of cells and proteins with 
superhydrophobic/superhydrophilic platforms.  
Surfaces with extreme wettabilities combined with low/high adhesive properties have been biomimetized 
after an intensive investigation to understand how Nature has developed surfaces with such 
characteristics. The ability to produce synthetically such kind of structures has attracted huge interest due 
to their potential for applications in microfluidic, controlled drug delivery and self-cleaning surfaces [2].  
Wettability is currently evaluated by the static and dynamic behavior of a liquid droplet over the surface 
[3]. The apparent contact angle (CA, θ), which is the angle formed by a liquid droplet on the three phase 
contact line – Figure 1.1, A – characterizes the static behavior. The dynamic comportment is evaluated by 
the sliding angle (α, the inclination angle of the surface that cause the droplet roll off) and contact angle 
hysteresis (CAH, the difference between advancing and receding CA) (Figure 1.1, B). Based on these 
definitions, the surface is classified as wetting, if the CA is lower than 90° and as nonwetting, if the CA is 
higher than 90°. When the liquid droplet is water the surfaces are called “hydrophilic” and “hydrophobic”, 
respectively (Figure 1.1, C and D) [2]. In terms of energy, wettable surfaces exhibit high values which may 
vary between 500 and 5000 mNm-1. Conversely, nonwettable surfaces are characterized by low surface 
energy with values ranging from 10 to 50 mNm-1 [2]. 
One type of nonwettable surfaces very well explored in the last years are the superhydrophobic ones, 
characterized by exhibiting water CAs greater than 150° (Figure 1.1, E). There are two types of 
superhydrophobic surfaces differing in the adhesive properties. If the CAH is lower than 5° the surface is 
non-adhesive and at minimum inclination, the droplets of water roll off. Otherwise, if the CAH is higher, the 
water droplet stay preferentially adhered onto the surface.  
The cooperation of the topographic design of the roughness with the intrinsic chemistry of the materials 
defines the wettability of the surfaces. In terms of topography, the existence of micro/nano roughness 
affects significantly the wettability properties of the materials since it increases the CA in low energy 
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surfaces and decreases it in high energy surfaces [4]. The most relevant traditional parameters to 
characterize the roughness of the surfaces (root-mean-square, correlation length, fractal dimension) were 
reviewed elsewhere [5], where it was also detailed the influence of such parameters in the wetting state of 
hierarchical natural structures.  
In the case of low adhesive superhydrophobic surfaces the existence of a hierarchical roughness from the 
nano to the micro scale, lead to a minimal contact between the liquid and the surface. The water 
dispensed onto this type of platforms acquires almost a spherical shape, in order to minimize the energy, 
being suspended on the top of the micro/nano structures that compose the surface and at minimal 
inclinations the droplets roll off [6]. In high adhesive surfaces the droplets also acquire a near-spherical 
shape due the presence of micro/nano structures but do not roll off easily. The different design of the 
surface features, when compared with low adhesive surfaces, explains the different behavior. In general 
the high adhesive superhydrophobic surfaces present a larger pitch which allows the liquid impregnation 
into the microstructures but only partially within the nanostructures [7].  
Physical models have been proposed to rationalize the effect of roughness and surface energy. The Young 
model (Figure 1.1, F) describes the contact between a sessile drop onto rigid, homogeneous, flat and inert 
surfaces - ideal smooth surfaces. Wenzel´s (Figure 1.1, H) proposed an equation to predict the influence 
of the surface roughness or morphology on the CA [3,4]. In this model it is assumed that water penetrates 
into the grooves of the surface structures. Otherwise, the Cassie-Baxter model (Figure 1.1, G) depicts the 
case in which the air bubbles entrapped inside the grooves of the topographic features prevent the water 
penetration, meaning that the liquid is only in contact with the top of the exposed protrusions. Transitions 
from the Cassie-Baxter to Wenzel state may occur and an intermediate state may be achieved (Figure 1.1, 
I). This shift is usually caused by the non-homogeneous distribution of structural and chemical features or 
even droplets press and impact [4].  
Currently, it is well know that the chemistry and the presence of micro/nano structures constitute key 
parameters influencing directly the performance of implantable materials due to the interaction with blood 
or extracellular matrix proteins as well as with the different cell types - such cross-talk between 
biomaterials surfaces and all biological components will strongly dictate the integration or rejection of the 
devices [8]. The surface of the materials constitutes the first line of contact with the biological parts not 
only in implanted materials but also in devices for diagnosis, treatment and diseases prevention.  
In the last 5-10 years, much work has been performed in the development and application of 
superhydrophobic surfaces but, until now, to the best of our knowledge a compilation of the most recent 
applications in the biomedical field was never presented.  
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Figure 1.1. Liquid droplets contacting solid surfaces form a contact angle θ where 3 different interfaces are involved: 
solid/liquid (SL), liquid/vapor (LV) and solid/vapor (SV). The wettability of the surfaces is evaluated regarding the static and 
dynamic behavior of the droplets. The static conditions comprise the apparent contact angle (CA, θ) which is the angle formed 
by a liquid droplet on the three phase contact lines (A). The dynamic behavior is related to the sliding angle (α), this means the 
inclination angle of the surface which cause the droplet roll off; and the contact angle hysteresis (CAH) determined by the 
difference between advancing CA and receding CA (B). Depending on the CA formed by a water droplet, the surfaces can be 
hydrophilic (θ<90°, C), hydrophobic (θ>90°, D), superhydrophobic (θ>150°, E) and superhydrophilic (non represented). 
Developed mathematical models could explain the droplet-surface interaction: the Young’s (F) model relates the CA to interfacial 
tensions (energies, γ) in an ideal smooth surface; Cassie-Baxter (G), Wenzel´s (H), and the intermediate (I) models have in 
consideration the effect of surface roughness.  
I
Hydrophilic
θ
Young Model Wenzel Model
Intermediate Model
θ
F G H
θ
Hydrophobic
DC
Sliding Angle (α)
Receding CA
Advancing
CA
Superhydrophobic
θ
E
γLV
γSV γSLθ
θ
A B
CassieFBaxter Model
θ
Chapter 1 Basic Concepts and Biomimetic Approaches of Superhydrophobic Surfaces 
! 7!
We will first overview the different repellent surfaces found in Nature, detailing the relationship between 
micro and nano structures and wettability. Such section will be followed by a brief description of the 
recreation, at the lab scale, of the most relevant micro/nano structured natural surfaces. This first part will 
also highlight the interactions of the proteins and cells with micro and nano structured surfaces, whereas 
the most important medical applications of the superhydrophobic surfaces will be compiled in the chapter 
2 of this thesis.  
 
1.3. Surface Micro/Nano Structures and Special Wettability of Natural 
Systems 
Natural systems offer us a huge number of examples of surfaces with very peculiar properties in terms of 
structures and functions. The perfect combination of both allows the achievement of maximal performance 
for a certain role. Exploring plants and animals enables to find a huge diversity of complex surfaces – see 
Figure 1.2.  
The most well-known and studied natural superhydrophobic structure is the isotropic surface of the lotus 
leaf (Figure 1.2, E). The extreme water-repellent properties of such biosurfaces results from the dual-scale 
hierarchical roughness, which is composed by papillose epidermal cells (Figure 1.2, E.1), with sizes 
comprised between 5 and 10 µm, covered by epicular waxes with approximately 150 nm (Figure 1.2, E.2) 
[9]. When water droplets falls on the lotus leaf, they are just in contact with the hydrophobic wax crystals 
on the top of the papillae, meaning that the contact between droplets and the surface is minimal. The 
hierarchical structure of the leaf surface is one of the promoters of CAs higher than 150° and CAH lower 
than 5°. Such characteristics are crucial for the self-cleaning effect; the droplets easily roll off the leaf 
carrying out contaminating particles (Figure 1.2, A) [10]. Lotus leaves are then classified as non-adhesive 
superhydrophobic surfaces. 
 
Chapter 1 Basic Concepts and Biomimetic Approaches of Superhydrophobic Surfaces 
! 8!
 
Figure 1.2. Examples of isotropic and anisotopic micro/nano structured surfaces found in Nature. Superhydrophobic isotropic 
surfaces are the most well studied structures and include low adhesive (I) and high adhesive (II) structures. Low adhesive 
superhydrophobic surfaces exhibiting self-cleaning effect (A) comprise insect wings (B, B.1), mosquito eyes (C, C.1), cicada 
wings (D, D.1) and lotus leaf (E, E.1-2), where the water droplets roll off easily when the surface is slightly inclined. High 
adhesive surfaces (F) as the case of some rose petals (G, G.1-2) have the capacity to retain the water droplets without roll off. 
Anisotropic natural structures exhibit directional adhesion (III). Representative examples are butterfly wings (H, H.1-2), water 
stride legs (I, I.1) and rice leaves (J, J.1). Other substrates could be used to collect water (IV), such as spider silk (K, K.1-3); 
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repel oil products (V) when surrounded by liquids (L) as it is the case of shark skin (M, M.1); or even have self-cleaning 
properties where the droplets slip without rolling off (VI; O) being the most well-known case the Nepenthes pitcher plant (P, P.1-
3). The scanning electron microscopy images of each natural system show that independently of the general behavior of the 
surfaces, they are composed by a hierarchical arrangement of micro and nano topographic structures.  
B, B.1, G and I, adapted from [77] with permission of RSC; C and C.1, adapted from [78] with permission of Wiley; D, D.1 and H.1, adapted from [26] with 
permission of Wiley; E, E.1-2, adapted from [79] with permission of the authors; G.1-2, adapted from [7] with permission of ACS Publications; H and H.2, 
adapted from [80] with permission of RSC; I.1, adapted from [81] with permission of NPG; J and J.1, adapted from [82] with permission of Wiley; K and K.1-3, 
adapted from [14] with permission of NPG; M and M.1, adapted from [83] with permission of IOP Publishing; O, adapted from [25] with permission of NPG; P, 
P.1-3, adapted from [84] with permission of Springer. 
 
An opposite effect is displayed by the rose petals which are also superhydrophobic but have the ability to 
retain small water droplets without rolling off when the surface is inclined or even tilted down (Figure 1.2, 
F and G) [7]. The adhesive effect derives from their array of micropapillae, comprising diameters of ca. 16 
µm and heights of ca. 7 µm (Figure 1.2, G.1), with nanoscaled cuticular folds, ca. 730 nm in width, on 
their top (Figure 1.3, G.2) [11]. When compared with the lotus leaf surface, rose petals have higher 
distances between the microstructures. The liquid droplets deposited onto such structures penetrate into 
the microscale grooves and just partially between nanostructures due to the formation of air gaps (Wenzel 
model) [7,12], resulting in a strong adhesion between the liquid and the rose petal surface.  
Nature also developed anisotropic surfaces in which the droplets of water can roll off following a 
preferential direction dictated by the structural features. Remarkable examples are butterfly wings (Figure 
2, H), water stride legs (Figure 1.2, I) and rice leaves (Figure 1.2, J). In the case of butterfly wings, they 
have multiscale structures composed by aligned shingle-like scales (Figure 1.2, H.1). Flexible nanotips are 
on the top of the ridging nanostrips both rearranged in a certain direction (Figure 1.2, H.2). Such oriented 
structured surface allows the adhesion and directional moving of the liquid on the solid surface. Similar 
behavior could be seen in rice leaves [13].  
Another type of natural surfaces allows the collection of water from the atmosphere in order to ensure the 
survival of the biological system under extreme drought environments. The most well-known cases are the 
desert beetles, cactus spines and spider silk (Figure 1.2, K and K.1).  For example, in the case of the 
spider silk two main driving forces act simultaneously allowing the propelling of water droplets through the 
fibers: (I) the differences of surface free energy along the fibers and (II) the pressure differences between 
the inner and exterior of the water droplets. The differences in free energy and droplet pressure are 
caused by the intercalary spindle knots composed by random nano fibrils (Figure 1.2, K.3) and joints 
composed by aligned nano fibrils (Figure 1.2, K.2). The droplets are condensed and targeted to surround 
the spindle knots [14]. 
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The previous described examples are air/liquid/solid systems, meaning interaction of liquids with solid-air 
surfaces. However, there are liquid/liquid/solid natural systems that have recently attracted researchers’ 
attention. Such solid surfaces (e.g. sharkskin (Figure 1.2, M), fish scales and clam shells) present liquid 
repellency when involved by a liquid environment (Figure 1.2, L). The surfaces are maintained clean when 
surrounded by oil polluted water and exhibit anti-bioadhesion properties. A detailed study of shark skin 
revealed the presence of a kind of tooth-like scale arrays (dermal denticles) with longitudinal grooves 
aligned according to the water flow direction (Figure 1.2, M.1). Due to the movement of the water through 
the surface structures, shark skin has low drag and prevents the adhesion and growth of marine 
organisms as well as the contamination by oily substances [15]. The understanding of the underlying 
phenomenology of such natural surfaces could have relevance in the biomedical area as it could help in 
the design of new antifouling substrates, channels and tubes with low dragging in fluid transport, or 
surfaces with particular biological effects upon in contact with cells and tissues. 
Although differently to the lotus leaves, Nepenthes pitcher plants (Figure 1.2, P and P.1-3) present a very 
peculiar self-cleaning effect. The liquid droplets slip instead of rolling along the surface (Figure 1.2, O). 
This type of plants is well known due to their capability to capture and digest arthropods, absorbing 
nutrients from them, after their slipping through the walls of the plants cavities [16]. Depending on the 
nutritional requirements of the plant, the inner surface of the pitcher switch from a wet state, during which 
the insects slip, to a dry state, where anchorage points are provided to prevent the insects sliding. The 
wettability is then a key factor in the survival of these plants. In this natural system, the micro roughness 
does not increase the hydrophobicity as it occurs in lotus leaves. The organized ridges that composed the 
roughness of the pitcher act as capillary forces inducing the rapid spreading of the water droplets along 
the wet surface, even against gravity forces [17].  
 
1.4. Biomimetic Surfaces 
During the course of evolution, biological systems have achieved distinct intelligent processes and 
properties relevant for their survival. The capacity of adaptation of the natural systems, in order to 
circumvent adverse conditions has inspired engineers to develop new functional materials [18]. Detailed 
analysis of the previous described natural structures revealed that the intrinsic materials properties and 
the micro/nano topographic structures play a crucial role in the wettability nature of the surfaces. These 
unique and versatile properties have led to the design and creation of novel superantiwetting surfaces: (I) 
Superhydrophobic  (Figure 1.3, I) [19]; (II) Superoleophobic (Figure 1.3, II) [20,21]; (III) 
Superamphiphobic (or Superomniophobic) (Figure 1.3, III) [22]; (IV) Smart switchable (Figure 1.3, IV) [23] 
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(V) Anisotropic surfaces/water collecting surfaces [24] and (VI) Slippery liquid-infused porous surfaces 
(SLIPS) [25]. 
 
 
Figure 1.3. Examples of micro/nano structured artificial surfaces produced by inspiration from natural systems. I) Examples 
of superhydrophobic surfaces with low adhesion where the liquid droplets are suspended on the top of the nano structures (A): 
polystyrene (B), copper (C) and a micropatterned Si replica (D). Examples of high adhesive superhydrophobic surfaces, where 
the water enters through the micro exposed elements but air pockets prevent the penetration into the nano roughness (E), are: 
micro patterned epoxy resin coated with nanostructures of n-hexatriacontane (F) and hierarchical hairy carbonaceous ﬁbers 
deposited on micro patterned Si (G). II) Superoleophobic surfaces of Cu(OH)2 nanoneedle arrays capable to control the oil 
adhesion depending on the nanostructures at the surface and the preloads on the oil droplet (A, A.1) and aluminum coated with 
a polyelectrolyte multilayer treated with perfluorooctanoate which repels oil in dry and wet environments (B, B.1-2). III) Surfaces 
capable to repel both water and organic liquids are named superamphiphobic or superomniophobic. Examples are coralline-like 
structured surfaces obtained by spraying nanocomposites of fluorinated multi-walled carbon nanotubes and fluorinated 
polyurethane (A); surfaces obtained by carbon nanospheres deposition, coated with a silica shell (B), in which the carbon core 
was removed by calcination (B.1), revealing a structured silica coating with holes (B.2); cotton textiles coated with micro and 
nano silica particles (C); and etched and fluorinated aluminum (D). IV) Smart surfaces capable to change their behavior when 
subjected to a certain stimulus have also been developed:  textile surfaces capable to switch from superoleophilic to 
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superoleophobic when immersed in a certain aqueous medium (A, A.1-3); hierarchical structured surfaces coated with poly(N-
isopropylacrylamide-co-acrylic acid) (PNIPAAm-co-AAc) (B) which are adhesive or non-adhesive depending on the temperature 
(B.1) and on the pH of the droplet (B.2); and silicon coated with PNIPAAm (C),  surfaces that depending on the temperature are 
superhydrophilic or superhydrophobic (C.1).  
I) A, E and F adapted from the reference [7] with permission of ACS Publications; B and C adapted from the reference [30] with permission of Springer; D, 
adapted from the reference [85] with permission of RSC; G, adapted from the reference [86] with permission of Wiley. II) A and A.1, adapted from the reference 
[87] with permission of Wiley; B and B.1-2, adapted from the reference [88] with permission of ACS Publications. III) A, adapted from the reference [89] with 
permission of RSC; B and B.1-2, images were adapted from reference [90] with permission of AAAS; C, adapted from the reference [91] with permission of 
ACS Publications; D, adapted from the reference [92] with permission of RSC. IV) A and A.1-3, adapted from the reference [93] with permission of NPG; B and 
B.1-2 the images were adapted from the reference [94] with permission of RSC; C and C.1 images were adapted from the reference [95] with permission of 
Wiley. 
 
The design of artificial bio-inspired surfaces involves up to five steps: (I) the search and subsequent 
detailed study of the unique wetting phenomena of the natural structure; (II) study of the correlation 
between multiscale structures and the wettability properties; (III) design and synthesis of adequate 
molecules; (IV) design of the multiscale structures; and (V) surface fabrication [18,26].   
Lotus leaf has been the main inspiring natural source to develop artificial non-adhesive superhydrophobic 
surfaces. Two strategies have been traditionally used:  (I) creation of micro/nano roughness onto low 
surface energy materials or (II) modification of micro/nano rough surfaces with materials owning low 
surface energy [27]. Combining physical and chemical methods, namely lithography, vapor deposition, 
plasma technique, sol-gel processing, layer-by-layer, among others, as reviewed elsewhere [28], two 
general designs may be obtained: surfaces with micro/nano random structures [29–33], and surfaces 
with controlled topographic features [34–37]. A recent review reported the latest advances in the general 
design of artificial superhydrophobic surfaces [19]. When the obtained micro/nano structured surfaces do 
not achieve the desired CA or sufficiently low surface energy to perform a certain function, other strategies 
were developed to circumvent this issue. In general, post-fabricated surfaces could be treated with self-
assembled monolayers of alkanothiols, organic silanes, fatty acids, aromatic azide or spin-coated with 
perfluorononane [28].  
Usually, the organic solvents are polar and present lower surface tensions than water (for example, n-
hexadecane 27.5mNm-1, n-decane 23.8mNm-1 versus water 72.8mNm-1) [38], which makes more difficult 
the production of surfaces that repeal organic liquids than superhydrophobic ones. Nevertheless, 
superoleophobic surfaces may also be obtained combining micro/nano roughness and coatings using 
materials with very low surface energy [39–42]. 
Most of the developed artificial superoleophobic surfaces are oil repellent when surrounded by liquids 
(liquid/liquid/solid systems). However, the evolution in surfaces preparation allowed the production of 
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solid/air/liquid superoleophobic systems. High adhesive properties (equivalent to water adhesion onto 
rose petals) of artificial superoleophobic platforms turn difficult the organic droplets rolling off and 
consequently prevent the self-cleaning effect [39,43–45]. Artificial self-cleaning surfaces with capability to 
repel organic substances were created using fish scales [15,46] and Nepenthes pitcher [25] as sources of 
inspiration. The amazing slippery properties of Nepenthes pitcher lead to the development of four-phase 
systems, namely air/liquid/liquid/solid surfaces, denominated by SLIPS [25]. SLIPS-based systems are 
composed by micro/nano structures embedded with a lubricant fluid. Differently from lotus leaves, these 
natural structures demonstrated slipperiness, without hysteresis, of pure or even complex liquids: blood 
and oil, ice, dust, insects and even bacteria [47,48]. The lubricant forms a continuous film, meaning that 
the friction onto the micro/nano structures of the solid surface is very low. The film has the same function 
as the air pockets on lotus leaves [25]. In addition, after a physical damage, SLIPS have the capability of 
self-healing [25]. Just selecting a lubricant immiscible with water and oils [49], SLIPS may exhibit 
omniphobic properties [22]. 
Functionalized surfaces capable to switch their wettability in a reversible way, as a response to an external 
stimuli (temperature, pH, photon energy, electric field, humidity, electrochemical and chemical 
treatments) [2] have been proposed due to increasing interest for a wide variety of applications. An 
overview of this kind of surfaces is reported elsewhere [10]. However, irreversible modifications of the 
physicochemical properties of super-repellent surfaces could also be important for their application or 
integration in other devices. Accurate, controllable, cost-effective and fast techniques to perform surface 
modifications/patterning are challenging [50]. The possibility to tailor optical, mechanical, chemical, 
wettable, among others characteristics, in confined and pre-selected areas has allowed the production of 
arrays which could be used as microfluidic devices and as screening chips. A detailed description of the 
applications of patterned superhydrophobic surfaces in biomedical field will be reported in the chapter 2 of 
this thesis. In general, there are two possibilities to control the wettability of the surfaces: (I) playing with 
the organization and spatial distribution of the micro/nano roughness and (II) modifying the chemical 
properties of the micro/nano structured surfaces by exposing hydrophilic or hydrophobic groups or even 
bonding/adsorbing biochemical cues [51]. For example, the increment of oxygen-rich groups is a pathway 
to increase the wettability of the surfaces. The treatment of poly(L-lactic acid) (PLLA) and polystyrene (PS) 
superhydrophobic surfaces by plasma and UV/Ozone exposure have been demonstrated useful to control 
the surface wettability [31, 52, 53]. Such treatments induced the formation of oxygen-containing species 
(C-O, C=O, O-C=O) responsible to increase the surface free energy and consequently turn the surface 
more wettable independently of the micro/nano roughness. In both PLLA and PS cases, depending on the 
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exposure time, the wettability of the surfaces was controlled within extreme ranges of CAs, in an accurate 
manner. The use of masks (generally platforms with predefined holes of controlled geometries) is a 
straightforward approach to confine the desired modifications into pre-selected areas, allowing the 
production of patterned superhydrophobic surfaces with the most favorable design for the proposed 
application.  
Having in consideration that smart and bioinstructive substrates have been widely used in the biomedical 
field [54, 55] we hypothesized that the combination of such features with extreme wettability could bring 
new possibilities of developing devices with unique features for both in vivo and ex vivo applications. 
 
1.5. Interaction of Cells and Proteins with Superhydrophobic Surfaces 
The interaction between cells and materials at the chemical or even physical level is extremely important 
for the success of therapeutic/diagnosis strategies involving implantable biomaterials [56]. Conceptually, 
four stages are involved in cell-material interactions: (I) adsorption of proteins from the biological milieu; 
(II) cells perception and sensing of the adsorbed cues; (III) cell attachment and finally (IV) the spreading or 
other biological consequence of the cells.  
Studies on cell-material interactions on surfaces varying their wettable properties, have been greatly 
focused within the hydrophilic-hydrophobic range (20°<CAs<110°). However, the curiosity about the 
biological response beyond such contact angles interval have been encouraging the development of new 
works in order to get further insights on such complex phenomena.  
The unique properties of the superhydrophobic surfaces triggered an increasing interest in their 
application in the biomedical field.  However, the biological performance of such type of surfaces needs to 
be previously understood with maximum detail. Just a very few works have been published reporting the 
interaction of proteins or cells with such micro/nano structured highly repellent surfaces. As explained in 
the previous sections of this chapter, the properties of the superhydrophobic surfaces are related with 
their micro/nano structured surface and surface chemistry, being both properties directly correlated with 
the wettability. Then, it is critical to understand the effect of these characteristics, in an individual manner, 
on protein and cells behavior. The current status of this field will be described in detail in the follow sub 
sections.  
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1.5.1. Proteins Adsorption 
The first happening, when any material is implanted in the human body, is the coating of the surface by 
proteins present in the blood or interstitial fluids (ECM proteins). Hydrophobic interactions, electrostatic 
attraction, van der Waals forces and hydrogen bonding are involved in protein adsorption [57–58]. In a 
general way, proteins tend preferentially to adsorb strongly on non-polar than on polar, on high surface 
tension than on low surface tension and on charged than on non-charged surfaces [59]. The 
destabilization of the proteins caused by non-polar surfaces facilitates the protein structural reorganization 
and reorientation leading to strong inter protein and protein-surface interactions [60]. In addition, it was 
also demonstrated that topography has a great influence on protein adsorption [57]. The adsorption can 
be more pronounced onto the nanostructured surfaces due to the existence of higher number of active 
sites as a consequence of higher surface area. However, the existence of roughness at the micro or nano 
scale is closely related to the surface wettability that could have an independent effect of the change in the 
exposed surface area. Several works have been developed focusing the interaction of proteins and cells 
with micro/nano structured surfaces with extreme repellent properties, as it was recently reviewed 
elsewhere [61,62]. Table 1.1 compiles the studies reported in literature focusing the interaction of 
proteins and cells with superhydrophobic surfaces.  
Table 1.1. Overview of the literature reports involving the study of proteins adsorption and cells adhesion/proliferation onto materials with superhydrophobic properties. 
Natural 
Inspiration 
Artificial 
Material 
Modification 
Performed 
Contact Angle 
(CA) 
Biological Entity Observations Ref. 
Lotus leaves ePTFE Biaxial stretching CA >150˚ HSA No adsorption was detected under environmental conditions; 
The degassing of protein solutions and surfaces improved the protein adsorption due to 
the air pockets removal, which increased the contact between the protein solution and the 
surface. 
[63] 
Lotus leaves 
and bird 
feathers 
TiO2 
nanotubes film 
onto a 
titanium 
substrate 
Electrochemical 
anodization 
Patterning: 
photocatalytic 
lithography 
0<CA<154˚ BSA  
FBS 
Human fetal osteoblast (hFOB 1.19) 
Human fibroblasts from osteosarcoma 
(MG63) 
HeLa cells 
Low amount of BSA bound to the superhydrophobic domains in the presence of trapped 
air; 
Significant amount of BSA was bound to the superhydrophilic domains with trapped air; 
After air removal, the protein adsorbed was similar in superhydrophobic and 
superhydrophilic areas; 
The protein composition of the cell suspension affected the adhesion of the cells. The 
effect of entrapped air was not visible; 
Cell adhesion did not correlate with bound protein in a one-for-one way. 
[64] 
Lotus leaves PS Phase separation CA ≈160˚ FN 
Murine osteoblastic cell line (MC3T3-E1) 
FN adsorbed in lower density and in a different conformation onto superhydrophobic PS 
when compared with normal PS; 
Uneven distribution of FN in superhydrophobic PS with micro-regions not covered by the 
protein; 
In superhydrophobic surfaces the vinculin was randomly distributed inside the cells;  the 
actin cytoskeleton is not completely matured; 
The low FN density adsorbed onto superhydrophobic surfaces led to lack of focal adhesion 
formation and actin organization; 
Cells were able to proliferate and maintain a stable population up to 21 days on the 
superhydrophobic PS but in a low density than normal PS. 
[65] 
Lotus leaves PS Phase separation 
Post-fabrication 
treatment: 
Argon plasma 
0<CA<151.4˚ 
Gradient of 
wettabilities 
FN 
Myoblast cell line 
Amount of FN adsorbed onto the surfaces was found to decrease monotonically with 
increasing wettability; 
The optimal FN conformation was observed on hydrophilic surfaces due to their surface 
nanotopography and surface energy; 
Non-monotonic dependence of the degree of differentiation on surface wettability: the 
maximal enhancement of differentiation was obtained on the hydrophylic surfaces; 
The alteration on FN conformation onto superhydrophobic areas delayed the cell 
adhesion; 
The cell density increased substantially with increasing wettability and it was observed 
stabilization between hydrophilic and superhydrophilic platforms. 
[66] 
Lotus leaves PS and PLLA Phase separation CA≈150˚ BSA 
Murine osteoblastic cell line (MC3T3-E1) 
Bovine articular chondrocytes (BCH) 
Protein adsorption was lower in superhydrophobic surfaces (rough substrates), when 
compared to more wettable substrates (smooth substrates); 
No differences were found on protein adsorption between superhydrophobic PS and PLLA, 
despite the differences in the roughness morphology; 
Cell viability was lower onto rough than at smooth counterparts, which could be correlated 
by the amount and conformation of adsorbed protein; 
The proliferation of both cell types was inhibited onto rough surfaces; 
[67] 
MC3T3-E1 cells seemed to be less affected than BCH. 
- Titanium Etching and 
oxidation 
CA≈92-157˚ Human fibroblasts from osteosarcoma 
(MG63) 
Surfaces just exhibiting nanostructures seemed to regulate osteoblast proliferation; 
The differentiation of osteoblast was not significantly affected by the absence of micro 
roughness; 
The combination of micro/submicro/nano structures resulted in a synergistic effect on 
cell differentiation and local factors secretion (osteoprotegerin and VEGF). 
[72] 
Lotus  leaves PLLA Phase separation CA≈154˚ Rat bone marrow derived stem cells  Superhydrophobic (rough) surfaces inhibited cell adhesion and proliferation when 
compared with non-superhydrophobic (smooth) substrates; 
The repellence of the surfaces prevented their contact with the cell culture medium, and 
consequently the protein adsorption and cell adhesion. 
[74] 
Lotus leaves PLLA Phase separation 
Post-fabrication 
treatment: 
Argon plasma  
0<CA<154˚ 
Gradient  of 
wetabilities 
Mouse lung fibroblast cell line (L929) In comparison with smooth PLLA, almost no cells adhered onto rough PLLA 
(superhydrophobic surbstrates); 
The superhydrophobic surfaces treated with plasma lost the water repellence properties in 
a controlled way until reach a superhydrophilic behavior; 
The cell attachment onto rough substrates was dependent on wettability; 
Optimal cell attachment in surfaces with CA ca. 90˚. 
[31] 
Lotus leaves PS Phase separation 
Post-fabrication 
treatment: 
UV/O3 exposure 
0<CA<155˚ 
 
Different 
wettabilities 
Human osteoblast cell line (SaOs-2) 
Mouse lung fibroblast cell line L929  
Mouse chondrogenic cell line (ATDC5) 
SaOs-2 and ATDC5 cells did not proliferate on superhydrophobic PS but L929 cell line 
exhibited a good proliferation; 
The attachment of SaOs-2 was higher for the PS surfaces (rough and smooth) treated for 
more time; and the high proliferation was observed in rough surfaces treated for 
intermediate times. 
[52] 
- Silicon  and a 
negative tone 
resist  
(AZ5214) 
Optical lithography 
(Deep Reactive Ion 
Etching Process) 
160˚<CA<170˚ Neurons and astrocytes Neuronal-glial co-cultures were successfully supported in the micro/nano roughness 
surface; 
3D neural networks were obtained being closer to the brain structure than 2D cultures. 
[75] 
!
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The adsorption of human serum albumin (HSA) was studied in expanded polytetrafluororethylene (ePTFE), 
a commonly used hydrophobic material in biomedical applications. ePTFE may become superhydrophobic 
upon stretching due to the formation of a fibrillar surface structure [63]. Under ambient conditions no 
protein adsorption was measured onto the superhydrophobic material. However, when the ePTFE surfaces 
were degassed, a significant protein adsorption was detected. The air entrapped in the features of the 
ePTFE surperhydrophobic surface prevented intimate contact with HAS solutions and consequently low 
protein adsorption. Huang et al. [64] confirmed the effect of air trapped on protein adsorption using 
surfaces coated with TiO2 nanotubes. The surfaces were patterned with 
superhydrophobic/superhydrophilic areas. The air trapped in TiO2 nanotubes prevented the contact of the 
protein solution with superhydrophobic domains. The protein adsorption was inhibited onto such regions 
when compared with superhydrophilic ones. However, this was reversed when the surfaces were 
sonicated and the air trapped in the nanostructures was displaced: more protein was detected in 
superhydrophobic than in superhydrophilic areas. Once again the extraction of the gas induces the 
transition from the Cassie-Baxter to a Wenzel regime where the protein solution could contact with a major 
surface area. Cassie-Baxter-based superhydrophobic surfaces are then considered resistant to protein 
adsorption due to the trapped air between the micro/nano stuctures, which acts as a “virtual layer” and 
impedes the subsequent platelet and cell adhesion. 
Fibronectin (FN) adsorption was analyzed onto PS superhydrophobic surfaces, a standard material used in 
cell cultures [65]. The physical modification of the PS platforms did not affect the chemical properties of 
the surface. Again, lower density of FN with a changed conformation was found onto micro/nano 
structured surfaces when compared with smooth platforms. As a consequence, the cell behavior was 
significantly affected [65]. Micro/nano structured PS superhydrophobic surfaces were then chemically 
modified by plasma treatment in order to investigate the influence of wettability in FN adsorption and 
conformation [66]. As expected, the amount of FN adsorbed decreased monotonically with increasing 
wettability, since this protein tend to adsorb in greater amounts onto hydrophobic surfaces. However, the 
conformation did not follow the same tendency. In micro/nano rough surfaces with hydrophilic properties, 
the protein adopted a more favorable conformation than in hydrophobic or superhydrophilic areas. This 
observation highlights a very important point that we consider worth to be studied in more detail, besides 
the total protein content, surfaces with extreme wettabilities could direct distinct conformational changes 
in the adsorbed proteins. Protein adsorption onto two different superhydrophobic materials obtained by 
the same methodology was compared [67]. Superhydrophobic PS and PLLA were prepared using a phase 
separation method. The different physical properties of the polymers induced the appearance of 
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completely different topographical structures. Once again, the non-wettable properties of the rough 
surfaces prevented the contact between the bovine serum albumin (BSA) solution and the surfaces, 
decreasing the amount of protein adsorbed. No differences were observed between the both materials in 
examination. Such kind of results suggests that the general wettability characteristics of a surface have a 
stronger influence on protein adsorption than its specific chemical and topographical properties.  
As demonstrated by all of the above described reports, the composition, orientation and the conformation 
of the adsorbed proteins could be determinant in cell attachment. The adsorbed proteins should exhibit 
appropriate conformations in order to maintain their biological functions, in particular the capacity to be 
recognized by the cells. In order to improve the performance of micro/nano structured superhydrophobic 
surfaces, surface modifications may be advantageous, namely the covalent grafting of key cell adhesive 
groups or the modification of surface chemistry by increment of the number of oxygen-rich species.  
In the opposite case of superhydrophilic surfaces, the higher adsorption of water produces repulsive forces 
on the proteins preventing their deposition and consequently the adhesion of the cells.  
 
1.5.2. Cells Interactions 
Cells sense the surrounded environment through membrane ion channels and a series of receptors. 
Integrins are the main responsibles for the establishment of connections between the cells and the surface 
[68] as well as to control cell shape changes, proliferation and cell migration. Integrins are composed by 
two non-covalently associated subunits (α and β) integrated in the cell membrane. There are several types 
of α and β subunits and their combination determines the ligand specifity of the integrin.  Although it is 
known that the complex process of cell-biomaterial interactions occurs after protein adhesion, the 
mechanism itself is not completely understood. It is known, however, that it is dependent on the surface 
properties (wettability, flexibility, topography, surface charge, chemistry and mechanical), on the type of 
cells and on the presence of proteins or other biochemical cues [53,56,61,69]. 
Since topography have a great influence on cell behavior, data have been reported on cell interaction with 
micro/nano surface structures such as grooves, ridges, steps, pores, wells and nodes at micro or nano 
scales [70]. Micro and nano patterned surfaces have been studied to understand the effect of the 
topography in cell behavior. An overview of the potential of chemical and topographical effect on cell-
material crosstalk was reported elsewhere [56]. It is very well-known that materials surface chemistry, 
topography and consequently wettability influence cell stages, namely differentiation, proliferation, matrix 
production, cell morphology and orientation [71]. One particular example is the influence of surface 
characteristics in the osteointegration of implanted materials. For example, Gittens et al. [72] showed that 
Chapter 1 Basic Concepts and Biomimetic Approaches of Superhydrophobic Surfaces 
! 20!
combined micro/submicro roughness and a high density of nanostuctures enhanced osteoblast 
differentiation, new bone formation in vitro, a better bone-to-implant contact in vivo and improved clinical 
rates in wound healing [72,73]. Such kind of hierarchical structure mimics the structure of the bone 
during the remodeling process. The resorption lacunae performed by osteoclasts consist in microscale pits 
(ca. 100 µm in diameter and 50 µm in depth) composed by submicro-scale structures and nano scale 
features created by fibers of the collagen [72]. Due to the synergistic effect of the combination of 
structures with different sizes in osteointegration, efforts have been done to obtain tailored hierarchical 
structured surfaces with appropriated chemical and surface energy properties [72]. Regarding the general 
properties of the superhydrophobic surfaces we hypothesize interesting possibilities of using such 
substrates in bone tissue engineering purposes.  
Similarly to that described for protein adsorption, the elevated repellency of superhydrophobic surfaces 
could prevent the contact of the cells with the entire surface area. Consequently the cells just have the 
chance to adhere onto the peaks of the micro/nano structures exposed onto the materials, limiting the 
adhesion and proliferation of the cells. On the other hand, the super-repellent surfaces exhibiting a Wenzel 
state should permit the penetration of the liquids in the micro-roughness, providing more points for 
proteins and cells adhesion [69].  Therefore any interpretation of the performance of cells adhering to 
superhydrophobic surfaces should require a careful characterization of how liquids and proteins interact 
with the micro/nano features of the substrates.  
The study of the interactions between bone marrow derived stem cells and PLLA biodegradable 
superhydrophobic membranes exhibiting random micro/nano surface structures showed an inhibitory 
effect in cell adhesion and proliferation when compared with smooth PLLA [74]. Veiga et al. [31] 
demonstrated that fibroblast-like cells exhibited a similar behavior when cultured onto the same PLLA 
surfaces. However, when the surfaces were treated with argon plasma, the hydrophilicity increased due to 
the formation of oxygen-rich groups on the surface, and the cell attachment was improved. Controlling the 
plasma treatment, gradients of wettabilities were produced allowing the control of cell adhesion in the 
space [31]. Based on that, and considering that PS is the standard material used in cell culture, Oliveira et 
al. [52] studied the cell adhesion/proliferation onto superhydrophobic PS, also obtained by a phase 
separation method. A vast range of wettabilities was obtained by treating the surfaces with UV/Ozone 
exposure for different times. The treatment did not modify significantly the nano/micro surface structures, 
but introduced oxygen-containing groups onto the surface, in a similar way of PLLA treated with argon 
plasma described above. The interaction of different cell types with smooth and rough PS surfaces was 
extensively investigated [52]. For short culturing time periods (4h and 2 days) the studied cell types 
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presented a rounder shape in superhydrophobic PS than after 6 days, where a few SaOs-2 (osteoblast-like 
cells) and ATDC-5 (chondrocyte-like cells) were spread. In smooth PS, all the cell types presented a 
normal morphology. The cell number over time was significantly high for L929 (fibroblasts) cells than the 
other cell types, probably due to their intrinsic higher proliferation rate. In addition it was observed that 
SaOs-2 and ATDC-5 did not proliferate onto rough or smooth PS when compared with normal PS used in 
cell culture plates. SaOs-2 adherence and proliferation was also studied onto UV/Ozone PS surfaces [52]; 
such cells showed a preference to hydrophilic environments independently of the roughness of the 
surface. Such results were also confirmed in another study [67]. In that work, the response of a cell line 
(murine osteoblastic cell line MC3T3-E1) and a primary cell culture (bovine articular chondrocytes isolated 
from cartilage of calf legs) seeded onto two different superhydrophobic surfaces (PS and PLLA) was 
studied in detail. The different roughness of both surfaces reduced the affinity of both types of cells, being 
the proliferation inhibited, and both cell types exhibited similar behavior. It was concluded that the overall 
wettability was the main factor affecting the cell behavior and not only the polymer chemistry or surface 
topography [67].  
The above mentioned examples confirmed the huge effect of wettability on cell behavior. The biological 
behavior could vary according to the cell type. The interaction of primary neurons with superhydrophobic 
surfaces, composed by nanopatterned pillars obtained by lithography, was studied in order to evaluate the 
ability for 3D network formation [75]. Neurons presented an enhanced survival rate when compared with 
2D standard cultures, which are flat surfaces. They adhered to the pillar sidewalls and pulled between the 
structures in a suspending position, developing a mature network. In this particular case, the 
superhydrophobic surface acts as a 3D scaffold.  Such substrates could be interesting to perform in vitro 
toxicity assays, as they could constitute a good model to study cancer cells differentiation and migration in 
a more realistic way.  
The previously described works demonstrate that the control of the adsorbed biomolecules and the spatial 
distribution of adhered cells are highly dependent on the combination of chemical and structural 
properties of the surface. Taking advantages of the performance of the micro/nano structures 
superhydrophobic surfaces implantable materials and other kind of devices were develop. An overview of 
the most relevant applications in biomedical field is compiled in chapter 2 of this thesis [76].  
 
1.6. Conclusions 
This review addressed a very concise compilation of the main characteristics of natural structures with 
extreme repellent properties. Surface topography and chemistry are the key factors to achieve such 
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behavior. Inspired by the properties of natural surfaces, artificial superhydrophobic platforms have been 
developed through different processes, combining micro/nano features and low surface energy materials. 
The unique properties of the superhydrophobic surfaces have been explored regarding their influence in 
protein adsorption and cell adhesion and proliferation.  Though being in a quite early stage, such studies 
were designed to understand the performance of such platforms in a biological context. Superhydrophobic 
surfaces have shown to be resistant to protein adsorption; but such effect could be dependent on how 
liquid interacts with the micro/nano texture (e.g. Cassie-Baxter versus Wenzel cases, or self-cleaning 
versus adhesive surfaces). Comparing with smooth substrates, the adhesion and proliferation of the cells 
were also affected when they were seeded onto such micro/nano rough surfaces and also when such 
surfaces were subjected to further chemical modifications. The possibility to manipulate the wettability of 
the micro/nano structured surfaces both in all extended surface area and in confined sites by using 
appropriate masks, has been extending the employment of superhydrophobic surfaces in the biomedical 
field. The most relevant examples will be compiled in the chapter 2 of this thesis.  
 
1.7. Future Perspectives  
The behavior of natural repellent systems has inspired the development of artificial superhydrophobic 
surfaces, however, their application have been greatly focused on materials for industrial applications or 
improvement of simple tasks in the daily life. Just in the last few years appeared the first reports 
associated with biomedical applications, but the studies related with biological integration of 
superhydrophobic surfaces are still in an early stage. More investigation about superhydrophobic surfaces 
interaction with biological entities and detailed explanations for the phenomena occurred at such kind of 
interfaces may constitute a driving force to extend future research. Since the protein adsorption is a 
dynamic process, involving attachment, detachment and conformation changes, the performance of 
superhydrophobic surfaces when studied in dynamic conditions (flowing environments) could give a more 
realistic view of those types of interactions. Until now, just static conditions are reported in literature.  
A deep understanding of the protein-superhydropobic surfaces interactions is important for the 
development of biomaterials, since protein adsorption is related with bacteria adhesion and formation of 
thrombus. In particular more investigation would be required on the conformational organization of 
adsorbed proteins in surfaces exhibiting wettabilities ranging from the superhydrophilic to the 
superhydrophobic range.  
Many methodologies have been used to modify the surfaces of the materials. However, most of the 
materials changed to achieve a superhydrophobic behavior are not able to be used in applications inside 
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human body due to the non-biocompatible properties or even the instability of the surfaces which may 
cause adverse responses when applied for long time periods. Advances in materials science research 
have been improved parameters such as stability, robustness and durability of surfaces, but more work is 
still to be done to obtain high performance and biocompatible superhydrophobic platforms.  
We also expect major advances in industrial production of superhydrophobic surfaces, including large 
areas with homogeneous properties and patterned platforms with areas of contrasting wettabilities. Once 
again, the stability of the surfaces in order to prevent or avoid the intermediate wettable state, resultant of 
the transition from a Cassie-Baxter to a Wenzel stage, constitutes a challenge. For example, the design of 
topographical structures with greater or optimized geometries could be a strategy to achieve more stable 
surfaces. Such progresses should be accompanied by the latest development micro/nano fabrication 
technologies.  
Moreover, having into account that superomniophobic surfaces are composed by materials and roughness 
that induce even lower surface energy when compared with superhydrophobic surfaces, the behavior and 
these surfaces should also be explored in biological context in order to obtain a preliminary overview of 
body acceptance when the surface of biomaterials show capacity to repeal water and organic (e.g. lipidic) 
molecules.  
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Chapter 2 
Micro/Nano Structured Superhydrophobic Surfaces in the Biomedical 
Field. Part II: Applications Overview 
 
2.1. Abstract  
The properties of the surfaces define the acceptance and integration of biomaterials in vivo as well as 
materials efficiency when used at research or manufacturing level. The presence of micro/nano 
topographical structures and low surface energy could bring several advantages when highly repellent 
surfaces are employed in the biomedical field. Biomimetic superhydrophobic surfaces have been explored 
for diverse applications: (I) as an intrinsic characteristic of biomaterials to be implanted; (II) as materials to 
exhibit special interaction with biological entities; or (III) to be used in ex vivo applications. This chapter 
aims to focus the main motivations and requirements in the biomedical field that pushed the utilization of 
superhydrophobic surfaces as suitable alternatives, as well as the great evolution of applications emerged 
in the last few years.  
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication:  
Lima A. C. and Mano J. F., Micro/Nano Structured Superhydrophobic Surfaces in the Biomedical Field. Part II: Applications Overview, Nanomedicine 
(Lond.), 10(1), DOI: 10.2217/NNM.14.175 (In press). 
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2.2. Introduction 
The design of innovative materials aimed to improve the quality of life of the patients is a continuous 
concern of clinicians, engineers and scientist. Materials for the regeneration of tissues or to replace 
damaged organs are examples of applications. The first contact between the material and the biological 
milieu occurs at the surface of the material, where is triggered a cascade of complex interactions [1]. The 
characteristics of the surfaces determine the biointegration of the material. The non-specific adsorption of 
proteins is the first instantaneously event, where surface properties such as chemistry, charge, topography 
and wettability play a crucial role [2]. The acceptance/integration of the biomaterials is defined by the 
control of the type, amount and conformation of the adsorbed proteins accompanied by cell response 
from the surrounded environment [3]. In the last few years, the study of the protein adsorption and cells 
attachment/proliferation onto the surfaces was extended from intermediary wettability states (hydrophilic-
hydrophobic) to extreme wettabilities, namely superhydrophilic and superhydrophobic [4-6]. This was 
motivated by the unique characteristics of surfaces obtained by inspiration in natural features, where the 
surface topography and chemistry play a crucial role [7]. Surfaces with extreme wettability have been 
shown capable to modulate the interfacial reactions of the biological entities and the surfaces of the 
materials. Besides influencing protein adsorption and eukaryotic cells attachment and proliferation, 
wettability effects platelet adhesion/activation, blood coagulation, and adhesion of bacteria [4]. The ideal 
sequence of interactions between the biological moieties and the biomaterials surfaces could be easily 
disturbed by adverse responses such as bacterial adhesion and infection [8], inflammation, and formation 
of a fibrotic capsule [9,10], being, once again, the intrinsic properties of surfaces important in controlling 
the performance of the implant.  
Materials could also be used in other biomedical applications which do not involve the direct contact with 
the inner of human body. Beyond scaffolds, cell carriers, drug delivery systems, prosthesis, among others, 
the wettability and the design of the micro/nano topographical structures at the interfaces also have an 
important role in the performance of a vast range or medical devices, namely diagnostic tools, biosensors, 
medical textiles, devices to produce the biomaterials and supports for fundamental research in 
biomedicine and biology. The employment of micro/nano structured surfaces, as it is the case of 
superhydrophobic substrates, could provide advantages that should be explored in such contexts. For 
example, beyond playing an important role in biocompatibility of the materials, micro/nano structured 
superhydrophobic surfaces are also known for contamination prevention and durability of materials [11]. 
The special behavior of the superhydrophobic surfaces encouraged the development of several materials 
and devices for biomedical applications with new or improved performance. The most representative 
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examples are summarized in Table 2.1. In the next sections representative examples will be overviewed on 
the use of the superhydrophobic surfaces in the biomedical field.  
 
Table 2.1. Representative examples of the applications of bioinspired superhydrophobic surfaces in the biomedical field. 
Applications Examples 
Superhydrophobic 
platform/material 
Observations 
Drug 
Release 
Systems 
Fiber mesh PCL/PGC-C18 [12] 
• Membranes with >25% PGC-C18 were in metastable-Cassie state; 
• The membranes composed by 30% and 50% PGC-C18 showed 
only ca. 10% SN-38 release over 9 weeks whereas 10% PGC-C18 
released ca. 60%; 
• Degassed fiber mesh (10% PGC-C18) released 80% on the content 
in less than 20 days. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Production of 
biomaterials 
with spherical-
shape 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Simple 
matrices 
Dextran-
MA/PNIPAAm: 
insulin and BSA 
encapsulation 
[21] 
PS, Cu, Al 
• Temperature responsive particles obtained by UV light exposure; 
• Particles with more PNIPAAm had higher swelling variations 
according to the temperature;  
• The release of insulin and BSA was followed during 2 days and 
less amount of proteins was detected at physiological 
temperatures when compared with room temperature;  
• Particle size: millimetric range. 
Chitosan: 
fibroblasts and 
drug encapsulation 
[26] 
PS 
• Particles for cell encapsulation obtained by a sequential process of 
crosslinking;  
• Upon in physiological simulated conditions the stiffness of the gels 
was improved due to attractive chitosan-chitosan forces: ca. 26 
kPa at 20˚C and ca. 70 kPa at 37˚C.  
• Viable fibroblasts for 7 days; 
• Dexamethasone fast release: ca. 60% released after 2h; 
• Particle size: ca. 2.7 mm. 
Collagen/Platelet 
Lysate gels: co-
encapsulation of 
growth factors and 
human adipose-
derived stem cells 
[22] 
PS 
• Fast crosslinking of the gels: 10-15 min at 37˚C; 
• Platelet lysates caused higher cell proliferation;  
• The cells migrate from the particles and established cell-cell 
communications, forming a tissue membrane; 
• Formulation without cells were also effective in accelerating the 
recovery of a simulated scratching and demonstrated angiogenic 
potential forming a strong blood vessel network in CAM model.  
• Very fast release of VEGF and PDGF-BB: 100% released after 8 h.  
• Particle size: 1.5-2.5 mm 
Alginate: co-
encapsulation of 
mesenchymal stem 
cells and FN [23] 
PS 
• Particles ionically crosslinked;  
• Mesenchymal stem cells and FN were successfully co-
encapsulated in mild conditions; 
• The cells remained viable for more than 20 days;  
• The combination of cells and proteins improved the regeneration of 
bone, visualize in vivo; 
• Particle size: ca. 2 mm 
Dextran and γ-
Cyclodextrins 
(post-preparation 
loading with 
dexamethasone) 
[24] 
PS 
• Dextran combined with structural monomers of γ-cyclodextrins was 
ca. 7 times more efficient in dexamethasone loading than particles 
without or with free cyclodextrins in the structure.  
• Sustained release of dexamethasone for at least 10 days.  
• The particles showed good cytocompatibility and good 
performance in inducing osteogenic differentiation of human 
adipose-derived stem cells, after 7 days in culture.  
Elastin-like  
recombinamers 
with RGD domains 
(scaffolds) [29] 
PS 
• SaOs-2 cells adhered onto the scaffolds surface due to the RGD 
domains in the elastin structure; 
• Particles with a crosslinking degree of 22% and 60% were 
compared; 
• The cells demonstrated preference for surfaces with higher 
stiffness corresponding to the more crosslinked structures; 
• Particle size: 800-900 µm  
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Production of 
biomaterials 
with spherical-
shape 
Methacrylamide 
chitosan microgels 
[37] 
Glass-based 
• Chitosan crosslinked by UV exposure after dispensing onto the 
surface using a spray system; 
• Size of the obtained microgels: <320 µm. 
Hierarchical  
systems 
Chitosan 
beads/magnetic 
microparticles [28] 
PS 
• Chitosan/genipin beads containing magnetic microparticles (Fe3O4, 
diameter ranging from 5–50 µm); 
• L929 cells were capable to adhere onto the surface of the beads; 
• The pathway of the particles inside a reactor was controlled by 
applying a magnetic field.  
SiO2-CaO 
nanoparticles 
organized in a milli-
sized structure [32] 
• The evaporation of the droplet containing nanoparticles led to a 
spontaneous assembly into polycrystalline aggregates: 
mesocrystals with sizes ca. 5 µm were formed; 
• After immersion into simulated body fluid for 7 days an apatite film 
grew on the surface of the samples. 
PNIPAAm/Au or Ag 
nanoparticles 
[35] 
PFTE 
superhydrophobic 
surface covered by 
2,2,4-trimethylpentane 
• Au nanoparticles ca. 10 nm; Ag nanoparticles ca. 15 nm; 
• Nanoparticles embedded in NIPAAm + crosslinkers solution were 
sprayed onto the surface;  
• Obtained magnetic particles with sizes comprising 200-500 µm. 
Core-shell 
and 
multilayered 
systems 
Dextra-MA/Alginate 
[31] 
Cu 
• Core/shell particles: 
Core: dextran-MA photocrosslinked encapsulatin CaCl2; 
Shell: Alginate with L929 cells crosslinked by the Ca2+ diffused from 
the core; 
• Each particle may be multifunctional: some compartments may be 
reservoirs for drugs and others for cells.  
Dextran-MA [31] 
• Hydrogels with a core/shell and multiple layered structure were 
obtained by sequentially dispensing and crosslinking dextran-MA 
onto the previously crosslinked structures. UV light exposure was 
used to induce the hardening of the particles; 
• The thickness of the layers was controlled by the volume 
dispensed, for example 2 µL led to a thickness of ca. 140 µm and 
6 µL ca. 500 µm; 
• Depending on the relative location of the encapsulated drugs, they 
were sequentially released: the drug model entrapped in the shell 
was released immediately and the drug model encapsulated in the 
core had a delay of  ca. 30 min.  
Chitosan/Pectin 
[30] 
PS 
• Core/shell microgels: 
Core: chitosan crosslinked under glutaraldehyde atmosphere;  
Shell: pectin ionically crosslinked; 
• Particles capable to control the release of an anti-tumor drug (5-
fluorouracil); 
• The pectin shell just dissolved in basic conditions, being the 
system resistant to acidic environments; 
• The chitosan core improved the effect of the drug against cancer 
cells (HeLa and SK-MEL-28 cells).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening 
systems  
 
 
 
 
 
Analytical sensor for blood typing 
[40] 
Substrate coated with 
Teflon powder 
embedded in a UV 
curable varnish 
• CAblood>150˚ ; 
• Blood sample: 3 droplets with 10 µL each; 
• Anti-A, B and D solution was injected into the blood droplets 
dispensed onto the superhydrophobic surfaces; 
• The droplets were monitored during 180s, taking photos at 30s 
intervals and then processed by image analysis; 
• Squares of 5 x 5 mm on the top part of the droplets were the 
selected areas to be analyzed.  
Materials properties: bioactivity of 
two different types of bioglass 
nanoparticles [42] 
PLLA 
(superhydrophobic 
platforms patterned 
with superhydrophilic 
squares by UV/O3 
treatment) 
 
• Binary (SiO2–CaO) and ternary (SiO2–CaO–P2O5) nanoparticles were 
confined into the wettable squares; 
• Ca/P ratios obtained for both types of nanoparticles were close to 
hydroxyapatite stoichiometric theoretical value, after immersed in 
simulated body fluid for 3 and 7 days; 
• Binary nanoparticles exhibited lower peaks of P and Ca than the 
ternary: ternary BG-NPs were more bioactive than the binary.  
 
 
Proteins-cells-
interactions 
 
Adsorption of 
proteins 
followed by 
cells adhesion 
[44] 
PS 
(superhydrophobic 
platforms patterned 
with superhydrophilic 
spots) 
• Albumin and fibronectin were adsorbed onto the 1x1 mm wettable 
squares varying their concentration and the proportion between 
both proteins 
• 4 µL of protein solution/spot; 
• The adsorption was dependent on the concentration of protein in 
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Proteins-cells-
interactions 
Adsorption of 
proteins 
followed by 
cells adhesion 
[44] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PS 
(superhydrophobic 
platforms patterned 
with superhydrophilic 
spots) 
the solution;  
• The cells were seeded onto the spots, after protein adsorption (10 
µL of cells suspension):  
For the same total protein: more cells adhered in the spots with 
higher content of fibronectin; 
For the same proportion albumin:fibronectin the cells adhered 
more onto the spots with higher total protein.  
Hydrogels  (cell 
encapsulation) 
[45] 
• Hydrogel liquid solutions containing L929 and MC3T3-EI cells (4 
µL) were confined into the wettable areas (4 mm2) and allowed to 
solidify via ionic crosslinking; 
• Combinations of materials were analyzed: alginate, chitosan, 
gelatin, collagen and hyaluronic acid; 
• Direct image analysis of the gels (calcein-AM and DAPI staining) 
was compared with destructive conventional methods (MTS and 
DNA quantification):  the results of both methods had coincident 
tendencies.  
Scaffolds (cell 
adhesion and 
proliferation) 
[46] 
• Solutions of biomaterials (9 chitosan/alginate combinations per 
chip) were dispensed onto the hydrophilic regions; 
• The scaffolds were obtained by a complexation reaction and in situ 
neutralization followed by freeze-drying; 
• The µCT allowed the rapid access in situ to the porosity of the 
scaffolds.  
• The properties of the scaffolds on the superhydrophobic chip were 
compared with scaffolds with the same composition but produced 
in a 96 cell culture plate (controls): the E’ followed the same 
tendency and had similar values; 
• The relative position in the chip did not affect any result; 
• Cell metabolic activity and number accessed by conventional 
methods was in agreement with results obtained by image analysis 
of the scaffolds onto the chip; 
• The volume of solution used to prepare the scaffolds in the chips 
was 1/50 of the volume used in 96 well plates; 
• It was verified a time saving of 9x in the µCT analysis. 
 
Nanocomposite 
hydrogels 
(interaction 
with pre-
osteoblasts) 
[47] 
• 30 formulations of chitosan/bioglass nanoparticles gels 
crosslinked with distinct amounts of genipin were analyzed into a 
single chip;  
• In situ evaluation of both mechanical/viscoeleastic properties 
under physiological-like conditions;  
• Cell-materials interactions:  
After 1 day: selective cell adhesion; 
After 3 days: different cell proliferation and morphology in the 
different formulations; 
• Neither cell adhesion nor cell proliferation depended directly of 
materials mechanical/viscoelastic properties; 
• The optimal condition was soft hydrogels composed by 2% (w/v) 
chitosan with 12.5% (w/w) nanoparticles and crosslinked with 2.5% 
(w/w) genipin.  
Scaffolds 
inflammatory 
response in 
vivo   [48] 
• Each chip had 36 spots with 4mm2; 
• Scaffolds composed by two polymers were prepared in each spot: 
chitosan + alginate or carrageenan;  
• The chips were implanted subcutaneously in Wistar rats and 
compared with scaffolds implanted one-by-one (conventional 
procedures); 
• The inflammatory response evaluated through lymphocyte analysis 
and histology of conventional scaffolds was consistent with the 
results obtained in the chip; 
• The relative position onto the chip did not affect the results;   
• Empty chips demonstrated cells adhered onto the wettable regions 
and no cells adhered onto superhydrophobic areas: very mild 
signals of inflammation were found 24h post implanting.  
 
 
Cell-cell communications and 
signaling 
 
 
 
Silicon and glass 
patterned with 
superhydrophilic areas  
[51] 
• NIH 3T3 fibroblast cells adhered selectively onto superhydrophilic 
areas of the patterned surfaces; 
• Cell-cell communications: 
Distances <150 µm: capacity to extend and communicate with 
neighboring cells;  
Distances >400 µm: no extension of the cells was observed; 
Distances between 200-400 µm: the cells partially extended to 
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Cell-cell communications and 
signaling 
neighboring.  
HEMA-EMA or PFPMA 
patterned with 
superhydrophilic areas 
[49] 
• Wnt (signaling protein of the brain) propagated without cell-cell 
contact: Wnt ligand expressing cells were cultured adjacently 
without direct contact with cells expressing aWnt reporter system.  
• Surfaces used for co-cultures of cells confined into different 
compartments showed 0.6% of MLTy mCherry and less than 0.1% 
of HeLa-GFP cells were capable to migrate and cross the 
superhydrophobic border after 48h of culture.  
Others 
Drug release profiles 
[54] 
PS 
 
• The release of BSA-FITC from alginate beads was followed by 
fluorescence microscopy and the release profiles were similar than 
those obtained by conventional in vitro studies;  
• Each particle was analyzed individually.  
Drug cytoxicity in 
microtissues [52, 53] 
• Superhydrophobic arrays with micro-indentations to induce rose 
petals effect (adhesion) or with wettable small areas (1 mm2); 
• Droplets of fibroblast-like cells suspension were deposited onto the 
micro-indentations or wettable areas and the surfaces were 
inverted allowing the formation of cells-spheroids by gravitational 
sedimentation (diameter 400-600 µm); 
• Different concentrations of doxorubicin were introduced into the 
droplets and cell viability monitored by image analysis (Live/dead 
staining): the cell viability decreased with the increase of drug 
concentration.   
Fabrics Anti-microbial textiles 
Cotton/Ag 
nanoparticles [78] 
 
• Non-modified cotton did not show any antibacterial activity whereas 
the modified cotton killed all the bacteria around the sample; 
• The reduction of bacterial growth was ca. 99% for 
superhydrophobic cotton; 
• No significant differences were observed between cotton coated 
with Ag nanoparticles superhydrophobic and not 
superhydrophobic; 
• Effective against Gram-positive and Gram-negative bacteria; 
• The antibacterial effect was a result of the leaching of bioactive Ag+ 
ions. 
Cotton [80] 
• Stable antibacterial effect and washing resistant coating with low 
surface energy materials (PDMASU and PFOTES); 
• Free of any antibacterial agent (e.g. Ag nanoparticles); 
• Cotton almost superhydrophobic  (CAwater≈147˚) and oleophobic 
(CAn-hexadecane≈120˚); 
• Non washed modified cotton showed a reduction of Escherichia 
coli bacteria of nearly 100% whereas washed cotton (10cycles) a 
reduction of ca. 60%.  
 
 
 
 
 
 
 
 
 
Blood 
contact 
materials 
 
 
 
 
 
 
 
 
 
 
 
Blood contact medical devices 
PDMS [82,83] 
• The treatment of PDMS with CO2-pulse laser (superhydrophobic) 
and grafted with HEMAPC (superhydrophilic) demonstrated less 
adhered platelets than non-treated PDMS and glass, demonstrating 
that extreme wettabilities affect the platelet adhesion and 
activation; 
• A relationship between the surface micro/nano roughness and 
platelet adhesion was verified onto PDMS patterned surfaces:  the 
higher the hydrophobicity caused by the roughness, the lower was 
the platelet adhesion. 
PCUs/carbon 
nanotubes [84] 
• CA>163˚ derived from the low surface energy caused by 
fluorinated alkyl side chains in the PCU and the roughness caused 
by the coating with carbon nanotubes; 
• Smooth surfaces (with the same chemistry) were more susceptible 
to platelet adhesion than nanostructured surfaces.  
• The early and further activation of the platelets (detected by the 
PAC-1 (gpIIb/IIIa) and CD62p (P-selectin) markers) was reduced in 
nanostructured superhydrophobic surfaces.  
PP [85] 
• Microstructured surfaces composed by a porous network;  
• CA≈158˚; 
• The anti-fouling properties could be related by the air entrapped in 
the structures that prevented the contact of the platelets with the 
surface.  
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Blood 
contact 
materials 
Vascular grafts ePTFE [91,92] 
• Superhydrophobic ePTFE vascular grafts (obtained by ion beam 
etching, CA 140-150˚) with 1.5 mm of internal diameter were not 
occluded after being implanted in rabbits for 1 week. The non-
modified counterparts were obstructed; 
• Later, the same grafts were tested in rabbits (1.5 mm internal 
diameter) and pigs (3.5 mm internal diameter) failing 15 min-1 h 
post-implanting in the right carotid artery; 
• No explanations were found for such opposite results.  
 
2.3. Drug Release Systems  
Drug release systems have been developed to protect and optimize the release of bioactive agents in order 
to improve their efficiency and decrease possible systemic side effects. One type of release systems is 
based on micro/nano sized carriers (micro/nano particles and capsules, vesicles, micelles and 
dendrimers) which are normally designed to be injected systemically until reach the target site. The other 
type is based on implantable systems for the local release of bioactive agents. These formulations include 
gels, rods, wafers and films, in which targeting or migration through bloodstream is not required. In any 
case the release of the therapeutic agent relies on the interfacial properties between the system and the 
biological milieu, through which the mass transport must occur. Any changes in the surface properties of 
such devices could have huge effects in their performance.  
Based on the repellent properties of superhydrophobic surfaces, Yohe et al. hypothesized that 3D 
superhydrophobic materials could be advantageous when acting as matrices for prolonged and local drug 
delivery [12]. Materials with appropriate micro/nano roughness, where air is entrapped and acts as a 
removable barrier, may delay/difficult the mass transport of a drug from the bulk of the material to the 
liquid environment. Those systems have to be used for local release because the air is removed in the 
same rate that the surrounded liquid diffuse and wet the structure, which mean that after a certain time 
period the entire system is involved by the liquid being the release no more controlled by the 
superhydrophobic properties of the system. Prolonged therapies for pain management, chronic diseases 
requiring permanent drugs administration or prevention of tumor recurrence after surgical resections, are 
possible applications for this type of systems.  
A superhydrophobic micro-sized fiber mesh composed by poly(ε-caprolactone) (PCL) and poly(glycerol 
monostearate-co-ε-caprolactone) (PGC-C18) was obtained by electrospinning (Figure 2.1, A and B) 
[12,13]. The high repellency of the mesh slowed the water penetration and the air entrapped acted as a 
removable barrier causing a delay in the release of the drug (Figure 2.1, D). The amount of PGC-C18 
dictated the wettability properties of the mesh: below 25% predominated the Wenzel state; above this 
value the mesh transited to a Cassie regime (Figure 2.1, C), decreasing the release rate of an anticancer 
drug (SN-38) – Figure 2.1, E. This innovative concept was extended and a similar system was studied for 
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anticancers dual release to prevent locoregional recurrence in colorectal cancer [13]. Herein, it was 
demonstrated that the 3D fiber-meshes had appropriated mechanical properties for surgical buttressing 
and released both chemotherapeutic agents for more than 90 days, resulting in significant cytotoxicity of 
human colorectal cancer cells.  
 
 
Figure 2.1. Superhydrophobic electrospun strip (A) and the microstructure of the meshes composed by PCL complemented 
with 10% PGC-C18 (B). The CA of the electrospun meshes varies in function of the amount of PGC-C18 used (C) and a 
transition between the Wenzel and Cassie state occurred for higher content of PGC-C18. (D) Schematic representation of the 
release mechanism from the superhydrophobic meshes. (E) Release profiles of SN-38 from PCL solely and PCL+PGC-C18 
meshes. The images were adapted from the reference [12,13] with permission of ASC Publications and Elsevier, respectively.  
 
We believe that the underlying concept used by these authors could be extended to drug release systems 
with other geometries (e.g. particles or other solid implantable devices) and sizes, by using adequate 
materials and technologies to texturize non-flat elements. For instance, particles with a superhydrophobic 
surface have already been produced by coating silica microparticles with polydopamine, which acted as 
reactive template to generate silver nanoparticles [14]. A lotus-leaf like surface structure was obtained. 
This concept should be possible to be applied in other kind of core materials. Superhydrophobic release 
systems could be especially important to control and to sustain the release of drugs that are released in a 
very fast way when encapsulated in conventional carriers. For example, the burst release of highly 
aqueous soluble drugs may be retarded turning the surface of the system superhydrophobic.  
 
B
C
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A
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2.2. Superhydrophobic Platforms for the Production of Spherical-Shaped 
Particles  
The spherical shape has been a widely employed geometry in particulate objects for biomedicine 
applications. In general, spherical particles or capsules from nano to milli sizes are explored as reservoirs 
for the release of bioactive agents [15], namely synthetic or natural small molecules, proteins, antigens, 
DNA, or even as cell containers [16,17] or scaffolds for cell growth [18]. 
The capacity of water droplets to acquire an almost spherical shape on the top of lotus leaves inspired the 
development of an innovative methodology aiming for a more efficient and cost-effective process to 
produce spherical particles. Our group suggested the use of biomimetic superhydrophobic surfaces as 
possible platforms to produce spherical hydrogel beads [19]. Aqueous solutions (containing a polymeric 
precursor, bioactive agents or even cells) were dispensed onto superhydrophobic surfaces using a 
micropipette (Figure 2.2, A). Microppipeting allowed the control of the volume dispensed, within a certain 
range, and consequently the size of the obtained particles (Figure 2.2, B). Depending on the polymers 
used, an adequate crosslinking process or solvent evaporation protocol must be applied to induce the 
hardening of the liquid droplets (Figure 2.2, C).  
In general, such method is highly cost-effective: no waste residues are produced, organic solvents are 
usually not required and is not necessary to use complex apparatus. In comparison with the conventional 
technologies to produce particles, the superhydrophobic methodology exhibits some important advantages 
[20]: (I) high encapsulation efficiency, due to the air-liquid interface where the particles harden and 
consequently the absence of a surrounded liquid medium from where the encapsulated molecules may 
diffuse and be lost (encapsulation efficiency of ≈100%); (II) a negligible contact area between the droplet 
and the surface due to the droplet suspension onto the micro/nano roughness of the platform; (III) 
absence of organic solvents, high temperatures or even mechanical forces that may be aggressive for 
labile molecules, living cells or even microorganisms; (IV) narrow particle size distribution due to the 
control of the volume dispensed to produce the particles; (V) the particles harden individually, preventing 
particle aggregation; (VI) possibility to produce complex spherical systems such as multilayered or 
hierarchical particles, in an easy way.  
Non-adhesive superhydrophobic surfaces should be selected in order to facilitate particles collection. 
Polystyrene (PS), metallic copper and aluminum surfaces exhibiting “lotus effect” were tested and 
demonstrated to be effective in the production of dextran-methacrylate/poly(N-isopropylacrylamide) 
(PNIPAAm) spherical-shaped gels [21]. The smart milli-sized particles obtained were crosslinked by UV 
light exposure and showed distinct release profiles when subjected to temperatures above or below the 
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lower critical solution temperature of PNIPAAm (≈32°C) (Figure 2.2, E.2). More complex systems 
regarding the structure, composition and content have been reported taking advantage of this 
methodology as producing technique. The most relevant and representative examples in biomedical field 
will be described in this section.  
 
 
Figure 2.2. Aqueous dispersions containing polymers, cells or bioactive agents may be dispensed onto the non-adhesive 
superhydrophobic surfaces (A) with controlled sizes (B) and hardened (C) through different processes depending on the 
polymers used. Alginate particles ionically crosslinked by dispensing CaCl2 (D) were used to encapsulate cells (D.1) and co-
encapsulate fibronectin and mesenchymal stem cells (D.2, I and II, respectively). Using photocrosslinkable polymers, such as 
dextran-methacrylate, spherical hydrogels may be obtained by UV light exposure (E). Multilayer particles were produced (E.1, I) 
for sequential drug release (E.1, II) and cell encapsulation (E.3, III). Responsive particles (E.2, I and II) composed by dextran-
methacrylate and poly(N-isopropylacrylamide) controlled the release profile of insulin and BSA according to the temperature. 
Simply by solvent evaporation (F) hierarchical particles composed by bioactive glass nanoparticles (F.1) were obtained. Initially 
the nanoparticles are randomly dispersed (I) in the aqueous medium and when the solvent evaporates they become organized 
(II) in a spherical-shape (III). Responsive chitosan microgels crosslinked under glutaraldehyde atmospheric environment (G, G.1) 
and coated with pectin layers were produced to release an anti-tumor agent, preferentially in sites with specific pH, such as 
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gastro-intestinal tract. B and D.1, adapted from the reference [19] with permission of RSC; D.2, adapted from the reference [23] with permission of Mary 
Ann Liebert, Inc.; E.1 (I), adapted from the reference [31] with permission of Wiley; E.2 (I and II), adapted from the reference [21] with permission of Springer; 
F.1, adapted from the reference [32] with permission of RSC; G and G.1, adapted from the reference [30] with permission of Elsevier. 
 
For many tissue and cell engineering strategies, hydrogels should be designed to be able to encapsulate 
living cells and maintain their viability upon implantation. For example, particles of collagen in combination 
with platelet lysates and human adipose-derived stem cells were produced in a very fast way, incubating 
liquid droplets onto superhydrophobic surfaces at 37 °C for 10-15 minutes [22]. Those particles induced 
a rapid cell proliferation and migration. Consequently the establishment of cell-cell communications led to 
a spontaneously formation of a tissue layer where the particles were interconnected by the cells. Due to 
the cocktail of growth factors provided by the platelet lysates such particles also showed angiogenic 
potential. The advantage of those particles as cells and growth factors suppliers were hypothesized to be 
useful for skin regeneration. The co-encapsulation of cells and a protein into alginate beads, as 
implantable systems for bone regeneration were also obtained using superhydrophobic surfaces [23]. The 
mild conditions provided by the superhydrophobic surfaces methodology resulted in the high viability of 
the incorporated cells evaluated over 3 days post-encapsulation, as well as through the release of viable 
cells, for more than 20 days. The absence of coagulation baths prevented the loss of fibronectin through 
migration from the particle to the surrounded medium (Figure 2.2, D.2). The combination of cells and 
fibronectin in the final system improved the regeneration of a cranial bone defect in Wistar rats within 4 
weeks, when compared with particles without cells. Particles with improved capacity to be loaded with 
hydrophobic drugs were produced by photopolymerization of dextran and γ-cyclodextrins onto the 
superhydrophobic surfaces [24]. Besides not being loaded with cells, such particles demonstrated 
potential to be used in bone tissue engineering strategies due to their efficient capacity to induce 
osteogenic differentiation of human adipose-derived stem cells.  
In the last examples particles were prepared using a unique crosslinking step. Multiple crosslinking stages 
are useful to produce systems with improved mechanical properties [25] or in the design of 
injectable/smart systems. Superhydrophobic surfaces showed to be suitable to implement such kind of 
sequential procedures. In a first stage, chitosan beads were ionically crosslinked in order to turn the beads 
manageable. In a second step, a rising in temperature above 37 °C led to a reinforcement of the 
mechanical properties of the final 3D structure due to the establishment of other attractive forces caused 
by the presence of β-glycerophosphate [26]. Dexamethasone and fibroblast-like cells were encapsulated 
independently in these beads to validate the applicability of this system in the biomedical field. Those 
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chitosan-based gels are interesting implantable systems because the beads are handleable and flexible at 
room temperature, increasing stiffness just after implantation.  
Besides systems able to encapsulate cells, some strategies are based on particulate systems able to 
sustain cell adhesion and proliferation over the surface that could be used as injectable scaffolds [27] or in 
biomaterials for cell expansion [28]. In a previous work it was shown that spherical scaffolds of elastin-like 
recombinamers with RGD domains could harden onto superhydrophobic surfaces by liophilization [29]. 
The spherical porous scaffolds were then collected and crosslinked by immersion in hexamethylene 
diisocyanate. The particles were found to act as excellent supports for cell adhesion and growth. In order 
to avoid crosslinking liquid baths, the crosslinking of such scaffolds could take place in adequate 
atmospheric environment, similarly with reported chitosan particles hardened under a glutaraldehyde 
atmosphere (Figure 2.2 G) [30]. Controlling the time of exposure to the vapor, different crosslinking 
degrees could be obtained.  
Superhydrophobic surfaces were also efficient in producing more complex spherical structures. 
Compartmental systems are relevant when multiple drug release is required or when different cell types 
need to be encapsulated. Lima et al. [31] demonstrated that through a bottom-up approach, the 
successive deposition of layers of hydrogel precursor solutions onto superhydrophobic surfaces alternated 
with crosslinking steps allowed the production of concentric multilayer particles (Figure 2.2, E.1). 
Depending on the volume dispensed, the thickness of the hydrogel layers could be controlled. The release 
kinetics of a drug-model was controlled depending on its relative location in two-compartmentalized 
particles. Cells were also immobilized successfully in the outer layer of the particles, in order to facilitate 
the access to nutrients and O2.  
Using the principle of multilayer systems, pectin coated chitosan microgels, suitable for oral administration 
of an anti-tumor drug, were produced using superhydrophobic surfaces (Figure 2.2, G and G.1) [30]. The 
coating with pectin improved the control of the drug release in acidic conditions, preventing the release in 
the stomach and allowing the release in the intestine where it should be absorbed. In comparison with 
solubilized form, the effectiveness of 5-fluorouracil was improved when encapsulated inside those 
microgels.  
Another explored spherical design was the production of multiscale systems composed by elements 
organized at the micro/macro levels. Magnetic microparticles were encapsulated in chitosan beads. The 
magnetic beads were tested to be applied in tubular bioreactors for cell culture due to the capability of 
cells to adhere and proliferate onto the surface of the particles, as well as their retention in a specific site 
where a magnetic field was applied [28].  Luz et al. [32] demonstrated that superhydrophobic surfaces 
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were suitable platforms to form hierarchical systems composed by SiO2–CaO based bioactive 
nanoparticles (BG-NPs). A colloidal suspension of BG-NPs was dispensed onto the superhydrophobic 
platforms and organized particles were obtained after self-assembly induced by evaporation (Figure 2.2, F 
and F.1). Due to the bioactive properties of the BG-NPs [33], the spherical aggregates demonstrated to 
have potential to promote apatite deposition in physiological-like conditions. Application of these particles 
as bone bonding material was hypothesized. Following this principle of self-assembly induced by 
evaporation Shao et al. [34] used superhydrophobic surfaces as platforms to concentrate molecules. This 
approach could be particularly useful in processing of samples for biochemical life sciences analysis. 
Spheres were obtained through the evaporation of the droplet, where analytes such as DNA or proteins 
were included. The loss of material was minimal when compared with non superhydrophobic substrates. 
The extreme repellency of the used surfaces prevented the typical “coffee staining effect”.  
Based on the idea of Song et al. [19] in using biomimetic superhydrophobic surfaces to produce hydrogel 
particles, Hu et al. [35] proposed a different strategy also to produce hydrogel spheres. While in the first 
methodology the particles were in contact with the superhydrophobic surface and surrounded by air 
(Figure 2.2), in this work, a hydrophobic commercial PTFE surface was covered by an organic solvent 
(2,2,4-trimethylpentane (TMP)) and aqueous spherical droplets were formed on the interface, after being 
dispensed using a micropipette or a spray (Figure 2.3 B, B.1-3). Similarly with the superhydrophobic 
surfaces technique, the particle size was controlled by the volume dispensed; however the evaporation of 
the droplets during crosslinking was prevented by the presence of the organic solvent surrounded the 
produced particles.  Hierarchical particles composed by poly(2-hydroxyethyl methacrylate) (pHEMA) and 
PNIPAAm encapsulating Au or Ag nanoparticles were obtained. A specific application was not 
demonstrated but we envisage an antibacterial and bactericidal potential of this particles due to the 
presence of Au and Ag nanoparticles, known to have antimicrobial properties.  
In most of the works described above micropipettes were used to dispense the precursor solutions onto 
the superhydrophobic surfaces. The main disadvantage is the impossibility to dispense smaller volumes 
than ca. 2 µL [31]. In addition, part of the liquid could remain adhered in the micropipette tip which in the 
case of very small volumes leads to an inaccuracy of the volume dispensed or even the impossibility to 
dispense the droplet onto the superhydrophobic surfaces due to the high repellent forces. The search for 
more accurate and automated dispensing systems is still a challenge to scale up this technology toward 
the production of smaller particles.  
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Figure 2.3. Spraying systems proposed to dispense droplets onto superhydrophobic surfaces. A generic spraying device was 
proposed to decrease the size of the particles produced using the solid-air interface between the superhydrophobic surfaces 
and the atmosphere (A). Photocrosslinkable chitosan (methacrylamide chitosan) was used and particles with diameters lower 
than 320 µm, in a hydrated state, were obtained. A similar spraying system was also used to produce hydrogel particles in a 
solid-liquid interface (B). Superhydrophobic surfaces (from PTFE) were immersed into an organic liquid (TMP); then the 
polymeric solution containing the monomer, co-monomer, crosslinker and initiator was sprayed onto the organic liquid. Micro 
scale particles were obtained (B.1). The typical shape of the precursor solution at air-PTFE and TPM-PTFE interfaces are shown 
in B.3 and B.3, respectively. A precise dispensing system based on an acoustic wave nebulizer which delivers a spray aerosol 
droplets onto a superhydrophobic surface (C) was also proposed. By an accurate measurement of the weight of the dispensed 
droplets, the exact volume is determined. The gentle shaking of the superhydrohobic surface joint the small droplets into a 
single one. A, adapted from the reference [37] with permission of ACS Publications; B, B.1-4 adapted from the reference [35] and C from [36] with 
permission of RSC.  
 
Having this in consideration, Vuong et al. [36] proposed an innovative, stable and precise microliter 
dispensing system. The technology principle was based on spraying the solution onto the 
superhydrophobic surface using an acoustic nebulizer (Figure 2.3, C). To control the volume of the droplet 
a weighing scale was used and the volume dispensed varied linearly with the operation time of the 
nebulizer. Another strategy to decrease the size of the obtained was proposed recently [37]. 
Methacrylamide chitosan aqueous solutions were dispensed onto superhydrophobic surfaces using a 
generic spraying device (Figure 2.3, A). After crosslinked by UV light exposure particles were obtained with 
diameters below 320 µm. The Cassie-Baxter regime of the surfaces allowed the preservation of the 
spherical droplets shape since their diameters were significantly larger than the pitch between the 
structures that composed the superhydrophobic platform. The average pitch of the surface was at least 1 
Manual&Sprayer Acoustic nebulizer
A
B
B.2
B.3
A.1
C
B.1
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order of magnitude shorter than the diameter of the smallest prepared droplets. In fact having an accurate 
dispensing system through which the particle size could be controlled, the only limitation to obtain 
particles in the nano scale is the distance between the top of the features that composed the 
superhydrophobic surface in use. More efforts should be made to improve such technology to permit high-
throughput generation of sub-millimetric particles, including the use of mobile substrates and optimized 
methodologies to retrieve the obtained particles from the platforms. The examples exposed are based on 
the use of superhydrophobic surfaces, where water-based spherical droplets are generated. In the future, 
we expect that other kind of surfaces will be employed to support organic-based systems that will allow 
producing particles based on polymers soluble in such solvents [38]. This could extend tremendously the 
impact of the technology in the pharmaceutical industry.  
 
2.5. Screening Systems based on Superhydrophobic Surfaces 
2.5.1. Analytical Sensors 
Miniaturized analytical devices using methods and strategies based on biochemistry, immunology and 
molecular biology have been developed as very important tools in monitoring health status worldwide. 
There are several advantages in scaling down biological analysis [39]. In general, the molecules that are 
desired to detect or to quantify could be present in very small amounts being micrometer-sized systems 
better suited than conventional laboratory tests tubes. In addition, small amounts of biological samples are 
required as well as smaller volumes of expensive reagents enable saving costs. Waste is reduced and 
parallel detections could be performed easily. The fabrication of chips has made a great progress. 
However, the high costs in manufacturing and, sometimes, the requirement of sophisticated 
instrumentations prevent their extensive application in the clinic. The demand for low-cost, disposable, as 
well as simple devices for massive, rapid or even multi-analyte detections for both clinical diagnosis and 
the study of chemical or biological entities was the driven force to investigate the application of alternative 
cheap platforms for sensor applications.  
The use of superhydrophobic substrates has shown to be applied in innovative analytical solutions. A lab-
on-chip analytical sensor was proposed based on the concept of spherical-shaped liquid droplets 
supported on superhydrophobic surfaces [38]. In this idea, droplets containing specific analytes may be 
dispensed onto the repellent surfaces, where a certain reaction occurs inside. The detection could be 
achieved by measuring the color intensity of recorded images [40] like in the case of liquid marbles [41]. 
Superhydrophobic surfaces are advantageous since as more repellent they are, more elevated is the 
center of gravity of the droplets, which facilitate the visualization and recording of the micro-scale physical 
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transformations or biochemical reactions occurring inside. Moreover, the use of non-adhesive 
superhydrophobic surfaces may prevent contaminations and allow their reuse. Such simple and fast 
technique may permit the development of chemical and biological reactions and biochemical assays in a 
high-throughput manner with reduced costs.  
The demand for more accurate and rapid typing tests in blood transfusion/transplantation medicine as 
well as in blood banking for screening or cross-checking donors was the driving force to explore 
superhydrophobic surfaces as suitable platforms for blood typing assays. Li et al. used polymeric 
superhydrophobic platforms to observe the haemagglutination reaction of human red cells [40]. The 
reaction occurring inside the blood droplet can be followed/recorded using a digital camera. Then, the 
collected images are processed by specific software for blood typing determination (Figure 2.4, A).  The 
successful results in ABO and RhD blood assays and the low production cost of superhydrophobic 
surfaces proof that such platforms are interesting to be used as laboratory consumables to support micro 
reactors for biochemical assays. We envisage that the versatility of the technology could permit the 
extension of such tests towards the detection of other biochemical markers and the use of other 
physiological fluids. 
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Figure 2.4. Examples of screening systems using superhydrophobic surfaces. (A) Blood type screening test obtained by 
colorimetric analysis of the droplets dispensed on the superhydrophobic surfaces, and where blood agglutination occurred after 
a mixture with antibodies (Anti-A, Anti-B and Anti-D). The red stars indicate where blood aggregation was triggered. (B) Square 
patterned superhydrophobic surfaces to analyze the bioactivity of different inorganic nanoparticles dispensed onto the 
hydrophilic areas (I). The nanoparticles were confined in such areas after solvent evaporation. The apatite deposition in each 
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spot was analyzed by EDS after immersion the chip in simulated body fluid medium (II). (C) Patterned chips for the study of 
proteins-cell-materials interactions: (I) proteins and subsequent cell adhesion; (II) viability of cells encapsulated in hydrogels with 
different compositions and (III) cell proliferation and viability on scaffolds also with different compositions. (D) Micro patterned 
superhydrophobic surfaces used to study cell-cell communications.  Cells adhered on the superhydrophilic areas, however 
depending on the distance (I), cells could establish cell-cell direct contact. Different designs of the patterned areas may be 
produced and used to study more than one type of cells (II). (E) Ring-shaped patterned chip (II) to follow the release of 
fluorescent molecules from each spherical shaped particle fixed on the center of each ring (III). The quantification was obtained 
by imaging analysis of captured fluorescent microscopy images over time. A, adapted from the reference [40] and B from [42] with 
permission of Elsevier; C, adapted from the follow references: [44] (I), [45] (II) and [46] (III) with permission of RSC and Wiley; D, adapted from the references 
[51] (I) and [49] (II) with permission of ACS Publications and Elsevier; E, adapted from the reference [54] with permission of ACS Publications. 
 
2.5.2. Screening of Materials Properties  
The possibility to screen the properties or effectiveness of multiple materials in a unique assay, decreasing 
the variability of the conditions, reducing costs and obtaining results in a fast way, lead to an increase 
interest in chips development for materials analysis. The principle is the printing of homogenous platforms 
with areas with certain properties or designs capable to retain the deposited materials. The entire chip is 
subjected to the same treatment with the aim to evaluate the desired effect/properties and compare in 
situ the different formulations tested in the different places of the chip. Different materials, concentrations 
or even combinations may be tested easily onto such platforms. 
Considering these statements and the possibility to pattern superhydrophobic platforms using a simple 
and cost-effective procedure, biodegradable superhydrophobic PLLA surfaces were patterned with small 
superhydrophilic squares to be employed as devices for in situ tests. As a first example of application, the 
obtained chips were used as disposable arrays to characterize, in vitro, the bioactivity of inorganic 
materials [42], a major important aspect of biomaterials to be used in orthopedic applications [43]. The 
proof-of-concept was performed by dispensing in the superhydrophilic areas suspensions of binary (SiO2-
CaO) and ternary (SiO2-CaO-P2O5) nanoparticles, let them dry and then immersing the entire chip in 
simulated body fluid (Figure 2.4, B I). The particles were confined into the wettable areas due to the strong 
contrast in surface tension with the surrounding superhydrophobic regions. The results demonstrated that 
ternary system promoted and enhanced apatite deposition, and such flat chips may be used in 
combinatory assays to easily evaluate certain properties of materials using very small amounts of samples 
(Figure 2.4, B II) [42]. Since the entire array is subjected to exactly the same conditions, more reliable 
results may be achieved. In principle such chips could be used to test other properties and also other 
classes of materials. Some more examples will be given in the next sections. 
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2.5.3. Screening of Proteins-Cells-Materials Interactions  
The study of the interactions between superhydrophobic surfaces and proteins or cells in conjoint to the 
possibility to modify its wettability have pushed the development of chips for high-throughput screening 
where materials characteristics, and different biological responses may be evaluated in a single 
experiment.  An array obtained by patterning PS superhydrophobic surfaces was explored as a 
multiplexing tool for the evaluation of the biological performance of independent combinations of 
biomaterials, cells and culture media [44]. Albumin and fibronectin, two proteins with important role in a 
variety of biomedical and biological aspects, were first adsorbed in the wettable zones of 
superhydrophobic-based chips. The interaction of cells with different concentrations and combinations of 
the two proteins was studied (Figure 2.4, C I). The results demonstrated that for the same total protein 
concentration, the cells preferred the spots with major proportion of fibronectin. For the same proportion 
between fibronectin and albumin, the cells adhered better in the spots with higher total protein amount. 
Such results were expected since fibronectin present RGD and PHSRN sequences which are integrin 
binding domains. In this case cell behavior was probed in essentially 2D environments. It would be 
interesting to extend this technology towards three-dimensional architectures, much more interesting for 
testing biomaterials and devices for tissue engineering. The same arrays were then used as combinatorial 
platforms for screening of cell interactions with different combinations of 3D materials with relevance in 
tissue engineering [45]. Two cell types were encapsulated in a vast range of natural-based miniaturized 
hydrogels (Figure 2.4, C II). The viability of encapsulated cells was determined via image analysis and 
compared with traditional materials/cell destructive testing methods. The results from the two 
characterization sources were similar, proving that image analysis of the array constitute a reliable and 
fast method for cell viability evaluation when encapsulated into different types of materials. The main 
limitation of this strategy is the difficulty to be used to analyze opaque materials, as the on-chip tests are 
based on image analysis. However, the hydrogels are highly hydrated and are most of the time 
transparent.  
Besides hydrogels, porous structures are important for tissue engineering applications. The production of 
3D millimetric scaffolds was performed in situ over the PS superhydrophobic substrates (Figure 2.4, C III) 
[46]. The structures were characterized regarding mechanical properties, porosity and pore size. The 
proportion between materials (sodium alginate and chitosan) was varied and cell-materials interactions 
were also evaluated by looking at the metabolic activity and cell number using both destructive methods 
and direct image-based analysis. This work demonstrated that these small chips could be considered 
reliable platforms for in vitro screening of the main properties currently assessed in scaffolds 
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characterization as well as for preliminary biological studies. The mechanical/viscoelastic properties of 
chitosan/bioglass nanoparticles composites and the respective interaction with pre-osteoblast cells was 
studied in detail using the same PS chips [47].  
In vitro experiments are very important in the first assessment of the biological behavior of biomaterials. 
The next step always involves the testing of the best formulations using appropriate in vivo models. 
Conventional in vivo screening of materials involves their implanting one by one, requiring often an highly 
number of animals, which in turn trigger ethical questions and elevated experimental costs. Patterned 
devices with areas of contrast wettablities, produced onto flat and flexible films, were hypothesized to be 
powerful tools for detection of hit spots with promising properties and exclude materials with uninteresting 
characteristics [48]. A group of scaffolds, fabricated from the combination of different amounts of 
chitosan, alginate and carrageenans, were dispensed as arrays over flexible patterned superhydrophobic 
PS chips. The chips were analyzed upon being implanted subcutaneously in rats [48]. The results 
obtained on-chip were compared with conventional individual implantation of the scaffolds and showed 
that these platforms could be used for high-content evaluation of in vivo biomaterials response. The 
employment of cheap superhydrophobic platforms as high-throughput devices for in vivo screening clearly 
mark an important step in biomaterials development. Time and costs could be saved and more realistic 
results could be obtained due to the consideration of the complex in vivo environment. In the referred work 
[48], just the inflammatory response caused by the biomaterials was explored. In the future, hybrid 
structures combining cells and materials should be tested in order to extend this methodology towards cell 
therapies for regenerative medicine.  
 
2.5.4. Screening of Cell-Cell Communications  
Tissue´s development involves the organization of multiple cell types undergoing processes such as 
intercellular communication and cell signaling. These complex phenomena are crucial for the whole 
organism development. The culture of multiple cell types in separated but adjacent compartments is a 
recurrent strategy to mimic these events. However, the existent techniques for cell patterning are 
complicated and have some limitations, which include the restricted geometry of the patterns and the 
number of the cell types used [49,50].  
The easy manufacturing processes to produce and pattern superhydrophobic surfaces, as well as the 
possibility to confine in certain areas different types of cells, have encouraged the use of such platforms 
for cell-cell interactions studies. For example, silicon and glass micropatterned surfaces were used to 
study the effect of the distance between adjacent cells. Cells adhered selectively onto the well-defined 
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wettable areas. Cell-cell interactions were affected by the distance between the superhydrophilic neighbor 
areas. For distances below 250 µm, cells were able to form filopodia projections and establish direct 
communication [51] – Figure 2.4, D I. In order to study the interactions between different cell types, 
surfaces of poly(2-hydroxyethyl methacrylate)-co-(ethylene dimethacrylate) (HEMA-EMA) or 2,2,3,3,3-
pentafluoropropyl methacrylate (PFPMA) grafted onto glass slides were patterned with distinct geometrical 
features [49] – Figure 2.4, D II. Suspensions containing different cell types were confined in the 
hydrophilic areas, creating multiple culture reservoirs in the same substrate. Once again, the cells adhered 
onto the more hydrophilic areas forming a monolayer. The entire platform was cultivated in conjoint 
standard culture medium to collect data related with cell-cell interactions and signaling processes. This 
strategy could be a valuable tool for creating complex cell patterns, just using the resources existent in 
conventional cell culture labs. No special apparatus are required to perform such cell cultures.  
Until now just cell-cell interaction studies at 2D level were performed, however, we envisage that patterned 
superhydrophobic surfaces could be interesting platforms to study the interactions of the cells when 
seeded onto 3D structures. The motivation is related to the fact that 3D rearrangements will be closer to 
the in vivo conditions, and would constitute better models for fundamental studies as well as in the 
development of screening and fabrication platforms in drugs development, models of diseases and tissue 
engineering. A first insight related with 3D cell structures, though not applied to cell-cell communications 
studies, was presented using superhydrophobic platforms to obtain cell spheroids. Based on a rose petals 
effect, which enables the fixation of the aqueous droplets, flat PS superhydrophobic surfaces were 
patterned with micro-indentations where liquid droplets containing cells were immobilized. Facing down 
the platforms with the droplets, 3D agglomerates of cells were obtained by gravity effect [52]. Such device 
was hypothesized to be applied in biomedical field as micro-bioreactors where chemical and biological 
combinatorial tests may be performed, for example, the screening of the cytotoxicity of drugs on micro-
tissues. Instead of suspending aqueous spherical droplets containing cells, semi-spherical droplets were 
dispensed over transparent wettable spots distributed in superhydrophobic PS surfaces [52]. By inverting 
the system, spheroids could be also generated for drug screening tests. In this case the transparent 
windows existing in each spot facilitate the visualization of the individual spheroid and the independent 
liquid exchange in each droplet.  
 
2.5.5. Screening of the Release of Bioactive Agents  
In vitro release studies of bioactive agents are rather important since they constitute the first prediction of 
the performance of drug delivery systems when applied in vivo.  Such preliminary studies are recurrent 
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tests used in lab research since they allow re-designing the systems in order to obtain the desired 
profiles/characteristics. Standard in vitro procedures are laboring and consume significant amounts of 
resources and lab space. The automation and miniaturization of conventional methodologies require 
complex, large and expensive mechanical systems. Patterned superhydrophobic surfaces were proposed 
as cheap platforms able to be used in high-throughput quantification of biomolecules released from 
biomaterials matrices [54]. Superhydrophobic surfaces were patterned to obtain a hydrophilic transparent 
disc containing a superhydrophobic opaque spot in the center (Figure 2.4, E II). Such donnut-shape was 
patterned in the surface of a superhydrophobic chip. A polymeric solution (sodium alginate - based) 
incorporating a bioactive agent model (bovine serum albumin labelled with a fluorescent marker) was 
dispensed on the superhydrophobic spots remaining with an almost spherical shape (Figure 2.4, E I A1 
and III). Such matrices were crosslinked with calcium ions (Figure 2.4, E I A2), in a similar process used 
in the preparation of alginate particles for theophylline release [19]. Each transparent ring was then filled 
with a physiological-like fluid acting as individual release media (Figure 2.4, E I B1). Over time the release 
of the molecules in each spot was followed by acquisition of fluorescent microscopy images (Figure 2.4, E 
I B2). The comparison between the image analysis results and in vitro conventional studies demonstrated 
that this technique was quite reliable, and minimal amounts of reagents and space were used [54].  
In principle all the systems described in the section 2.2 for drug release applications are suitable to be 
tested in this chip, provided that the bioactive agent to be studied was previously labelled with a 
fluorescent molecule. Furthermore, this technology may also be generalized to other types of matrices as 
well as other crosslink pathways. The use of confocal microscopy (or other advanced 3D imaging 
technologies) to monitor the distribution of the drug in the entire volume of each particle as a function of 
time could permit a true 4D monitoring of the release of entrapped molecules inside the matrices. 
 
2.6. Microfluidic Devices Based on Superhydrophobic Surfaces 
Nano/microfluidic devices have been used in several biomedical applications [55]. Devices for cell culture 
[56], medical diagnosis (e.g. biosensors) [57], and microparticles production [58] are just a few examples. 
Nano/microfluidic systems are emerging as powerful tools bring advantages such as minimal use of 
reagents/samples, quality control and miniaturization when compared with conventional procedures. Such 
devices exploit small size and the characteristics of the fluids flow inside the channels, offering as well new 
capabilities in the control of concentrations of molecules in space and time [59].  
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In microfluidics, the wettability of the channels is important to manipulate the flow of the liquids. Water 
super-repellent surfaces were hypothesized to bring advantages due to the possibility to reduce the drag in 
microchannels (low-friction) [60] and to produce microvalves [61].  
In another approach, the surface-tension driven force using selective hydrophobic/hydrophilic contrast is 
an interesting strategy to control the liquid flow and it is the principle for the development of 
superhydrophobic-based open microfluidic devices [62]. In this case the liquid can flow in pre-defined 
paths [63] without the need of physical walls in the channels. The micro/nano roughness in combination 
with the chemistry inside the channels will dictate the behavior of the liquid flow [64].  
The demand for more affordable, accurate, simple and low cost technologies for diagnosis (e.g. infectious 
diseases) or even to measure the health status have inspired the application of paper in microfluidic 
devices [65]. The introduction of paper with contrast wettabilities in biomedical area started with patterned 
paper where hydrophilic millimetric-sized channels surrounded by hydrophobic regions was proposed as 
suitable low-cost platforms for multiplex bioassays [66]. Hydrophilic channels were created and a sample 
of liquid could migrate from one edge through the channels by capillary action to achieve 3 distinct 
detection areas (control and two detection chambers). The device was used to quantify glucose and BSA 
from 5 µL of urine [66]. Based on this system, a more complex device was proposed for the detection of 
biomarkers of the liver: alkaline phosphatase, aspartate aminotransferase and total serum protein. The 
reliable results obtained using blood from a finger stick showed that such device could be used in routine 
clinical screening [67].  
The importance of paper as a simple and cheap substrate for many biomedical and biological applications 
has pushed the development of methodologies to enhance its water repellency. For example, 
superhydrophobic paper was obtained by a phase separation technique through the precipitation of 
poly(hydroxybutyrate) (PHB) onto the surface of paper [68, 69]. Such paper was easily patterned using 
argon plasma treatment and hypothesized to be used in applications such as microfluidic or lab-on-paper 
devices [70]. Recently, the same superhydrophobic paper was patterned by printing and writing processes 
[68]. The inject printing of hydrophilic ink with distinct grey intensities allowed to control the wettability of 
the surface and the liquids flow. Aqueous-based liquids were driven through the patterned channels just by 
tilting the surface.  
Patterned PS superhydrophobic surfaces were proposed by Oliveira et al. [62] as possible open-
microfluidic devices (Figure 2.5, A). Such surfaces exhibited higher wetting contrast when compared with 
hydrophobic ones, turning the liquid flow through the superhydrophilic paths in horizontal position more 
efficient than in hydrophilic channels patterned on smooth surfaces. Since PS is the material used in cell 
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culture dishes, we envisage that such microfluidic devices patterned with appropriated designs could be 
used for screening of cell cultures under dynamic conditions.  
 
 
Figure 2.5. General microfluidic systems proposed using different superhydrophobic and highly water repellent surfaces: (A) 
polystyrene superhydrophobic platform patterned by argon plasma treatment or UV/Ozone exposure was proposed as a 
microfluidic platform for continuous liquids flowing and; (B) PDMS microfluidic platform where the flow of the droplets was 
controlled along the desired path. (C) Process to fabricate a glass-based hydrophobic platform to produce microbead gradients 
(C.1) by dispensing a suspension of green fluorescein microparticles. The same surface modification strategy was implemented 
in a microwell system (D). Cells were seeded inside the microweels and a gradient of doxorubicin concentration was created. 
The viability of the cells in contact with different amounts of drug was accessed by Live/Dead assay (live cells were green and 
dead cells were red) (D.1). (E) Superhydrophobic glass coated with diatomaceous earth, where a channel-like pattern was 
obtained by argon plasma treatment, showed to be a suitable device to produce gradients of concentrations of 
materials/molecules. A, adapted from the reference [62] with permission of The Japan Society of Applied Physics; B, adapted from the reference [71] 
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with permission of ACS Publishing; C and D, adapted from the reference [74] with permission of Wiley; E, adapted from the reference [73] with permission of 
ACS Publishing. 
 
Draper et al. fabricated patterned polydimethylsiloxane (PDMS) superhydrophobic surfaces to be 
integrated in microfluidic devices for passive manipulation of droplets flow at the micro scale level (Figure 
2.5, B) [71]. The innovation is that no pillars or electrodes were required to control the movement of the 
droplets inside the channels which turn the system simpler to operate. Acceleration, deceleration, 
merging, and path control could be controlled just by playing with surface design and repulsion properties 
of the channels. This strategy could be useful for analytical and detection devices. 
The existence of a gradient of properties, concentration of molecules, content of particles or other relevant 
ingredients, turn such type of anisotropic biomaterials interesting for biomolecules delivery, drug screening 
and cell biology studies [72]. The extreme contrast of surface tensions obtained in patterned 
superhydrophobic surfaces encouraged the development of a bench top methodology powered by capillary 
flow and molecular diffusion of precursor liquids into a defined path to obtain gradients in hydrogels [73]. 
An easy and rapid microfluidic device to formulate gradients in-house was recently proposed [74]. 
Wettable channels were defined onto a glass coated with a hydrophobic spray (Figure 2.5, C A). The 
precursor solution was pipetted in the pre-wetted hydrophilic channels (Figure 2.5, C B). The liquid flowed 
through and created a gradient by convection, in a short time period. This concept was applied in simple 
straight channels where a gradient (Figure 2.5, C.1) and a cross gradient of microparticles content was 
generated and in a microwell system, that permitted to study the effect of a drug gradient on cell viability 
(Figure 2.5, D). Other kind of substrates, such as superhydrophobic glass or PS coated with siliceous 
exoskeleton of diatoms patterned by argon plasma treatment, were also proposed to produce these kind of 
materials (Figure 2.5, E) [73].  
Due to the relevant role of the gradients of cues in biomedicine, it is expected in the next few years a 
significant increase of the employment of materials with these characteristics mainly for cell-based 
experiments and high throughput screening under dynamic conditions or through gradients of distinct 
properties.  
 
2.7. Superhydrophobic Textiles in Biomedicine 
When in contact with human body, textiles have appropriate temperature and humidity conditions to 
promote the growth of micro-organisms. The rapid and uncontrolled colonization by microbes could lead 
to serious healthcare problems. Having into account the increasing concern related with public hygiene, 
the research to fight against micro-organisms growth have been gained attention. The modification of 
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textiles is an interesting strategy to achieve this purpose. One specific case in biomedicine is the battle to 
eliminate bacterial strains. Such micro-organisms develop resistance to antibiotics easily and in a very fast 
way. The development of innovative strategies is continuously required in order to obtain novel 
antibacterial or bactericide products [75].  
It is well known that inorganic nano-structured materials, namely Ag, Au, ZnO, TiO2, Cu nanoparticles, have 
anti-microbial properties [76].  For example, silver is known to be ‘oligo-dynamic’, having anti-microbial 
and bactericidal effects but low toxicity to human cells. Silver effect has been demonstrated against more 
than 650 diseases-causing organisms as well as in prevention of biofilms formation [75,76]. Regarding 
this, the coating of textiles with silver nanoparticles merged as a way to promote the antibacterial 
properties of fabrics [77]. Superhydrophobic cotton was obtained after being coated with silver nano 
particles with 100-500 nm and treated with octyltrithoxysilanes (Figure 2.6, A) [78]. The incorporation of 
silver nanoparticles demonstrated to be efficient against both Gram-positive (Staphylococcus aureus) 
(Figure 2.6, B) and Gram-negative bacteria (Escherichia coli) (Figure 2.6, C).  
An interrelationship between low surface energy of cotton fibers and bacteria growth inhibition was 
established [79]. In this way, the coating of cotton fabrics with materials having low energy, such as 
fluoropolymers and silicon-based polymers, were reported as an alternative strategy to obtain anti-
microbial hydrophobic and oleophobic surfaces [80]; without the need of incorporating anti-microbial 
substances.  
 
 
Figure 2.6. (A) Structure of the fibers of superhydrophobic cotton. The structure of the fibers became rough, due to the 
presence of the nanoparticles. The antibacterial activity of the superhydrophobic cotton was verified against Staphylococcus 
aureus (B) and Escherichia coli (C). Images adapted from the reference [78] with permission of Elsevier. 
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Biomedical applications of superhydrophobic anti-microbial textiles were not explored until now. We 
envisage that the combination of anti-microbial properties with an extreme water/oil repellency behavior 
may be advantageous in the biomedical field. For example, pressure ulcers affect millions of hospitalized 
patients each year. The normal healing process is frequently impaired due to the development of biofilms 
in the ulcer site [81]. The employment of highly repellent textiles that do not absorb undesirable fluids, 
being easily cleaned, and combined with the capability to inhibit the bacteria contamination of the ulcers, 
could prevent their evolution until reach critical states or even avoid some interference in the normal 
healing process. 
 
2.8. Biomaterials in Contact with Blood  
2.8.1. Biomaterials for Medical Devices 
Direct blood contact materials, which include implantable systems and devices for catheterization, 
drainage and blood circulation, may trigger undesirable interactions between blood and the device. Blood 
proteins adsorb rapidly onto materials surface, followed by the adhesion and activation of the platelets. 
During the activation of the platelets, coagulation factors are released and may promote the formation of 
thrombus, causing the functional failure of the devices. The fabrication of blood-compatible materials is 
still a challenge. Tailoring the surface chemical composition, surface roughness and consequently the 
wettability, constitutes a possible strategy to achieve adequate properties for this purpose. Therefore, also 
in this case superhydrophobic surfaces could be used. 
Khorasini et al. [82] developed a strategy to improve the antithrombogenic properties of PDMS. Despite 
owning good general physical and chemical properties under biological environment, PDMS lacks in the 
long-term stability being required an improvement of its antithrombogenic properties. PDMS with extreme 
wettabilities were studied to prevent the platelet adhesion. Applying a CO2 pulsed laser treatment the 
hydrophobicity of PDMS was incremented. The water CA raised from 105° to 170° (superhydrophobic 
PDMS). In order to achieve proper comparisons, superhydrophilic PDMS was obtained by grafting 
hydroxyethylmethacrylate phosphatidylcholine (HEMAPC), where the water CA decreased to values around 
10°.  The laser treatment leads to the appearance of roughness onto the PDMS surface that was then 
attenuated by HEMAPC grafting. Platelet adhesion was found to be very limited onto both 
superhydrophobic and superhydrophilic PDMS, when compared with the untreated material. These results 
allowed concluding that chemical cues, such as grafting of negative-charge groups, and extreme wettability 
properties of PDMS inhibit platelet activation. 
Chapter 2  Applications of the Superhydrophobic Surfaces in the Biomedical Field 
! 58!
To better investigate the influence of the topography on platelets adhesion, a study was developed 
comparing the effect of the micro with nano structures onto PDMS surfaces [83]. PDMS with micro-pillars 
demonstrated low platelet adhesion when compared with smooth PDMS (Figure 2.7, A.1-6). Since the 
wettability is directly related to surface topography, a correlation between the wettability of the PDMS and 
the adhesion of the platelets was established. The lower the spacing between the micro-pillars, the more 
hydrophobic was the PDMS surface and less platelets adhered (Figure 2.7, A.2-4). In addition, PDMS with 
nano-grooves was also studied (Figure 2.7, A.5). These patterned surfaces were not superhydrophobic but 
inhibited platelet adhesion, probably due to the small spacing between the grooves which prevented the 
pseudopodium formation. In order to generalize the tendencies above described, these kinds of studies 
should be extended to other materials and on textured surfaces decorated with different geometrical 
features. 
 
 
Figure 2.7. Platelets adhesion onto PDMS smooth (A.1), micro patterned with different distances between the pillars (A.2-A.4) 
and sub micro grooved (A.5) surfaces. The quantification of platelets demonstrates that submicra structures and lower pitches 
in micropatterned PDMS inhibited platelet adhesion (A.6). Poly(carbonate urethane) (PCU) was also studied to averiguate the 
effect of superhydrophobicity. Smooth surfaces (B.1, CA!≈109.1°±1.58) were coated with aligned carbon nanotubes (B.2, 
CA!≈163.6°±1.18). Higher number of platelets with a spread morphology was observed on smooth PCUs (B.3 and B.4) when 
compared with superhydrophobic ones (B.5). The superhydrophobic PCU surface was clean and just a very few round shape 
platelets (B.6) were found. The blood compatibility of polypropylene (PP) was studied when films were in contact with platelet 
rich plasma and fresh human blood. The original PP films exhibited higher platelet adhesion (C.1) as well as blood cells (C.2). 
In contrast, the superhydrophobic surfaces exhibited an opposite effect, where almost no platelets (C.3) or blood cells (C.4) 
were visualized. A.1-6, adapted from the reference [83] with permission of Trans Tech Publications; B.1-6, adapted from the reference [84] with permission 
of Wiley; C.1-4, adapted from the reference [85] with permission of Elsevier.  
PDMS PCUs
PP
A.1 A.2
A.3 A.4
A.5 A.6
B.1
B.2
B.3 B.4
B.5 B.6
C.1 C.2
C.3 C.4
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Poly(carbonate urethane)s (PCUs) (Figure 2.7, B.1) are used in biomedical applications due to their 
acceptable blood compatibility and long term-stability. The increment on PCU hydrophobicity was achieved 
by coating their surface with vertically aligned carbon nanotubes with diameters of ca. 40 nm and length 
of 20 µm (Figure 2.7, B.2) [84]. The adhesion of activated platelets was much higher on smooth than on 
superhydrophobic nanostructured PCUs (Figure 2.7, B.3 and B.5).  The nanostructured surfaces 
remained without adhered platelets after the experiments. As seen before with patterned PDMS, PCUs 
coated with nanotubes surfaces may be as well a good strategy to improve the hemocompatibility of 
biomaterials. Once again, the methodology used to perform the coating with carbon nanotubes should be 
tested in other materials used in blood-contact applications and long term cytotoxicity studies should also 
be done.  
The effect of surface micro/nano structures and superhydrophobicity was also tested in polypropylene 
(PP) materials [85]. Both platelets and blood cells did not adhered onto modified PP surfaces (Figure 2.7, 
C.1-2 versus C.3-4); the main reason could be related to the presence of an air layer on the 
superhydrophobic surface that acts as a “virtual wall” (Cassie-Baxter regime), preventing the contact 
between platelets and the material.  
All the previously reported studies analyzed the materials in static conditions, meaning that the material 
was placed in contact with plasma rich platelets and the number of platelets adhered was determined. 
However, dynamic studies are required to investigate the effect of continuous flow of blood or even in vivo 
implantation, in order to obtain more reliable information on the hemocompatibility of the materials.   
 
2.8.2. Vascular Grafts 
A more specific case of blood-contact materials are grafts or patches used in the treatment of vascular 
diseases. Different strategies have been proposed to prevent coagulation and platelet adhesion in these 
devices. For example, enzymes or cells with antithrombogenic properties have been attached onto the 
surface of materials aimed at being in contact with blood. However, some problems results from those 
strategies. Enzymes can lose their activity, compromising the antithrombogenic effect. In addition, some 
studies reporting the coating of materials with endothelial cells demonstrate controversial results, being 
inconclusive about the benefits of this coating [86–88]. Expanded polytetrafluoroethylene (ePTFE) has 
been reported as one of the most inert polymers being interesting for biomedical applications due to its 
non-thrombogenic properties [89]. One of the strategies proposed to improve the performance of ePTFE 
was the modification of the wettability of the luminal side of the vascular graft. Using ion beam etching, 
the CAs raise from 109° to 140°-150°. An independent study revealed an inhibition of the spreading of 
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skin fibroblasts onto superhydrophobic ePTFE when compared with the same material exhibiting a 
hydrophilic surface [90]. In order to verify the effectiveness of the superhydrophobic properties in vascular 
grafts applications, in vivo studies were performed in rabbits’ carotid arteries using the same ePTFE grafts 
[91]. The results revealed that after 1 week post implantation the treated hydrophobic grafts remained 
clear and untreated grafts were occluded. No anticoagulants were administered and the surface remained 
superhydrophobic for at least 6 months [91].  
A very similar study was reported by Toes et al. [92], using the same ePFTE grafts and patches (also 
treated with ion beam etching). Blood interactions with the implants as well as their in vivo performance 
were both evaluated. The results demonstrated that the superhydrophobic treatment did not improve the 
performance of the grafts. After 15 min - 1 h they were completely occluded in the two tested animal 
models utilized: rabbits and pigs. Such controversial results were not expected and no reasons were found 
to explain the failure of the superhydrophobic ePFTE in vivo. This means that more studies are required 
using different materials, grafts with different inner diameters as well as different in vivo models to 
conclude the real influence of superhydrophobicity in this kind of applications.  
 
2.9. Conclusions 
The unique properties of superhydrophobic surfaces have been explored in a variety of applications in the 
biomedical field. Superhydrophobic materials aimed to be used in direct contact with human body, such 
as drug release systems, showed benefits in sustain the release for long time periods. Superhydrophobic 
vascular grafts were hypothesized to improve the antithrombogenic properties of the grafts, but the 
controversial results obtained in vivo did not allow concluding about the effective benefits of 
superhydrophobicity. However, for blood contact materials, such as catheterization and blood passing, the 
majority of the modified materials proposed demonstrated that the presence of micro/nano roughness 
and extreme wettabilities prevented platelet adhesion and activation. Independently of the wettability, the 
presence of nano features was critical to impede the adhesion of platelets.  Fabrics were also modified to 
obtain other properties such as anti-microbial capacity. The most used process was the coating with 
inorganic-based nanoparticles with anti-microbial characteristics, which in turn increased the roughness of 
the cotton fibers until reach a superhydrophobic behavior. A correlation between low energy surfaces and 
anti-microbial properties was established in absence of added anti-microbial agents.  
Superhydrophobic surfaces demonstrated appropriated properties to execute in vitro tests. Patterned 
platforms exhibiting areas of wettability contrasts were proposed as devices for high-throughput screening. 
Superhydrophobic-based chips could be produced using simple and cost-effective methodologies. Until 
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now the effectiveness in the screening of properties of materials, materials-proteins-cells interactions, cell 
spheroids response to drugs, cell-cell communications and drug release systems was successfully 
demonstrated. Patterned surfaces as open microfluidic devices have been proposed, but applications 
should be better explored in the future.  
For more industrial applications, superhydrophobic surfaces were proposed to suppress some 
disadvantages of the conventional methodologies employed to produce particles. It was demonstrated that 
highly repellent platforms were successful in producing drug release systems or cell-laden spherical 
biomaterials in mild conditions and with high encapsulation efficiency. The nano roughness inherent to 
superhydrophobic surfaces as well as efficient dispensing systems of small droplets have been 
conditioned the production of nanoparticles using this approach.  
 
2.10. Future Perspectives  
Very interesting applications of micro/nano structured superhydrophobic surfaces in the biomedical field 
have emerged in the last few years. The understanding of the biological interactions with this kind of 
surfaces still in immature stage, being required deeper explanations for their performance in vivo. 
Focusing in the particular case of vascular grafts, the examples reported using superhydrophobic grafts in 
animal models are quite inconclusive. We strongly believe that new investigations combining the most 
advanced materials used in those applications combined with cutting-edge technology could bring detailed 
explanation for the real influences of the materials characteristics on hemocompatibility. So far, 
membranes for controlled drug release were the only superhydrophobic systems proposed for implanting. 
The effect of superhydrophobicity should be extend to systems (including 3D devices) such as particles, 
scaffolds, patches, prosthesis with convoluted shapes, among others, and the integration in different 
human body tissues or organs studied in detail.  
We also expect major advances in industrial production of superhydrophobic surfaces, including large 
areas with homogeneous properties and patterned platforms with areas of contrasting wettabilities, which 
in turn could be used as consumable devices in biotechnological and biomedical research and industry. 
Superhydrophobic chips are being well explored for a wide range of screening tests: materials 
characterization, drug screening, in vitro biological testes and in vivo materials testing. Such miniaturized 
systems are cheap alternatives for selection of the most appropriate materials to be applied in the 
biomedical field.  
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Regarding the immature stage of the superhydrophobic-based microfluidic devices it is estimated that in 
the next few years such substrates will be greatly explored for medical diagnosis, biomaterials testing or 
even in cell studies.  
The use of superhydrophobic surfaces as platforms for producing particles has also demonstrated great 
advances in the last 4 years. Despite all the advantages of the technique and the different systems 
developed to encapsulate cells and drugs, efforts have also been done to decrease the size of the particles 
to amplify their possible applications. The size of the particles is limited by the dispensing system used as 
well as by the peak-to-peak distance of the surfaces roughness. In order to scale up this 2D particles 
production technology the development of an accurate automatic dispensing system is required.  
One of the most obvious application of superhydrophobic films is the coating of textiles to avoid the water 
impregnation. However, the full potential of these special textiles in biomedical applications have not been 
explored, in particular the combination of such properties with others (e.g. stimuli responsiveness, 
advanced mechanical properties, anti-microbial).  
The fast growing in the application of the superhydrophobic surfaces in the biomedical field verified in the 
last 5 years was an impulse for the pursuance in exploration for more applications that will require the 
effort of multidisciplinary and creative teams.  
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Chapter 3 
Advances in Particulate Systems for Biomedical Applications: Non-
Spherical and Compartmentalized Approaches 
 
3.1. Abstract  
The search for more efficient therapeutic strategies and diagnosis tools is a continuous challenge. The 
discovery of new active substances requires a significant adaptation of the existent formulations as well as 
the methodologies to produce carriers preserving drugs stability and bioactivity. Until few years ago the 
most relevant parameters in particles formulation were the chemistry and the size. Currently, it is known 
that other physical characteristics can remarkably affect the performance of particulate systems. Advances 
in understanding the biological mechanisms behind diseases and tissues regeneration have widened the 
field of applications of particulate systems. Particles are no more just protective systems for the 
encapsulated drugs, but they play an active role in the success of the therapy. Moreover, particles have 
been explored for innovative purposes as templates for cells growth and as diagnostic tools. Particles with 
non-conventional shapes exhibit advantages due to the increasing circulation time in blood stream, less 
clearance by the immune system and more efficient cell internalization and trafficking. Creation of 
compartments has been found useful to control drug release, to supply the target with more than one 
bioactive agent or even to act as theranostic systems. It is expected that such complex shaped and 
compartmentalized systems improve the therapeutic outcomes and also the patient’s compliance, acting 
as devices that serve for simultaneous diagnosis and treatment of the disease, combining agents of very 
different features, at the same time. In this chapter, the most recent advances in particle shape and 
compartmentalization and applications of newly designed particulate systems on biomedical field are 
analyzed at the light of relevant examples. 
 
 
This chapter is based on the following publication:  
Lima A. C., Alvarez-Lorenzo C. and Mano J. F., Advances in particulate systems for biomedical applications: non-spherical and compartmentalized approaches, 
Submitted.  
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3.2. Drugs and Cells Encapsulation: Opportunities and Challenges 
Particulate systems have been widely used as containers of drugs or cells with the purpose of releasing 
them in a certain site to prevent or treat a variety of diseases or trauma. Particles designed with adequate 
properties have also been used as diagnosis tools or even as bioreactors.  
In the particular case of pharmaceutical applications, the discovery of new bioactive substances (e.g. 
peptides, proteins, and nucleic acids) brings new challenges related to the needs of overcoming the 
deficient solubility/stability of a large number of both synthetic and biotechnological-origin substances as 
well as of improving the efficiency and safety profiles of old drugs as a way to extend their therapeutic and 
commercial value [1,2]. Among other various approaches, encapsulation into optimized particles is 
opening new opportunities. In general terms, encapsulation is the process to confine bioactive agents into 
a matrix, generally in a particulate form, in order to confer protection, control the release and/or even 
target the molecules to the site of action. Prior to designing the carrier for a drug, several parameters that 
could affect the efficacy of the system must be considered – see Figure 3.1.  
 
Figure 3.1. The chemistry at surface and bulk level as well as the physical features such as mechanical properties, size, 
porosity, surface topography/texture, shape and compartmentalization should be carefully considered during the 
design/engineering of particulate systems for biomedical applications.  
 
Important challenges in the designing of drug delivery systems are efficient drug encapsulation and spatio-
temporal control of the release. Particle features will define biodistribution, drug release profile, targeting 
and clearance of the encapsulated drugs [3]. The most used routes for drug administration are oral, 
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transdermal, intravenous, subcutaneous, in situ implanting and inhalation. In the last few years 
sophisticated advanced dosage forms have been presented to facilitate the administration and local or 
systemic release of the drugs, but also to sense the microenvironment along the pathway to achieve the 
target site circumventing certain barriers and responding to the therapeutic demands [4].  
A huge challenge in particles engineering is the development of systems capable to mimic the natural 
phenomena of the human body´s. For example, particles have been proposed as artificial Antigen 
Presenting Cells (aAPCs), where the antigen may be encapsulated or disposed onto the particle surface, 
for vaccination, with the aim to protect or to treat diseases manipulating the immune responses. Vaccines 
could promote either immunity or tolerance and are responsible to generate antibodies and activate T or B 
cells in order to protect the body against future pathogens encounter as well as against the attack of 
diseased cells such as tumors. This is a complex process involving different cell types (e.g. dendritic cells, 
T and B cells) and signaling molecules such as inflammatory and suppressive cytokines [5]. 
Another example of the complexity of human body is occurred when a tissue is damaged. In such cases 
many natural biomolecules diffuse into the required sites to trigger the adequate cell response in an 
attempt to restore the tissue homeostasis. Growth factors and cytokines are very important biomolecules 
acting integrated with other biomolecules within a timing period and in a specific cell phenotype [6]. In 
general, orchestrated interactions are involved, determining a complex sequence of cell migration, 
proliferation, differentiation and protein synthesis. Skin wound healing [7], bone repair [8,9], 
reestablishment of vascularized networks [10] are examples of natural processes highly dependent on the 
coordinated activity of biomolecules release and different cell types activity. The administration of drug 
release systems capable to sustain the plasma concentration of natural bioactive agents or mimic the local 
signaling is a strategy explored in many therapeutic applications. Recombinant growth factors [6] or even 
cocktails of these kind of proteins obtained from the platelets existent in the blood plasma (platelet lysates) 
[11] have been used as bioactive agents for regeneration of several tissues. Vascular endothelial growth 
factor has been used to promote angiogenesis and for ischemia treatment [12,13]; bone morphogenic 
proteins for bone regeneration [14]; epidermal growth factor for treatment of skin lesions resultant from 
burns or chronic ulcers [15]; glial cell-line neurotrophic factor for spinal cord injuries or peripheral nerves 
regeneration [16]; and IL-10 for treatment of inflammatory bowel disease and to suppress inflammation 
[17–19]. Nevertheless, the main limitation of those systems relies on over simplification because typically 
only one bioactive agent is delivered with the risk of providing supraphysiological doses or even not 
triggers a complete and fast desired effect. Currently, it is known that in the natural milieu multiple signals 
act in a spatiotemporal controlled manner. Different cells could release the same biomolecule 
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simultaneously or at different time, and the same type of cells could release multiple biomolecules also 
simultaneously or following different patterns [20]. Thus, sophisticated drug carriers are required in order 
to mimic better the natural physiological processes.  
Several strategies have been proposed to regulate the release of the bioactive agents (Figure 3.2) playing 
with the materials used to produce the particles as well as with the structural design of the system.  
 
 
Figure 3.2. Strategies to encapsulate single bioactive agents in a matrix: A. adsorption/immobilization onto the surface of the 
particles; B. physical dispersion inside the matrix: homogeneous arrangement or exhibiting some special organization (e.g. 
gradients); C. establishment of links between the particle matrix and the bioactive agent (e.g. covalent bonds, electrostatic 
interactions, among others); D. encapsulation in a multiscale system where the bioactive agents are encapsulated into small 
matrices which in turn are encapsulated in higher scale structures (e.g. nanoparticles inside microparticles).  
 
The simplest and more conventional strategies to encapsulate molecules are the surface 
adsorption/immobilization (Figure 3.2 A) and the physical dispersion of the drug inside a matrix (Figure 
3.2 B). The dispersion into the matrix could be performed before the particles processing or by 
impregnation of the prepared ones. In this strategy, when more than one drug is encapsulated, the release 
of the substances will occur simultaneously; the differences in release rate may only depend on the 
molecular size and establishment of interactions of each molecule with the network (Figure 3.2 C). A more 
complex approach to control the release is to encapsulate the drugs into nano- or micro-particulate 
systems, which in turn will integrate bigger particles (Figure 3.2 D). Multicompartmentalization enables 
efficient protection of each substance when entrapped into individual compartments as well as a precise 
tailoring of its release pattern. The first steps in developing multicompartmentalized systems not only for 
drug release but also for cell encapsulation and diagnosis have already been done. However, the 
production of such sophisticated complex systems is quite far to be scaled up and commercialized.  
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Particulate systems have also demonstrated to be suitable for diagnosis. Combination of elements for 
diagnosis and therapeutics in the same particles has emerged due to the increased concern in 
development of noninvasive diagnostic and more efficient therapeutic tools. Theranostic systems have the 
ability to target and treat a specific disease while the particles localization is monitored by imaging tools. 
Depending on the contrast agent used, particles localization may be followed by optical and nuclear 
imaging, magnetic resonance imaging (MRI), computer tomography (CT) or ultrasound imaging (US) [21]. 
The design of such multiple functional particles should involve the definition of adequate materials to 
prepare the particles matrix and coatings, targeting, detection components, and the bioactive agents – 
Figure 3.3. The complexity of these systems, due to the wide range of characteristics, turns their 
production a challenging process. 
 
 
Figure 3.3. General architecture of theranostic particles and key components: targeting entities, therapeutic molecules, 
detection components and a coating or a polymeric matrix to support the previous enumerated entities. Image from the 
reference [21].  
 
Although a strong evolution have been seen in the development of advanced particulate systems for drugs 
encapsulation and diagnosis, different strategies to treat the wide range of diseases that could affect the 
humans have been proposed as alternatives. The continuous development of innovative particulate 
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systems is a huge demand with the aim to achieve more efficient and faster treatments as well as to 
reduce the side effects of the existent treatments. In this context, the combination of cells with particulate 
systems has been emerged as new tools: particles may be capable to be internalized by the cells, may act 
as protection and support for cells encapsulated in the matrix of the particles or even act as cell support 
where cells may adhere onto the particle surface. In cell-based therapies, when the cells are administered 
without a biomaterial carriers occurs a fast loss of cells (>90%). A very small percentage of cells remain in 
the tissue site of interest [22–25]. In addition, many cell types require sites of adhesion in order to be 
alive and proliferate; the particles could then provide anchoring ligands or even an appropriate 
microenvironment to enhance the functions and integration of the transplanted cells [26–28]. Autologous 
or non-autologous cells could be isolated and immobilized in particulate systems capable to control the 
diffusion of molecules and the release of the cells – Figure 3.4. Adequate cell types should be selected 
and integrated in the particulate systems according to the needs of the patients. Primary cells [29], stem 
cells [30–32] and bioengineered cells [33,34] are considered a valuable strategy for treatment of disease 
or even for regeneration of tissues.  The encapsulated cells could segregate biomolecules (e.g. growth 
factors) and the matrix could act simultaneously as a cell reservoir and a release system of bioactive 
agents. Cells could have a relevant role in therapies when are able to supply bioactive agents such as 
insulin in diabetes [35], erythropoietin in anemia [36] and factor VIII and IX in hemophilia [37]. Cells can 
be also manipulated to deliver non-autologous therapeutic agents for cancer therapy [38] and bone repair 
[39]. In xenotransplantation, the particles should also provide protection against the immune system 
through blocking antibodies and T cells [40].  
Generally the cells are entrapped in homogeneous spherical matrices but the adequate structuring of 
particles may widen cell applications in therapeutics. For example, the encapsulation of more than one 
cell type, in individual compartments may be advantageous in complex therapies involving multiple cell 
types or signaling processes. The particles could help in reducing the necessity of immunosuppressant 
drugs and also fix protected cells in the place where they are necessary to promote the recreation and 
maintenance of functional tissues [41,42]. The cutting edge discoveries in the design of biomimetic and 
biodegradable microcarries with characteristics to be combined with different types of cells leads to a 
burgeoning number of possible therapeutic applications. An overview of microparticulate systems for cell 
encapsulation including the use of natural-based macromolecules and examples of application in 
biomedical field has been reported elsewhere [40,41].  
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Figure 3.4. Main requirements of particles for cell encapsulation: protection against immune cells and antibodies, adequate 
diffusion properties to allow the entrance of nutrients and O2, and the expelling of metabolites and growth factors.  
 
It is important to notice that until now the most explored particles exhibit a spherical structure. This is the 
most stable shape resulting from the maximization of the volume/surface ratio. The surface tension tends 
to be minimized and the particles reach a spherical shape [43]. Spheres are obtained spontaneously in 
the most used methodologies to produce particles (e.g. emulsions and spraying) and for this reason it is 
the most studied type of architecture. However, particles with chemical and structural anisotropy have 
gained importance in the last few years due to the possibilities they offer for regulating several processes 
inside the human body. A huge variety of particles prepared from one or more materials, with varied 
chemical properties and architectures have been proposed for biomedical applications, namely therapies, 
diagnosis, vaccination and tissue regeneration. This chapter intends to provide an overview of the 
evolution of the particulate systems as drug and cell carriers in order to fulfill the complex demands of 
diagnosis and therapeutic strategies. An explanation of the main formulation and design parameters of the 
particles will be provided. In particular, our attention will be focused in the most sophisticated design of 
particulate systems, comprising the non-spherical shape and the compartmentalization. Non-conventional 
architectures are relatively recent emergent areas and for this reason a compilation of composition, 
preparation and biomedical applications of particles with those parameters will be extensively analyzed.  
 
3.3. Design Criteria of Particulate Carriers 
Strategies to improve the pharmacokinetics and biodistribution of the drugs in the organism have been 
developed mainly based on the use of polymeric particles, liposomes, dendrimers and micelles. 
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Depending on the application and administration route, several physicochemical parameters should be 
considered in the design formulation of such systems [44]. This is also valid for diagnosis particulate 
systems as well as for particles acting as cells carriers or cell support. In the case of particles combined 
with cells, the physical and chemical properties of the matrix should be capable to maintain the viability of 
the cells and to permit the integration of the system in the host to achieve the desired therapeutic effect. 
The main parameters to consider during the design of the particles will be discussed in the following 
subsections.  
 
3.3.1. Surface and Bulk Characteristics 
The properties of the biomaterials regulate their interaction with the biological milieu, thus dictating the 
success or the failure of the entire system. In the past, the development of biomaterials for drug delivery, 
tissue engineering and others biomedical purposes was greatly focused in controlling the chemical 
characteristics. Synthetic or natural-based polymers are the most used source of materials in particulate 
formulations for drug/cells encapsulation. Playing with their molecular weight, combination of different 
polymers (e.g. copolymers, interpenetrated networks, semi-interpenetrated networks) and with the nature 
of other excipients required for drugs stabilization, appropriated formulations can be designed to fulfill the 
required demands [45,46] (Figure 3.1 A). A lot of discussions have been centered in the use of either 
synthetic or natural polymers to meet on-going and evolving challenges in biomedical applications. Both 
types of polymers have advantages and disadvantages and for this reason great efforts have been done to 
formulate systems combining different polymers. Inorganic materials such as silica-based networks or 
metal oxides have also been proposed as components of drug delivery systems and diagnosis tools due to 
their biocompatible properties and their hydroxyl groups rich surface that prevents their clearance from 
the body [47]. Since the interaction of the particles with biological moieties occur firstly on the surface, 
great attention has been focused on the modification of the surface chemistry in order to minimize the 
recognition by the immune systems [48,49] or even to promote specific cell adhesion [50] (Figure 3.1 A). 
The spontaneous coating of particulate carriers upon administration, generally by albumin and antibodies, 
results in their quick immune clearance. The phagocytic cells are not capable to recognize particles 
without bound or adsorbed opsonins onto their surface.  In the presence of opsonins there are different 
processes through which phagocytic cells can identify the particles: one of the processes is mediated by 
receptors of the phagocytic cells that recognize active proteins on the particle surface; the other is related 
to the non-specific adherence of the phagocytes to the particles exhibiting a hydrophobic surface due to 
the protein coating [51]. Opsonization was also shown to be dependent on the charge of the surfaces of 
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the particles [51]. Typically, due to the nature of the cellular phospholipid membrane, positively charged 
particles have high tendency to attach and being internalized, when compared with negative or neutral 
ones [52]. Thus, the main strategy used to minimize the recognition and the consequent early clearance 
of the particles is the coating of the surfaces with hydrophilic and non-ionic or negative-charged molecules. 
With a completely different objective, the surface of the particles could be modified with targeting ligands, 
which directly and indirectly control the biodistribution and clearance of the particles [53].  
Similarly to the surface, the bulk of the particles also play a crucial role in the success of the systems. The 
materials used to obtain the bulk of the particles should degrade at adequate rates without releasing toxic 
degradation products.  
In the case of drug release systems erosion and degradation (both at surface and bulk) affect directly the 
drug release rate [54]. In the case of drug carriers, the interaction of encapsulated drugs with the 
materials constituting the bulk of the particles is other strategy used to control release of the drug 
molecules. This involves the selection of materials able to establish physical or chemical linkages with 
drug molecules and, upon physiological environment, release them without loss of bioactivity [55,56]. The 
porosity and network density derived from the concentration or cross-linking of the material are also 
relevant parameters to have into account during the particles design, due to their influence on control of 
the bioactive agents release. In the case of cell encapsulation, a suitable matrix must biocompatible and 
support cell survival and prevent necrosis within the particles. Then, the matrix must be permeable to 
oxygen, to incoming nutrients and outgoing toxic metabolites [40]. In specific cases, when the entrapped 
cells are able to secret molecules of interest (e.g. growth factors), the matrix should also allow the 
diffusion out of those bioactive agents. Ideally, the bulk of the particles should also provide anchoring 
points for cell attachment and proliferation, which implies the selection of adequate materials [57] capable 
to mimic the extracellular matrix (ECM). The degradation kinetics of the bulk must also be considered. It 
should be adequate to application: it must be slow when the aim is protect the cells or more faster when 
the aim is to supply the damaged site with cells. Upon degradation, the entrapped cells may proliferate 
and fulfilling the damaged tissue and secreting their own ECM.  
 
3.3.2. Size 
 Physical aspects of the particles, including size, shape, mechanical properties, surface texture and 
compartmentalization have gained increased attention of researchers due to the needs for improving the 
existent therapies or even to develop new strategies for diseases that currently do not have an effective 
therapy or an early diagnostic. Currently guidelines related with the most appropriated sizes are quite well 
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established according to the administration route as well as to obtain the therapeutic effect desired 
[58,59]. The size is one of the parameters that dictate the in vivo behavior of the particles, for example, 
circulation time, extravasation, targeting, immunological recognition, cellular internalization and trafficking, 
degradation and clearance [60].  Macro, micro and nano-scale systems have been produced using a 
variety of methodologies: emulsifying followed by cross-linking or solvent evaporation, self-assembly, 
microfabrication procedures, jet breaking, or superhydrophobic surface processing among many others 
methodologies [58,61]. Control of the particle size depends on the production method utilized, which in 
turn should be adequate to process the selected materials. Volumes of the precursor solutions dispensed 
by nozzles, micropipettes, spraying systems, or the mixing conditions (stirring, sonication, vortexing) 
control the size of the particles obtained.  
In the case of intravenous applications, particle size has a significant impact on circulation time and in the 
hydrodynamics forces while flowing in the blood stream. Particles larger than 1.5 µm are not 
recommended due to the risk of obstruct the smallest capillaries and because they are rapidly cleared 
from the circulation. In general, particles smaller than 100 nm are capable to leave the blood stream 
through the fenestrations between the endothelial cells that composed the blood vessels [62]. This is the 
main driving force to develop passively target systems for tumor diagnosis and treatment, since such 
regions are highly and leaky vascularized [63].  
Particles are susceptible to be cleared by spleen (>200 nm) and kidneys (<10 nm) [64], as well as to be 
captured by the Kupffer cells of the liver. Independently of the administration route, the size of the 
particles influences the cellular uptake, namely phagocytosis and endocytosis. Generally, smaller particles 
are internalized by endocytosis and larger ones (>500 nm) by phagocytosis, but the last pathway just 
occur in specialized cells, such as macrophages [43]. However, exceptions have been verified: for 
example endothelial cells have shown the capacity to internalize particles with 5 µm via endocytosis [65]. 
The intracellular transport to reach the targeted organelle is also dependent on the size of the particles. 
Non-phagocytic cells could internalize particles smaller than 1 µm through different pathways and smaller 
particles (<200 nm) reached faster the lysosomes than the larger ones. This information could be 
particularly important for drug and gene delivery because controlling the size of the particles, the 
residence time of the release systems inside the cells may be prolonged and a rapid lysosomal 
degradation may be avoided, improving the approximation of the particles to the nuclei of the cell [66]. 
Relevant sizes for in vivo performance are summarized in Table 3.1.  
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Table 3.1. Relevant sizes in biological systems. Adapted from [62]. 
Size Statement 
4.5 nm and 25 
nm 
Endothelium normal tissue has abundant small pores and a few large ones.  
100 nm Recurrent size of the drug-loaded polymeric micelles used in clinical trials.   
150 nm Adequate size for extravasation in liver. The fenestrations of blood vessels in the liver have 100-175 nm.  
200 nm 
Particles larger than 200 nm have short circulation because they are uptaken by the reticuloendothelial 
system.  
380 nm 
Appropriate size for application in tumor tissues. The cutoff of porous blood vessels in tumors is around 
380-780 nm.  
500 nm Maximum size of particles aimed to penetrate through cell membrane.  
1 µm Particles below this size may enter in the lymphatic system and migrate to mesenteric lymph nodes.  
5 µm Maximal size for rigid particles to circulate within the smallest capillaries.  
40 µm Sizes higher than 40 µm are used in embolization therapies.  
 
The size and density of the particles are also an important parameters of systems administered through 
the pulmonary route. The deposition of the particles occurs mainly at near airway bifurcations, where the 
velocity of airflow is high and where changes in the direction of bulk airflow occurs, generating inertial 
forces. Such inertial forces induce the impaction of large particles onto the airway surface. Gravitational 
sedimentation is responsible for the deposition of particles with sizes ranging from 0.5 to 5 µm in the 
small conducting airways, where the air velocity is low. Particles smaller than ca. 0.5 µm follow a 
Brownian motion and are mainly deposited in small airways and alveolar region, where the airflow is also 
low. Due to the Brownian movements, submicron particles require a long time to deposit, being exhaled in 
a very fast way after administration. In addition, particles with 5 µm or even more are highly susceptible to 
be cleared or even retained in the upper airways, being the combination of chemical and physical 
properties a strategy to circumvent such paradox [67]. In a general way, the particles for pulmonary 
administration are designed with geometrical sizes ranging from 1-5 µm with densities ca. 1 g/cm3. 
Suitable particles for this application may also be designed with a non-standard density and geometrical 
size. Large porous particles, with a density of 0.1 g/cm3 and diameter of ca. 7 µm, showed higher 
accumulation in the lungs than the non-porous counterparts (density ca. 0.94 g/cm3) [68]. Porous 
particles with diameter >5 µm and non-porous particles with diameter <5 µm, derived from the same 
polymer and encapsulating insulin were compared [68]. Only porous particles were capable to maintain 
the high levels of insulin in the blood for more than 4 hours. The low clearance of the porous particles by 
phagocytic cells was also confirmed. After inhalation ca. 30% of phagocytic cells contained non porous 
particles and only ca. 8% contained porous particles [68]. Thus, the size is not the only parameter 
influencing the performance of the particles; such examples showed that the design of new carriers 
involves others particles characteristics, such as structure (density). 
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In the specific case of particles encapsulating cells, the size of such matrices should be adequate to 
ensure the adequate diffusion of nutrients and gases to all the cells entrapped in the network. This is 
particularly relevant when the particles have high diameters and, as a consequence, the cells in the core 
have restricted access to nutrients and O2 and the metabolites do not diffuse out and accumulate around 
the cells causing viability loss.  
 
3.3.3. Mechanical Properties  
The capacity of the red blood cells to cross through the capillaries fenestrae even when the diameters are 
smaller than the own diameters of the erythrocytes, demonstrate that the mechanical properties of the 
carriers could be an important characteristic to achieve the target site. The potential of the rigid particles 
to clot the vessels turned the flexibility a relevant property of the particles. It has been demonstrated that 
flexible structures exhibit higher circulation times and suffered phagocytosis by macrophages in lower 
extension than rigid ones [69] for particles exhibiting similar chemistry and size; correlations between 
Young modulus of the particles and the uptake rate of internalization have been proposed [70]. Cells 
exhibit a different behavior when contact with materials having different mechanical properties [71,72]. In 
addition, it is important to note that the mechanical properties exert an effect on cell behavior in 
combination with other particles characteristics, namely material chemistry, size and shape [69,73]. The 
mechanical properties of the particles also influence the pathway followed in the endocytosis process [70]. 
For example, hydroxyethyl methacrylate (HEMA) particles were prepared with different crosslinking 
degrees to exhibit different mechanical properties [74]. Although the softer particles showed higher 
swelling when immersed in cell culture medium, the size of all the formulated particles was similar. Cells 
derived from a hepatocellular carcinoma (HepG2) internalized softer particles at a faster rate and larger 
amount than stiffer ones (Figure 3.5 I). The mechanical properties of the particles did not affect the cell 
viability. The cell adhesion was lower when the cells were cultured with stiffer particles. The organization of 
the cytoskeleton was also affected after internalization of both types of particles (Figure 3.5 II).  
In the specific case of cell encapsulation for tissue engineering and regenerative medicine purposes, the 
mechanical properties of the matrices may greatly influence the differentiation of stem cells into certain 
phenotypes.  One specific case is the differentiation of mesenchymal stem cells: on stiff substrates bone 
differentiation is promoted, but in soft matrices the differentiation into adipocytes is privileged [71]. When 
the cells are entrapped inside matrices they interact with the material, generally the first happening is cell 
adhesion. Regarding that the mechanical properties of materials surfaces exert an effect on cell 
differentiation, probably into 3D particles any effect could also occur. However, more studies are required 
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in order to deep the knowledge about the effect of mechanical properties of the matrices in the 
encapsulated cells.  
 
 
Figure 3.5. I. Internalization of HEMA particles exhibiting soft and stiff characteristics by HepG2 cells. The cells internalized 
higher amounts of soft particles. No particles (soft or stiff) were observed colonizing the cell nuclei. In both cases the particles 
were distributed in the cell cytoplasm (inside lysosomes) and no differences between both types of particles were observed. II. 
Effect of stiffness of the particles in cell cytoplasm after 24h. The F-actin organization changed after particles internalization. 
Independently of the mechanical properties of the particles a reduction of the oriented stress fibers was observed. Image 
adapted from [74].  
 
3.3.4. Shape 
Natural “particulate” systems are characterized by a huge variety of physical structures and shapes that 
facilitate their functioning. For example, bacteria are identified by their unique shapes, namely, rods, 
spirals and ellipsoids [75]. Even in the human body, very different shaped cells may be found: 
erythrocytes, platelets and endothelial cells have completely different shapes as well as mechanical 
properties, which are according to their different functions.  
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Currently, it is well known that shape, along size and chemistry, plays a crucial role in drug delivery [76]. Recent 
studies reporting the potential of anisotropic particles as drug carriers revealed, in most of cases, satisfactory 
results. The shape of the particles could be seen as an active parameter influencing directly and indirectly the 
performance of the systems. The anisotropic structure of the non-spherical particles confers unique degradation 
profiles to the particulate systems [76] and may greatly influence drug release kinetics. Several methodologies have 
been proposed to produce particles with complex shapes [77–79]. One versatile technique proposed by Mitragotri’s 
group, permitted to obtain a wide range of particles shape comprising sizes between 60 nm and 30 µm is related 
with the stretching of spherical particles [79]. Films prepared from a suspension composed by spherical polymeric 
particles and polyvinyl alcohol were stretched enabling the production of particles with different shapes.  
Representative shapes of the obtained particles are depicted in Figure 3.6: rectangular disks, rods, worms, oblate 
ellipses, elliptical disks, UFO’s, barrels, bullets, pills, pulleys, biconvex lenses, ribbons, bicones, diamond disks, 
emarginated disks, flat pills, elongated hexagonal disks, ravioli and tacos (Figure 3.6). The therapeutic benefits of 
non-spherical shaped particles when used mainly as drug carriers have been demonstrated in the last few 
years. The main differences in the interaction of spherical and non-spherical particles with biological 
entities will be described below.  
 
Chapter 3 Non-Spherical and Compartmentalized Particles for Biomedical Applications 
!
! 85!
 
Figure 3.6. Variety particles shapes produced by heating and stretching polystyrene spheres in one and two dimensions: A) 
Spheres; B) Rectangular disks; C) Rods; D) Worms; E) Oblate ellipses; F) Elliptical disks; G) UFOs; H) Circular disks; I) Ribbons 
with curled ends; J) Bicones; K) Diamond disks; L) Emarginate disks; M) Flat pills; N) Elongated hexagonal disks; O) Ravioli; P) 
Tacos; Q) Wrinkled prolate ellipsoids; R) Wrinkled oblate ellipses; S) Porous elliptical disks; T) Barrels; U) Bullets; V) Pills; X) 
Pulleys; Y) Biconvex lenses. Adapted from [79].  
 
3.3.4.1. Effect on Circulation and Biodistribution 
Several in vivo studies demonstrated that particles with non-spherical shapes have different 
distribution/accumulation profiles in spleen, lungs, and tumor tissues, when compared with their spherical 
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counterparts [77]. The orientation of non-spherical particles when flowing in the blood stream is crucial for 
their clearance from circulation. In the case of spherical particles, circulation can be easily predicted due 
to their isotropy. However, the movements of non-spherical (anisotropic) particles are much more complex 
because such particles may align or tumble inside a fluidic stream [76]. For example, filamentous flexible 
micelles (filomicelles from di-block copolymers such as poly(ethylene glycol)-poly(caprolactone) (PEG-PCL) 
and poly(ethylene glycol)-poly(ethyl ethylene) (PEG-PEE)) were kept in the blood circulation for more time 
than spherical and shorter filomicelles due to their alignment with the blood flow [80]. Disk-shaped 
liposomes also demonstrated higher circulation time when compared with spherical counterparts [81].  
Undesirable structures are filtered in the spleen and liver by passing through slits between the endothelial 
cells that compose the blood vessels. For example, spherical particles should have less than 200 nm in 
diameter to be eliminated in the spleen. Abnormal or worn-out red blood cells, which are disk-shaped 
structures with a diameter of ca. 10 µm, are normally eliminated in the spleen, liver and bone marrow, 
indicating that the shape and mechanical properties could be more relevant than the size itself. The 
flexibility of red blood cells allows their passage through very small fenestrations. The ability of the 
particles to cross the fenestrations of the blood vessels is extremely important in applications regarding 
tumor diagnosis and treatment.  The effect of shape of silica particles on the accumulation in organs when 
injected intravenously was analyzed for spherical, hemispherical, discoidal and cylindrical particles 
comprising approximated volumes and sizes [82]. Organ accumulation varied significantly with the shape 
of the particles: in the lungs discoidal particles accumulated 4 times more than spheres and 8 times more 
than cylinders and hemispheres; in the liver cylinders accumulate 2 times more than spheres and 
hemispheres and 5 times more than discoidal particles, and no differences were visualized between 
spheres and hemispheres; in the heart discoidal particles accumulated in major level than the other three 
shapes; in the spleen no differences were obtained for discoidal and hemispherical particles, but both 
accumulate more than cylinders and spheres. The influence of the shape was not noticeable in tumorous 
tissues, brain and kidneys, probably due to the large size of the particles for being retained in these 
tissues. Although more studies are required to understand so different interactions, elongated particles, as 
the case of discoidal ones, seem to be more capable to escape to internalization by different cell types. 
Discoidal particles showed larger propensity to adhere to the vessel because they drifted laterally towards 
the walls when flowing in the blood stream, which justify their lower accumulation in the liver where the 
main sequestration mechanism is performed by Kupffer cells. In general, the cells easily internalized the 
other shapes, namely spherical, quase-hemispherical and cylindrical, which had an aspect ratio closer to 
the unit. The major conclusion from the studies described above is that geometry has a huge effect on 
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biodistribution and should be carefully considered during particles design depending on the final aim to be 
achieved both in therapeutic or imaging puroposes. 
 
3.3.4.2. Effect on Internalization and Trafficking  
The shape influences cell internalization as well as particle trafficking in the cell cytoplasm [43,83]. Cell 
attachment onto the particle surface is the first event in the internalization. Phagocytosis is an innate 
immune process related to the clearance of undesirable particles, such as rod-shaped and spiral-shaped 
bacteria, disc-shaped cells such as old erythrocytes and airbone particles such as pollen and dust. These 
examples present very peculiar non-spherical geometries [84]. In the case of more elongated particles, the 
region where the macrophages firstly adhere will dictate if the cells will be capable to internalize the 
particles or just spread onto their surface. Champion and Mitragotri [84] studied the effect of size and 
shape (spheres, oblate ellipsoids, prolate ellipsoids, elliptical disks, rectangular disks and particles with a 
shape similarly to UFO’s) in phagocytosis, using polystyrene particles. The results confirmed a strong 
dependence on the shape, specifically on the point of the initial contact between particles and cells. For 
elliptical discs, if the contact occurs at the pointed end, the particles are internalized in a few minutes, but 
if the contact is done on the flat region, the macrophage is not able to internalize the particle (Figure 3.7 
I). Similarly, UFO’s-like particles were internalized when the contact between the macrophages and 
particle occurred either at the dome or the ring regions but not when it happened at the concave region 
(Figure 3.7 II). In a more detailed study, it was shown that the shape of the particles influences 
independently macrophages attachment and internalization. Attachment was higher for prolate and oblate 
ellipsoids than spheres, but for the same time period the most internalized particles were the oblate 
ellipsoids and the spheres. Phagocytosis is related with the remodeling of actin cytoskeleton and the 
shape determines the extent of this process, which in turn determines the velocity of the particle 
internalization. Probably, the lower aspect ratio of oblate ellipsoids is related with less actin rearrangement 
and a faster/more efficient internalization [85]. 
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Figure 3.7. I. Interaction of macrophages with polystyrene particles with non-spherical (A, B D and E) and spherical (C and F) 
shapes. II. The plot indicates the first point of contact between the macrophages and the particles as well as the velocity of 
internalization. The images were adapted from [84]. 
 
The effect of the shape on endocytosis by HeLa cells (from cervical cancer) was studied using cubic and 
cylindrical-shaped PEG hydrogel particles obtained by particle replication in non-wetting templates [86]. 
Cubic particles with side lengths of 3 and 4 µm were not internalized whereas with 2 µm were internalized 
by most cells. Cylinders were internalized at higher percentage than cubes, but the kinetics of 
internalization varied with the aspect ratio: internalization was 4 times faster for cylindrical-shaped 
particles with high aspect ratio when compared with lower ones. Similar results were obtained in a study 
where larger amounts of higher aspect ratio rod-shaped mesoporous silica particles were internalized in a 
fast way by A375 human melanoma cells [87]. F-actin proteins of the cells that internalized the particles 
with high aspect ratio, appeared disrupted and disorganized. In addition, the F-actin network was 
anisotropic with poorly formed filament bundles accumulated in cell membrane and at the edges of the 
lamellopodium and filopodium. The adhesion of the cells was also influenced when cells and particles 
were cultured in conjoint. Higher cell adhesion onto the cell plates was found in cultures in the presence 
of particles with low aspect ratio. The cell migration was faster in the presence of particles, but the 
spherical ones had a stronger effect than the rod-shaped. All these findings indicate that cell functions 
were greatly influenced by the shape of the internalized particles. Asbestos particles exhibit a fiber shape 
and they are easily uptake by cells. Such particles are well know to affect cell signaling pathways, 
activation of transcription factors and gene expression implicated in the development of inflammation, 
fibroproliferative diseases, and cancers [88,89]. 
Kinetics of the intracellular trafficking was also demonstrated to be dependent on the particles shape. For 
example, spherical and elliptical-disk poly(lactic-co-glycolic acid) (PLGA) particles produced by emulsion 
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and film-stretching method, respectively, were internalized by Human Umbilical Vein Endothelial Cells 
(HUVECs) through an endocytosis process. The internalized spherical particles accumulated around the 
nuclei faster than the disks, meaning that the rate of internalization was higher for the spherical-shaped 
particles [90]– Figure 3.8. This information could be especially important for the design of DNA carriers 
that should deliver their content in the nuclei.  
 
 
Figure 3.8. PLGA particles internalized by HUVECs by endocytosis accumuled around the cells nuclei. In images i, ii and iii it 
is possible visualize the spherical shaped particles and in images  iv, v and vi the elliptical disks. Image adapted from [90].  
 
3.3.4.3. Effect on Cytotoxicity 
Particle shape can also determines cytotoxicity at sub-cellular scale [91]. Cytotoxicity and proinflammatory 
response against lung fibroblasts and alveolar macrophages, respectively, of poly(3,4-
ethylenedioxythiophene) (PEDT) nanoparticles having three different shapes (obtained by chemical 
oxidation polymerization using sodium bis(2-ethylhexyl) sulfosuccinate micelles as the soft template) was 
systematically evaluated. The results demonstrated that not only the concentration and time affected the 
cell viability, but also the particles aspect ratio: when the aspect ratio increased, the apoptosis and 
necrosis decreased. It would be interesting verify cross-correlations with the total volume/size of the 
particles and to check if such behavior could be found in particles produced with other materials and 
surface chemistries. Different (opposite) results were obtained for rod-shaped mesoporous silica particles 
[87]: a slightly toxicity against A375 human melanoma cells was noticed for the particles with high aspect 
ratio. In addition, the cells that internalized this type of particles were more susceptible to apoptosis. For 
polystyrene particles obtained by a film stretching method, endothelial cells in contact with spheres and 
elliptical disks remained spread on the substrate and did not show morphological changes; as expected, 
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the particles were internalized by endocytosis and accumulated around the nucleus [92]. Differently, when 
cultured in conjoint with needle particles, the endothelial cells changed significantly the morphology and 
lower extent of internalization was observed. In this case, part of the cells contracted and others lifted off 
from the culture substrate. Despite of the cytoskeleton changes, these cells showed higher mobility than 
those cultured with spherical or disk-shaped particles allowing to conclude that the contraction of the cells 
was not permanent. The results also demonstrated that needles caused higher membrane disruption than 
spheres, but no significant differences were noticed in the metabolic activity of the cells, meaning that the 
particles were non-toxic. Such polymeric particles could be an innovative strategy for intentional transient 
disruption of cell membranes allowing the entrance of bioactive agents inside the cells and used as 
alternative to conventional methods such as electroporation, ultrasound or chemical penetration 
enhancers. However, very few studies are reported in literature relating the particles shape with the 
viability of the cells. More efforts in this area are required in order to establish the adequate characteristics 
that particles should have for specific applications.  
 
3.3.5. Compartmentalization  
Compartmentalization of particles could be regarded as a biomimetic strategy – Figure 3.9. The interior of 
the eukaryotic cells is divided in compartments (organelles) with a range of sizes varying from 10-25 nm to 
100-500 nm [93]. The proper functioning of the cell depends on a variety of processes involving each one 
of the existent compartments. Although each cell compartment has a specific function, they work in 
cooperation to maintain the functionality of the cell. Even regarding to human body as an entire system, it 
has a very complex architecture divided into compartments (organs) that have specific functions and in 
conjoint have the aim to maintain the system alive.  
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Figure 3.9. Based on the organized structure of the human body which is composed by macro scaled compartments (organs) 
as well as on the micro/submicro arrangement of the organelles inside the cells, compartmentalized particles with a wide range 
of structures have been developed to be applied in the biomedical field with the aim to simulate some complex natural 
biological processes. Images obtained from [94]. 
 
Multicompartmentalized particles have emerged as possible multicontainers to improve the efficiency of 
the particles in certain complex biological applications. In a general way, compartmentalization provide 
several advantages: (i) the possibility to encapsulate more than one drug, cell types or even combine 
drugs and cells in independent regions of the particles; (ii) controlled anisotropy and (iii) hierarchical 
compositions. A wide range of spherical and non-spherical compartmentalized particles with new 
architectures and varying the chemical properties of the compartments has been designed for application 
in the biomedical field. Although the evaluation of the effectiveness of those advanced systems is at an 
early stage, a more detailed discussion on the potential of the use of multicompartmentalized particles in 
multiple biomedical applications is provided in section 3.5 of this chapter.  
 
3.4. Applications of Non-Spherical Particles  
As described in the previous section, shape design may offer interesting possibilities for regulating particle 
interactions with biological entities: internalization, cell trafficking, clearance, circulation in blood stream, 
or toxicity. The control of the biological response through variation in the particles geometry is an 
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interesting point to be explored since the biological responses are, generally, strongly dependent on the 
chemical nature of the biomaterials. The use of systems with non-conventional shape and by playing with 
the aspect ratio of the particles may improve the performance of the system for given biomedical 
applications, as discussed in next subsections.  
 
3.4.1. Elongated Particles 
Non-spherical PLGA particles with an elongated shape were successfully prepared via emulsion/solvent 
evaporation and were loaded with a variety of bioactive agents: a hydrophobic drug (paclitaxel), a 
hydrophilic protein (bovine serum albumin,-), and nanoparticles (cadmium sulfide). PLGA particles 
deformation, size and encapsulation efficiency were tuned by controlling several parameters during the 
production, namely the pH of the aqueous phase, the volume of the oil phase, and the concentration of 
both surfactant and surface-active agents. Such particles were proposed as alternatives to spherical ones, 
with the aim to avoid their clearance during the circulation in the blood stream and also to improve their 
extravasation [95].  
The effect of particle geometry on the interactions with the immunological system was investigated for 
vaccines and anticancer strategies using particles as artificial antigen presenting cells – Figure 3.10. T-
cells are known to provide protective immunity to pathogens.  In addition, it has been explored that T cells 
specific for antigens expressed on tumor cells could be an interesting strategy to treat cancer. Two main 
approaches have been used to amplify the T-cell response: in vitro isolation, expansion and administration 
of tumor-reactive T-cells and immunization of the patient (through administration of natural or artificial 
antigen presenting cells) to induce expansion of the tumor-specific T-cells in vivo [96]. PLGA particles 
coated with anti-CD28 antibody and MHC-IgG dimer were produced in spherical and ellipsoid-shape 
varying long axis lengths, and consequently the aspect ratio to be used as aAPCs [97]. The ellipsoidal 
particles increased the number of CD8+T cells in ca. 3-fold, after 7 days, when compared with spherical-
shaped counterparts. In addition, cell expansion increased with increasing particles aspect ratio. The 
efficacy in activating T-cells in vitro was then analyzed. The formation of conjugates was 2.5-fold higher 
between T-cells and ellipsoids than spheres, which suggested the preference of T-cells for the flat parts of 
the particles. In vivo experiments also confirmed the importance of the shape in cancer treatment. 
Animals injected with ellipsoidal particles showed a delay in tumor growth and higher survival rate over the 
experimental period than animals treated with spherical counterparts.  
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Figure 3.10. General formulation of aAPC: an antibody (anti-CD28) and a dimer (MHC-IgG) were immobilized on the surface 
of PLGA particles (A). The T-cells will recognize such molecules on the particle surface and will interact with particles (B and C). 
The particles with different aspect ratios (D) induced different cell proliferation (E). Higher aspect ratio seemed to increase 
significantly the T-cell expansion. When T-Cells were administered with ellipsoidal aAPCs the increase of the tumor size was 
lower than in the same conditions with spherical aAPCs (F), showing the potential of elongated particles in those types of 
treatments. Adapted from [97].  
 
3.4.2. Erythrocyte-Shaped Particles 
The ability of erythrocytes to circulate for long time periods, to repeatedly deform and pass through narrow 
capillaries and to act as delivery vehicles, has inspired the development of new advanced drug delivery 
systems. There are two main ways to obtain such biomimetic systems: (i) load natural erythrocytes 
without compromise their structure (cargo-erythrocytes or ghost-erythrocytes) or attach physical or 
covalently therapeutic molecules to their external surface; (ii) engineering artificial carriers (generally 
polymeric) mimicking the biological and physicochemical properties of erythrocytes [98]. Erythrocite-like 
carriers have been mainly tested for cancer and enzyme deficiencies treatment due to the capacity to 
efficiently transport proteins, nucleic acids and small-molecule drugs along the bloodstream until reach the 
targeted tissue [99,100]. 
Natural erythrocytes can be loaded with therapeutic agents after being soaked in hypotonic solution, which 
caused the formation of pores (10-500 nm) in the cell membrane. Through those pores, the cell will 
release their natural intracellular content while the therapeutic agents will passively diffuse into the cells. 
The pores have the capacity to reseal and the erythrocytes maintain their biophysical and immunological 
properties [101]. Alternative methodologies do not require the reversal lesion of the natural membranes of 
the erythrocytes. Such strategies consist in conjugation of the drugs to receptors on the cell membrane, or 
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preparing hierarchical carries using drug-loaded artificial lipid vesicles that can diffuse directly into the 
erythrocytes [102]. 
Completely artificial erythrocytes-like structures may be produced due to the advances in 
micro/nanotechnology as well as in materials science. Elliptical polystyrene disks were stretched in a 
plasticized film of poly(vinyl alcohol) and glycerol in order to obtain the discoid shape of the erythrocytes 
[65]. The obtained particles were coated with an anti-intercellular adhesion molecule (ICAM-1, a 
transmembrane glycoprotein used to target intra-endothelial drug delivery systems) and once injected in 
mice showed longer circulation time and lower retention in pulmonary blood vessels compared to 
spherical particles. This could be particularly useful when the accumulation in organs is not desired; poor 
biodistribution for one targeting strategy may be the ideal result for another. 
Erythrocyte-shape soft-hydrogels, composed by PEG, were obtained by stop-flow lithography, in which 
monomers mixed with photoinitiators flowed in microfluidic channels and were crosslinked applying UV 
light irradiation [103]. Such particles were highly deformable and able to pass through very small 
microchannels simulating the small natural capillaries. Ring shaped particles were also produced using 
the same methodology and in comparison with erythrocyte-shaped hydrogels they demonstrated less 
resistance during the passage through the simulated capillaries. The lower cross-sectional area of the 
rings enables their bending with lower energy and an easier passage. This study demonstrated that the 
shape of the particles influence their behavior upon simulated physiological conditions, meaning that 
depending on the function of the carriers, the most appropriate shape should be selected.  
Other strategy used to obtain this kind of shapes was based on particle replication in non-wetting 
templates (PRINT), allowing a precise control of distinct parameters (Figure 3.11) [104]. The obtained 
particles showed that increasing their deformability the circulation time also increased. Higher circulation 
times are interesting properties for drug delivery applications. In addition, the flexibility of the erythrocyte-
like particles also influenced their biodistribution. Organ accumulation was dependent on the flexibility of 
the particles through controlling the crosslinking degree. As represented in Figure 3.11 D in some organs 
were accumulated higher amount of stiffer particles (e.g. in lungs and heart) and in other organs were 
accumulated more the flexible ones (e.g. spleen and blood). These results showed that such erythrocyte-
like particles might be interesting systems for medical imaging where varied biodistributions are often 
desirable characteristics.  
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Figure 3.11. Using a PRINT technique (A), HEA hydrogel particles were obtained with erythrocyte-like structure 
(B). Such particles were capable to pass through very small fenestrations simulating blood capillaries (C). The 
accumulation of the particles in different tissues 2h after administration in mice demonstrated that those particles 
could accumulate in certain organs and such accumulation depended on the particles rigidity (D). Scale bar 20 µm. 
Image adapted from [104]. 
 
Biomimetic hydrogel particles of 2-hydroxyethyl acrylate (HEA) cross-linked with PEG diacrylate (PEGDA) 
with a negative surface charge and adequate elastic modulus exhibited mechanical properties similar to 
those of erythrocytes [104]. As observed for superhydrophobic technology used to produce spherical 
particles encapsulating drugs or cells [42,105–111], the incorporation of drugs (for example) inside such 
artificial erythrocyte-like particles should be relatively simple: just mix the bioactive compounds with the 
material before printing/crosslinking.  
The formation of polyurethane (PU) erythrocyte-shaped particles starting from spherical ones obtained by 
electrohydrodynamic jetting, was analyzed in detail [112]. The concentration of the PU, the temperature 
and consequently the rate of solvent evaporation were crucial parameters to obtain particles with the 
above-mentioned non-spherical shape. In addition, using a co-jetting system, core-shell erythrocytes-like 
particles were obtained (described in detail in section 3.5). Although the main focus of this review is to 
analyze the shape of the particles, the chemistry is other important parameter in the design erythrocyte-
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shaped artificial particles. Such property could be tailored and a compilation with the last advances in this 
area is reported elsewhere [98]. 
 
3.4.3. Non-Spherical Micelles 
Amphiphilic molecules such block copolymers [44] are capable to assemble and form non-spherical 
shaped micelles. Similarly to the examples of particles above described, non-spherical micelles could have 
advantages when applied in the biomedical field either as drug carriers or as diagnosis systems.  
Block copolymers composed by hydrophilic and hydrophobic blocks, namely PEG-PEE or PEG-PCL, have 
shown to form biocompatible filomicelles (worm-like micelles) that remain in circulation ten times longer 
than the spherical counterparts [80] – Figure 3.12. Once loaded with the same dose of paclitaxel, 
filomicelle carries (8 µm) were shown able to cause more cell apoptosis, and consequently be more 
efficient in the in vivo reduction of tumor size after 1 week, than non-encapsulated drug and smaller 
elongated micelles (1 µm). Moreover, compared to animals treated with spherical micelles, those treated 
with poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) filomicelles showed better tolerance to the 
treatment and greater and more sustained tumor shrinkage and tumor cell apoptosis [113]. Since 
flexibility is an important parameter to achieve the target tissues, the performance of PEO-PEE and PEO-
poly(lactic acid) (PEO-PLA) spherical and worm-like micelles was studied through permeation in agarose 
gels as a strategy to mimic porous tissues [114]. Using gels with a pore size of 100 nm, it was verified 
that spherical vesicles stuck at the entrance of the gel whereas the worm-like micelles were capable to 
permeate through the gel due to their shape and flexibility. Paclitaxel-loaded PEO-b-PCL elongated micelles 
can be stored at low temperatures and neutral pH for months, without degradation [115]. In the tumor 
environment, the increase of temperature or environmental acidification triggers a transition from 
elongated to spherical shape, by a degradation process, and accelerates drug release. Such worm-like 
micelles may thus improve the efficiency/safety ratio of the treatment compared to micelles made of 
conventional surfactants.  
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Figure 3.12. A. Filomicelles, in the nanometer scale, resulted from the self-assembly of amphiphilic di-block copolymers. B. 
Fluorescent filomicelles injected in vivo remained in the blood circulation up to one week. C. Longer degradable filomicelles 
circulate longer up to a limiting length. D. Filomicelles with two different lengths and loaded with paclitaxel were administered in 
mice. The filomicelles caused higher tumor cell apoptosis one week after when compared with free drug administration. Larger 
micelles were more effective E. The decrease of the tumor size was more visible in the mice treated with longest filomicelles 
and high drug dose. Adapted from with [80].  
 
Non-spherical micelles also were effective in tumor diagnosis. PEO-PHB-PEO and Pluronic® 127 were 
combined to encapsulate a near-infrared fluorophore into elongated micelles. Such elongated shape 
prevents the clearance of the particles by the first mechanism that acts against particles systemically 
injected (i.e. reticuloendothelial system) through reducing the macrophages uptake. This increased the 
blood circulation time of the particles and their accumulation in tumor region and in liver 24 h post 
administration. Low levels of fluorescence were visualized in other organs, namely, spleen, heart, lung and 
kidney showing promising properties for tumor-targeted imaging and drug delivery [116].  
 
3.4.4. Shape-Switching Particles  
The dynamic modification of particles key properties has gained attention in view to precisely control the 
particle interactions with biological milieu. Stimuli-responsive materials may be used to prepare the 
systems for biomedical applications. These materials may be stable at may be stable along wide ranges of 
some external variable (e.g. pH, temperature, ionic strength) but undergo drastic conformational changes 
upon narrow modification of this variables around a given critical point [117]. Temperature and pH 
stimulus have been exploited and the obtained devices may be capable to display wettability changes in 
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the surface, switch their swelling capability, exhibit sol-gel transition, alter the permeability to molecules, 
exchange their aggregation status (colloidal systems) [117].   
The optimization of particle geometry, parameter known to have a pivotal role in determining the biological 
applications [118], has been studied in detail. Shape-switching particles have been proposed with the aim 
to surpass the requirement of different shapes to achieve the optimum performance of a drug delivery 
system. From the information compiled above none specific shape has been identified as the best one to 
enable the particulate system to accomplish all the desired functions; this means that spherical shape 
may be advantageous for a given application but for others non-conventional shapes could improve the 
performance of the carrier. In many cases the conditions/stimuli that induce shape transitions are quite 
distant from the physiological conditions, limiting their applicability in the biomedical fields. In addition, if 
the shape switching is irreversible, their applicability could also be restricted. Having this into account 
shape-memory systems have been studied [119–121]. These systems can be deformed by application of 
an external stress and fixed in a second shape. This is the temporary shape, which in turn will be retained 
until the shaped body, is exposed to an appropriate stimulus. This stimulus will induce the recovery of the 
original shape.  
Elliptical-shaped PLGA particles showed to switch in real time their shape in response to high 
temperatures (ca. 40 °C) and low pH (e.g. 5). The ellipsoids were obtained by a stretching a film 
containing spherical PLGA particles. Two competing forces (interfacial tension and polymer viscosity) 
modulate the shape of the particles: the interfacial tension between PLGA and surrounding liquid induces 
the change to an energetically favorable shape (spherical, in this case).  The elliptical-sphere transition 
could be induced under physiological conditions (e.g. temperature increased by application of ultrasounds 
or phototermal activation and through the acidic pH of tumoral tissues) over periods ranging from minutes 
to hours or days, being this time controlled by appropriate selection of polymer molecular weight, particle 
size and strength of the stimulus. The increase of the temperature affects the viscosity of the polymer and 
the acidic pH influences the interfacial tension creating favorable characteristics to occur the shape 
switching. Shape change allowed the control of the interaction of the particles with macrophages, and this 
system was hypothesized being useful for preventing premature clearance in the blood stream, and being 
more efficiently used as drug delivery system. Switching of the shape modulates the interactions with the 
cells. The particles with higher aspect ratio (in this case ellipsoid disks) were able to mitigate the 
phagocytosis, increasing their blood circulation time and accumulation in target tissues. This type of 
particles may be useful for tumor therapy: elongated particles can accumulate in tumors via passive or 
active targeting but slow internalization by the target cells. Then, upon accumulation in the desired site, 
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the spherical shape will be advantageous to for faster cell internalization. The shape change of PLGA 
particles is not reversible. An higher level of control on the biological interaction could be possible with the 
use of more sophisticated systems enabling controlled reversible changes of particles shape under 
physiological conditions.  
Six-arm PEG-PCL particles showed reversible shape switching. Such biocompatible and biodegradable 
particles changed their shape from spherical to elliptical either extracellularly or intracellularly with the 
cyclic heating and cooling between 43 °C and 0 °C under a stress-free condition. Similarly, with PLGA 
particles described above, the shape of PEG-PCL controlled the uptake of the particles by macrophages: 
spherical shaped were uptake whereas ellipsoidal with high aspect ratio avoid this interaction [121].  
Spherical micelles composed by DNA-brush copolymers are transformed to cylinders in the presence of 
DNAzyme due to the rearrangement of the copolymer [122] – Figure 3.13. Shape transition was verified 
to be reversible: the cylinders recover the spherical after an input of DNA sequence in the micelles. Once 
again, cylindrical micelles showed prolonged blood circulation times [80], while the possibility to control in 
a reversible manner the shape of those particles was valuable for tailor the interaction with cells.  
Another approach consists in playing with the degradation of the particles in order to modify the shape of 
the particles over time. For example, photo-curable hydrogels of PEG and PLA copolymers exhibit different 
degradation pattern depending on the UV exposure during the fabrication. The rupture of degradable 
bridges between non-degradable blocks allowed the division of the particles into smaller structures with 
distinct shapes [123].  
 
 
Figure 3.13. Micelles containing a DNA in the hydrophilic part of the polymer that compose the structure formed a spherical 
shape. In the presence of a DNAzyme the particles switch to an elongated shape due to the absence of DNA in the polymer 
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structure. The particles have the capacity to recover the spherical shape upon adding a DNA sequence. TEM images of the 
particles are represented in A and the explanation scheme in B. C represents the evolution of the particles length after adding 
DNAzyme: a) 0 min, b) 2 min, c) 2 h, d) 1 day and e) 2 days. Adapted from [122].  
 
Particles prepared from other types of materials (not polymeric) such as gold or silver, also showed shape-
switching capability. Gold nanoparticles have been explored in biomedical field for tumor 
therapeutics/diagnosis. They demonstrated capacity to switch their shape when irradiated with an intense 
pulsed laser radiation [124]. When exposed to radiation, nanorods melt and acquired a spherical shape. 
Similarly, prismatic silver nanoparticles may switch, in a reversible process, into disks when maintained in 
the dark [125]. Although this type of particles have been quite studied for applications in tumor therapies 
and diagnosis or even antimicrobial strategies, the influence of their shape in their performance for these 
specific application still remains to be elucidated.  
 
3.4.5. Self-Folding Containers  
Besides changes in the aspect ratio of the particles it would be interesting to envisage more general 
changes in the shape of polymer-based systems. For example, a very recent type of containers are based 
on self-folding structures: through self-assembly, thin films with a certain geometry spontaneously curve, 
roll-up or fold into particular three-dimensional structures such as cylindrical tubes, spirals, corrugated 
sheets or polyhedral [126]. The folding could occur in response to stimulus [127], such as electrical 
signals, pH, temperature, magnetic field or chemicals. 2D films may also fold immediately after removal 
from the substrate used as support for the 2D structures production. The application of self-folding 
systems in the biomedical field is currently in an immature stage, since there is still a paucity of 
information about shape stability under physiological conditions. Nevertheless, the possibility to control the 
shape of the 3D final system as well as wall chemistry, thickness and porosity, prompted the in vitro 
evaluation of those systems in encapsulation of drugs and cells [128,129]. A bilayer self-folding device 
composed by a pH-sensitive hydrogel (poly(methyacrylic acid) (PMAA) capable to swell when in contact 
with biological fluids (intestine), and a non-swelling layer of poly(hydroxyethyl methacrylate) (PHEMA) was 
proposed as drug carrier for prolonged release at the intestine site (where drugs are generally absorved) – 
Figure 3.14. A drug-containing layer, with adhesive characteristics, was deposited on the polymeric 
substrate. When adhered to the mucosa, the system curls due to the difference in swelling of both 
polymers. The mucoadhesion was improved and at the same time the drug was protected against leakage 
[130]. The system could be integrated in a capsule in order to reach the intestine and avoid the adherence 
of the device in other parts of gastrointestinal tract (e.g. stomach).  
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A self-folding porous microwell container was designed to allow the interaction of the encapsulated cells 
with the surrounding environment in all dimensions [131]. Conventional cell culture plates the cells are 
adhered onto a flat substrate, which do not accurately mimic the natural milieu due to the lack of 3D cues 
from the external media. The building of the 3D polyhedral microwell was obtained by the spontaneously 
fold of a 2D template caused by a surface-driven process due to the melting of the hinges between the 
adjacent faces. Such 3D microwells had porous faces to allow the entrance/exit of cell culture medium 
and other relevant molecules such as, nutrients and metabolites. Fibroblasts and pancreatic beta cells 
were successfully encapsulated in the polyhedral containers, with different shapes and sizes, composed 
by an epoxy negative photoresist (SU-8) and biodegradable PCL [132] . 
 
 
Figure 3.14. Multilayer system capable to fold preferentially in the small intestine (due to their pH-sensitive composition) 
protecting and controlling the release of a drug in this site. I. Schematic representation of the self-folding system. II. Optical 
images of the system before (a) and after folding (C) when immersed in a buffer solution simulating the conditions in the small 
intestine. III. Comparison of the performance of the self-folding device with other administration strategies, namely a patch and 
a solution. Adapted from [130].  
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3.5. Applications of Compartmentalized Particles   
Particles with one compartment are the most studied for biomedical applications. Solid matrices, 
unilamellar liposomes, micelles and a variety of hollow particles, generally with a spherical shape, are 
recurrent systems used in drug delivery and cell encapsulation. Such architectures sometimes do not 
exert the optimal function due to their extreme simplicity. Using the Nature as inspiration source, 
sophisticated particulate systems with exotic geometries and multi-domains structures have been strongly 
hypothesized to have improved performances when applied in the biomedical field.  
Several approaches have been proposed to develop systems capable to release more than one drug with 
appropriate kinetic profiles for the envisaged application. One possibility to encapsulate multiple molecules 
in different regions of the particles is playing with chemistry of system. A very interesting example is that of 
micelles composed by the biodegradable triblock copolymer poly(ethylene glycol)-b-poly(ε-caprolactone)-b-
poly(2-aminoethyl ethylene phosphate) (PEG-b-PCL-b-PPEEA), which exhibit capacity to co-deliver siRNA 
and paclitaxel. In vitro and in vivo studies showed the synergistic effects that these particles might provide 
for tumor treatment. Paclitaxel is entrapped in the micelle core via hydrophobic interactions with PCL, 
while siRNA is adsorbed onto the micelle surface through ionic interaction with the PPEEA block. Although 
these micelles just have one compartment, by playing with the interactions between materials and 
bioactive agents it was possible to obtain a co-delivery system where the therapeutics are immobilized in 
distinct sites of the particles [133].  
The aim of this particular section is to offer an overview of unconventional multicompartmentalized 
architectures. In the following subsections the most representative systems are described focusing on their 
advantages when applied as therapeutic, diagnosis or theranostic tools.  
 
3.5.1. Core/Shell and Multilayered Particles 
Core-shell particles are the simplest compartmentalized systems and have been widely used as drug 
carriers. This kind of particles could comprise a solid or a liquid or an empty (air) core surrounded by a 
solid shell. In addition, depending on the technique and materials used, multiple layers may be created in 
order to obtain multilayered particles.  
Inspired by the water repellent behavior of the lotus leaf, artificial superhydrophobic surfaces have been 
explored as suitable platforms to obtain in an easy and fast way natural-based multilayered hydrogel 
particles – Figure 3.15. Those multicompartmentalized onion-like structures were obtained by dispensing 
a polymeric solution and subsequent crosslinking to form the core. Through a sequence of dispensing 
solutions to coat the previous solidified particle and crosslinking, the desired number of layers could be 
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produced [134]. This technique allowed the preparation of core/shell dextran/alginate particles where the 
core was designed to be a reservoir for bioactive agents and cells were encapsulated in the shell. As the 
cells were placed in the periphery of the particles, the design of such cell carriers avoided the problem of 
the access of nutrients and oxygen to the cells. Multiple dextran-layered particles were also produced and 
model drugs were encapsulated individually in each layer. Depending on their relative position, the release 
profile was different. This technique was also used to produce chitosan microgels coated with pectin for 
oral controlled release of a chemotherapeutical agent (5-fluorouracil) [109].  
 
 
Figure 3.15. Compartmentalized particles were obtained using a biomimetic methodology that involved successive steps of 
dispensing liquid polymeric solutions and crosslinking strategies (I). Concentric multilayer (II) or core/shell (III) particles were 
prepared encapsulating model drugs or cells in individual compartments. Depending on the layer where the drug is 
immobilized, the release kinetic could be controlled (IV). A specific application was studied with 5-fluoraracil encapsulated in a 
chitosan core coated with one pectin layer. In acidic conditions the pectin layers led to remarkable lower drug release, meaning 
that depending on the pH, a controlled release of such chemotherapeutic agent was achieved (V). Images adapted from 
[108,109].  
 
Onion-like structured hydrogels were also obtained by using a multi-step interrupted gelation process 
under controlled physico-chemical conditions [135]. Physical hydrogels composed by natural polymers, 
namely chitosan, were obtained without the need to recur to an external crosslinking process. The 
proportion of acetylated and deacetylated chitosan groups plays an important role in the balance between 
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hydrophilic and hydrophobic interactions. Upon a sequence of neutralization steps, membranes were 
formed due to the disappearance of ionic repulsions between polymer chains and subsequent 
establishment of hydrogen bonding, hydrophobic interactions and crystallite formation. Between each layer 
pair, intermembranar spaces were formed where cells (chondrocytes from rabbits) were injected with a 
syringe. The cells proliferated over 45 days secreting ECM that fulfilled the intermembranar space of the 
hydrogel. Alginate-based spherical hydrogels were also proposed as onion-like multilayered systems for 
biomedical applications. Particles were obtained through a dynamic self-assembly process based on the 
interaction of sodium alginate with calcium ions. In this processing technique cells or drugs could be 
encapsulated in the different layers during the particles preparation and the existence of intermembranar 
spaces may be tailored. The performance of the system as drug carriers was evaluated in vitro and 
showed a pulse-like drug release profile [136]. These technologies cannot present the advantages of the 
one involving the superhydrophobic supports that permit the sequential bottom-up deposition of individual 
layers in mild conditions and virtually with 100% of encapsulation efficiency.  
Compartmentalized particles can also be integrated in other structures to improve the general 
performance of the system. In this context, core/shell PLGA particles were used as structural elements of 
a fibrous scaffold with the aim to control the release of proteins, avoiding the initial burst release (Figure 
3.16). The particles were obtained by immiscible coaxial electrospraying and then incorporated into the 
fibers of the scaffold via electrohydrodynamic jetting. Control of protein release was dependent on the 
uniformity of the PLGA shell and on the adjuvant polymers incorporated in the core, which in turn had 
different interactions with the studied protein [137]. Since lysozyme is a positive charged protein, it was 
not able to establish electrostatic interactions with chitosan and the release was fast. However, when it 
was used Pluronic F68/poly(acrylic acid) (PAA), a polyelectrolyte complexation occurred between PAA and 
the protein and the release was much more slower.  
 
 
Figure 3.16. Core/Shell particles encapsulating lysozyme were obtained as structural elements of a fibrous scaffold (I and II). 
The particles allowed the control of lysozyme release, avoiding the typical initial burst (III).  Image adapted [137].  
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Multicompartmentalization may be also achieved combining polymeric materials with inorganic entities. 
Hybrid core/shell particles were prepared with a gold core (ca. 60 nm) that was coated with a 
biocompatible hydrogel (NIPAAm and acrylic acid) shell with thickness varying between 20 to 90 nm. 
These particles demonstrated pH and temperature-responsiveness being adequate for drug delivery. The 
shell showed temperature-responsiveness when the cores were activated under light exposition [138]. 
Another hybrid core/shell system was produced by copolymerization of PNIPAAm with acrylamide 
surrounding multiple gold nanoparticles through an emulsion process combined with photopolimerization. 
The response kinetics of PNIPAAm to temperature, microwaves and light was accelerated due to the 
presence of the gold nanoparticles. The increased sensitivity allowed faster particle response and such 
behavior could be interesting for drug release applications that require very fast transitions [139]. More 
complex structures, namely core/double-shell microgels were prepared using PNIPAAm as the template 
(core) in the synthesis of two layers: N,N’-(1,2-dihydroxyethylene)bisacrylamide and poly(N-
isopropylacrylamide-co-acrylic acid). The erosion of the inner shell transforms the particles in core/shell 
multiresponsive systems in which the core (temperature responsive) and the outer layer (pH and 
temperature responsive) behave as independent structures separated by the space correspondent to the 
dissolved shell. Such multicompartmentalized particles were suggested to be useful for co-encapsulation 
and release because the shell remains unperturbed by the properties, contents or responsiveness of the 
core [140].  
Multicompartmentalized particles described above exhibited the most conventional particle shape: 
spherical. Advances in methodologies of particles preparation have allowed the development of 
procedures that combine multicompartmentalization with non-conventional shapes. Starting with a 
core/shell immiscible liquid system, composed by a photopolymerizable PEG in the shell and dextran in 
the core, a concave architecture was obtained [141]. Upon a selective polymerization, the dextran core 
remained liquid and migrated from the inner to the periphery yielding dextran-PEGDA particles with two 
compartments and an anisotropic structure [141].  
Although in the most of the cases the particles produced were envisaged to be applied as drug delivery 
systems, studies to support this application still missing. A few in vitro results [109,134–136] 
demonstrated that core/shell and multilayered particles showed promising characteristics to be used as 
drug release systems and cell encapsulation.   
 
 
 
Chapter 3 Non-Spherical and Compartmentalized Particles for Biomedical Applications 
!
! 106!
3.5.1.1. Layer-by-Layer Coated Particles and Capsules  
Layer-by-layer (LbL) technology has been used in a variety of biomedical applications [142]. 
Compartmentalized systems may also be obtained by LbL assembly through alternate deposition of 
oppositely charged materials onto a solid core. Besides electrostatic forces, other kinds of interactions can 
be used in this assembly process [143]. The core may remain solid or be liquefied (sacrificial structure) 
after the deposition of the layers. Depending on the materials used for the core, this procedure can avoid 
the use of organic solvents, which is important to encapsulate cells or labile molecules such as proteins or 
nucleic acids. Three main strategies are currently used to encapsulate drugs in those kind of systems: (I) 
using the bioactive agents as multilayer constituents; (II) preloading the core template and (III) post-loading 
by modifying the permeability of the multilayered structure – Figure 3.17. Low encapsulation efficiency is 
the main limitation of LbL particles [144], while their main advantage is a great flexibility that enables a 
successful internalization by the cells.  
 
 
Figure 3.17. Schematic representation of the main strategies to encapsulate bioactive agents into LbL multilayered particles: 
a) use the bioactive agent to construct the multilayer shell; b) load the template with bioactive agent that will be retained inside 
the multilayer shell after core removal and c) bioactive agents entrapment through altering the permeability of the multilayered 
shell. Image obtained from [144]. 
 
A wide range of spherical LbL systems have been developed and loaded with bioactive agents (acting as 
drug carriers [142,144] or even cells (acting as cell supports in possible injectable systems [145–147] – 
Table 3.2.  
Table 3.2. Examples of spherical LbL systems with adequate characteristics to be applied in biomedical field. 
Core template Layers Type of 
particle 
Drug Characteristics Applications Ref. 
Sulfonated polystyrene 
beads or carboxylated 
quantum dots 
 PLL modified with iminobiotin, followed by 
the linker protein (neutravidin) and biotin 
end-functionalized PEG 
Solid - PEG was used to avoid rapid particles clearance; 
In acidic conditions (tumor regions) the particles gradually lose their PEG shells, allowing 
the exposed PLL layer to facilitate cellular uptake.  
Drug delivery  
Cancer therapies 
[148] 
Silica core with a 
mesoporous shell 
Poly(L-glutamic acid) (PGA) conjugated with 
doxorubicin cross-linked using 2,2′-
diaminodiethyl disulﬁde dihydrochloride 
(cystamine) in the presence of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide 
hydrochloride 
 
Solid and 
hollow 
Doxorubicin The particles were stable at neutral pH and in absence of hydrolases. In acidic conditions 
and presence of carboxypeptidase the amide bonds in PGA-Dox were cleaved and Dox was 
released; 
Less Dox was released from solid particles when compared with capsules due to the limit 
access of the enzyme to the polymer; 
Both types of particles were internalized by LIM1215 human colorectal tumor cells: within 
the cells, the liposomal hydrolases and the reducing environment caused the release of 
Dox and consequently, the tumor cells dead.   
Drug delivery  
Cancer therapies 
[149]  
Calcium carbonate 
particles 
Poly-L-arginine and dextran sulfate Hollow Antigens and 
immunomodulators 
The immunostimulation of the capsules was achieved by using a lipid coating; 
The particles containing lipids were more effective in dendritic cells activation; 
Activation of dendritic cells could be modulated by deposition of different lipids.  
Antigen carriers  
Vaccination 
[150] 
Silica Poly(vinyl pyrrolidone) and poly(methacrylic 
acid) 
Hollow Rifampicin  
(Low water solubility 
drug) 
Very fast release (90% of the encapsulated drug was released after 20min); 
The empty capsules were cytocompatible;  
The loaded particles demonstrated a similar effect of free drug due the fast release.  
Drug release 
system  
Tuberculosis  
 
[151] 
Carboxylmethyl cellulose 
(CMC)– 
doped CaCO3 particles 
Chitosan, alginate 
Crosslinking: glutaraldehyde 
Hollow Doxorubicin  High loading capacity; 
Diffusion-controlled release; 
The system induced the apoptosis of HepG2 tumor cells; 
Encapsulated doxorubicin had better efficacy than when administered in the free form. 
Drug delivery  
Cancer 
therapeuties 
[152] 
Artemisinin crystals  Chitosan, gelatin, and alginate Solid Artemisinin  
(low solubility) 
Sustained release of artemisinin;  
The hydrophilicity of the drug was improved.  
Drug release  
Cancer therapies 
[153] 
Magnetic alginate 
microspheres 
sodium poly(styrene sulfonate) and 
poly(allylamine hydro- chloride) 
Hollow Doxorubicin  Noncontact high-frequency magnetic field application heated the system and increased the 
drug release; 
The doxorrubicin released from the capsules presented similar toxicity to free drugs; 
For high drug concentrations the loaded particles showed lower cytotoxicity.  
Magnetic targeted 
drug delivery  
[154] 
Commercial 
microparticles (MF, from 
Microparticules GmbH) 
Poly(allylamine hydrochloride)  
and poly(sodium-4-styrenesulfonate)  
 
hollow Photoacid 
generators  
and  
FITC-dextrans (drug 
models) 
The photoacid generators were integrated in the shell multilayers; 
UV exposure caused the activation of the photoacides that released protons and induced 
particle swelling;  
Prolonged exposure led to a breakage of the capsules, which promoted a rapid release of 
the entrapped substances. 
Controlled release  [155] 
Amino-functionalized 
silica particles  
Chitosan and dextran sulfate Hollow Bovine serum 
albumin 
The burst release was controlled by its reduction in 10%; 
Good cytocompability. 
 
Controlled drug 
release 
[156] 
CaCO3 particles Poly(allylamine hydrochloride),  
poly(sodium-4-styrenesulfonate),  
dextran sulfate sodium salt and 
poly-L-arginine hydrochloride 
Hollow Nonactive prodrug: 
a self-quenched 
ﬂuorescence-
labeled ovalbumine 
Biodegradable particles; 
Upon internalization the shell of the particles were degraded by intracellular proteases;  
The enzymatic degradation converted the nonactive prodrug (non-fluorescent) into an active 
state (fluorescent).  
Drug release  
Conversion of the 
nonactive 
prodrugs into 
active drugs 
inside the cells 
[157] 
Mesoporous silica 
particles 
Chitosan and 
dextran sulfate 
Hollow FITC-albumin 
(protein drug model) 
Biodegradable capsules;  
Enzymatic degradation; 
The control of the release was obtained by altering the surface charge of the particles, 
which had a large effect on the adsorption of enzymes; 
The larger amounts of chitosanase adhered onto anionic than onto the cationic surface.  
 
Controlled drug 
release  
[158] 
Commercial 
microparticles (MF, from 
Microparticules GmbH)  
Poly(ferrocenylsilane) (PFS) Hollow TRITC-dextran (drug 
model) 
Redox change responsive particles;  
PFS polyelectrolytes feature redox-active ferrocene units in the main chain; 
Chemical oxidation caused the fast expansion of the particles and consequently an 
increase in the permeability; 
Additional external layers of poly(styrene sulfonate) (PSS−) and poly(allylamine 
hydrochloride) (PAH+) allowed the  control of the swelling.  
Controlled drug 
delivery 
[159]  
Amine-functionalized 
silica particles 
Thiolated poly(methacrylic acid) 
(PMASH) and poly(vinylpyrrolidone) 
(PVPON) 
Hollow Oligopeptide 
antigens 
Oligopeptide sequences were covalently linked to a negatively charged carrier polymer via 
biodegradable linkages; 
The resultant polymer+oligopeptide was adsorbed onto silica particles templates and then 
covered by the LbL shell; 
In the presence of a natural reducing agent, glutathione, cleavage of the disulﬁde bonds 
causes release of the peptide from the capsules; 
The peptide-loaded capsules were successfully used to deliver their cargo to APCs and 
activate CD8 T lymphocytes. 
Drug delivery  
Vaccination 
 
 
[160, 
161] 
CaCO3 particles Chitosan and a biomimetic elastinlike 
recombinamer (ELR) 
Hollow BSA (drug model) Temperature-responsive system; 
The release of BSA was dependent on the number of layers; 
The relase was sustained over 14 days; 
Capsules cultured with L929 cells did not affect the cell viability. 
 
Controlled drug 
release 
[162] 
CaCO3  particles 
encapsulating micelles of 
polystyrene-b-poly(acrylic 
acid) 
Poly(allylamine hydrochloride)  
and poly(sodium-4-styrenesulfonate)  
 
Hollow Rhodamine B and 
lysozyme  
The negatively charged micelle remained in the inner of the capsules after core removal;  
The system selectively entrapped positively charged  water soluble molecules;  
The content was released in a sustained manner.  
Drug Release  [163] 
Liposomes  Chitosan and dextran sulfate or DNA  Hollow Glucose, 
Alendronate and 
1-hydroxy pyrene-
3,6,8-trisulfonic acid 
The release was suppressed by the polymeric capsule; 
The release was triggered by DNA denaturation, which in turn improve the permeability of 
the shell.  
 
 
Controlled drug 
release 
[164] 
Liposome  Alginate and chitosan    Hollow 
 
osteogenic protein-1 No toxic effects were observed against MC3T3-E1.4 mouse preosteoblasts; 
The in vivo studies showed no significant toxicity, immune responses and/or change in 
organ functions; 
This hybrid core–shell nanoparticulate delivery system localizes the effect of the released 
bioactive load within the site of injection in muscle with no signiﬁcant tissue distress. 
Drug delivery  
Tissue 
Engineering 
[165] 
 
Nanocolloids of insoluble 
drugs  
Poly(allylamine hydrochloride),  
poly(dimethyldiallylamide ammonium 
chloride)  
and  sodium poly (styrene sulphonate)  
Solid Tamoxifen and 
paclitaxel  
The release of the drugs was controlled s according to the composition, density and 
thickness of the shell; 
The particles were targeted by attaching specific ligands to the external polymer layer; 
The targeted particles showed higher toxicity against cancer cells than the non-targeted 
counterparts.  
Controlled drug 
delivery 
Cancer therapies 
[166] 
Drug crystals Poly(dimethyldiallyl ammonium chloride), 
sodium poly(styrenesulfonate) and gelatin 
A/B 
Solid Dexamethasone  The release could be controlled by the shell; however the release was very fast.  Drug release 
Systems for eye 
administration  
[167] 
Drug crystals Poly(allylamine hydrochloride), protamine 
sulfate and BSA 
Solid Curcumin LbL assembly with biocompatible polyelectrolytes was used to provide a particle coating 
with a high surface potential and stabilization of drug nanocolloids; 
Polyelectrolyte LbL encapsulation allowed sustained low water soluble drug over the range 
of 10-20 h 
Release systems 
Cancer 
therapeutics 
[168] 
PS 
and silica  
Poly-L-glutamic acid poly-L-lysine Solid and 
hollow 
BMP2 and TGFβ1 The GFs were embedded in the multilayer shell; 
Embryoid bodies (EBs) cultured in contact with capsules differentiated into mineralized 
structures which did not occur when both GFs were dispersed in culture medium; 
The multilayers protected the GFs from degradation and the capsules acted as reservoirs of 
bioactive agents;  
The subcutaneous implanting of capsules and EB embedded in an alginate matrix showed 
the appearance of bone forming cells and vascularization surrounding the implant. 
Drug delivery  
Tissue 
Engineering 
[169] 
MnCO3 particles BSA deposition followed by glutaraldehyde 
crosslinking 
Hollow TRICT-dextran 
(macromolecule 
model) 
Biocompatible and biodegradable of natural-based particles; 
Reversible pH-responsiveness; 
The capsules were permeable for macromolecules at pH below 4 or above 10, while were 
impermeable in other pHs; 
Macromolecules were loaded and sealed for at least for 2 weeks. 
Drug release  
 
[170] 
Alginate  Chitosan and alginate Hollow Human osteoblast-
like cells (SaOs-2) 
The cell viability was not compromised in capsules with eight layers.  
 
Mini-rectors or 
scaffolds or cell 
carriers for cell 
therapies  
[145] 
CaCO3 particles Chitosan and a biomimetic elastin-like 
recombinamer with bioactive RGD and 
scrambled non-functional RDG 
Hollow DQ-ovalbumin (drug 
model) 
Cell viability was not affected even in the presence of high concentration of capsules: cells 
cultured in the presence of particles with functional RGD exhibited high viability; 
The capsules were successfully internalized by the cells;  
Surface functionalization did not influence capsules internalization by hMSCs 
Drug delivery  
Intracellular 
release  
[171] 
!
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The systems described in the Table 3.2 are suitable for being engineered and functionalized in order to 
have a good performance when administered in vivo. Regarding the shape of this type of particles, the 
majority of the capsules produced by LbL are spherical-shaped structures. The increasing attention on 
non-spherical shaped particles also pushed the development of more geometrically complex LbL systems, 
being currently in a very early stage. The size and shape of LbL particles could be tailored according to the 
template used to support the multilayers.  For example, using a biconcave template and LbL technique, 
soft particles with erythrocyte-shape were prepared [59,172].  The elastic modulus of the studied particles 
was of the same order of magnitude as the natural erythrocytes and the artificial particles were capable to 
stretch to pass through small diameter capillaries and to recover the discoidal shape [59,172]. Rod-shape 
particles have been prepared using polystyrene microspheres as templates [173]. After assembly of 
poly(L-lysine) (PLL) and BSA, the particles maintained the spherical shape. The rod-shape was just 
obtained when the template was removed. The presence of the BSA was crucial to obtain such non-
spherical shape. The mechanism proposed is related to the collapse of the LbL shell upon adding the 
THF. A gel-like interconnected structure was formed after the swelling and the release of polystyrene under 
sonication. The particles solidified upon water adding exhibiting a rod-shape [173].  
Conventional LbL capsules are, generally, composed by two distinct phases; namely, a LbL shell with an 
air or a liquid core. However, more complex architectures are also possible. A three-phase system with a 
LbL shell surrounding a hydrogel bead where the space between the hydrogel bead and the LbL shell is 
fulfilled with liquid. Although no application was explored for this complex system, the authors 
hypothesized its potential in the biomedical field [174]. Other examples of complex systems are beads 
with self-exploding polyelectrolyte shells (dextran-hydroxyethyl methacrylate/dimethyl aminoethyl 
methacrylate (Dex-HEMA/DMAEMA) core surrounded by dextran sulfate/poly-L-arginine layers) [175]. 
These particles are capable to release micrometer-sized capsules (also composed by dextran sulfate/poly-
L-arginine) at the time of explosion. Such hierarchical compartmentalized system was composed by beads 
with ca. 150 µm loaded with 3 µm LbL microcapsules. The rupture of the LbL shell could be triggered by 
the dex-HEMA degradation, which in turn increases the pressure inside the big capsule and favors the 
release of the small capsules. The release may be tuned by controlling the crosslinking density of the gel 
network. An interesting application for this self-exploding system could in vaccination field. An ideal 
vaccination system should allow the administration of the prime and booster doses (for generation of 
immunity) in a single injection and co-delivery of the adjuvant and the antigen to enhance the immune 
response.  
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A compartmentalized hierarchical system composed by capsules inside capsules was inspired by the cells 
structure [176] – Figure 3.18. Iron oxide magnetic nanoparticles and a drug model were encapsulated in 
LbL microcapsules protected by a temperature-responsive chitosan/elastin-like recombinamer (ELR) 
multilayer shell. Then, such loaded microcapsules were encapsulated in macro-capsules together with 
other small molecule, using an alginate bead as sacrificial template. The shell of the macro capsule was a 
multilayer of chitosan and alginate. A decrease in the release kinetics of a model drug was achieved 
changing the temperature from 25 to 37 °C, due to the presence of the temperature-sensitive ELR in the 
shell. The presence of the magnetic nanoparticles turns the system responsive to external magnetic fields. 
Playing with the shells (number and materials) the permeability may be tuned and other stimuli responsive 
strategies may be integrated, which makes these systems very versatile.  
 
 
Figure 3.18. Schematic representation of hierarchical systems composed by nanoparticles and/or drugs inside LbL 
microcapsules, which in turn were encapsulated inside macro-scale LbL capsules. Image from [176].   
 
Following the concept of hierarchical systems, poly(L-lactic acid) (PLLA) microparticles with cells adhered 
on their surfaces were encapsulated in macro capsules in which the shell was a multilayer assembly of  
PLL, alginate, and chitosan [146]. PLLA microparticles acted as adhesion points for anchorage-dependent 
cells, and the LbL shell in combination with the liquefied environment enhanced the diffusion of the 
molecules for cell survival [146,147] - Figure 3.19. These systems may also be customized to host 
different cell types and microparticles. In addition the solid microparticles may act as reservoirs of 
molecules of interest (e.g. growth factors). This hierarchical system may be useful as cell carriers or small 
bioreactors for cell expansion and micro-tissues formation or for models for drug screening.  
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Figure 3.19. Hierarchical system composed by LbL capsules where PLLA microparticles were encapsulated and acted as 
supports for adherent cells expansion. Capsules without (A) and containing (B) solid PLLA microparticles inside the liquid 
liquefied core. Image from [146].  
 
3.5.1.2. Mesoporous Particles 
Mesoporous particles are particularly interesting for cancer diagnosis, anticancer drugs delivery, and 
targeted therapies due to their high surface area, easy and versatile surface modification, tunable pore 
size, particle size and shape and general good biocompatibility (e.g. silica) [177,178]. The simplest 
structures are hollow mesoporous particles combining a large void space in the core and the mesoporous 
network in the shell (one compartment) – Figure 3.20. The presence of a hollow, confer low density and 
the extensive presence of mesoporous channels on the shell turns those systems highly permeable.  
The hollow could be used as a reservoir for drug storage and delivery. The shell of the particles could have 
a well-tuned thickness within the nanometer scale range being the structure responsible for the control of 
the mass transport during the release of the bioactive agents. The mesoporous particles may be loaded 
during their processing by using a template where the drug is encapsulated. The template may be 
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removed after the mesoporous shell growth onto its surface [179]. When this strategy is not suitable, the 
particles may be loaded after being processed. In this later case, the porous shells play an important role 
in allowing the entrance of the bioactive agents.  
 
 
Figure 3.20. Representative scheme of preparation of hollow mesoporous particles. Using a soft-template, two routes may be 
followed: 1) heterogenerous and 2) self-generated. In the first case nucleation of the precursor/surfactant mixture occurs at the 
interface between the core and the liquid medium containing surfactants and precursor molecules. Then, the shell grows due to 
the precursor hydrolysis around the core template and the self-assembly of the surfactants. In the second process the precursor 
is integrated in the core. The core template is gradually consumed and the shell is formed by self-assembly of surfactants 
present in the liquid medium. In both strategies the final stem is the core and mesoporous templates removal. Image from 
[177].  
 
The shells of these kinds of particles may be made from materials such as carbonates, metals and metals 
oxides [180–182]. Several morphologies of hollow mesoporous materials were then proposed: spheres 
[183], vesicles [184,185], helicoids [186]. Methodologies and different of types of mesoporous hollow 
structures developed up to now have been reviewed elsewhere [177]. Observing the general structure of 
those particles, they are simple core/shell systems in which the core is air and one bioactive agent is 
encapsulated; see some examples in Table 3.3. However, the advances in the design of mesoporous 
particles allowed the development of more complex systems, enabling the encapsulation of more than one 
entity or even more structures with higher complexity. 
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Table 3.3. Examples of hollow mesoporous particles with one compartment and used for drug release. 
Hollow Mesoporous nanoparticles Drug Advantages Ref. 
Aluminosilicate 
treated with 3-
aminopropyltriethoxysilane 
Ibuprofen Improved capacity to storage the drug. [187] 
Carbon spheres treated with 
tetraethoxysilane (TEOS) 
and n-octadecyltrimethoxysilane 
(C18TMS) and then PEGylated 
Doxorrubicin High stability and dispersity; 
Lower in vitro cytoxicity when compered with non loaded and non PEGylates 
counterparts; 
Higher in vitro cytoxicity against Hela and NIH3T3 cells for PEGylated loaded 
particles. 
[188] 
Hollow mesoporous silica nanoparticles 
with three pore sizes 
 
 
Doxorubicin  Doxorubicin release dependent on the pore size; 
Negligible cytotoxicity and efficient cellular uptake; 
Higher pore sizes, more efficient cellular uptake of drug and faster 
intracellular release. 
[189] 
]mesoporous zirconia nanocapsules Doxorubicin Highly compatible;  
High loading capacity; 
pH dependent release; 
High drug released in cancer cells due to the acidic environment inside cells 
(more cytotoxicity in tumor than in normal cells). 
[190] 
Rattle-type Fe3O4@SiO2 hollow 
mesoporous 
Doxorubicin Fast cell uptake; 
Sustained release; 
Doxorubicin-loaded spheres exhibited greater 
cytotoxicity than free drug. 
[191] 
Hollow silica nanocapsules siRNA and  
Fe3O4 nanoparticles 
Controlled porous size; 
Excellent loading capability;  
Successful intracellular transfection in vitro. 
[192] 
 
Hollow mesoporous silica nanoparticles are the most studied for biomedical applications. Such particles 
are ideal drug vehicles due to their high biocompatibility, biodegradability and high drug loading capacity 
as well as capacity to control the release of molecules. Such type of particles could be engineered in order 
to accomplish specific functions. Examples are molecularly/magnetically target drug delivery, 
simultaneous multi-modality bioimaging and therapeutic capability, in vivo stimuli responsive drug release 
and multiple bioactive agents release. One example of a hierarchical system involving porous core/shell 
particles is the entrapment of small-sized superparamagnetic Fe3O4 nanoparticles into a hollow silica 
mesoporous particle [192]. Fe3O4 nanoparticles entered inside the particle through the pores of the silica 
shell. The obtained system was multifunctional, being successful in siRNA transfection through 
internalization as well as acting as agent contrast for MRI. Other examples are double-shelled mesoporous 
silica particles developed for the encapsulation of multiple bioactive agents [193]. This system had a 
mesoporous silica shell (nanosphere or nanolayer) coated by other mesoporous silica shell. Both layers 
formed a hierarchical arrangement of the pores onto the particles capable to control and sustain the 
release of two anticancer drugs. Irinotecan and docetaxel were encapsulated in the particles to show the 
versatility of the particles in acting as carriers for hydrophilic and hydrophobic drugs, respectively. A 
sustained release of the hydrophilic drug was achieved due to the difficult diffusion through the two layers 
instead of one. Docetaxel was accommodated in the hollow core of the particles being diffused out slowly 
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due to its hydrophobic characteristic. The particles were successfully uptaken by the cells showing 
potential for intracellular delivery. The results demonstrated an enhanced anticancer effect when 
compared with drugs administered in a free way: the intracellular release is more effective than the 
diffusion of free drugs into the cells. Advances in procedures to prepare mesoporous particles have 
allowed the development of other complex architectures (e.g. combination of hierarchical and multilayered 
systems) with spherical and non-spherical shapes: (I) spherical hollow silica particles with double 
mesoporous shell; (II) spherical mesoporous silica particles coated by a double mesoporous shell; (III) 
ellipsoidal hollow particles with double mesoporous shell; (IV) ellipsoidal Fe3O4 particles encapsulated in 
silica mesoporous particles (1 layer) and then surrounded by the double mesoporous shell and (IV) 
ellipsoidal Fe3O4 particles inside the cavity of ellipsoidal double mesoporous shell – see Figure 3.21. 
Although not studied before, we hypothesized that non-spherical double mesoporous silica particles with a 
Fe3O4 core would be interesting systems for cancer theragnosis: the elongated shape would increase the 
circulation time of the particles and the cell uptake, the presence of Fe3O4 nanoparticles could act as 
contrast agent for MRI, and the double shells improve the control of the release of encapsulated drugs. 
Another way to obtain multilayered structures is combining mesoporous particles templates with LbL 
deposition [149]. Wang et al. [194] coated mesoporous silica nanoparticles previously loaded with a 
hydrophobic drug (e.g. thiocoraline or  paclitaxel). The mesoporous particles were immersed in an organic-
based drug solution allowing the diffusion of drug molecules into the particles. Then, a multilayer shell was 
build depositing poly(N-vinylpyrrolidone) and thiolated poly(methacrylic acid). After the core removal, were 
obtained the capsules loading a hydrophobic drug, which is quite difficult using conventional templates 
(e.g. CaCO3, alginate). The examples described above show that hollow mesoporous particles could 
integrate multiple functions. Although the most studied application is related with intracellular delivery of 
bioactive agents, these particles could also be interesting systems for diagnosis. A few examples of 
mesoporous particles encapsulation functional inorganic nanostructures for theranostic purposes are 
reported in Table 3.4.  
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Figure 3.21. Architectures of the hollow mesoporous silica spheres with single (a1) and double (a2 and a3) mesoporous 
shells. Rattle-type mesoporous silica particles having a single (b1) and double (b2 and b3) mesoporous shells. Non-spherical 
hollow mesoporous silica (ellipsoids) with single (c1 and c2) and double (c3) mesoporous shells. Fe2O3 ellipsoidal particles (d1) 
coated with a single (d2) and double (d3) mesoporous shells. Finally, rattle-type Fe2O3 rattle-type particles exhibiting a single (e1) 
and double (e2 and e3) mesoporous shells. The set of images with number 4 are the schematic representations of the double-
shelled structures. Image from [193].  
 
Table 3.4. Examples of mesoporous particles for diagnosis and theranostic purposes. 
Particles Content Properties Ref. 
Multi-shelled mesoporous silica nanospheres 
(double- and triple-walled) – rattle-type or hollow 
structures 
Doxorubicin and ﬂuorescein FITC Inclusion of functional species into shell-to-shell cavities;  
Dual-modality for imaging and drug co-delivery vectors through the appropriate selection of pH-dependent molecules; 
Doxorubicin (DOX), loaded in the outer periphery space, was successfully carried and released in the cell cytoplasm;  
The fluorophore was effectively encapsulated in inner of the spheres; 
The particles showed capability to be used as tracking tools both in vitro and in vivo.  
[195] 
 
Hollow silica mesoporous nanocapsules 
composed by an inorganic core 
 
Doxorubicin and 
Fe3O4 or Au nanoparticles  
Anticancer drug delivery and MRI cell imaging applications; 
Very low cytotoxicity against various cell lines, low hemolyticity against human blood red cells and no significant coagulation effect 
against blood plasma. 
[196] 
Ellipsoidal multifunctional mesoporous 
nanostructures coated by positively charged 
polyelectrolyte (PAH) and negatively charged 
ﬂuorescent quantum dots (QDs) 
Doxorubicin and Fe3O4 elliptic core High biocompatibility; 
Dose-dependent cell uptake;  
The nanoparticles accumulated mostly in the cytoplasm; 
Excellent capability of the nanocarriers as contrast agents in MRI. 
[197] 
Hollow mesoporous silica (HMS) nanocages 
composed by a hollow cubic core and a 
mesoporous shell 
The particles were PEGylated. 
Doxorubicin and rhodamine B 
isothiocyanate 
Cubic cores allowed much higher storage capacity than spherical counterparts; 
Sustained release of the drug; 
Good cell uptake and efﬁcient cell death in vitro; 
Higher suppress of tumor growth when compared to free doxorubicin in vivo; 
Fluorescent candidates for optical imaging. 
[198] 
Hollow mesoporous silica nanocages 
 
Doxorubicin and molecules labeled 
with dyes 
Good biocompatibility;  
Molecules labeled with dyes were used as traceable detectors by fluorescence imaging; 
Chemotherapeutic sustained release. 
[199] 
Hollow magnetic mesoporous double-shell 
nanostructures with a nanorod-shaped core 
Docetaxel or camptothecin and 
rhodamine B isothiocyanate and PEG 
Excellent blood compatibility, very low cytotoxicity towards HeLa and MCF-7 cells; 
Particles could be taken up by cancer cells effectively in a dose-dependent manner; 
Potential application as MRI contrast agents and chemotherapeutic agent. 
[200] 
Mesoporous silica nanocapsules Temperature-sensitive and 
biocompatible perfluorohexane 
(bubble generator) 
 
 
Inorganic enhancement agent for high intensity focused ultrasound (HIFU) imaging; 
Excellent biocompatibility/degradability and uptake by tumor cells;  
Perfluorohexane bubbles were released, in a sustained way, through the particles mesopore channels when the local temperature 
rise due to the HIFU application;  
The rise of temperature caused tumor tissue destruction: pronounced coagulative necrosis effect on bovine liver tissues at low 
power, when compared with mesoporous particles without perfluorohexane.  
[201] 
Multifunctional mesoporous nanocapsules 
decorated with manganese  
Perfluorohexane MRI guided due to the manganese oxide presence; 
Good tumor location;  
Enhanced therapeutic effect; 
The application of HIFU allowed the release of perfluorohexane and consequently the destruction of tumor cells.  
[202] 
Multifunctional rattle-structured: porous silica 
shell doped with gadolinium  
Cisplatin anticancer drug and 
radiosensitizer and gadolinium  
Synergetic chemo-/radiotherapy and magnetic/luminescent dual-mode imaging; 
Loaded particles were more efficient than free cisplatin in vitro. 
[203] 
Mesoporous silica-coated hollow manganese 
oxide (HMnO@ 
mSiO2) nanoparticles 
No drug 
Magnetic resonance imaging (MRI) 
contrast agent 
Adipose-derived mesenchymal stem cells (MSCs) were eﬃciently labeled using electroporation; 
The mesoporous shell and the large surface area-to-volume ratio resulted in an enhanced water accessibility to the core and 
consequently in the improvement of the signal.  
[204] 
!
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3.5.2.  Compartmentalized Vesicles and Micelles 
Vesicles composed by lipids (liposomes) or by amphiphilic block-copolymers (polymersomes) with 
compartmentalized architectures have been also proposed for biomedical applications. For example, 
liposomes containing inside a hyaluronic acid microgel (one microgel or multiple microgels per liposome) 
were proposed by An et al. [205] to mimic the corneocyte cell structures. Mature corneocytes are dead 
cells, covered by a protein or lipid shell in which the matrix of such natural capsules is filled by keratin 
fibrillae, having a special role in skin homeostasis. Such particles may be ideal vehicles to be employed in 
cosmetics, dermatology and in the pharmaceutical field.  
Multicompartmentalized spherical liposomes were also proposed for a few biomedical applications, 
namely salmon calcitonin administration by a oral route for osteoporosis treatment [206] and cisplatin 
release inside tumoral cells for cancer therapy [207].  
Multivesicular liposomes showed to be capable to sustain the release of morphine in Beagle dogs for more 
than 12 days, upon administration in the epidural space [208]. The release of ciprofloxacin from normal 
liposomes revealed a lower performance when compared with hierarchical liposomes composed by small 
liposomes encapsulated into bigger ones. After 30 min the total content of the normal liposomes was 
released, whereas just 50% of the hierarchical liposomes content was released after 6h [209].  
Polymersomes have also been developed with complex architectures. Multicompartmentalized 
poly(dimethylsiloxane)-graft-poly(ethylene oxide) (PDMS-g-PEO) and poly(butadiene)-block-poly(ethylene 
oxide) (PBut-b-PEO) polymersomes were developed using multiple emulsion into a microfluidic device 
[210]. Besides being multicompartmentedb (small polymersomes inside a big polymersome), non-
spherical polymersomes with regular polyhedral shapes were also produced by double emulsions 
(aggregation of polymersomes). In addition, polymersomes-in-polymersomes, composed by one or 
multiple bilayers of PEG-b-PLA diblock-copolymers, were developed also using emulsions in microfluidic 
devices [211]. Two architectures were developed: (i) polymersomes containing a single inner 
polymersome and (ii) polymersomes containing several inner polymersomes. The existence of multiple 
reservoirs was demonstrated to be suitable to encapsulate different bioactive agents and for releasing 
molecules in a programmed fashion due to the sequential dissociation of the membranes [211].  
Nanosized poly(trimethylene carbonate)-b-poly(l-glutamic acid) polymersomes were encapsulated in larger 
ones PBut-b-PEO creating independent compartments in each particle [212].  The lumen of the nanosized 
vesicle is one compartment and the cavity of the giant polymersome is other compartment. Doxorrobicin 
was then encapsulated in the nanosized polymersomes during the vesicles formation leadind to a 
subsequent controlled and sustained release of the drug. In this case the diffusion of the molecules was 
Chapter 3 Non-Spherical and Compartmentalized Particles for Biomedical Applications 
!
! 119!
hampered by the existence of more than one membrane. Although just one drug was encapsulated, such 
system could be explored for multidrug release due to the existence of multiple individual compartments.  
Compartmentalized micelles were also obtained from the combination of water-soluble PEO with two 
hydrophobic, but immiscible components (a polymeric hydrocarbon and a perfluorinated polyether). 
Playing with the proportions between the polymers, the shape of such compartmentalized particles was 
also controlled [213]. A few examples of multicompartmentalized micelles derived from the conjugation of 
PEE, PEO and poly(γ-methyl-ε-caprolactone) are depicted in  Figure 3.22.   
 
 
Figure 3.22. Self-assembled compartmentalized structures with stratified spherical (a); segmented worm-like (b) and 
raspberry-like spherical (c) architectures. The correspondent cryo-TEM images are labelled with d, e, and f, respectively. Image 
adapted from [213].  
 
The ability of micelles to be loaded with two different molecules was proved by multicompartmented 
structures formed by self-assembly of mikto-arm star block copolymers. Such copolymers were composed 
by PEO which confers water dispersibility, PEE and polyperfluoropropylene oxide (PFPO) both segregate 
within the micelle cores. The obtained compartmentalized micelles were immersed in an aqueous solution 
where two poor water-soluble molecules were dispersed and used as model drugs. Then, pyrene was 
selectively uptake and entrapped in PEE domains whereas 1-naphthyl perfluoroheptanyl ketone was 
entangled in the PFPO chains [214].  
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3.5.3. Janus Particles  
Very peculiar compartmentalized particulate systems are the Janus structures, characterized by 
possessing non-centrosymmetric architectures and the hemistructures may comprise different 
compositions and functionalities [215,216].  Such particles may have controlled size and shape as well as 
unique surface characteristics in which the compartmentalization transform such structures in 
multifunctional entities. Depending on the envisaged application, hard (inorganic), soft (polymeric) or 
hybrid soft/hard anisotropic functional and structural structures may be designed with morphologies 
comprising spherical-, dumbbell-, rod-, disk-, sheet-like, among other structures – Figure 3.23. Several 
methodologies can be used to produce those kind of structures [215]: self-assembly, emulsions/phase 
separation, microfluidics, biphasic electrified jetting, protonation-deprotonation cycling, among others 
[215–218].  
 
 
Figure 3.23. Schematic representation of possible Janus structures. Image from [219]. 
 
Soft Janus particles have gained particular attention for applications as drug vehicles due to the possibility 
to encapsulate independently more than one bioactive agent and release them in a controlled manner. A 
recurrent strategy to produce Janus polymeric particles is the phase separation method because it is 
considered a simple method and allows the production of many biphasic soft particles with a vast range of 
morphologies and sizes. The limitations of this procedure are related to the difficulty in the control of the 
size of the particles and in some cases (self-assembly of block copolymers) the yield is very low [215]. 
Microfluidic devices are alternative strategies to produce this kind of particles. The monomers solutions 
flow in Y-shaped channels to form the two-phase stream with a planar sheath-flow geometry. The final 
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structures may be obtained by crosslinking through light exposure, for example [215]. A wide range of 
Janus structures with different morphologies have been produced by electrodynamic cojetting 
methodology. Briefly, two immiscible polymers are dispensed using needles, controlling their diffusion rate 
[217]. Afterwards, the solidification is also controlled through the rate of evaporation of the solvent. This 
technique was improved and such kind of particulate systems were also produced using aqueous-based 
solutions. With electrohydrodynamic cojetting two very similar polymers solutions could be used [220]. 
However, this technique is confined to a certain types of materials: for example just conductive polymers 
may be employed.  
 Other techniques such as lithography, templating and surfaces-controlled nucleation have been used to 
produce such particular compartmentalized particles. However, these techniques present several 
limitations namely the requirement of complex apparatus, difficulties in preparation of nano-scaled 
particles, uncontrollable sizes and structures, and limitations in the type of materials used [215].  
Hard Janus particles could be obtained by the follow mechanisms: direct heterogeneous nucleation, non-
epitaxial deposition followed by coalescence/crystallization, reaction at liquid/liquid interfaces and self-
regulated homogeneous or heterogeneous nucleation [221]. Such particles are composed by at least two 
different inorganic materials with magnetic, electric, semiconducting, optical, among others properties.  
The combination of polymeric materials with inorganic entities forms the hybrid soft/hard particles. Such 
particles aimed to combine properties of the both groups. The most used techniques to obtain hybrid 
Janus are phase separation [222,223], controlled surface nucleation of polymeric particles onto inorganic 
structures [216,224] and self-organized precipitation [225,226]. 
Table 3.5 lists several examples of soft, hard and hybrid Janus particles being highlighted their shape and 
properties. 
Table 3.5. Representative examples of soft, hybrid and hard Janus particles. 
 Type of Janus 
particles 
Materials Preparation Method Properties/Applications Ref. 
So
ft
 P
ar
tic
le
s 
 
Dumbbell Polystyrene, poly(butylmethacrylate) and 
poly(methyl methacrylate) 
Phase separation  (seeded polymerization technique) Particles with controlled shape and surface chemistry; 
Amphiphilic particles;  
No application 
[227] 
Dumbbell Amphoteric polystyrene Phase separation (seeded polymerization technique) Particles with chemical anisotropy; 
pH-sensitive anisotropy due to the different surface coatings; 
No application. 
[228, 
229]  
 
Spherical Poly(9,9-bis(2-ethylhexyl)fluorine-2,7-diyl) 
Poly(para-phenylene) 
Miniemulsion Multicomponent spherical particles; 
No application. 
[230] 
Snowman-like Polystyrene and poly(methyl-methacrylate) Phase separation (different homopolymers in the 
polymer blend) 
The morphology could be tuned by changing the molecular weight of the polymers; 
Broad size distribution and the use of surfactant could limit certain biomedical 
applications.  
No specific application 
[231] 
Multiple 
structures 
Polystyrene, polyisoprene and their block-
copolymers 
Self organized precipitation Depending on the copolymerization ratios, different structures were obtained; 
Different polymer ratio: one-dimensionally stacked lamellar structures, onion-like 
concentric-layered lamellar structures, and 
hexagonally arranged dots and aligned striations inside the particles; 
Polymer ratio  1:1: hemispherical shaped particles where the variation of the 
concentration caused different proportions between both hemispheres; 
No application. 
[232] 
Spherical and 
cylindrical 
micelles 
Polystyrene-block-polybutadiene-block-poly(methyl 
methacrylate) (SBM) triblock terpolymer having 
symmetric end blocks and a very small fraction of 
polybutadiene 
 
Crosslinking the lamella-sphere 
Morphology of the SBM triblock terpolymer in the bulk 
state via 
cold vulcanization with sulphur monochloride (S2Cl2) 
These Janus particles consist of a tightly crosslinked polybutadiene nanoparticle core 
with ca.13 chains each of PMMA and PS protruding out of it, in separated hemispheres;  
No application. 
 
[233–
235] 
Spherical Polystyrene 
Poly(propylene carbonate) 
Poly(9,9-dioctyl- fluorene-2,7-diyl-co-bis-N,N- 
fluorene-2,7-diyl-co-bis-N,N- phenyl-1,4-phenylenedi 
amine) (PFB)  
Poly(9,9- dioctylfluorene-2,7-diyl-co-
benzothiadiazole) (F8BT) 
Miniemulsion, phase separation No application [236] 
Spherical micelles Polybutadiene  
Poly(methacrylic acid) 
Polystyrene  
Triblock copolymer 
Cross-linking the middle block of a microphase 
separated triblock copolymer followed by alkaline 
hydrolysis of the poly(methyl methacrylate) (PMMA) 
ester groups 
Amphiphilic Janus micelles with a hydrophobic polystyrene  hemicorona and a 
hydrophilic poly(methacrylic acid)  hemicorona, both surrounding a cross-linked 
polybutadiene  core;  
No application.  
[237] 
Cylinders, sheets, 
and ribbons 
Poly(tert-butoxystyrene)-b-poly(butadiene)-b-poly(tert-
butyl methacrylate) 
Self-assembly via film casting followed by crosslinking 
(photo or with sulfur monochloride) 
The shape of the final system was defined by the selected solvent and crosslinking 
conditions; 
No application. 
[238] 
Spherical micelles Poly(2-vinylpyridine)-b-poly(methyl methacrylate)-b-
Poly(acrylic acid) (P2VP-PMMA-PAA) 
Phase separation (self –assembly of block copolymers 
in aqueous solvent) 
No organic solvents were required; 
The middle block of the polymer was hydrophobic and the other blocks were amphoteric 
and hydrophilic;  
Two-compartment shells (Janus micelles with segregated arms) were obtained at pH 1-
2;  
No application. 
[239] 
Janus micelle 
with a prolate 
ellipsoidal (cigar-
like) overall shape 
and an oblate 
ellipsoidal (disc-
like) core 
poly(N-methyl-2-vinyl pyridinium iodide) (P2MVP)  
and 
Poly(acrylic acid) (PAA), poly(ethylene oxide) (PEO) 
or  
Poly(acryl amide) PAAm. 
Phase-separation (co-assembly of two fully water-
soluble block copolymers, which one composed by 
polyelectrolyte block and a neutral block) 
One-step procedure was used; 
Janus particles formed spontaneously in a reversible process, controlling the polymer 
mixing fraction, solution pH, and ionic strength; 
The polymers aimed to constitute the core (PAA and P2MVP) were intrinsically mixed 
while the corona segments (PEO and PAAm) repelled each other as much as possible.  
No application.  
 
[240] 
 
Disk-like micelles Poly(2-methylvinylpyridinium iodide)-b-poly(ethylene 
oxide)  
Poly(acrylic acid)-b-poly(acryl amide) 
 
Phase-separation (co-assembly of two fully water-
soluble block copolymers) 
No application. [241] 
Spherical micelles P2VP-b-PEO and P2VP-b-PNIPAAm Phase separation (self –assembly of block copolymers 
followed by crosslinking of the core) 
pH-responsive core composed of P4VP and a mixed shell composed of thermosensitive 
PNIPAM and hydrophilic PEG; 
Temperatures above LCST of PNIPPAm caused a phase separation of the mixed 
PNIPAM/PEG shell resulted in core–shell–corona micelles; 
In acidic conditions the core is unstable, and the high level of swelling of P4VP caused 
micelles disintegration;  
No application. 
[242] 
Patchy spherical 
micelles 
Poly(ethylene oxide)-b-poly(3-caprolactone)-b-poly(2-
aminoethyl methacrylate) (PEO-b-PCL-b-PAMA) 
Phase separation (self –assembly of block copolymers 
in aqueous solvents) 
The core of the micelles was formed by PCL. The PEO and PAMA chains formed the 
phase-segregated patchy; 
The formation of the Janus structure was achieved by adding tetramethyl orthosilicate: 
the deposition of the silica was catalized by the cationic polymer present in the system 
(PAMA block); 
No application. 
[243] 
Spherical Isobornyl acrylate Microfluidic (co-flow device) Magnetic anisotropic particles were obtained by dispensing magnetite (Fe3O4) crystals in 
one hemisphere; 
 No application. 
[244] 
Two and three-
phase spherical 
particles  
 
Methacryloxypropyl dimethylsiloxane and a mixture 
of PEG diacrylate, pentaerythritol triacrylate and 
acrylic acid 
 
Microfluidic (co-flow device) Amphiphilic particles with selective functionalization;  
Epoxy groups were integrated in the hydrophilic compartment of the particle, turning this 
part of the system preferred for protein attachment; 
No specific application.  
[245]  
Rectangles  
 
PEG diacrylate (PEGDA) Photolithographic –based microfluidic  PEGDA particles with different chemistries in the same particle;  
No application. 
[246] 
Unimolecular 
particles 
Polystyrene-b-poly(2-vinylpyridine)-b-poly(ethylene 
oxide) (PS-b-P2VP-b-PEO or SVEO) triblock 
copolymer 
Chemical crosslinking induced micellization Intramolecular crosslinking of the middle P2VP block using 1,4- dibromobutane (DBB); 
Increasing the solution concentration allowed the self-assembly of the unimolecular 
polymeric Janus nanoparticles into supermicelles; 
No application.  
 
 
[247] 
H
yb
ri
d 
So
ft
/h
ar
d 
pa
rt
ic
le
s 
Spherical  Poly(MMA co -HEMA)/CdS QD–polymer hybrids and  
nanoparticles with poly(MMA- co -HEMA)/Cd(AA)2 
ionomers mixed with modified ferroferric  oxide 
(Fe3O4) 
Microfluidic (co-flow device) Magnetic and fluorescent particles;  
No application.  
[248] 
Spherical  Poly(acrylamide-co-acrylic acid) and Au 
nanoparticles 
 
Electrohydrodinamic cojetting followed by thermal 
crosslinking 
Bicompartmented system with a hierarchical structured hemisphere composed by the 
Au nanoparticles;   
No application. 
[220] 
Dumbbell or 
snowman  
Polystyrene/SiO2 
 
Seeded emulsion polymerization process: the styrene 
monomer was polymerized onto the silica surfaces in 
the presence of hydrophilic macromonomers.  
The silica was able to be functionalized with methacrylate groups but other groups may 
be added; 
No application. 
[224] 
Dumbbell Polystyrene/SiO2 
 
Miniemulsion polymerization of nanodroplets of 
styrene, inorganic  tetraethoxysilane, and silane 
coupling agent (3-aminopropyl)trimethoxysilane; 
The high temperature caused the elastic stress driven 
by the entropy change in the swollen networks 
resulting in a phase separation. 
Magnetite nanoparticles were encapsulated in the polystyrene hemisphere – magnetic 
responsive particles; 
No application. 
 
 
[222] 
Spherical Negatively charged poly(acrylic acid) (PAA)-coated 
Fe3O4 nanoparticles 
partially functionalized by polystyrene sodium 
sulfonate (PSSNa) 
or  
polydimethylamino ethylmethacrylate (PDMAEMA) 
Masking technique was used to prepare stable 
dispersions of Janus nanoparticles in water. 
The particles were capable to form small clusters with controlled size by lowering the 
pH; 
pH below the pKa of PAA rendering  that the part of the particle coated with PAA was 
hydrophobic while the part functionalized with PSSNa or PDMAEMA remained 
hydrophilic; 
When the two polymers bear opposite charges aggregation occurs, being this process 
reversible.  
No application. 
[249] 
Spherical Polystyrene/γ-Fe3O4 and polyisoprene Self-organized precipitation. The magnetic nanoparticles were firstly encapsulated in amphiphilic block-copolymer 
inverse micelles; 
Magnetic particles were composed by a polyisoprene and a polysyrene hemisphere  
being the magnetic micelles  accumulated in the second compartment. 
No application. 
[250] 
H
ar
d 
pa
rt
ic
le
s 
Dumbbell Au and Fe3O4 Epitaxial growth of Fe3O4 particles on the surface of  Au 
particles by decomposition of iron pentacarbonyl, 
Fe(CO)5. 
The particles exhibited surface plasmon absorption (Au) and magnetic properties (Fe3O4); 
Particles suitable for tracking drug delivery, however the application was not studied in 
detail.  
[251] 
Dumbbell Fe3O4-- Ag 
FePt - Ag 
Au - Ag 
 
Fe3O4 or Au or FePt nanoparticles were dissolved in a 
proper organic solvent and mixed with an aqueous 
solution of silver nitrate and then the emulsion was 
stabilized by ultrasounds.  
 
The nanoparticles self-assemble in the liquid-liquid interface of the emulsion and just 
part of the nanoparticles was exposed to   to contact with Ag;  
For this reason, the particles formed are anisotropic with dumbblell architecture;  
The size of the Ag compartment could be controlled by the reaction time; 
Each compartment could be specifically functionalized via ligand exchange; 
Magnetic responsive particles with hydrophilic and fluorescent properties were obtained; 
No specific application. 
[252] 
Spherical γ-Fe2O3/SiO2 Flame synthesis technique where both precursors 
suffered combusting; 
The high temperatures melt the SiO2 and the γ-Fe2O3, 
and consequently occurred a phase separation 
process.  
Amphiphilic particles were obtained by functionalization of SiO2 hemisphere with 
oleylamine, being capable to form magnetic capsules; 
Application: partially sacrificial templates for hollow magnetic capsules. γ-Fe2O3/SiO2 
were coated with PVP and Au nanoparticles and then the SiO2 removed. The magnetic 
core remained inside the PVP/AU capsules.  
No application for biomedical field.  
[253] 
Chapter 3 Non-Spherical and Compartmentalized Particles for Biomedical Applications 
!
! 125!
In the last years several types of Janus particles have been produced but the study of their specific 
application in the biomedical field is quite scarce. Examples of systems used for sensing, diagnosis, 
therapeutics, theranosis and tissue engineering applications that were reported in literature will be 
described in this subsection [254]. The tunable and controllable architecture of the Janus particles provide 
spatially controlled functionalities in a wide range of sizes, which could be useful for biomedical 
applications. For example, disk-shaped Janus particles composed by a fluorescent graphically encoded 
region and a probe-loaded region were used to detect DNA oligomers [255]. The particles were designed 
to detect DNA sequences specifically. The systems could also be used in high throughput analyses.  
The same concept was used to multiplex detection of proteins.  PEG-based microparticles were obtained 
having a distinctive graphical code (unpolymerized holes in the wafer structure of the microparticles). This 
code is used to identify the antibody probe covalently incorporated in an individual compartment of the 
particle. The particles may be suspended in the sample of the medium that is desired to test providing an 
enhanced binding capacity when compared with 2D surface techniques (e.g. ELISA). Those particles may 
be used in a microfluidic system, where combining different particles, different proteins may be quantified 
in a single assay [256]. Magnetic particles integrating a color-barcode were also designed for multiplex 
detection of DNA. Due to the magnetic properties, the particles could be actively positioned for code 
readouts and be stirred for improvement of the reaction kinetic in microscale environments [257].  
In gene delivery, the enhancement of both drug bioavailability and targeting are very important 
characteristics in carriers design. The most usual approach to obtain a targeted drug delivery system is 
the use of conjugated ligands on the surface of the particles. In some cases it could be advantageous to 
decoupling the target function from the therapeutic functions in the same particle. In this context, 
biosegmented metallic nanorods were used to deliver exogenous genes, in which one compartment of the 
particle was used to immobilize the targeting molecule and the other acted as the reservoir for the nucleic 
acid [258]. This strategy allowed to control the ligand density and the type of ligand could be changed 
according to the target. This system owns toxicity issues inherent to the use of metals. We believe that, 
whenever possible, biocompatible polymers should be used as they offer a large spectrum of chemistry 
possibilities and high control of the degradation kinetics and water uptake.  
PLGA Janus solid matrices were also proposed as multicompartmented structures for delivery of multiple 
payloads [259]. A hydrophilic (doxorubicin hydrochloride) and a hydrophobic (paclitaxel) drug were 
encapsulated in the individual compartments of the Janus nanoparticles, showing the versatility of such 
structures in encapsulating drugs with different properties. Two different drugs (benzyl alcohol (BA) and 3-
phenylpropionic acid (PPA)) linked onto different parts of the Janus PEG-based dendrimers showed a 
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sequential release profile. The BA showed a faster release and PPA a slower release kinetics [260]. The 
obtained Janus dendrimers were not cytotoxic against red blood cells and human umbilical vein 
endothelial cells, demonstrating potential to be used as drug delivery systems for combinatorial therapies. 
Multicompartmentalized Janus structured liposomes composed by two different types of vesicles 
connected through a tight bilayer interface (like two vesicles connected), were proposed for the 
combinatory release of chemotherapeutics [261]. However the optimization of the methodology to obtain 
nanosized systems and the study of the kinetic releases and biodistribution upon administration are still 
required.  
Theranostic approaches constitute another biomedical application for Janus particles. The combination of 
therapeutic agents and imaging modalities into a single particulate system could maximize the final effect. 
Janus spherical systems composed by two hemispheres, in which one was polystyrene able to be 
functionalized with ligands for targeting and the other hemisphere was coated with a gold film are one 
example [262]. The gold could be used for sensing or imaging via surface-enhanced Raman scattering 
being possible to follow the interaction of the particles with the target cells.  
The advances in the techniques to produce those compartmentalized particles lead to use of a microfluidic 
platform to produce hydrogels with magnetic anisotropy where cells and magnetic nano or submicron 
beads were encapsulated in individual compartments of alginate, with the aim to reduce the contact 
between the two moieties. The particles presented good cytocompatibility and super-paramagnetic 
properties [263]. The combination of polymeric biomaterials and magnetic nanoparticles may be useful in 
Tissue Engineering strategies [264,265]. Recently, an interesting system for vascular tissue engineering 
was developed based on the concept of Janus architecture combined with magnetic response [266]. 3D 
cell aggregates (spheroids) were build up and combined with magnetic nanoparticles being the cells and 
the magnetic nanoparticles confined in independent compartments (Figure 3.24). The main advantage of 
this strategy was to avoid the uptake of the magnetic particles by the cells, thus decreasing adverse effects 
related with the internalization of nanoparticles. Using a Janus structure, the cell viability, activity and 
phenotype were not significantly affected. In addition, the possibility to control the spatial distribution of 
the magnetic spheroids in combination with their easy capacity to fuse with each others, allowed obtaining 
a vascular construct with 5 mm in diameter using magnetic force assembly. This work demonstrated the 
importance of the development of advanced engineered structures in order to achieve a structured tissue, 
without significant cell loss and modification.  
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Figure 3.24. When magnetic nanoparticles are in embedded the ECM and mixed with the cells of a spheroid (A), the particles 
are internalized by the cells causing a significant decrease in the viability (C). Janus spheroids, where the particles are 
separated from the cells (A and B), seemed to be advantageous, not affecting the cell viability (C). Applying a magnetic force it 
was possible to control the position of the Janus spheroids (D). After a certain time, the spheroids found and formed continuous 
tissues (E). Image from [266]. 
 
Even more complex Janus structures could be obtained; such as Janus particles with more than two 
compartments. For example, highly organized complex particles were obtained using electrohydrodynamic 
co-jetting methodology in combination with synthetic polymer chemistry. Each obtained particle had three 
compartments (created by dispensing three polymeric solutions in parallel) displaying orthogonal 
anchoring groups on distinct surfaces of the compartments. Such PLGA disk-shaped compartmentalized 
particles had 10-15 µm in diameter and an average aspect ratio of 1:2 (height:diameter) and were 
chemically functionalized with different PLA derivatives. This showed that each compartment was 
susceptible to be specifically modified. Such multifunctional particles could be interesting systems for 
cancer therapies because beyond having compartments for compounds encapsulation, the entire surface 
could be modified using different ligands [267]. 
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3.6. Conclusions and Future Perspectives 
We overviewed the importance of several characteristics of the particulate systems for applications in 
therapies and diagnosis. Both chemical and physical properties influence the performance of the particles. 
The materials used to prepare the particulate systems define the bulk and surface chemistry. The 
chemical properties will play an important role the interaction of the particles with biological milieu and 
entrapped moieties. When administered in the human body, the first contact between the particles and the 
biological occurs at the surface of the particles being the charge, the hydrophilicity/hydrophobicity nature 
and targeting elements important properties to have into account in particles formulation and design. The 
surface characteristics dictate the initial biological reaction, this means if the particles are cleared or 
maintained in circulation as well as the internalization kinetics by the target cells. In the case of physical 
properties, an emerging attention has been focused on shape and compartmentalization. Non-spherical 
shapes could be useful to control the particle circulation time, extravasation and internalization by the 
different types of cells. Compartmented particles are quite complex systems but with several advantages, 
namely the possibility to encapsulate different bioactive agents, cells or even other particles, turning the 
therapy or diagnosis more efficient. Although it is known that mechanical properties have also influence in 
particles internalization and cell attachment, deep studies are required in order to understand in a detailed 
way the effect of such characteristic. It is predictable a continuous development of sophisticated 
architectures executing more and precise functions is order to fulfill all the demands of the complexity of 
human disorders.  
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Chapter 4 
Detailed Description of Experimental Testing and Materials 
 
The aim of this chapter is to present detailed information about the materials and techniques used under 
the scope of this thesis. Although the experimental procedure is described in the experimental section of 
each corresponding chapter of the section III, herein the objective is to give some general theoretical 
concepts and justify the selection of the materials and methods employed to develop the systems 
proposed. The information described here will complement those given in each chapter. It is important to 
highlight that information related with reagents suppliers and specification of general equipment’s are 
described in each chapter of section III and will not be mentioned here.   
 
4.1. Superhydrophobic Surfaces Methodology 
In all the chapters of the experimental work described in this thesis (see section III) the superhydrophobic 
methodology was used to obtain the proposed particulate systems. In 2010, Song et al. [1] suggested the 
use of biomimetic superhydrophobic surfaces as platforms to produce hydrogel particles. This 
methodology was inspired in the water repellent properties of the lotus leaves. As described in the chapter 
1 and 2, the water droplets acquire an almost spherical shape when are on the top of those natural 
surfaces due to the combination of micro/nano topographical features and low surface energy. Thus, 
Song et al. [1] hypothesized that dispensing a polymeric precursor solution on the top of substrates 
exhibiting water repellency similar to lotus leaves, followed by a crosslinking step, it would be possible to 
obtain almost spherical particles. On the scope of this thesis, different polymeric hydrogel systems were 
developed demonstrating the versatility of the superhydrophobic surfaces methodology in encapsulation of 
drugs and cells as well as in preparation of complex architectures. All the characteristics and advantages 
of this technique in preparation of spherical particulate systems have already been described in the 
chapter 2.  
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Two different materials were modified in order to obtain biomimetic superhydrophobic surfaces. Their 
properties and the procedure to obtain superhydrophobic characteristics will be described in the follow 
subsections.  
 
4.1.1. Superhydrophobic Surfaces Preparation 
4.1.1.1. Polystyrene 
Polystyrene (PS) superhydrophobic surfaces were used in chapters 5, 6, 7 and 8. Such surfaces were 
obtained by a phase separation method, which is a simple, fast and inexpensive method. In addition, PS is 
a recurrent material used in the labs namely in cell culture tissue plates, as well as main compound of 
particles for biomedical applications [2]. PS superhydrophobic surfaces could even be implanted in vivo 
causing minimal inflammatory responses [3], this means that it should not release toxic or undesirable 
species that could contaminate the particles during the solidification process. As referred above, to 
prepare PS superhydrophobic surfaces a phase separation method was employed [4]. Briefly, a PS 
solution in tetrahydrofuran (THF) was prepared with a concentration of 70 mg/mL and then mixed with 
ethanol in the proportion 2:1.3 (v:v). Ethanol is a nonsolvent of PS and acts as a precipitator. This was the 
reason that led to the appearance of some aggregates when the ethanol was mixed with the PS solution. 
However, after several minutes, the aggregates dissolved in the mixture. Then, the solution was dispensed 
on the top of smooth PS substrates (obtained from commercial petri dishes) previously cleaned with 
ethanol. The reaction occurred during approximately 1 min and then, the substrates were immersed in 
ethanol for at least 1 min – Figure 4.1 I. Two macroscopic phases were formed: one polymer rich phase 
and one polymer poor phase. The precipitated polymer acted as a nuclei and the polymer rich phase 
preferred to aggregate around the nuclei in order to decrease the surface tension, which explain the 
almost spherical structures aggregated onto the PS formed film (Figure 4.1 II). In addition, the mixture of 
THF and ethanol is less volatile than THF solely, causing an increase of reaction time and a more uniform 
formation of the micro/nano spheres [5,6].  
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Figure 4.1. I. Schematic representation of the procedure to obtain PS superhydrophobic surfaces. II. Smooth PS exhibiting a 
contact angle (CA) of ca. 77° (before modification) and the topographical structures of the superhydrophobic PS surface (after 
modification). The water CA achieved was higher than 150° and the surfaces exhibited aggregates of nanostructures onto 
microstructures recreating the hierarchical structure of the natural water repellent systems. Images adapted from [7]. 
 
In order to improve the hydrophobicity of the obtained surfaces a chemical surface treatment was also 
performed. A self-assembly monolayer of perfluorodecyltriethoxysilanes (1% (v/v) PFDTS in ethanol) coated 
the micro/nano topographical features of the PS modified substrates, after being activated by an argon 
plasma treatment (40 s, 30 W, Plasma Prep5; Gala Instruments).  This treatment activated the surfaces 
generating hydroxyl groups, which are reactive groups that interacted with fluorinated hydrocarbons 
existing in the PDFTS. Having into account that hydroxyl groups are water adsorption sites, this treatment 
eliminated possible water anchor sites [8].  
 
4.1.1.2. Copper  
In chapter 9, it was used copper (Cu) superhydrophobic surfaces obtained by a chemical-base deposition 
method where a micro/nanostructured film was spontaneously deposited onto such substrates [9]. In 
comparison with PS surfaces, slightly higher water repellency and resistance to UV light exposure were 
achieved [7]. However, the fragility of the film can limit the application on those surfaces.  
The process of the preparation of Cu superhydrophobic surfaces was the following (Figure 4.2 I): the Cu 
substrates were immersed in ammonium hydroxide solution (0.03 M, pH 9-10), for 5 days at 4 °C, that 
caused the formation of a uniform blue film coating. The Cu surfaces had to be very well cleaned with 
solutions of HCl (1 M), otherwise the film was not deposited or was heterogeneous. The film was 
composed by a large number of Cu(OH)2 needles that growth through a crystallization process (Figure 4.2 
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II). The Cu platform was further modified by a deposition of a self assembly monolayer of PFDTS (1% (v/v) 
in ethanol) in order to improve the water repellency properties [9].  
 
 
Figure 4.2. I. Schematic representation of the procedure to obtain Cu superhydrophobic surfaces. II. Cu substrate before film 
deposition, exhibiting CA around 56° and after immersion in ammonia and PFDTS solution. On the surface of the Cu grew up 
micro and nano structures of Cu(OH)2  which combined with a PFDTS increased the water contact angle to ca. 164°. Image 
adapted from [7].  
 
4.1.2. Materials, Bioactive Agents and Cells Used in the Preparation of the Particulate 
Systems  
4.1.2.1. Natural-Based Hydrogels 
Hydrogels are three-dimensional structures obtained through crosslinking of water-soluble polymers 
creating a water insoluble network. A variety of formulations at chemical and physical level may be 
obtained. Particles, films, coatings, scaffolds are examples of hydrogel structures widely used in 
biomedical applications, namely tissue engineering and regenerative medicine [10,11], drug release 
systems [12,13], diagnostics [14], cell immobilization [15-17], separation of biomolecules or cells 
[18,19], and as materials to regulate biological adhesions [20].  
Hydrogels are highly porous networks and their structure may be tuned by controlling the density of the 
crosslinking. With this, their swollen rate when immersed in aqueous environments is also controlled. The 
porosity of the hydrogels is the main responsible for the loading and release of molecules when used as 
drug carriers. Small or even macromolecules may diffuse in and out of the hydrogel network at a rate 
dependent on the diffusion coefficient. The high water content within the hydrogel structure turns those 
materials typically highly biocompatible. In addition, hydrogels exhibit physicochemical similarities with 
native extracellular matrix (ECM) due to the composition (particularly in the case of carbohydrate-based 
hydrogels) and mechanical properties [15]. In most of the cases, the hydrogels are quite deformable 
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which could be an advantage to adapt their shape to the site where they are applied, as for example when 
implanted in injured tissues or even to be administered through injectable procedures. On the other side, 
hydrogels also have a few limitations mainly as the result of their low tensile strength, being not the most 
appropriated materials for applications where strong mechanical properties are required. When used as 
drug carriers, hydrogels have two main restraints derived from their high affinity to aqueous environments 
and from their porous structure: (I) the limited capacity to be loaded with hydrophobic drugs and (II) the 
rapid release of the content. In addition, some hydrogels do not allow cell attachment and proliferation 
being problematic when it is desired to use them as cell carriers or scaffolds. In such cases, the recurrent 
strategy is to modify the polymer backbone with adhesive peptides, such as RGD [21].  
Hydrogel crosslinked networks may be obtained through the establishment of physical or chemical 
interactions between the polymer chains. Physical crosslinked gels are, generally, obtained through simple 
and fast procedures. Examples are ionic interactions, crystallization, hydrogen bonds, protein interactions, 
among others. Chemical crosslinking may be achieved by radical polymerization, chemical reaction of 
complementary groups (crosslinker agents), high-energy irradiation and using enzymes [22].  
Natural-based materials were selected to develop the different systems proposed in this thesis. They have 
the advantage of showing low/non toxicity, low immunogenicity and general good biocompatibility. In 
addition, natural-based polymers could be processed in mild conditions [23]. The most relevant properties 
of such polymers will be described in detail in the next subsections. 
 
I. Dextran  
Dextran is a polysaccharide obtained from bacteria cultures of Leuconostoc mesenteroides. It shows a 
linear polymer backbone composed mainly by D-glucopyranose residues connected by 1,6- and some 1,3-
glycosidic linkages (Figure 4.3) [24].  
 
Figure 4.3. Structure of Dextran.  
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Moulds, bacteria and also mammalian cells may degrade such glycosidic linkages [25]. Bacteroides are 
anaerobic gram-negative intestinal bacteria present in the colon, exhibiting dextranase activity meaning 
that are capable to hydrolyze the glycosidic linkages. Various drug-dextran prodrugs have been proposed 
[26] because the drug-dextran conjugation remains intact and unabsorbed from the stomach to the small 
intestine, but in the colon the dextranases cleave the dextran chain randomly at the terminal linkages, and 
release the drug [24]. Dextran have also been used to produce particles for colon-specific drug delivery 
[24, 27] and used in tissue engineering [28-30]. 
Dextran hydrogels can be created by either physical or chemical crosslinking. Physical crosslinking was 
obtained by self-assembling of enantiomeric lactic acid oligomers (stereocomplex formation) grafted onto 
dextran backbone [31]. Chemical crosslinking was already achieved by using quite aggressive molecules 
such as isocyanates and glutaraldehyde [27,32]. Owing to its chemically reactive hydroxyl groups (3 
groups per glucopyranose unit), dextran can be modified with functional groups (e.g. methacrylate) to form 
3D network structures by UV light exposure. The main advantage of using a photo crosslinkable polymer 
and superhydrophobic surfaces is that just is necessary to dispense one solution onto the surface, unlike 
in the ionic crosslinking that it is necessary dispense the polymeric solution and then the crosslinking 
agent. Furthermore, in chapters 5 and 9, dextran-methacrylate (dextran-MA, Figure 4.4) allowed to 
produce the particles just using aqueous soluble molecules, avoiding the use of organic solvents. The 
polymer was modified following a protocol described in literature [33]. Approximately 25 g of dextran were 
dissolved in 225 mL of dimethyl sulfoxide (DMSO) under a nitrogen atmosphere. Then, 5 g of 4-(N,N-
dimethylamido)pyridine (DMAP) were added and after being completely dissolved, 20.5 mL of glycidyl 
methacrylate (GMA) were incorporated. The solution was stirred at room temperature for 48 h. The 
reaction was stopped by adding 3.3 mL of HCl (37%), which induced the neutralization of the DMAP. The 
solution was then dialyzed against water for 1 month using membranes with a MWCO of 12 400 Da, and 
finally frozen and lyophilized. 
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Figure 4.4. Structure of the glycidyl methacrylate used to modify the dextran. After the reaction, two isomers may be obtained: 
3-methacryloyl-1-glyceryl ether or 2-methacryloyl-1-glyceryl ether.  
 
II. Chitosan  
Chitosan is a derivate of chitin, the most abundant natural polysaccharide after cellulose. Chitin is the 
main component of the exoskeleton of crustaceans, insects, spiders and cells walls of algae, fungi and 
yeast. When the chitin is deacetylated, it becomes soluble in acidic conditions and it is denominated 
chitosan.  
Chitosan is a linear polysaccharide composed by randomly distributed β-(1-4)-linked D-glucosamine 
(deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit) (Figure 4.5). The protonation of the –NH2 
on the C-2 position of the D-glucosamine unit, is the responsible for its solubilization. In addition, chitosan 
solubility is limited to acidic environments (pH < 6.5) and neutralization is required prior to biological 
applications.  
 
 
Figure 4.5. Chemical structure of chitin and chitosan.  
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Chitosan 3D structures are commonly obtained by crosslinking the chitosan acidic solution using 
dialdehydes (glutaraldehyde, formaldehyde, PEG dialdehyde diethyl acetal) and other molecules such as 
genipin. Most of the crosslinkers used to perform covalent crosslinking may induce toxicity both in the 
encapsulated cells as well as in the body if found free traces when the gel is administered or implanted. 
Ionic crosslinking provides mild conditions because non-toxic agents are required. It is known that chitosan 
is a polycationic polymer capable to interact with negatively charged components, either ions or 
molecules, forming a network through establishment of ion bridges [34]. As said before, the neutralization 
of the chitosan is a requirement for biomedical applications. The acidic solution of chitosan may be easily 
neutralized with a polyol counterionic dibase salt such as β-glycerophosphate (β-GP). This is achieved just 
mixing the acidic solution of chitosan with a β-GP solution. The obtained mixture is thermosensitive and it 
is suitable to gelify at physiological temperatures. This system showed promising characteristics to be 
used injectable system for biomedical applications [35,36]. Playing with neutralization and ionic 
crosslinking, in chapter 6, chitosan hydrogels were prepared using mild conditions for cell encapsulation. 
 
Purification of chitosan 
The chitosan used in chapter 6 was previously purified through dissolution in an acetic acid solution 
followed by precipitation. The purification was carried out in order to eliminate some impurities or even 
insoluble fractions (e.g. chitin) that could remain in the commercial chitosan. Around 10 g of commercial 
powder of chitosan were slowly dissolved in 1 L of an aqueous acetic acid solution (2% v/v) at room 
temperature. The obtained solution was filtered twice using a nylon filter and a Millipore membrane (5 
µm). The pH of the chitosan solution was adjusted to 8 by adding NaOH 2M. The increase of the pH 
caused the precipitation of the chitosan. Afterwards, the chitosan precipitate was collected by filtration and 
washed with water until reach the pH 7. Upon complete neutralization, the chitosan precipitate was 
dehydrated in ethanol-water solutions, frozen at -80 °C and finally dried by lyophilization.  
 
III. Collagen  
Collagen is the major insoluble fibrous protein in the ECM and in the connective tissue, being the most 
abundant protein in the animal kingdom. Although there are around 16 types of collagen, the most 
common in the human body are type I, II and III. Despite having different structures all types of collagen 
have a common role: imparts strength, support and elasticity of the tissues. Fibroblasts and epithelial cells 
secrete the different types of collagen.  
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In chapter 7, this protein was used to prepare gels in a fast way for applications in skin regeneration. 
Models of bioengineered skin capable to mimic the anatomy, physiology, biological stability and aesthetic 
nature are difficult to achieve. Tissue engineering strategies for skin should have some essential 
characteristics, such as, being easy-to-handle to apply in the wound site, provide a functional barrier with 
appropriate water and oxygen flux, be adherent, have adequate mechanical properties, undergo controlled 
degradation, and avoid toxic and inflammatory responses [37]. In this way, type I collagen could be 
particularly important in scenarios such as chronic wounds, where the healing process is extremely 
difficult. In these cases, the dermis and epidermis layers are disrupted due to an inflammatory process 
where an abnormal presence of proteinases cause the destruction of the ECM and consequently the dead 
of the cells [38]. Type I collagen was selected because it is highly present in the skin (around 70-80% of 
the dry weight of the skin is type I collagen) [39] and it has been demonstrating potential to be used as a 
scaffold [40].  
Collagen shows a fibrillar structure because the molecules pack together to form long thin fibrils with 
similar structure – Figure 4.6. Type I collagen was the first type to be characterized. Its abundance in 
tendon tissue and in rat tails made it easy to isolate. It is composed by long (100-200 nm) and thin (1.5 
nm in diameter) fundamental structural units. These units consist in three coiled subunits: two α1 chains 
and one α2. Each chain contains precisely 1050 amino acids wound around one another in a 
characteristic right-hand triple-helix (Figure 4.6). The most abundant amino acids in collagen structure are 
glycine (Gly), proline (Pro) and hydroxyproline being, in general, in the follow sequence: Gly-Pro-X, where X 
can be any amino acid. Each amino acid has a precise function to maintain the three-stranded collagen 
helix in a stable state [41].  
 
 
Figure 4.6. Assembly of collagen type I. The peptide chains form triple helices with approximately 100-200 nm in length and 
then are assembled via the staggered lateral packing into nanofibers which form a hydrogel. Image adapted from [42]. 
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Collagen type I is soluble in acidic conditions, but changes in pH, ionic strength and temperature trigger 
the self-assembly process described in Figure 4.6, where hydrogels are formed in a very fast way. The 
conditions to obtain those gels are very mild for encapsulation of cells and labile molecules, leading to 
develop strategies for tissue engineering applications.  
 
IV. Alginate  
Alginate is an anionic polysaccharide extracted from brown algae or produced by some bacteria. It is a 
linear unbranched copolymer composed by blocks of β-D-mannuronic acid (M) and α-L-guluronic acid (G) 
residues linked by 1,4-glycosidic bonds. Both residues are covalently linked in different sequences, 
namely, rearranged in homopolymeric (GG blocks and MM blocks) or heteropolymeric block structures 
(GM blocks). Alginate-based gels have been widely explored and used in biomedical applications due to 
their minimal toxicity, low cost and easy processing. Alginate-based hydrogels could be formed in a fast 
way via ionic interactions between carboxylic acids and divalent cations such as Ca2+, Mg2+ and Ba2+ - Figure 
4.7. The crosslinking of the alginate via ionic interactions have been demonstrated to be mild for cell 
encapsulation, unlike other covalent crosslinking strategies. The main disadvantage of alginate for cell 
encapsulation is related with the absence of anchorage points for adhesive cells. For these purposes the 
functionalization of the alginate with RGD domains [43] has been proposed or the re-formulation of the 
system adding specific molecules capable to promote cell adhesion. 
 
Figure 4.7. Alginate-based hydrogels could be prepared by ionic crosslinking following an egg-box model. The Ca2+ ions are 
placed in the interstices of guluronate blocks of one polymer chain and junctions with the guluronate blocks of adjacent polymer 
chains are formed. Image adapted from [44].  
 
Alginate has been the most explored polymer for cell encapsulation purposes due to its abundance, water 
solubility, mild gelling properties and biocompatibility [45-47]. In addition, it is being used in proof of 
concepts or as controls to other polymers in cell encapsulation purposes [48]. Due to the resemblance to 
the natural ECM [21], alginate systems have been successful in encapsulation of transplanted cells, 
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providing immunoisolation for the cells and avoiding the need of immunosuppression additional 
treatments [49, 50].  
Alginate spherical gels obtained by ionic crosslinking with Ca2+ ions and encapsulating different types of 
cells were prepared in various chapters of this thesis. Differently from the conventional procedures to 
prepare alginate particles, here the use of superhydrophobic surfaces methodology avoided the use of 
coagulation baths. In the chapter 6, alginate particles containing L929 cells were used as controls in order 
to evaluate the efficiency of the strategy used to encapsulate cells in chitosan gels. In chapter 8, alginate 
particles were prepared encapsulating a protein (fibronectin, FN) and cells (mesenchymal stem cells, 
MSCs), and subsequently studied as a suitable system for bone regeneration. In chapter 9, cells (L929 
cells) were encapsulated into alginate layers with the aim to proof the concept that superydrophobic 
surfaces methodology is a suitable procedure to prepare compartmented particles, namely core/shell.  
 
4.1.2.2. Cyclodextrins: γ-cyclodextrins  
Cyclodextrins (CDs) are a family of cyclic oligosaccharides composed by glucopyranose units linked by α-
(1,4) bonds. There are three main types of CDs (α, β and γ, Table 4.1) which are composed by 6, 7 or 8 
α-(1,4)-linked glycosyl units, respectively [51]. CDs are obtained as a result of intramolecular 
transglycosylation reaction from degradation of starch by cyclodextrin glucanotransferase enzyme. The 
most important characteristic of the CDs is the ability to form inclusion complexes, i.e. host-guest 
complexes with hydrophobic solid, liquid and gaseous compounds. Molecular complexation occurs inside 
the hydrophobic cavity of the CDs and no covalent bonds are formed. The complexation occurs through 
the release of water molecules from the cavity. This displacement is caused by the hydrophobic guest 
molecules to attain an apolar-apolar association, decreasing the CD ring strain and achieving a more 
stable energy state. This is a dynamic equilibrium [51].  
 
Table 4.1. Properties of the most common CDs. Table adapted from [51]. 
 
 
CDs have been widely used in pharmaceutics approaches due to their capacity to form inclusion 
complexes with hydrophobic bioactive agents. Currently, it is well known that poor water-soluble drugs 
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prevent the achievement of therapeutic concentrations in physiological fluids, being required innovative 
strategies to circumvent these limitations. CDs may be used as building blocks in drug delivery systems 
because their capacity to host bioactive agents is enhanced when they self-assemble to form aggregates, 
crosslink together or copolymerize with other compounds. Consequently, each obtained carrier has a 
particular drug release kinetic [52]. In addition, all types of CDs are non-toxic when administered orally 
due to lack of absorption from the gastrointestinal tract. Through parenteral administration, γ-CD, 2-
hydroxypropyl-β-CD, sulphobutylether β-CD, sulphated β-CD and maltosyl β-CD appeared to be safe. Since 
the γ-CDs (Figure 4.8) are the less studied and having into account that such molecules have also 
interesting properties for medical applications when compared with α- and β-CDs (insignificant irritation, 
rapid and complete degradation into glucose units by intestinal enzymes and less toxicity than the other 
types), we select them to be used in the work presented in chapter 5. It was hypothesized that the 
performance of dextran-MA particles in loading and releasing a hydrophobic drug (dexamethasone) could 
be improved if CDs were incorporated in the network. Two formulations were prepared and studied: 
dextran-MA particles containing free γ-CDs and Dex-MA particles containing γ-CDs as structural 
monomers.  
 
 
 
Figure 4.8. Structure of the γ-CD. 
 
To obtain the monomers of CDs, these molecules were modified by functionalizing their structure with 
methyl groups [53] capable to establish covalent linkages with Dex-MA or between γ-CD monomers. 
Acrylamidomethyl-γ-CDs (γ-CD-NMA) (Figure 4.9) were synthesized mixing 17.12 g of γ-CD and 13.36 g of 
(hydroxymethyl)acrylamide (NMA) in 50 mL of HCl solution (1% v/v). The solution was stirred and kept at 
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80 °C for 30 min. The precipitation of the γ-CD-NMA was induced by adding 300 mL of acetone. The 
suspension containing the γ-CD-NMA was stored overnight at 4 °C and after filtered and washed with 
acetone (2-3 cycles). The collected product was dried under vacuum for 2 days at room temperature and 
stored at 4 °C.  
 
 
Figure 4.9. Structure of the γ-CD-NMA.  
 
4.1.2.3. Bioactive Agents  
I. Dexamethasone 
Dexamethasone is a small drug (MW 392.46) that acts as anti-inflammatory and immunosuppressant, and 
it is also known to stimulate the up-regulation of same major bone-related genes during osteogenesis [54]. 
When used as stimulus for cell osteo differentiation, it causes variations in cell proliferation, up regulation 
of alkaline phosphatase (ALP) and increases the mineral deposition. This synthetic glucocorticoid was 
employed in chapter 5 and 6. Such type of drugs has appeared as alternatives to growth factors (GFs) in 
musculoskeletal regeneration. The small size of those drugs does not trigger immune responses. In 
addition, the bioactivity of the small molecules does not require structural integrity and are, in comparison 
with recombinant proteins, inexpensive compounds. Small drugs are capable to diffuse across the cell 
membrane to reach the target acting as signaling molecules. The optimal concentration to achieve the 
osteogenic differentiation is between 10 and 100 nM; concentrations above 1000 nM trigger side effects 
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and prolonged exposures cause osteoporosis. Then, the encapsulation and controlled release is an 
interesting strategy to overcome those problems.  
Dexamethasone is a hydrophobic bioactive agent, being difficult to encapsulate high quantities of this drug 
inside hydrophilic matrices. A recurrent strategy is to dissolve it in an organic solvent (e.g. ethanol, 
chloroform, DMSO, among others) and then dilute the concentrated solution in aqueous buffers (strategy 
used in chapter 6). However, traces of such aggressive solvents may remain in the developed 
formulations, turning the systems not appropriate for certain applications. A different approach to load 
hydrophilic matrices with dexamethasone was evaluated in chapter 5. The loading capacity of Dex-MA 
hydrogels as well as the release profile of dexamethasone were studied in detail when γ-CDs were 
included in the particle network. No organic solvents were required to load the particles with this 
hydrophobic drug.   
 
II. Platelet Lysates  
Platelet cells are key components in homeostasis, in stimulation of connective tissue and 
revascularization. These small cells, with a regular shape and 2-3 µm in diameter, have a lifespan of 5-9 
days. The physiological range of platelets in humans varied from 150 to 400 x 109 cells/L, circulating 
normally in the blood. The blood is composed by 93% erythrocytes, 6% platelets and 1% white blood cells. 
In the body, the platelets are activated when contact with von Willebrand factor, collagen and by thrombin 
action. Upon activation they secrete the content of their alpha (responsible for the platelet adherence to 
the endothelium) and dense granules (responsible for the activation of the intrinsic coagulation pathway). 
In addition, the GFs released by the platelets have a role in the healing, namely in inflammation, 
proliferation and remodeling processes [55].  
Human platelet lysates (PLs) have been successfully used as substitute of fetal bovine serum (FBS) in cell 
cultures avoiding the risk of xenogeneic immune reactions or transmission of bovine pathogens [56].  
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Figure 4.10. – Molecules secreted by platelets: signaling proteins (growth factors, chemokines and other cytokines), adhesive proteins and 
proteases, and small molecules. The table describes the approximate contents of GFs in human PL. Image adapted from [55] and table from 
[57].  
 
PLs are obtained from the blood, which in turn is centrifuged to separate the platelets from the other cell 
types. Upon activation, platelets release a pool of biologically active proteins and other substances (Figure 
4.10) constituting an appealing autologous source of GFs for biomedical applications. There are several 
methods to induce the release of the GFs from the platelets: adding bovine thrombin, calcium chloride, 
collagen type I and by mechanical disruption through freeze-thaw cycles. In chapter 7, PLs from different 
apheresis collections were processed by freeze-thaw methodology, which is a simple, fast and cheap 
method, and it was demonstrated to be more efficient in platelets activation than other techniques 
[58,59]. The blood samples used to prepare the PL were obtained at Galicia Blood Transfusion Center 
(Spain) from three different donors. The samples were centrifuged at 1400 rpm, at 25 °C, during 15 min. 
The plasma was collected carefully in order to not mix with the red blood cells deposited at the bottom of 
the centrifuge tubes. Then, three cycles of frozen at -80 °C and heating at 37 °C were performed to the 
collected plasma in order to cause the disruption of the platelet membranes to release their content. After 
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this step, the samples were again centrifuge at 4 °C, 12000 rpm for 12 min with the aim to remove 
remaining platelets and potential antigens. The supernatant was carefully collected and stored at -80 °C.  
The concentrated PLs were obtained by PL lyophilization in aliquots of 1 mL followed by their 
reconstruction in adequate volumes of PBS pH 7.4 to obtain the desired concentrations: 500 µl or 333.33 
µl to obtain the PL concentrated 2x and 3x, respectively.  
 
III. Fibronectin  
Fibronectin (FN) was entrapped in alginate particles in chapter 8. This is a large multifunctional 
glycoprotein (≈450 KDa), present in ECM, and involved in numerous physiological processes: cell 
adhesion, spreading, migration, differentiation and survival as well as wound healing [60-62]. It is 
composed by homologous repeating structural motifs designed type I, II and III modules. Those motifs are 
grouped together into functional domains with specific biological activities. This protein has protein-protein 
interaction sites distributed along the FN structure and cell binding sites localized in FNIII: RGD28 on 
FnIII10 and the synergy site PHSRN on FnIII9 [63,64] – Figure 4.11. Due to the well-known effect on cell 
behavior, FN was selected to integrate in the alginate mesh in order to provide adhesion sites for the cells 
as well as to improve the general performance of the system.  
 
 
Figure 4.11. Fibronectin structure with its binding sites. FN contains cell binding sites (RGD28 on FNIII10 and the synergy 
site PHSRN on FNIII9) and protein-protein interaction sites. Image from [64].  
 
Adsorbed FN onto scaffolds [65], as a coating layer, was a strategy employed to promote cell adhesion 
onto the PCL fibers as well as in chitosan/alginate scaffolds [66]. In other strategy, hydrogels matrices 
where FN was immobilized in a hyaluronic acid network also demonstrated to be effective in enhancement 
of cell adhesion [67]. In addition, the inclusion of FN in an alginate hydrogel matrix contributed to improve 
the regeneration of nerves [68]. In chapter 8, FN was mixed with alginate where mesenchymal stem cells 
were entrapped. The effect of the FN on cell viability was studied. 
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4.1.2.4. Cells Immobilized in the Hydrogel Particles 
I. Cell Lines 
Cell lines have the particularity to proliferate indefinitely, this means that they have unlimited cell division 
and an infinite lifespan, being also named immortalized cells. Such modification in cell growth control is 
generally induced by viral or tumorigenic transformations. In addition, cell lines are not susceptible to 
being differentiated. Cell lines are suitable to study a number of biological responses in vitro, offering the 
advantage of being more homogeneous and standardized than primary cells. In chapters 6 and 9 L929 
cells were encapsulated into the hydrogel spherical gels. L929 cells (purchased from European Collection 
of Cells Cultures - NCTC clone 929 ATCC®CCL-1TM) are fibroblasts isolated from Mus Musculus mice. 
These adherent cells are suitable for toxicity testing. L929 cells were expanded at pH 7.4 in low-glucose 
DMEM supplemented with 3.7 g/L sodium bicarbonate, 10% (v/v) FBS and 1% (v/v) penicillin-
streptomycin. The cells were incubated at 37 °C in humidified air atmosphere of 5% CO2 in 75 cm2 flasks.  
At approximately 90% of confluence the cells were washed with PBS, and collected by adding 0.05% 
trypsin-EDTA for 5 min at 37 °C. Tripsyn-EDTA is a mixture of proteases derived from porcine pancreas 
and due to its digestive strength; it is widely used for cell dissociation, routine cell culture passaging and 
primary tissue dissociation. After the detachment of the cells, the trypsin was inactivated by adding fresh 
cell culture medium. The cell suspension obtained was then centrifuged at 300 g at 25 °C. The 
supernatant was discarded and the cell pellet was suspended in a neutralized chitosan (chapter 6) or 
sodium alginate  (chapter 6 and 9) solution in order to be encapsulated.  
 
II. Primary cells  
Primary cells are cells obtained directly from the subject and maintained for growth in vitro. The main 
advantage of primary cell cultures is that they mimic more closely the physiological state of cells in vivo, 
generating more relevant data. When compared with cells containing mutations and chromosomal 
abnormalities (e.g. cell lines), which provides poor indicators of normal cell phenotype and progression of 
early-stage diseases, primary cells are considered the best representatives of the main functional 
component of the tissue in vivo from which they are derived. Primary cells undergo a limited, 
predetermined number of cell divisions before entering senescence. In addition, such cells are quite 
fastidious. They require optimized growth conditions, where tissue specific cytokines and GFs are 
necessary for their propagation in serum-free or low-serum growth media. The cell types most frequently 
found in primary cell culture are epithelial cells, fibroblasts, keratinocytes, melanocytes, endothelial cells, 
muscle cells, hematopoietic and mesenchymal stem cells. In this thesis, two primary cell types were used. 
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In chapter 7, human adipose derived stem cells (hASCs) (StemPRO® purchased from Gibco®) isolated from 
human lipoaspirate tissue were expanded to 5-8 passages and encapsulated in hydrogel particles. The 
characterization of these cells by the supplier demonstrated very similar phenotypic and functional 
characteristics to bone-marrow-derived mesenchymal stem cells, being capable to differentiate into 
multiple mature cell phenotypes in vitro: adipocytes, osteoblasts, and chondrocytes. These cells also could 
be differentiated into non-mesenchymal cell types: neuronal and glial progenitors, hepatocytes and 
vascular endothelial progenitors, cardiomyocytic, pancreatic and epithelial phenotypes. Another 
particularity of those hASCs is their capacity to secrete pro-angiogenic, immunomodulatory and anti-
apoptotic factors [69-76]. hASCs are interesting cells for studies of cell differentiation and tissue 
engineering strategies with potential to be used in clinical applications. hASCs were expanded in 
appropriate media supplied by Gibco®: MesenPro®  supplemented with 2% (v/v) growth supplement (FBS), 
1% (v/v) L-glutamine and 1% (v/v) penicillin/streptomycin. The cells were maintained in humid conditions 
at 37oC and 5% CO2. Upon confluence, the cells were tripsinised and the obtained cell suspension was 
centrifuged. The pellet of the cells was then suspended in a polymeric solution to prepare the hydrogel 
spherical systems.  
In chapter 8, it was used mesenchymal stem cells isolated from Wistar rats femoral bone marrow 
(rMSCs), using protocols reported in literature [77,78]. The isolation and characterization of the obtained 
cells was performed by the group that collaborates in the experimental activities under the scope of this 
work (CICS, University of Beira Interior). Autologous MSCs were selected according to the aim of the work, 
this means capacity to regenerate bone. It is known that rMSCs could be differentiated into mesodermal 
lineage cells including osteoblasts, chondrocytes, muscle cells, adipocytes and tenocytes when properly 
stimulated [79]. rMSCs were expanded in DMEM-F12 supplemented with 10% (v/v) FBS, penicillin (100 
U/cm3), streptomycin (100 µg/cm3), and amphotericin (0.25 µg/cm3) at 37 °C and 5% CO2 humidified 
atmosphere. After reached the confluence, the cells were collected using 0.18% trypsin in 5mM EDTA for 
3-5 min at 37 °C, posteriorly neutralized with fresh cell culture medium. The cell suspension was 
centrifuge and the cells were used to encapsulate in hydrogel beads.  
 
4.2. Characterization of the Modified Materials 
4.2.1. Fourier Transform InfraRed  
Fourier transform infrared (FTIR) is a spectroscopy technique where the IR radiation passes through the 
sample and part of the radiation is absorbed by the sample and the other part is transmitted. The 
obtained spectrum represents the molecular absorption/transmission and results from transitions 
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between vibrational energy states, ranging from simple coupled motion of two atoms in a diatomic 
molecule to a more complex motion in large polyfunctional molecules. Each spectrum is unique, and it is 
possible to detect specific functional groups and identify compounds [80]. FTIR is a very fast technique 
and requires very small amounts of samples. The samples should be as dried as possible in order to avoid 
the interferences of water molecules.  
In chapter 5, FTIR was used to verify if the γ-CD were modified as expected. This was achieved by 
detecting the group added onto the γ-CD by measuring characteristic absorption and comparing it with the 
spectra of the unmodified γ-CD. The samples in a powder form were mixed with KBr in order to form a 
pellet to be analyzed. KBr is a commonly used material because it has good transmission properties, not 
exhibiting peaks and thus not interfering with the spectrum of the added substance. The IR spectrum was 
recorded over the range 400-4000 cm-1 (Bruker IFS 66V FT-IT).  
 
4.2.2. Proton Nuclear Magnetic Resonance  
Nuclear magnetic resonance (NMR) is a recurrent technique to determine the structure of organic 
molecules as well as interaction of various molecules and the composition of mixtures of biological or 
synthetic solutions or composites. The principle of NMR is that the nuclei of elemental isotopes have a 
characteristic spin. When subjected to a strong magnetic field, the nuclei resonate at a characteristic 
frequency in the radio frequency range of the electromagnetic spectrum. This means that when an 
external magnetic field is applied could occur an energy transfer between the base energy to a higher 
energy level. Such energy transfer happens at a certain wavelength that corresponds to radio frequencies, 
and when the spin returns to its base level energy is emitted at the same frequency. Then, this signal is 
detected and processed [81]. Pronton NMR (1H NMR) was performed in chapter 5 to characterize the 
modified dextran and γ-CDs. Using this technique, the number of protons in a molecule, the groups 
attached and the number of “neighbor” hydrogen atoms were detected. The 1H NMR spectra were 
recorded (Mercury 300, 300MHz) dissolving 0.3 g of modified and non-modified dextran in 0.7 mL of 
deutered water and 30 mg of γ-CD and γ-CD-NMA in 1 mL of deutered water. The degree of substitution 
was determined using the integral of key protons existent in the groups added to the dextran and γ-CD. 
The description of the peaks and equations used are described in detail in chapter 5.  
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4.3. Preparation of Spherical Hydrogel Particles Using Biomimetic 
Superhydrophobic Surfaces   
In this thesis, two main types of particles were produced using the PS or Cu biomimetic superhydrophobic 
surfaces: simple particles composed by homogeneous matrices and multicompartmented core/shell and 
multilayered particles. According to the material used, adequate procedures to harden the particles were 
used. A detailed description of the procedure used to obtain each system developed under the scope of 
this thesis, will be present in the follow subsections.  
 
4.3.1. Simple Homogeneous Matrices 
Homogeneous matrices were obtained by dispensing a solution containing the polymer or the precursors 
monomers as well as the bioactive agents or cells that were desired to encapsulate, onto the 
superhydrophobic surface. Micropipettes were used as dispensing systems and the volumes dispensed 
could be controlled adjusting the volumes of these devices. However, using this kind of dispensing 
systems volumes lower than 2 µL were not possible to be dispensed, preventing the preparation of smaller 
particles. The hardening of the particles was achieved by adequate procedures selected according with the 
polymers used. In the Figure 4.12 are summarized the systems proposed:  
 
Figure 4.12. Schematic representation of the procedures to prepare the different homogeneous matrices proposed in this 
thesis.  
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4.3.2. Core/Shell and Multilayered Particles 
Particles with more complex structures were also prepared using the superhydrophobic surfaces 
methodology. Core/shell and multilayered particles were prepared and are described in chapter 9. Both 
types of particles were obtained by subsequent deposition of liquid droplets onto the superhydrophobic 
surfaces followed by a crosslinking to obtain the core structure. The core/shell particles were finalized by 
dispensing another amount of a liquid precursor solution onto the hardened cores. The liquid coated the 
solid core, and upon hardening it formed a shell layer. The multilayered particles were obtained in the 
same way, but repeating the process until reach the desired number of layers – Figure 4.13. It was 
observed that the number of layers was limited by the effect of the gravity, which caused the deformation 
of the spheres. Different applications were proposed to use the core/shell and multilayered particles; the 
details are extensively described in the chapter 9.  
 
Figure 4.13. Schematic representation of the procedure to prepare multicompartmentalized spherical particles (core/shell 
and multilayered) using the superhydrophobic surfaces methodology.  
 
4.4. Characterization of the Particulate Systems  
4.4.1. Particle Size 
The size of the systems developed under the scope of this thesis was accurately measured. The particles 
were examined using a stereomicroscope and images obtained using a camera coupled to the 
stereomicroscope. Then, using an image treatment software such as ImageJ and Soft Imaging System®, 
the diameter of the particles was measured.  
 
4.4.2.  Degree of Swelling  
An intrinsic property of the hydrogel networks is related to the capacity to retain high amounts of water in 
their structure. The evaluation of degree of swelling of each hydrogel is an important parameter to 
characterize these systems. The extension of the swelling in the presence of a liquid (generally, water) is 
Chapter 4  Detailed Description of Experimental Testing and Materials 
!
! 174!
dependent on the several factors such as the nature of the polymer that compose the mesh and the 
degree of the crosslinking. The degree of swelling of the systems proposed in chapter 5 and 6 was 
measured based on the follow equation (eq.):  
 %Swelling = !!!!!!! ×100    Eq. 1 
 
where mi and m0 are the weights of the swollen and dry beads, respectively.  
A certain number of particles were immersed in a medium (selected according to the applications and 
characteristics of the system) and at pre-defined time points, the particles were collected. The excess of 
the medium was removed with a filter paper and the samples were immediately weighted. The details 
related with number of particles used in the experiment and the medium content are described in each 
corresponding chapter.  
 
4.4.3. Morphological Characterization   
Scanning electron microscopy (SEM) is a commonly used technique to analyze the topography of the solid 
materials and structures. This procedure consists in the use of a focused beam of high-energy electrons 
capable to generate signals at the surface of the solid sample. The accelerated electrons carry significant 
amounts of kinetic energy and when interact with the surface of the material they are decelerated and part 
of the energy is dissipated. Consequently, a variety of signals are generated. The electron-sample 
interactions (secondary electrons) are collected from a selected area and the information related with 
external morphology (texture) is translated in a 2D image. The main advantage of SEM relies on the 
examination of the topographical features at high magnifications, allowing the observation of the 
morphology at sub-micron scales. 
In this thesis, SEM was employed in chapters 5, 7 and 8 for the assessment of surface of the particles as 
well as the inner morphology when the particles were previously sectioned. Prior to analysis, all the 
samples were coated with a conductive material (gold) by sputtering, with the aim to increase the degree 
of magnification avoiding the damage of the samples by the high-energy electron beam. Freeze-dried or 
air-dried particles were immediately coated with gold and visualized. Particles in a hydrogel state were 
firstly fixed in 0.25-2.5% (v/v) glutaraldehyde, overnight, at 4 °C. Then, the particles were dehydrated in 
ethanol solutions (70%, 80%, 90% and 100%) for at least 10 min each and finally coated with gold and 
observed.  
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4.4.4. Mechanical Properties  
The mechanical properties of the hydrogels proposed in chapter 6 were evaluated by dynamic mechanical 
analysis (DMA). The test consists in applying an oscillatory force to the sample followed by the analysis of 
the sample response to that force. This technique allows obtaining information about the mechanical 
properties of materials as a function of time, temperature and frequency. The properties may be 
expressed in terms of elastic modulus, viscous modulus and damping capability. The samples need to 
have specific geometries such as cylinders or cubes in order to have a uniform distribution of the applied 
load during the compression experiments. In the analysis of spherical samples, the load is applied on the 
top of the sphere and non-accurate results could be obtained. Having this in consideration, gels were 
prepared in 96-well plates exhibiting a cylindrical shape following the same procedure and the same 
proportions of materials as described for the fabrication of spherical systems onto the superhydrophobic 
surfaces. Data was collected using a range of frequencies between 0.1 and 15 Hz, under physiologic 
simulated conditions, this means immersed in PBS pH 7.4.  The strain amplitude was constant and was 
approximately 1% of the original height of the sample. Before initialization of the test, a small preload was 
applied to ensure the contact between the sample and the compression plates. The effect of temperature 
on the mechanical properties of the gels was evaluated by collecting data at two temperatures: 20 °C and 
37 °C.  
 
4.4.5. Double Bond Detection 
The presence of double bonds (C=C) in the particles formulated in the chapter 5 was evaluated by using 
the bromine test. The presence of double bonds means that the particle was not completely crosslinked, 
being C=C bonds available to establish linkages. Bromine test is a simple qualitative assay to detect the 
presence of carbon to carbon double and triple bonds and also phenols. The bromine solution has a 
characteristic yellow-orange color and reacts with sites of unsaturation through an addition reaction. The 
reaction is represented in Figure 4.14. 
 
 
Figure 4.14. Reaction of bromine with unsatured compounds.  
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This test was performed to ascertain whether all the double bonds were consumed. Particles (8 spherical 
gels) of each formulation were immersed in 200 µL of bromine solution. The bromine aqueous solution 
was composed by 32 mL of water, 7.6 mL of NaClO (33 mg/mL) and 10.7 mL of NaBr solution (1.1 g of 
NaBr in HCL (1M)). The color of the solutions, after 5 minutes, was compared with equivalent amounts of 
precursor liquid solutions and the original bromine solution.  
 
4.4.6. Quantification of Unreacted Photoinitiator  
The quantification of the exceeding photoinitiator in the formulations described in chapter 5 was 
determined by high-performance liquid chromatography (HPLC). HPLC is a method that allows the 
separation of the components, their identification and quantification. This method is particularly useful 
when the sample is a mixture of molecules and when the compound that is desired to quantify is present 
in small amounts. The technique consists in the passage of the sample mixture through a column filled 
with a solid adsorbent material. In the column, the compounds of the sample are separated due to 
differences in interaction with the adsorbent material (physical interactions), which cause different flow 
rates. The compounds that are more strongly attracted to the adsorbent material slowed down, while the 
other compounds move faster. The sample is injected in the column (stationary phase) mixed with a 
pressurized solvent that is referred as the mobile phase. Both composition of the mobile phase and 
temperature influence the interactions on the sample with the adsorbent material in the column and 
consequently the separation of the products. After the compounds of the sample being separated, a signal 
correlated to the amount of each one is generated by a detector (e.g. UV/VIS or mass spectrometry).  
The unreacted photoinitiator (Irgacure 2959) released from the photocrosslinked particles was quantified 
after particles immersion in acetonitrile to release all traces of unconsumed molecule. Three particles of 
each formulation were immersed in 1 mL of acetonitrile and kept under stirring for at least 6 h. The 
mobile phase used was composed by acetonitrile:water (90:10) and the sample was injected in the 
column (Accucore C18, 3 mm x 150 mm,  particle size 2.6 µm) with a flow rate of 0.5 mL min-1.  The 
column was kept at 37 °C and the Irgacure 2959 was sensed by a UV-VIS detector (SpectraSystem 
UV8000).  
 
4.4.7. Drug Loading  
In chapter 5, the particles prepared were loaded with a hydrophobic drug (dexamethasone) after being 
crosslinked. The different formulated particles were immersed in an aqueous solution of dexamethasone 
(30 µg/mL, 10 particles in 10 mL of drug solution). The total amount of dexamethasone loaded in each 
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formulation was determined by UV-VIS spectrophotometry (described in detail in the subsection 4.4.10.1 
of this chapter). Part of the dexamethasone loading was due to the swelling capacity of the formulations, 
this means the dexamethasone dissolved in the amount of water uptake by the particles. The other part is 
due to the improved affinity of the system caused by the presence of CDs. Then, the amount of drug 
loaded via equilibrium due to the water uptake capacity of the particles was estimated following the eq. 2 
[82] Loading! aqueous!phase = !!!! ×!C!!!!! Eq. 2 
 
where Vs is the volume of water sorbed by each particle, Wp is the weight of the particle in a dry state and 
C0 is the concentration of drug in the loading solution.  
Dextran particles combined with CDs were designed to have a special affinity to uptake hydrophobic drugs. 
Then, the partition coefficient KN/W between the particles and the loading solution was determined from the 
equation:  
 Loading! total = (!!!!!/!×!!)×!!!!      Eq. 3 
 
where Vp is the volume of the dried particles, and the other parameters are the same of Eq. 2. This 
parameter was important to determine the differences in drug loading capacity between systems without 
CDs, with free CDs and copolymerized CDs.  
 
4.4.8. Distribution of Molecules Inside the Particles 
The spatial distribution of bioactive agents inside the particles was visualized using widefield fluorescent 
microscopy. In this technique, the labeling of the bioactive agents, materials and even cells with a 
fluorophore is required. The samples are excited and then emitted light in a certain wavelength allowing 
the visualization of the sample. Each fluorophore has a specific excitation and emission wavelength. The 
labeled samples were maintained in the dark in order to prevent the rapid loss of fluorescence.  
In chapter 8, the distribution of the FN was observed by modification of the protein with Alexa fluor 555 
dye. A solution of FN (1 mg/mL) was modified. Briefly, 50 µL of sodium bicarbonate solution (1 M) were 
mixed with FN solution in order to increase the pH of the solution because the succinimidyl esters involved 
in the reaction between Alexa fluor 555 and FN react efficiently at pH 7.5-8.5. This solution was mixed 
with Alexa fluor 555 under magnetic stirring for 1 h. Finally, the labeled protein was purified using a 
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column with Bio-Rad BioGel P-30 Fine size exclusion purification resin. The particles encapsulating the 
labeled protein were prepared following the same procedure as described in the subsection 4.3.1 of this 
chapter. The particles were then visualized using a widefield fluorescent microscope (Stemi 1000 PG-
HITEC Zeiss) applying appropriate filter for excitation (555 nm) and emission (565 nm).  
In chapter 9, three fluorophores were encapsulated in the particles as models of drugs: 4′,6-diamidino-2-
phenylindole (DAPI), Rhodamine B and fluorescein-5(6)-isothiocyanate (FITC). They were encapsulated in 
the different layers of the particles, just by mixing 50 µg of their powder with 1 mL of dextran-MA (15% 
(w/v)) solution. Then the particles were sectioned, using a bisturi, and visualized using widefield 
fluorescent microscope (Stemi 1000 PG-HITEC Zeiss) in order to observe the distribution of the different 
molecules in the particles. 
 
4.4.9. Enzymatic Degradation Assay  
The degradation of biomaterials is an important characteristic of implantable systems in the human body. 
In the case of drug release systems this is particularly relevant because it will also influence the release 
kinetic of the molecules. The effect of the presence of PLs in the degradation of Coll particles was 
performed in an extremely harsh environment (chapter 7). Considering that one possible application of 
this system is the treatment of skin ulcers, where a significant amount of enzymes capable to degrade the 
proteins of the ECM are concentrated, it is important to know the resistance of the systems under these 
conditions.  
In chapter 7, the degradation of the particles was followed during 24h. Particles of each formulation 
(collagen solely and collagen combined with PL) were immersed in an enzymatic solution (collagenase 50 
µg/mL in tricine buffer pH 7.5) at 37 °C. Images of the particles were collected using a camera connected 
to a stereomicroscope.  
  
4.4.10. Drug Release Studies and Quantification Techniques 
The release kinetics of the bioactive agents entrapped in the developed systems was studied in vitro. Drug 
release studies allowed having an insight about the potential of the system under controlled conditions, 
being particularly useful to redesign the systems when the release profile achieved does not follow the 
desired kinetics. To monitor the amount of the drugs released by the particulate systems, a defined 
number of particles was immersed in a release medium, pre-established according to the experimental 
design. Then, pre-defined volumes of release medium were collected and the amount of bioactive agent 
determined according to different procedures. The following subsections will describe the techniques used 
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in the quantification of the different released molecules. The experimental details, such as number of 
particles, volume of the release medium, volume of the release medium collected (sample) as well as the 
pre-defined times at which samples were collected are described in detail in the corresponding chapters of 
section III.  
 
4.4.10.1. Ultraviolet–Visible Spectrophotometry 
In chapters 5 and 6, the release of dexamethasone was followed by UV-VIS spectrophotometry. This 
technique is commonly used in analytical chemistry for quantification of substances, using light in the 
visible and ultraviolet ranges. This technique assumes that the absorbance characteristics of the liquid 
samples follow the Beer-Lambert law. According to this law, the absorbance is directly proportional to the 
path length and to the concentration of the specie in the solution. This means that, the absorbance of a 
solution increased when the attenuation of the light beam that cross the sample also increase. Different 
molecules absorb radiation in different wavelengths. The record of the release of a molecule through UV-
Vis spectrophotometry requires a previous scan of the molecule absorbance spectrum in order to detect a 
defined peak suitable to be correlated with known concentrations. For example, the absorbance peak of 
dexamethasone was found at 241-242 nm. The following step was the construction of a calibration curve 
where the absorption values of solutions with well-known concentrations were correlated with the 
concentration values. The establishment of such correlations, usually based on a straight line function, 
permit to determine unknown concentrations using the absorbance measurements.  
 
I. Bicinchoninic Acid Method 
The total protein released from the particles of collagen+PL described in chapter 7 was determined by UV-
VIS method. Firstly, a colorimetric assay based on bicinchoninic acid (BCA) method was performed. It was 
employed because it was not possible to have a defined absorbance peak of the samples and correlate it 
with known protein concentrations. The BCA method is based on reduction of Cu2+ to Cu1+ by the proteins 
in an alkaline medium (the buriet reaction). The Cu1+ cations are detected with high sensitivity using the 
reagent containing BCA. The chelation of two molecules of BCA with one cuprous ion formed a water-
soluble purple-colored reaction product with a strong absorbance at 562 nm. The color formation depends 
on the macromolecular structure of the proteins, the number of peptide bonds and on the presence of 
four particular amino acids: cysteine, cysteine, tryptophan and tyrosine. Then, protein concentrations are 
determined with reference to standards, used to obtain a calibration curve. Generally bovine serum 
albumin (BSA) is the protein used to perform the standard solutions. However the standard selected 
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should exhibit structure as close as possible to the protein under study. This test is not specific; this 
means that all the proteins in the solution having the properties above mentioned are quantified. 
 
II. Enzyme-Linked Immunosorbant Assay  
The quantification of the released GFs, namely VEGF and PDGF-BB, as well as their content in the platelet 
lysates were determined by enzyme-linked immunosorbant assay (ELISA), in chapter 7. This method 
allows the quantification of small amounts of a specific protein when mixed in a cocktail of molecules. The 
principle of the method (Figure 4.15) consisted in the using of a 96-well plate coated with specific capture 
antibodies, where the target protein in the sample could bind. After, the biotin-labeled detection antibody 
could attach to the immobilized conjugate previously formed. Finally, HRP-conjugated streptavidin is added 
and then the colorimetric substrate solution. The intensity of the color developed is proportional to the 
amount of target protein bound. The absorbance of the samples was measured by UV-VIS 
spectrophotometry at 440 nm and then correlated with a calibration curve.  
 
 
Figure 4.15. Schematic representation of the ELISA method.  
 
4.2.10.2. Inductive Coupled Plasma Spectroscopy 
This technique determines chemical elements in the samples. In chapter 8, inductive coupled plasma 
(ICP) allowed to quantify the Ca2+ released from the alginate beads to have an insight about the stability of 
the particles when immersed in cell culture medium. The samples collected were injected in the ICP 
equipment and the argon plasma excited the ions present in the samples. Then, the electrons emitted 
energy at a characteristic wavelength when they return to ground state. The light emitted was measured 
by an optical spectrometer, yielding an intensity measurement that was converted to concentrations by 
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comparison with calibration standards.  In order to avoid the obstruction of the small pipes of the 
equipment, the collected samples were diluted in a HNO3 solution (1% v/v) to guaranty the 
dissolution/digestion of any solid trace that could remain.  
 
4.4.11. Mathematical Models 
The study of the release kinetics provides important information about the function of systems. Drug 
release is the process in which drugs migrate from the initial position in the polymeric network to the 
outside of the system and then to the release medium. This process is affected by multiple complex 
factors: physicochemical properties of the drugs, structural characteristics of the particles, release 
environment and possible interactions between these factors. It is critical to correlate the macroscopic 
data and the transport behavior at molecular level to elucidate the release mechanism of the system. The 
diffusion properties, swelling capability and material degradation are the main factors that influence the 
performance of a release system and define the release kinetics [83]. Mathematical modeling provides 
insights into the release mechanisms of a specific system simplifying the complex release processes [84]. 
In this way, each mathematical model is focused in one or two factors that influence the release kinetics, 
which cause some inaccuracy between theoretical and experimental obtained data.  
In chapters 6 and 9, the application of the several mathematical models was useful to have an insight 
about the type of drug release mechanism occurred in the developed systems. The equations used were 
the following:  
Chapter 6: 
Zero order: M! = M! + k!t!!!!Eq. 4 
First order: logM! = logM! + !!!.!"! t!!!!Eq. 5 
Higuchi: M! = M! + k!t!/!!!!!Eq. 6 
Korsmeyer-Peppas: M! = k!"t!!!!!Eq. 7 
Chapter 9: 
Considering the lag time: M!/M! = k(t− t!"#)!.!!!!!Eq. 8 
Where M0 was the initial amount of drug, Mt was the cumulative amount released at time t, tlag was the lag 
time between the start of the experiment and the detection of the drug, and k, k0, k1, kH, and kKP were 
specific constants of each model.  
Zero-order release kinetics is related to systems capable to release the drug with a constant rate over a 
period of time. The first order model, the release of the drug is dependent on the drug concentration. The 
Higuchi model is related with the release of water soluble and low soluble drugs incorporated into semi-
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solid or solid matrices by diffusion processes. In the Korsmayer-Peppas equation, n characterizes the 
release mechanism. The release of the drug follows an anomalous mode when 0.43<n<0.85, meaning 
that the release is controlled by diffusion and by swelling. Using the software OriginPro8 the experimental 
data, in the 10-60% amount released interval, was treated and the best fit was selected based on the 
highest correlation coefficient (R2).  
 
4.5. Biological Studies  
4.5.1. In vitro Tests 
In vitro tests, to evaluate the status of the cells, were performed in all the chapters of this thesis. In some 
cases were evaluated the viability, proliferation and differentiation of the cells entrapped in the spherical 
gels (3D cell cultures), and in other cases it was evaluated the effect of a bioactive agent released by the 
particles in a monolayer of cells (2D cell cultures). In vitro tests are essential to obtain the first screening 
about the performance of the proposed system under conditions mimicking the in vivo environment.  
 
4.5.1.1. Cell Cultures  
I. 2D Cell Cultures  
2D cell cultures were performed in some chapters of this thesis in order to evaluate the toxicity of the Dex-
MA+CDs particles or the effect of the release bioactive agents from collagen+PLs spherical gels in the cell 
proliferation/migration.  
In chapter 5, SaOs-2 cell line (HTB-85TM from ATCC®) was used to evaluate the effect of the formulations 
composed by Dex-MA solely or combined with γ-CDs or γ-CD-NMA on cell viability. Those cells were 
collected from human osteosarcoma and are widely used to study for bone applications due to their 
osteoblastic features.  SaOs-2 cells were expanded in DMEM-F12 supplemented with 10% (v/v) FBS and 
1% (v/v) penicillin/streptomycin at 37 °C in humidified incubator with 5% CO2. Cells were then tripsinized 
and seeded onto 48-well plates with a density of 50 000 cells/well in 1 mL of cell culture medium. After 
cell adhesion, 2 particles of each formulation were added into the wells. After 24h and 48h, the cell 
viability was evaluated by LDH assay (described in detail in subsection 4.1.3). The same formulations but 
loaded with dexamethasone were cultured in contact with a monolayer of hASCs in order to evaluate the 
potential of the system in inducing the osteogenic differentiation. The characteristics of hASCs were 
already described in the section 2.4.2 of this chapter. In this assay, the hASCs were seeded in 6 well 
plates with a density of 25 000 cells/well with 5 mL of culture medium which was slightly modified in 
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order to provide the phosphates and the ascorbic acid required in osteogenic differentiation. In addition, 
multiple controls were performed to evaluate the effect of dexamethasone in a precise way.  
I) Culture medium of the experiment: MesenPro® supplemented with 2% (v/v) growth supplement (FBS), 
1% (v/v) L-glutamine and 1%(v/v) penicillin/streptomycin, 10 mM β-GP, 50 µM ascorbic acid;  
II) Negative control 1: MesenPro® supplemented with 2% (v/v) growth supplement (FBS), 1% (v/v) L-
glutamine and 1%(v/v) penicillin/streptomycin. 
III) Positive control 1: MesenPro® supplemented with 2% (v/v) growth supplement (FBS), 1% (v/v) L-
glutamine and 1%(v/v) penicillin/streptomycin, 10 mM β-GP, 50 µM ascorbic acid and 100 nM 
dextamethasone.  
IV) Negative control 2: MesenPro® supplemented with 2% (v/v) growth supplement (FBS), 1% (v/v) L-
glutamine and 1%(v/v) penicillin/streptomycin, 10 mM β-GP, 50 µM ascorbic acid. 
V) Positive Control 2: MesenPro® supplemented with 2% (v/v) growth supplement (FBS), 1% (v/v) L-
glutamine and 1%(v/v) penicillin/streptomycin, 10 mM β-GP, 50 µM ascorbic acid and 400 ng/mL 
of dextamethasone.  
In chapter 7, the particles composed by collagen+PL were cultured in contact with a monolayer of hASCs. 
To evaluate the cell proliferation due to the released bioactive agents contained in the PLs, hASCs were 
seeded onto 48 well plates in a density of 7 500 cells/well in 100 µL of the same medium used for cell 
expansion, described in the subsection 4.1.2.4 of this chapter. After 24h (to allow the adhesion of the 
cells) the medium was replaced by 200 µL of culture medium without FBS, in order to avoid the stimulus 
of the FBS in cell proliferation, and then evaluate precisely the effect of the PL. Two particles of each 
formulation were immersed in each well, contacting directly with the cell monolayer. The plates were 
incubated in the standard conditions: 37 °C and humidified atmosphere with 5% CO2. The medium was 
replaced every 3 days. The cell proliferation was evaluated at pre-established time points using the CCK-8 
kit, described in detail in de subsection 4.5.1.5 The effect of the PL in the filling of a cell gap was also 
performed, by performing a scratch in a monolayer culture. A detailed description of this test will be 
provided in the subsection 4.5.1.2.  
 
II. 3D Cell Cultures  
In chapters 6, 7, 8, and 9, different cell types were encapsulated in the different spherical hydrogel 
systems. The characteristics of the cells used were already described in the subsection 4.1.2.4 of this 
chapter. After being encapsulated following the procedures described in the section 4.3 of this chapter, 
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the particles were collected from the superhydrophobic surface and immersed in appropriate cell culture 
medium.  
The Chi (chapter 6) and the core/shell dextran-MA/alginate (chapter 9) particles encapsulating L929 cells 
were cultured in the same medium as described for the expansion of this type of the cells. In both cases, 
the cell viability was evaluated by live/dead assay, following the procedure described in the subsection 
4.5.1.4.  
The collagen and collagen+PLs beads (chapter 7) encapsulating hASCs were cultured in a slightly 
modified medium. Since the aim of the work was to evaluate the effect of the PLs, the medium used was 
free of FBS in order to not stimulate the cells with the GFs or other cytokines that compose the FBS. The 
hardened gels were then collected and cultured in 200 µL of culture medium, 2 particles/well in 96 well 
plates. At 1, 3 and 7 days the cell proliferation was evaluated using the live/dead assay and the CCK-8 kit, 
that are described in detail in the subections 4.5.1.4 and 4.5.1.5.  
The alginate formulations described in chapter 8 were cultured in the same medium used for rMSCs 
expansion. The cell viability was then evaluated by live/dead fluorescent assay as well as using the LDH 
and MTS kits – see section 4.5.1.4. The same formulations were also cultured in osteogenic medium. 
This medium was composed the same type used in the previous experiments but supplemented with the 
standard molecules used in induction of osteogenic differentiation: 0.1 mM L-ascorbic acid 2-phosphate, 
10 mM β-GP and 100 nM dexamethasone.  
 
4.5.1.2. Scratch Wound Assay 
The scratch wound assay was performed in chapter 7 using commercial silicon inserts purchased from 
Ibidi®, which allowed the formation of a defined cell-free gap – Figure 4.16. hASCs were seeded in each 
compartment of the insert. After reach confluence, the cell culture medium and the inserts were removed 
from the petri dish carefully in order to prevent the detachment of the cell monolayer. The cells were 
washed with PBS and 1 mL of fresh culture medium was added. The particles described in the chapter 7 
(collagen or collagen+PL beads) were placed in direct contact with a cell monolayer in a density of 10 
particles/mL of culture medium. Since the aim of the work was to evaluate the effect of the PL in cell 
proliferation/migration the cell culture medium used was FBS-free. Optical microscope images of the gap 
between both cell groups were collected starting from the moment that the particles were added: 0, 2, 4, 
8, 12, 24 and 48h.  
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Figure 4.16. 1) Silicon inserts and micro-dishes used in the scratch wound assay; 2) the cells were seeded in each 
compartment of the silicon insert; 3) the inserts were removed when the cells reach confluence; 4) cell culture medium was 
added to the micro-dish and then the particles were immersed in the culture medium. Image adapted from [85]. 
 
4.5.1.3. Cell Distribution and Morphology Inside the Particles 
I. Optical Microcopy  
Optical microscopy was used routinely in chapters 7 and 8 to observe the cells inside the particles, their 
migration from the particles to the bottom of the well plates as well as to discard contaminations during 
the culture period that was quite long. The observation of the cells inside the particles was possible 
because the produced gels were transparent. Images were collected at pre-established time periods, using 
cameras coupled to the used microscopes.  
 
II. Confocal Microscopy: Phalloidin/DAPI 
Confocal microscopy was used to have an insight of the cell distribution inside the spherical hydrogels. In 
chapters 7, 8 and 9, the cells were labeled with Phalloidin and DAPI fluorophores and after were observed 
at confocal microscope allowing the acquisition of images. Unlike other kinds of microscopy (e.g. widefield 
microscopy), confocal allows to collect information selectively along thick samples, being a valuable tool to 
analyze 3D structures. This is possible because the depth of field is controlled and a serial of optical 
sections are collected throughout of Z-axis of the sample.  
Phalloidin belongs to a group of bicyclic heptapeptides, denominated by phallotoxins, and it is obtained 
from poisonous mushrooms. Labelled phallotoxins binds to actin allowing its identification and 
quantification in cell cultures. In general, phallotoxins have similar affinity for large and small filaments 
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and the binding is established in a stoichiometric ratio of 1 phallotoxin molecule per actin subunit. The 
contrast between stained and unstained areas is extremely large.  Phallotoxins are capable to stabilize F-
actin, inhibiting depolymerization by cytoshalasins, potassium iodide and elevated temperatures. 
Fluorescent phalloidins only binds to the native quaternary structure of F-actin and generally do not 
permeate the cell membrane. For these reason correct fixation procedures should be used to retain the 
quaternary structure of the protein and to permeabilize the cells [86].  
 DAPI is a blue fluorescent stain with specificity to stain the double-stranded DNA (dsDNA) inside the cell 
nuclei. DAPI attaches to adenine-thymine clusters in the DNA minor groove in the follow proportion: one 
molecule of stain per 3 base-pairs. The fluorescence is directly proportional to the amount of DNA [87]. 
In all cases the particles with the cells were fixed using 4% (v/v) paraformaldehyde and then incubated in 
Phalloidin solution for 45 min and then in DAPI solution for 3-10 min. This was performed always in the 
dark in order to avoid the loss of fluorescence of these molecules. Between each immersion/incubation, 
the particles were washed several times with appropriate solutions (e.g. PBS pH 7.4 or 0.15 M of NaCl 
supplemented with 10 mM CaCl2) to remove all the traces of the fluorophores. The concentrations used in 
each system are described in the respective chapter in the section III of this thesis.  
 
4.5.1.4. Cell Viability  
In this subsection will be described the mechanism of each used technique to evaluate the viability of the 
cells both in 2D and 3D cultures. The experimental procedure, namely reagent volumes, concentrations, 
incubation times and temperatures as well as other measurement details are extensively described in 
each respective chapter of section III. These details varied slightly according to the brand of the kit used 
and they were always adapted and optimized for each system. 
 
I. Live/Dead Assay  
Live/dead assay is a simple, fast and accurate tool for screening cell viability by fluorescence detection. 
Calcein AM was used to identify the live cells. Despite not being fluorescent, this hydrophobic molecule 
easily permeates intact live cells. Upon hydrolysis by intracellular esterases, the Calcein AM is converted 
into Calcein, which is a hydrophilic fluorescent dye. The Calcein retained in the cell cytoplasm allowed the 
visualization of the live cells through adequate methods (fluorescent/confocal microscopy, excitation ≈ 
495 nm and emission ≈ 515 nm). The dead cells were labeled by propidium iodide (PI), which is not 
permeant in live cells. PI binds to DNA by intercalating between the bases, with little or no sequence 
preference. The stoichiometry is one dye molecule per 4-5 base pairs of DNA [88]. Upon binding the 
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fluorescence of the PI is enhanced 20-30 fold (excitation ≈495nm and emission ≈ 635 nm).  The cells 
with not damaged membrane will exclude the PI. Calcein-AM/PI was performed in chapters 6, 7, 8 and 9. 
 
II. Lactate Dehydrogenase Detection 
Lactate dehydrogenase (LDH) is an oxidoreductase enzyme that catalyzes the interconversion of pyruvate 
and lactate. Having into account that LDH is a fairly stable enzyme and that dead cells release it, LDH 
detection/quantification has been used to evaluate the tissues and cells status. The LDH reduces NAD to 
NADH, which is specifically detected by colorimetric assay (UV-VIS spectrophotometry). In chapter 5 and 8 
a LDH kit was used to quantify the percentage of the viable cells existent at pre-established periods of 
time.  
 
III. MTS 
In chapter 8 was used the (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) (MTS) assay to evaluate the viability of the cells. The cells are capable to produce reducing 
agents, namely NADH or NADPH, that pass their electrons to an intermediate transfer reagent which in 
turn can reduce the tetrazolium into formazan. The formazan product is soluble in aqueous medium and 
is proportional to the number of viable cells in culture, being detected by UV-VIS spectrophotometry. Upon 
death, the cells lose the ability to reduce the tetrazolium products [89]. 
 
4.5.1.5. Cell Proliferation 
I. MTT  
In chapter 5 was used (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromid) (MTT) assay. This 
method is based on the cleavage of the yellow tetrazolium salt MTT to purple formazan crystals by 
metabolic active cells [90]. Similarly with MTS, the pyridine nucleotide cofactors NADH and NADPH are 
the main responsible for this cellular reduction. The formazan crystals formed were solubilized resulting in 
a colored solution that was evaluated by UV-VIS spectrophotometry. The correlation with the cell number 
was established using a calibration curve obtained by testing a series of sample with known numbers of 
cells.  
 
II. CCK-8 
This assay, utilized in chapter 7, use the highly water soluble tetrazolium salt WST-8 [2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] to produce water-
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soluble formazan dye upon a reduction process, similarly with MTS and MTT.  The dehydrogenases in the 
cells reduce the WST-8 into a yellow colored formazan, which is soluble in tissue culture medium. The 
amount of formazan formed is proportional to the number of living cells. The sensitivity of CCK-8 is higher 
than MTT and MTS.  
 
4.5.1.6. Differentiation Studies  
In the chapter 5 and 8 was studied the osteogenic differentiation of the cells both in 2D and 3D. To 
evaluate the effectiveness of the applied stimulus, the follow techniques were performed.  
 
I. Alkaline Phosphatase Activity Quantification 
ALP is an important cell surface metalloenzyme with a role in hard tissue formation. It is highly expressed 
in mineralized tissue cells. Although the mechanism of this enzyme in not completely understood, it 
appears to act both to increase the local concentration of inorganic phosphatase, a mineralization 
promoter, and to decrease the concentration of extracellular pyrophosphate, an inhibitor of mineral 
formation. In this way, the high level of activity provides information related to hard tissue formation. In 
addition, it is known that ALP is one of the first functional genes expressed in the calcification process, 
indicating that acts in an early stage. This means that ALP is one of the first key players to be recognized 
in the process of osteogenesis [91]. The activity of ALP is commonly evaluated using a p-nitrophenol 
assay. At pH 10.5 and 37 °C the ALP is capable to hydrolyze the paranitrophenyl phosphate into free 
paranitrophenol causing a color transition from colorless to yellow. The expression of ALP, both in a 
membrane form or in a secretory form, is a characteristic of osteoblasts, being a strong indicator of these 
type of cells [92].  
To quantify the ALP activity, in chapter 5, the hASCs were lysed after being cultured for 3, 7 and 12 days. 
In each well it was added 300 µL of 10 mM Tris–HCl buffer (pH 7.5) with 0.1% Triton X-100. The cell 
lysate was collected and exposed to freezing-thawing cycles: at least 45 min at -80 °C and then at room 
temperature during the time necessary to thawing. This step was to ensure that all the cells were lysed. 
The follow step was the centrifugation of the lysates (14 000 rpm, 15 min at 4 °C) in order to separate 
pieces of cell membranes that could remain in the suspension. 50 µL of the supernatant was collected 
carefully and incubated with ALP substrate for 30 min at 37 °C. During the incubation the absorbance at 
405 nm was read at 5, 10, 15, 20 and 30 min. The final calculations were performed using a calibration 
curve prepared using solutions with known concentrations of p-nitrophenyl phospate. In addition, the 
results were presented normalized by the protein concentration, which was measured by the BCA method 
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already described. This allowed expressing the activity of the ALP as amount of ALP per time per amount 
of total protein.  
 
II. Alkaline Phosphatase Staining 
ALP staining was performed in chapter 5 to complement the results of the ALP quantification. After 12 
days in culture, the culture medium in the wells was removed and the cells were fixed with 4% (v/v) 
paraformaldehyde in PBS for 5 min at room temperature. The cells were, then, washed with PBS and 
finally stained for 10 minutes, at room temperature, and in the dark using the follow mixture: 0.2% 
naphthol AS-BI phosphate in 112 mM 2-amino-2-mathylpropanediol and 0.2% fast red violet in a 1:1 (v:v) 
proportion. Images were immediately taken using an inverted light microscope coupled to a camera.  
 
III. Alizarin Red Staining  
Calcium and inorganic phosphates are accumulated, serving as nucleating agents for the formation of the 
main inorganic component of bone: hydroxyapatite (Ca10(PO4)6(OH2)2). Some cells, when cultured ex vivo 
could form minerals if stimulated appropriately. The mineralization may be accessed by the follow 
procedures: fluorescent calcein binding, Von Kossa staining and Alizarin red staining. Alizarin red staining 
allows observing the mineral distribution, namely the calcium deposits and could be used to stain in vitro 
cell cultures as well as histological samples [93]. 
Alizarin red is a fast and cheap method and for this reason was used in chapter 8 to visualize the mineral 
deposition by the cells encapsulated in alginate particles when cultured in osteogenic medium. The cell-
laden particles were fixed overnight in an aqueous solution of glutaraldehyde (2.5% v/v) at 4 °C. Then the 
particles were dehydrated in solutions of ethanol and finally embedded in paraffin. Using a microtome, 
slices with 4-5 µm thick were obtained and then stained by immersion in an alizarin red aqueous solution 
(40 mM, pH 4.3). This procedure was advantageous to study the inner of the particles and not only the 
surface. 
 
4.5.1.7. Cryopreservation of Cell-Laden Particles 
The storage of materials containing cells for later application is a critical step in the development of tissue 
engineering strategies involving cells. The most simple preservation technique is refrigeration, however the 
limited shelf life and risks of contamination are problematic. The cryopreservation of the materials with 
cells has been studied as possible method to circumvent the obstacle related to preserving and storing of 
“living” biomaterials [94], although very few studies have focused this problem. The principle of this 
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approach is that chemical, biological and physical processes are “suspended” at cryogenic temperatures. 
In chapter 7, cell-laden particles were cryopreserved in order to investigate the effect of the standard 
cryopreservation procedure in the hASCs entrapped in collagen+PLs particles. Cell-laden particles were 
suspended in a cryopreservative solution composed by FBS:DMSO (90:10 v/v). Then the suspension of 
particles was kept at -20 °C for 24h and then stored at -80 °C. DMSO is a cryoprotectant required to 
protect the cells against freeze injuries, namely in avoiding the formation of ice crystals. Studies have been 
proved that DMSO has toxic side effects to human body  [95]. After 1 month, the cryopreserved particles 
were thawed at 37 °C, the mixture of FBS:DMSO was discarded quickly and the particles were washed 
with cell culture medium at 37 °C several times to remove all traces of DMSO. Afterwards, the cells were 
cultured normally and the viability of the cells was study using the Live/Dead essay ( already described in 
this chapter) after 7days.  
 
4.5.2. In Vivo Tests 
Studies using animal models are, generally, considered reliable and appropriate analogues to specific 
clinical conditions.  Adequate models are selected according to the application aimed for the developed 
system. In vivo studies are mainly used to evaluate the preclinical status of translational technologies [96], 
where are included the performance of materials or systems as the hydrogels spherical systems proposed 
in this thesis.  
 
4.5.2.1. Chorioallantoic Membrane Model 
The chicken embryo chorioallantoic membrane (CAM) is a recurrent test for neovascularization analysis. 
The complete development of the embryo lasts 21 days before hatching. During the embryo development 
three membranes are formed aiming the embryo protection and nourishing: the yolk sac membrane, the 
amnion and the CAM. CAM is responsible by mediate the gas and nutrient exchanges until hatching. This 
membrane has a very dense network composed by arteries, veins, and an intricate capillary plexus (Figure 
4.17). The vascular system of the chick embryo attains its final arrangement on day 18, just before 
hatching. The current legislation about the animal experimentation in the European Union allows 
experimentation with chick embryos without authorization from animal experimentation committees. 
However, the experiments should begin and end before hatching. 
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Figure 4.17. Localization of the CAM inside the egg and the detailed description of the CAM. 1: chorionic epithelium; 2: 
mesoderm with blood vessels depicted in red; 3: allantoic epithelium. Image adapted from [97].  
 
This assay consists in implanting the material on the chick embryo chorioallantoinc membrane through a 
hole cut in the eggshell. The number of blood vessels formed can be quantified via image analysis. 
Technically, CAM is a quick, simple and inexpensive test when compared with mammalian models, and 
have been demonstrated suitable to give strong and accurate indications about the angiogenic 
performance of the systems under study [98,99]. This in ovo test was performed in chapter 7 to evaluate 
the angiogenesis potential of theagen and collagen+PL systems. Firstly, the fertilized eggs were incubated 
horizontally at 37 °C and 60% humidity. At day 3, around 2 mL of albumin was removed by punctured the 
egg with a needle. A circular window was performed in the eggshell and the eggs returned to the incubator 
for 4 days more. The opened window was very well covered with parafilm in order to avoid contaminations 
or the drying of the exposed membrane. At day 7, two beads of each formulation were placed in contact 
with the CAM and controls were also performed by dispensing equivalent amounts of PL without being 
encapsulated in collagen beads. Images of the membrane were collected 3 days after the beads being 
implanted using a camera coupled to a stereomicroscope. The membranes were fixed with 10% (v/v) 
formaldehyde for at least 10 min at room temperature. Then, using a bisturi, the membranes were cut 
and disposed carefully in a glass slide. The images collected were used to count manually the blood 
vessels growth.  
 
4.5.2.2. Cranial Defect Model  
Calvarial defect is a versatile model that allows the evaluation of biomaterials and bone tissue engineering 
approaches within a reproducible, nonload-bearing orthotopic site. Wistar rats were used to examine the 
healing of cranial bone defects filled with alginate-based particulate systems  (chapter 8). All procedures 
involving use of the animals were conducted in accordance with the guidelines of the National Institutes of 
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Health Guide for the care and use of laboratory animals. The surgery consisted on drilling circular defects 
with approximately 5 mm in diameter in the parietal bones of the skull. Extremely care was taken to not 
damage the dura matter beneath the bone as well as the sagittal suture line. The rats were anesthetized 
with ketamine (40 mg/kg) and xylazine (5 mg/kg) administered by an intraperitonial injection.  Twelve rats 
were used (three groups of four rats each):  
(I) controls: empty defects 
(II) alginate beads with FN (4 beads/defect) 
(III) alginate beads with FN and rMSCs (4 beads/defect).  
After the surgery the rats were maintained in individual cages with free access to water and food. Four 
weeks post-surgery, animals were euthanized with an overdose of anesthetic and the crania were removed 
and fixed immediately in formaldehyde for further analysis. During this procedure other organs were also 
collected and fixed: brain, heart, lungs, liver, spleen and kidneys, in order to check the existence of 
pathological abnormalities.  
 
I. MicroComputed Tomography  
Microcomputed tomography (µCT) uses an X-ray source to obtain cross-sectional images of 3D objects 
without damage the samples. Then, the images obtained may be combined to reconstruct a 3D model 
[100]. In chapter 8, µCT technique enabled the collection of data from the cranial bone of the rats to 
evaluate the formation of new tissue in the damaged sites. Images of the rats skulls were acquired using a 
Skyscan 1072 scanner. Scans were performed using a X-ray with 51 kV of energy, 195 µA of current and 
an exposure time of 1.7 seconds using a pixel size of 14.7 µm. The raw data was transformed into binary 
using a dynamic threshold of 42-255 (SkyScan CT Analyzer v1.5.1.5 software). Then a 3D virtual model of 
calvaria bones was created using the SkyScan ANT 3D creator v2.4 software.  
 
II. Histology: Hematoxylin and Eosin Staining  
Hystological sections of the bone collected from the calvaria of the rats could show the formation of new 
bone in the defect site as well as the status of the tissues surrounded the damaged area, e.g. the 
presence of inflammatory cells. The collected calvaria bones were processed, starting with decalcification 
in hydrochloric acid. Then, the decalcified samples were dehydrated in a series of ethanol concentrations 
followed by xylene solution to remove the water from the tissues. After this, the samples were embedded 
in paraffin blocks, which were sectioned using a microtome to obtain 4-5 µm thick sections. Using a glass 
slides as supports for the sections containing the sample, the tissue was depparaffined by a quick 
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immersion in xylene and stained using Hematoxylin and Eosin (H&E). H&E staining is a standard protocol 
to identify microscopically the morphology of the cells and tissues. Hematoxylin stains the nucleus with a 
dark blue color, whereas the eosin stains the cell cytoplasm with a pink color. Finally, the samples were 
visualized using optical microscopy.  
 
4.6. Statistical Analysis 
All the experiments were performed with at least three replicates. The results were expressed by mean ± 
standard deviation. The data collected was treated with the GraphPad Prism statistic software. Firstly, the 
Shapiro-Wilk test was used to ascertain about the normality distribution of the population. The null 
hypothesis assumed was that the means of each set were equal. The hypothesis was evaluated with 95% 
confidence level (α=0.05). Then, the groups were compared performing analysis of variance (one-way 
ANOVA) followed by Tukey’s multiple comparison test and the significant differences between groups were 
determined.   
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Chapter 5 
Free and Copolymerized γ-Cyclodextrins Regulate the Performance 
of Dexamethasone-Loaded Dextran Microspheres for Bone 
Regeneration 
 
5.1. Abstract  
Polymeric particles acting as sources of biological cues to promote tissue regeneration are currently an 
interesting topic in bone tissue engineering research. In this study, microspheres of dextran-methacrylate 
(dextran-MA) and γ-cyclodextrins (γ-CD) for the delivery of osteogenic agents were prepared by means of 
photopolymerization on biomimetic superhydrophobic surfaces. The effects of the incorporation of the γ-
CD units as free entities or as structural monomers (acrylamidomethyl-γ-cyclodextrin, γ-CD–NMA) on 
dexamethasone loading and release performance were evaluated in detail in order to achieve osteogenic 
diﬀerentiation of human stem cells. The copolymerization of dextran-MA with γ-CD–NMA improved the 
loading capacity of the particles and also provided a sustained release of dexamethasone for several days. 
The biological studies revealed that such microspheres were cytocompatible and capable of inducing the 
diﬀerentiation of human adipose-derived stem cells (hASCs) to osteoblasts, as determined from an 
increase of alkaline phosphatase (ALP) activity between days 3 and 7. Such results were also conﬁrmed 
using ALP staining. Therefore, immobilization of γ-CDs onto the dextran-MA network may be particularly 
useful for the development of cytocompatible implantable spherical biomaterials for bone tissue 
engineering purposes.  
 
 
 
This chapter is based on the following publication:  
Lima A.C., Puga A. M., Mano J. F., Concheiro A. and Alvarez-Lorenzo C., Free and copolymerized γ-cyclodextrins regulate the performance of dexamethasone-
loaded dextran microspheres for bone regeneration, Journal of Materials Chemistry B 2014, 2: 4943-56.  
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5.2. Introduction  
Cyclodextrins (CDs) are appealing biocompatible tools for the design of drug delivery systems based on 
hydrophilic hydrogels [1]. The capability of CDs to form inclusion complexes with a variety of active 
substances usually does not diminish, but enhances even when the CDs are trapped in a polymer network 
[2,3]. Thus, poorly soluble drugs can be homogeneously loaded up to a great extent in hydrophilic 
networks forming complexes with CDs [4-6]. Regarding control of the release kinetics, the inclusion 
complex capability of CDs can be exploited in two different ways: (a) as free entities, i.e., not chemically 
bound to the network, CDs can accelerate or retard drug diffusion through the network depending on drug 
solubility and interactions with the polymer component of the hydrogel; and (b) as chemically bound 
moieties, CDs act as binding points for the drug, regulating the release by an affinity-dependent 
mechanism [1]. Different from other additives, such as micelle-forming surfactants or liposome-forming 
lipids that require self-assembly for hosting drugs and regulating the diffusion from polymer networks 
[7,8], CDs offer relevant advantages as highly stable unimolecular guest agents. Several approaches can 
be followed to immobilize CDs in polymer networks through covalent bonds under mild conditions 
[1,9,10]. Recently, γ-CD nanogels obtained via direct crosslinking in an emulsified system were shown to 
be able to load dexamethasone for application as eye drops, being highly biocompatible in in vivo studies 
performed in rabbits [11]. 
The aim of this work was to use the superhydrophobic surface technology [12] to produce spherically 
shaped microgels combining dextran-MA and γ-CD that can deliver dexamethasone and induce the 
differentiation of stem cells into osteoblasts, for tissue engineering or regenerative medicine purposes. The 
influence of free γ-CDs and copolymerized γ-CD–NMA on the capability of hydrogel particles to load and to 
control the release of the poorly water soluble corticoid drug was evaluated in detail. Dextran is a highly 
hydrophilic and biocompatible natural polysaccharide consisting mainly of linear chains of α-1,6-linked 
glucopyranose monomers, widely used as carriers for hydrophilic bioactive agents and as components of 
scaffolds [13,14]. On the other hand, γ-CDs are highly soluble in water (18.5–39 g per 100 mL at 20–35 
°C) allowing the production of hydrogels with high content in freely dispersed γ-CDs [9]. Moreover, 
monomers of γ-CD have been previously shown to be useful to enhance the uptake of hydrophobic drugs 
by acrylic networks [15]. Despite the potential advantages of combining dextran and CDs, very few binary 
systems have been reported yet. Fernández et al. [16] synthesized a copolymer of dextran and amino 
derivatives of β-CD to be applied as a thermoprotectant of trypsin. Later, Ramirez et al. [17] reported 
covalently bonded β-CD-dextran as a macromolecular carrier for naproxen, a poorly soluble non-steroidal 
anti-inflammatory drug. Using click chemistry, Nielsen and co-workers [18] synthesized an open-chain 
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polymer resultant of the combination of alkyne-modified dextran and β-CDs functionalized with azide 
groups. Using two formulations proposed in such work, Fülöp et al. [19] studied their complex forming 
properties with a model drug and their aggregation ability. Stable nanoassemblies spontaneously formed 
by mixing dextran-β-CD polymers and dextran-adamantyl have been explored for drug delivery due to their 
low toxicity [20]. However, to the best of our knowledge, dextran–CD networks have not been explored yet 
for sustained release in tissue engineering applications. In this context, particulate drug delivery systems 
are especially attractive due to its potential to be implanted via minimal invasive maneuvers [21-24]. 
Under osteogenic stimuli, some stem cells have the ability to differentiate into osteoblasts, expressing 
characteristic markers such as bone-specific ALP [25]. This ability of the stem cells can be favorable in the 
development of bone tissue engineering strategies. For example, human adipose-derived stem cells 
(hASCs) have been shown to exhibit potential to differentiate into mesodermal phenotypes including 
osteoblasts, chondrocytes, adipocytes, endothelial, neural and muscle cells [26,27]. An advantage of 
adipose tissue as a source of stem cells is its abundance and easy accessibility. The osteogenic 
differentiation of hASCs in vitro has been reported by supplementing the cell culture medium with ascorbic 
acid, β-glycerophosphate (β-GP) and a glucocorticoid such as dexamethasone [28,29]. The osteogenic 
differentiation varies with the dexamethasone dose; the optimal concentration being between 10 and 100 
nM. Toxic effects have been found at 1000 nM dexamethasone [30]. In fact, the prolonged duration of 
exposure in vivo may cause severe osteoporosis [31,32]. 
To prepare the proposed spherical microgels (dextran + CDs) a technique consisting of the 
photopolymerization of aqueous dispersion droplets onto superhydrophobic surfaces was implemented. 
Compared to other techniques, this bioinspired methodology is simpler, cheaper and faster, does not 
require the use of organic solvents or a complex apparatus and allows obtaining particles with narrow size 
distribution and 100% encapsulation yield of freely diffusible species [33]. This technology permits also the 
production of multilayered particles [34] for protein or cell encapsulation under mild conditions [35]. The 
loading capability, the ability to sustain the release of dexamethasone, the cytocompatibility of the final 
formulated systems and their potential to be applied in bone regeneration were evaluated in detail. 
 
5.3. Experimental Section  
5.3.1. Materials  
PS sheets from square Petri dishes (Bdbioscience, Enzifarma, Portugal) and polystyrene granules from a 
grade for injection molding (Styrolution PS 158k; UL Ides, Portugal) were used in the preparation of the 
superhydrophobic substrates. Tetrahydrofuran (THF, 99.9%) was from Riedel de Haen (Germany). 
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1H,1H,2H,2H-Perfluorodecyltriethoxysilane (PFDTS, 97%), dextran from Leuconostoc mesenteroids (MW 
100–200 kDa), 4-(N,N-dimethylamido)pyridine (DMAP, 99%), hydrochloric acid (HCl, 37%), acetone, 
dexamethasone for cell culture, penicillin/streptomycin solution, L-glutamine, β-glycerophosphate 
disodium salt hydrate (β-GP), ascorbic acid, ALP substrate, p-nitrophenyl phosphate liquid substrate, 
naphthol AS-BI phosphate disodium salt, fast red violet, 2-amino-2- methyl-1,3-propanediol, and 
Dulbecco's Modified Eagle medium (DMEM) nutrient mixture F-12 Ham were obtained from Sigma-Aldrich 
(USA). The BCA kit was purchased from Pierce (USA), the cell proliferation kit (MTT) and the cytotoxicity 
detection kit (LDH) were supplied by Roche (Switzerland). Paraformaldehyde tablets were obtained from 
Panreac (Spain). Mesenchymal stem cells, StemPRO® human adipose-derived stem cells (hASCs), 
MesenPro RS basal medium and MesenPro RS growth supplement were from Gibco (Invitrogen, USA). 
Phosphate buffer solution 10x and dimethyl sulfoxide (DMSO) were from Fisher Chemicals (UK). Glycidyl 
methacrylate (GMA) was from Fluka (Sigma-Aldrich, USA), Irgacure 2959 from Ciba (BASF, Germany) and 
dexamethasone was from Fagron (Spain). γ-Cyclodextrin (γ-CD) Cavamax W8 was from ISP and N-
(hydroxymethyl)acrylamide (NMA) from Merck (Germany). Purified water (resistivity >18MU cm; MilliQ®, 
Millipore, Spain) was obtained by means of reverse osmosis. All the other chemicals were used as 
received. 
 
5.3.2. Polystyrene Superhydrophobic Surfaces 
Polystyrene (PS) superhydrophobic surfaces were prepared using a phase separation method as described 
elsewhere [36]. Briefly, a PS solution (70 mg/mL) in THF was mixed with ethanol (2:1.3 v/v). The mixture was 
dispensed onto smooth PS commercial substrates which were then immersed in ethanol for 1 min and dried under 
nitrogen flow. In order to increase the superhydrophobicity of obtained surfaces, the rough PS surfaces were 
modified with PFDTS (1% v/v in ethanol) after argon plasma treatment for 40 s at 30 W (Plasma Prep5, Gala 
Instruments, Germany). 
 
5.3.3. Synthesis of Dextran-Methacrylate  
Dextran-MA was synthesized as previously described [37]. Briefly, dextran (25 g) was dissolved in DMSO 
(225 mL) under a nitrogen atmosphere. Then, 4-(N,N-dimethylamino)pyridine (5 g) was added and, when 
the dissolution was complete, glycidyl methacrylate (20.5 mL) was incorporated. The solution was stirred 
at room temperature for 48 h, and then the reaction was stopped by adding an equimolar amount of 
concentrated HCl solution (3.3 mL of HCl, 37%) to neutralize 4-(N,N-dimethylamino)pyridine. The reaction 
mixture was transferred to a dialysis tube (MWCO 12400 Da) and dialyzed during 1 month against 
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demineralised water. Finally, dextran-MA was lyophilized (Manifold freeze-drier, Telstar cryodos, Spain). 1 
H NMR spectra of unmodified and modified dextrans (0.3 g in 0.7 mL of deutered water) were recorded 
(Mercury 300, 300 MHz, Varian, Australia) and then analyzed using MestReNova software (MestreLab, 
Spain). 
 
5.3.4. Synthesis of Acrylamidomethyl-γ-Cyclodextrins  
γ-CD (17.12 g) and NMA (13.36 g) (NMA–γ-CD 10:1 molar ratio) were added to 50 mL of HCl solution 
(1% v/v). The solution was heated at 80 °C and stirred continuously for 30 min. Then, 300 mL of acetone 
were added to precipitate γ-CD–NMA. The flask was kept at 4 °C overnight. The precipitate was filtered 
(Albet® 145, Spain), repeatedly washed with acetone (200 mL) and filtered again (2–3 cycles). Finally, the 
product was dried under vacuum for 2 days at room temperature and stored at 4 °C. The IR spectrum of 
the γ-CD–NMA monomer was recorded over the range 400–4000 cm-1 (Bruker IFS 66V FT-IR, Germany) 
using the potassium bromide (KBr) pellet technique, and 1H NMR spectra of unmodified and modified γ-
CD (30 mg/mL in deutered water) were recorded (Mercury 300, 300 MHz, Varian, Australia) and then 
analyzed using MestReNova software (MestreLab, Spain). 
 
5.3.5. Microgels Preparation 
Dextran-MA solutions (5% or 10% w/v; 1 mL) were prepared in water or in an aqueous medium containing 
200 mg of γ-CD or γ-CD–NMA. Irgacure 2959 (60 mL or 100 mL of 0.5% w/v in water) was added to the 
solutions (Table 5.1). 5 mL of each solution were dispensed onto the PS superhydrophobic surfaces, and 
crosslinked under UV light (365 nm; Camag, Switzerland) for 50–60 min. The solid particles were dried in 
air overnight, washed with water for 48 h and dried again in air at room temperature. 
 
Table 5.1. Composition of the dispersions used to prepare the microgel particles. Amounts refer to 1 mL of water 
Code Dextran-MA g-CD g-CD–NMA Irgacure 
2959 
5% Dextran-MA 50 mg — — 60 µL 
5% Dextran-MA + 20% γ-CD 50 mg 200 mg — 60 µL 
5% Dextran-MA + 20% γ -CD–NMA 50 mg — 200 mg 60 µL 
10% Dextran-MA 100 mg — — 100 µL 
10% Dextran-MA + 20% γ -CD 100 mg 200 mg — 100 µL 
10% Dextran-MA + 20% γ -CD–NMA 100 mg — 200 mg 100 µL 
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5.3.6. Microgels Characterization  
5.3.6.1. Quantification of Unreacted Photoinitiator  
Three particles of each formulation were immersed in 1 mL of acetonitrile and kept under magnetic 
stirring for at least 6 h at room temperature. The amount of Irgacure 2959 released was quantified by 
HPLC using an Accucore C18 (3 mm x 150 mm, 2.6 mm) column kept at 37 °C, a UV-Vis detector (275 
nm, SpectraSystem UV8000 – Thermo Scientific) and acetonitrile:water (90:10, 0.5 mL/min flow) as the 
isocratic mobile phase. 
 
5.3.6.2. Double Bond (C=C) Detection (Bromine Test)  
5% (w/v) dextran-MA, 10% (w/v) dextran-MA, 20% (w/v) γ-CD and 20% (w/v) γ-CD–NMA precursor 
solutions (40 µL , equivalent volume to prepare 8 particles) and the diﬀerent formulated cross-linked 
particles (8 units) were placed in contact with 200 mL of bromine in water at room temperature. After 5 
min, the color of the solutions was observed and compared with the original bromine in water solution. 
The bromine in water was prepared mixing 32 mL of water, 7.6 mL of NaClO solution (33 mg/mL) and 
10.7 mL of a solution of NaBr (1.1 g) in 1 M HCl. 
 
5.3.6.3. Degree of Swelling 
The degree of swelling was evaluated in sextuplicate as the difference between the weight of 10 particles 
swollen in water for 6 days (mi) and the initial weight of the dried particles (m0) as follows: 
 %!Swelling = m! − m!m! ×100!!!!Eq. 1 
 
 
5.3.6.4. Particle Size 
The sizes of dried and swollen particles were evaluated using an Olympus SZ-CTV optical 
stereomicroscope (Tokyo, Japan) connected to a JCV TK-S350 video camera (Tokyo, Japan). Eight 
particles of each formulation were sized using image analysis software (Soft Imaging System®, Mu¨nster, 
Germany). 
 
5.3.6.5. Scanning Electron Microscopy 
The particles were allowed to swell in water at room temperature. Then, some were collected and allowed 
to dry in air, and the others were immediately frozen in liquid nitrogen and freeze-dried. The images of the 
particles, after gold coating, were obtained using an EVOLS15 microscope (Zeiss, Oberkochen, Germany). 
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5.3.6.6. Dexamethasone Solubilization  
A large excess of dexamethasone (8 mg) was dispersed into 50 mL of water and maintained under 
magnetic stirring during 48 h. Then, the dispersions were filtered through a 0.22 µm nylon membrane to 
remove the non-dissolved drug. The concentration of the dissolved dexamethasone was 
spectrophotometrically measured at 241 nm (Agilent 8453, Waldbornn, Germany). 
 
5.3.6.7. Dexamethasone Loading 
Ten particles of each formulation were dried in air overnight and then immersed in 10 mL of aqueous 
solution of dexamethasone (30 µg /mL) for 6 days at room temperature. The absorbance of each solution 
was measured at 241 nm over time. The experiments were repeated six times for each formulation. The 
amount of drug loaded via equilibrium between the aqueous phase of the microgels and the loading 
solution was estimated as follows [37]: Loading! aqueous!phase = V!W! !×C!!!!!!Eq. 2 
 
where Vs is the volume of water sorbed by each particle, Wp is the dried weight of the particles, and C0 is 
the concentration of drug in the loading solution.  
 
5.3.6.8. Dexamethasone Release 
Dexamethasone-loaded particles (10 units) were dried overnight and then immersed directly in 2 mL of 
water and placed in an incubating mini shaker (VWR) at 37 °C and 200 rpm. At 24, 120, 264, 336 and 
432 h, 1 mL of water was added to the initial release medium. Samples of the release medium were 
taken periodically and returned to the container after measuring the absorbance at 241 nm. The 
experiments were repeated four times for each formulation. 
 
5.3.6.9. Cytocompatibility Studies 
Two particles of each formulation (4 replicates) were placed in 48 well plates containing SaOs-2 cells 
(ATCC HTB-85; 50 000 cells per well, 1 mL) in DMEM-F12 with 10% FBS and 1% penicillin/streptomycin, 
and kept in a humidified incubator at 5% CO2 and 37 °C. After 24 h and 72 h of incubation, aliquots of 
100 µL of the culture medium were taken and mixed with 10 µL of the reaction medium contained in the 
Cytoxicity Detection kit (LDH). Blank (100 µL of the cell culture medium), negative (an aliquot collected 
from a well containing just cells) and positive (an aliquot collected from a well to which 20 µL lysis factor 
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was added) controls were also performed. The plates were incubated for 10 min at room temperature 
protected from light. 50 µL of stop solution was added to each well and the absorbance was measured at 
490 nm using a microplate reader (BIORAD Model 680 Microplate Reader). The cytotoxicity was estimated 
as follows: 
 %Cytotoxicity = abs!"#!$%&!'( − abs!"#$%&'"!!"#$%"&abs!"#$%$&'!!"#$%"& − abs!"#$%&'"!!"#$%"&×100!!!!Eq. 3 
 
 
5.3.6.10. Osteogenic Differentiation 
 hASCs were cultured in MesenPro® RS medium supplemented with 2% (v/v) growth supplement (FBS), 
1% (v/v) L-glutamine (200 mM) and 1% (v/v) penicillin/streptomycin (Medium 1). Then, they were seeded 
(passage 5, 25000 cells per well, 1 mL) in 6 well plates and after 24 h the medium was replaced by 5 mL 
of fresh medium. Three particles of each formulation (placebo or loaded with dexamethasone) were placed 
in direct contact with the cells and the Medium 1 was supplemented with 10 mM β-glycerophosphate and 
50 mM ascorbic acid. Four controls were carried out in this experiment: 
i) negative control 1: cells cultured in MesenPro® supplemented with 2% (v/v) growth supplement, 1% (v/v) 
L-glutamine (200 mM) and 1% (v/v) penicillin/streptomycin (Medium 1); 
ii) positive control 1: cells cultured in standard osteogenic differentiation medium, i.e., Medium 1 
supplemented with 10 mM β-GP, 100 nM dexamethasone for cell culture and 50 mM ascorbic acid 
(Medium 2); 
iii) negative control 2: cells cultured in Medium 1 supplemented with 10 mM β-GP and 50 mM ascorbic 
acid (Medium 3); 
iv) positive control 2: cells cultured in Medium 1 supplemented with 10 mM β-GP, 50 mM ascorbic acid 
and 400 ng mL-1 of dexamethasone were used to load the formulations under study (Medium 4). 
 
The plates were incubated at 37 °C in a humidified atmosphere with 5% CO2 and 2 mL of medium were 
replaced twice a week. The cells were routinely observed using inverted microscopy (x10) in order to 
discard any contamination. Experiments were carried out in triplicate. Cell proliferation was evaluated 
using the MTT assay. At 3, 7 and 12 days of incubation 4 mL of culture medium were withdrawn and 100 
µL of MTT solution (5 mg/mL in PBS) were added to each well. These plates were incubated at 37 °C for 
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4 h and then 1 mL of MTT solvent (10% SDS in 0.01 M HCl) was added to each well and the plates were 
incubated again at 37 °C overnight. Aliquots of 200 µL were transferred to 96 well plates and the 
absorbance was read at 550 nm (BIORAD Model 680 Microplate Reader). The respective calibration curve 
was constructed using cultures with a known number of cells in order to estimate the cell number in the 
experiment. For ALP quantification, the cells were lysed at 3, 7 and 12 days by addition of 300 µL 10 mM 
Tris–HCl buﬀer (pH 7.5) with 0.1% Triton X-100. Samples were exposed to three freezing (-80 °C for 45 
min)/thawing cycles. Lysates were centrifuged at 14000 rpm for 15 min at 4 °C. 50 µL of the 
supernatant were incubated with 150 µL of the ALP substrate in 96 well plates at 37 °C for 30 min. The 
absorbance at 405 nm was read at 5, 10, 15, 20 and 30 min using an ELISA plate reader (BIORAD Model 
680 Microplate Reader). The ALP activity was quantified using a calibration curve prepared with p-
nitrophenylphosphate solutions. The obtained values were normalized by the protein concentration 
measured using a BCA protein detection kit in order to express the results as nmoles of ALP per min per 
mg of protein.  
ALP staining was carried out as follows. After each culture period, the medium was removed, and the cells 
were fixed with 4% paraformaldehyde in PBS for 5 min at room temperature and then washed twice with 
PBS. The cells were then soaked in a staining solution prepared by mixing 0.2% naphthol AS-BI phosphate 
in 112 mM 2-amino-2-methylpropanediol (AMPD) and 0.2% fast red violet in a 1:1 (v:v) proportion, 
incubated in darkness for 10 min at room temperature and visualized through an inverted light 
microscope. 
 
5.3.6.11. Statistical Analysis 
 All data are presented as mean ± s.d. for at least three independent measurements. Groups were 
compared using one-way ANOVA (Tukey's multiple comparison test), with p < 0.05 indicating statistical 
significance. 
 
5.4. Results and Discussion 
5.4.1. Synthesis of Dextran-MA and γ-CD–NMA 
Dextran functionalized with methacrylate groups (dextran-MA) was obtained by reaction of dextran with 
glycidyl methacrylate (GMA) in DMSO in the presence of a base (DMAP) as a catalyst [37]. After 48 h of 
reaction at room temperature, DMAP was neutralized with hydrochloric acid in order to avoid alkaline 
hydrolysis of the methacrylic ester, and finally dextran-MA was purified by dialysis. The hydroxyl groups of 
dextran were ionized at alkaline pH and reacted with methylene carbon of the epoxy group of GMA to form 
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the 3-methacryloyl-1-glyceryl ether of dextran or the respective isomer 2-methacryloyl-1-glyceryl, as shown 
in Scheme 5.1. 
 
 
Scheme 5.1. Reaction of dextran with GMA in the presence of DMSO and DMAP. The glycidyl group may interact with any of 
the hydroxyl groups present in the dextran structure, and two region isomers could be created: 2-methacryloyl-1-glyceryl ether 
and 3-methacryloyl-1-glyceryl ether. 
 
In the reaction mixture, the molar ratio of GMA to glucopyranose units was approximately 1. Based on 1H 
NMR spectra (Figure 5.1) and taking into account that each glucopyranose unit has 3 hydroxyl groups that 
could react with GMA, the degree of substitution (DS) was determined as (100X/Y)/3; X being the average 
integral of the protons in the double bond present in the added groups (5.75 and 6.2 ppm), and Y the 
integral of the peak at 4.95–5.1 ppm corresponding to the anomeric proton [37]. The DS obtained was 
ca. 32%, which indicated that, on average, 1 hydroxyl group per glucopyranose unit was substituted [55]. 
These results were in agreement with the high yield of reaction previously reported in the literature, which 
indicated that more than 90% of the added GMA was incorporated into the polysaccharide [37].  
 
Dextran
GMA
+
Methacryl
+
DMSO
+
DMAP
30methacryloyl010glyceryl9ether
20methacryloyl010glyceryl9ether
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Figure 5.1. 1H NMR spectra of dextran as supplied (gray line) and after reaction with GMA (black line) dissolved in deutered 
water. 
 
The γ-CD–NMA monomer was prepared according to a previously established protocol that renders one 
CH2=CH– group per γ-CD, as confirmed from the 1H NMR spectrum (Figure 5.2 B). The DS was 
estimated from [100X/(Y/8)]/3, where X was the average integral of the protons in the vinyl groups (6.2 
and 5.8 ppm), and Y the integral of the peak (5.0 ppm) corresponding to 8 protons of the γ-CD (1 proton 
per glucopyranose unit). The obtained result indicates that ca. 12% of the glucopyranose units were 
modified, meaning that on average each γ-CD had one NMA group. Thus the MW of γ-CD–NMA can be 
estimated to be 1378.24 g mol-1 [15] (Scheme 5.2). FTIR analysis of γ-CD–NMA clearly showed the bands 
of carboxylic (C=O) and amide II (NH) groups at approximately 1700 cm-1 and 1540 cm-1, respectively, and 
a small peak due to C=C vinyl groups at 1665 cm-1 (Figure 5.2 A) in agreement with previous reports 
[15,39]. 
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Figure 5.2. (A) FTIR and (B) 1H NMR spectra of γ-CD (black lines) and γ-CD–NMA (blue lines). 
 
 
Scheme 5.2. Scheme of the γ-CD monomer (γ-CD–NMA) after reaction with one N-(hydroxymethyl)acrylamide (NMA). The 
molecular weight of the monomer was estimated assuming that each γ-CD has one NMA group. 
+
γ#CD
MW=1297.12.g/mol
NMA
MW=101.1.g/mol
H+ γ#CD#NMAMW=1378.24.g/mol
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5.4.2. Hydrogel Particles Production and Characterization 
The spherical particulate hydrogels were obtained under mild conditions on superhydrophobic surfaces 
[12]. Fixed volumes of dextran-MA solutions containing γ-CD or γ-CD–NMA (Table 5.1) were dispensed 
onto the PS superhydrophobic platform and cross-linked under UV light using Irgacure 2959 as the 
photoinitiator. The particle size ranged from 681 to 915 µm (Table 5.2). Three different network types 
were prepared using two dextran-MA concentrations (5% and 10% (w/v)): (i) particles formed by a dextran-
MA solely network; (ii) particles that consist of a dextran-MA network with free γ-CDs; and (iii) particles 
formed by copolymer networks of dextran-MA and γ-CD–NMA.  
 
Table 5.2. Size and swelling degree of particles prepared with different combinations of dextran-MA and γ-CDs, and the 
amount of unreacted Irgacure 2959 remnant in each particle formulation after UV photocrosslinking. 
Code 
Particle size  
(mean ± SD) 
(µm) 
Swelling degree 
(mean ± SD) 
(%) 
Irgacure 2959 unreacted  
(% of the initial amount added) 
Dried 
particles 
Swollen 
particles 
5% Dextran-MA 681±36 1008±55 223±11 0.48 
5% Dextran-MA + 20% γ-CD 683±36 1041±75 248±33 8.12 
5% Dextran-MA+ 20% γ-CD-NMA 790±37 1197±78 253±15 1.06 
10% Dextran-MA 862±27 1377±81 338±18 0.99 
10% Dextran-MA + 20% γ-CD 873±36 1477±70 329±15 2.40 
10% Dextran-MA + 20% γ-CD-NMA 915±37 1536±82 242±13 0.87 
 
The inter- and intra-chain bonds that may occur in such formulations are depicted in Scheme 5.3. 
Hardening of the precursor spherical droplets under UV radiation was affected by the presence of γ-CD 
units. Droplets without γ-CD showed faster and more successful cross-linking by just adding half of the 
volume of Irgacure 2959 (0.5% w/v) indicated in Table 5.1. It has been previously reported that CDs 
interact selectively with alkyl side chains [40]. Both dextran-MA and Irgacure 2959 have alkyl groups, 
namely methyl groups (–CH3), that may form inclusion complexes with γ-CDs in the precursor solution, 
which in turn may limit the interaction of the photochemically generated free radicals with the monomers 
and consequently decrease the polymerization efficiency [41]. To overcome this problem, the amount of 
Irgacure 2959 was increased (Table 5.1). The unreacted photoinitiator was quantified in freshly prepared 
(unwashed) particles. Significant amounts were found in microgels prepared with free γ-CD (Table 5.2). In 
contrast, almost all the photoinitiator was consumed during preparation of the formulations composed of 
dextran-MA solely and dextran-MA + 20% γ-CD–NMA. In the absence of CDs, all Irgacure 2959 molecules 
and methacrylate groups of dextran-MA are available for reaction. In the dextran-MA and γ-CD–NMA 
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mixtures, the presence of more reactive double bonds caused greater consumption of the photoinitiator. 
Nevertheless, even under the most unfavorable conditions, more than 90% of the photoinitiator was 
consumed in the crosslinking. To gain further insight into the polymerization yield, double bonds remaining 
after cross-linking were quantified by means of a bromine test. Bromine reacts very rapidly with alkenes 
leading to attenuation of the characteristic yellow-orange color of the bromine solution.  
 
 
Scheme 5.3. Photocrosslinking of the dextran-MA solution drops may result in three distinct covalent bonds: (A) dextran-MA–
dextran-MA; (B) dextran-MA–γ-CD–NMA; (C) g-CD–NMA–γ-CD–NMA. 
 
As expected, dextran-MA solutions (precursor solutions used to prepare the particles) dramatically altered 
the color of the bromine solution (Figure 5.3 A and E); the attenuation being more accentuated for higher 
polymer concentration solutions. The γ-CD–NMA solution also showed a slight lightening of the original 
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color (Figure 5.3 K), which was not induced by γ-CD solution (Figure 5.3 J). Such color modifications 
confirmed the presence of C=C double bonds in dextran-MA and γ-CD–NMA through the methacrylic and 
acrylic added groups, respectively. By contrast, the particles did not cause modifications in the color of 
bromine solution (Figure 5.3 B–D and F–H) meaning that the UV cross-linking was efficient and almost all 
C=C bonds disappeared. Therefore, the process implemented to prepare dextran-MA particles enables the 
obtaining of spherical microparticles with nearly 100% crosslinking yield, with minor amounts of the 
residual photoinitiator. For subsequent experiments, the particles were washed to remove the traces of the 
unreacted photoinitiator.  
 
 
Figure 5.3. Color of bromine aqueous solutions 5 min after pouring 40 µL of precursor solutions used for particle production 
or 8 particles of each formulation. 
 
Stereomicroscope images of the particles after being dried are shown in Figure 5.4. The particles made 
from 5% dextran-MA solutions were ca. 200 µm smaller than those prepared with the 10% polymer (Table 
5.2) due to the lower polymer density. For the same content in dextran-MA, copolymerization with γ-CD–
NMA increased the particle size, probably due to the considerable volume occupied by the γ-CD units in 
the copolymer mesh. In contrast, free γ-CDs did not significantly modify the size of dextran-MA solely 
networks. The low standard deviations obtained in size measurements clearly indicate that the accurate 
volume of precursor solution dispensed on the superhydrophobic surfaces allows the production of 
particles with a narrow particle size distribution. After swelling, the increase in the particle diameter (300–
400 µm and 600–700 µm for 5% and 10% dextran-MA formulations, respectively) confirmed their high 
ability for water uptake. In the 5% dextran-MA particles, γ-CD or γ-CD–NMA did not affect the swelling 
(225–250% for the three studied formulations) (Table 5.2). The swelling degree of 10% dextran-MA 
particles without and with free γ-CD was around 338 ± 18% and 329 ± 15%, respectively.  However, the 
dextran-MA + γ-CD–NMA copolymer particles exhibited a lower swelling degree, approximately 242 ± 13%, 
which is in agreement with the denser interconnected network that can be created due to the additional 
covalent linkages that γ-CD–NMA molecules can establish among themselves and with dextran-MA 
(Scheme 5.3).  
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Figure 5.4. Stereomicroscope images of the dried particles. The scale bar is 500 μm. 
 
The digital (Figure 5.4) and SEM (Figure 5.5 and 5.6) micrographs confirmed the spherical shape of the 
formulated gels. Regarding the structure of the particles, the SEM micrographs of the freeze-dried particles 
(Figure 5.5) revealed a porous surface due to the dry process used; conversely, the air-dried particles 
(Figure 5.6) showed a smooth surface. It is also noticeable that all particles exhibited a heterogeneous 
internal structure, as visualized in freeze-dried and in air-dried particles. The particles seemed to have a 
coating layer that probably resulted from the non-homogeneous cross-linking due to a more intense UV 
photocrosslinking efficiency on the surface than in the inner part of the spherically shaped gels. 
 
 
Figure 5.5. SEM micrographs of swollen freeze-dried particles and their respective cross-sections. 
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Figure 5.6. SEM micrographs of the air-dried particles, cross-sections and respective magnifications. 
 
5.4.3. Dexamethasone Loading and Release 
The loading of a drug in a hydrogel depends on: (i) the easiness of the drug molecules to diﬀuse into the 
hydrogel mesh (which is determined by the cross-linking degree and the aﬃnity of water for the network), 
(ii) the drug concentration in the loading solution and (iii) the aﬃnity of the drug for the network 
[9,38,42]. The maximum solubility of dexamethasone was experimentally determined to be 64.2±1.95 
µg/mL. The loading of the particles was carried out by soaking in a 30 µg/mL drug solution to avoid the 
precipitation risk. As explained before, all dextran microgel particles presented high affinity to water (Table 
5.2). The swelling values observed suggest that the mesh sizes of the swollen hydrogels are enough for 
the free entrance of dexamethasone molecules. Nevertheless, the capability of dextran-MA solely particles 
to uptake the drug was quite limited (Figure 5.7). The main aim of this work was to engineer a system with 
enhanced drug–network interactions by means of the incorporation of free γ-CD or the copolymerization 
with γ-CD–NMA. The polarity and size of dexamethasone make it suitable to form inclusion complexes 
with γ-CDs [11,9]. Thus, a greater uptake by the formulations that contained CDs (free or attached to the 
dextran backbone) was hypothesized. In fact, the particles containing γ-CD–NMA were the most eﬀective: 
5% dextran-MA+ 20% γ-CD–NMA particles captured ca. 15.24 µg/mg and 10% dextran-MA + 20% γ-CD–
NMA ca. 8.69 µg/mg (Table 5.3).  
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Figure 5.7. Dexamethasone loaded by 10 particles of dextran-MA particles immersed in 30 µg/mL drug solution at room 
temperature. 
 
Microgels with free γ-CD showed an intermediate behavior, probably because free γ-CDs were partially 
removed during the washing step but also due to the absence of the cooperative contributions that can 
take place when the CDs form part of the polymer network. The amount of dexamethasone loaded by 
simple equilibrium between the aqueous phase of the network and the loading solution, which leads the 
drug concentration within the particles to be approximately equal to that of the loading solution, and can 
be estimated to be close to 0.067 µg/mg for 5% dextran-MA microgels and 0.101 µg/mg for 10% dextran-
MA microgels (Table 5.3).  
 
Table 5.3. Dexamethasone loaded by the microgels and network/water partition coefficient (K
N/W
). Mean values and, in 
parenthesis, standard deviation. 
Formulation Total amount of drug loaded (µg/mg) Drug loaded in aqueous phase (µg/mg) KN/W 
5% Dextran-MA 0.28 (0.37) 0.067 7.3 (12.2) 
5% Dextran-MA + 20% γ-CD 2.54 (0.50) 0.070 82.4 (16.8) 
5% Dextran-MA + 20% γ-CD-NMA 15.24 (0.50) 0.075 505.5 (16.7) 
10% Dextran-MA 1.08 (0.47) 0.101 32.8 (15.7) 
10% Dextran-MA + 20% γ-CD 1.47 (0.42) 0.098 45.8 (14.0) 
10% Dextran-MA + 20% γ-CD-NMA 8.69 (0.31) 0.073 287.2 (10.5) 
 
Experimental loading data were slightly greater than these amounts for dextran-MA microgels prepared in 
the absence of γ-CDs (Table 5.3), which means that unspecific hydrophobic interactions of 
dexamethasone with dextran weakly contribute to the loading. To gain an insight into the role of the CDs 
units in the loading process, the partition coefficient, KN/W, between the microgel particles and the drug 
loading solution was estimated from the following expression [38]: 
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Loading total = (V! + K!/!V!)×C!W! !!!!!!Eq. 4 
 
where Vp is the volume of the dried polymer and the other symbols maintain the same meaning as in Eq. 
(2). The values of KN/W for 5% dextran-MA + 20% γ-CD–NMA particles and 10% dextran-MA + 20% γ-CD–
NMA particles were as high as 505 and 287, respectively, while the respective formulations prepared with 
free γ-CD had KN/W values of 82 and 46, respectively (Table 5.3). These findings clearly prove the 
advantage of the immobilization of γ-CDs by means of copolymerization, and also that the greater the 
relative content in γ-CD (either free or copolymerized), the higher the increase in affinity of the network for 
dexamethasone. Compared to a previously reported macrogel of crosslinked γ-CD units that exhibited KN/W 
values in the 60–180 range [9], the microgels prepared by copolymerization of dextran-MA with γ-CD–
NMA are clearly advantageous. This finding may be related to the higher degree of swelling that dextran 
chains communicate to the networks, which should facilitate the access of dexamethasone to the γ-CDs. 
Tuning the time of immersion in the loading solution and the amount of particles, it is possible to regulate 
the amount of dexamethasone loaded in order to attain concentrations which are able to induce 
osteogenic differentiation (40–400 ng/mL [30] with a low mass of particles. Regarding dexamethasone 
release (Figure 5.8), if the drug only interacts with dextran-MA, the release rate should be practically 
independent of the γ-CD proportion in the hydrogel, except if the mesh size becomes altered [43]. 
Conversely, if drug–γ-CD complexation occurs, the release rate would be controlled not only by the 
diffusion of the free drug (hosted in the aqueous phase) but also by the stability constant of the 
complexes. In such a case, the greater the content in γ-CDs, the slower is the release [43]. 
Dexamethasone release from air-dried microgel particles is depicted in Figure 5.8. Copolymerization of 
dextran-MA with γ-CD–NMA was advantageous in terms of the amount of dexamethasone loaded and 
ability to sustain the release for a long period of time. Disregarding the dextran-MA proportion, the 
particles exhibited a rapid release in the first 24 h (45–47% release) followed by a more sustained release 
for at least 10 days. Moreover, the release of dexamethasone from copolymerized dextran-MA and γ-CD–
NMA particles became much slower when a certain drug concentration in the medium was reached, even 
under sink conditions, as observed previously by Rosa dos Santos et al. [44] for soft contact lenses with b-
CD pendant groups. This finding indicates that the equilibrium between drug release and drug 
reabsorption by the microgel particles is attained. To trigger the release of the drug, at certain time points 
(24, 120, 264, 336 and 432 h), 1 mL of fresh medium was added to the initial volume of release medium 
(2 mL) in order to disturb the equilibrium. 5% dextran-MA + 20% γ-CD–NMA and 10% dextran-MA + 20% γ-
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CD–NMA particles released 71% and 77% dexamethasone in 11 days. Diﬀerently, particles containing free 
γ-CDs exhibited a faster delivery (ca. 60%) in the first 24 h, reaching 90% release after 11 days. The 
amount of dexamethasone released from dextran-MA solely was too low for precise quantification (in 
agreement with the previous low loading).  
 
 
Figure 5.8. Dexamethasone release profiles in water referred to the particle mass (A) and to the total amount of 
dexamethasone loaded (B). Arrows indicate the moment at which an additional volume (1 mL) of release medium was added. 
 
In sum, γ-CD covalently integrated in the hydrogel network provided a unique way to control the loading 
and the release of dexamethasone, which may be useful for the design of osteogenic systems. Comparing 
the three studied formulations, the copolymerization of γ-CD–NMA with dextran allows the increase in the 
amount and the period of time during which dexamethasone is released. The drug:CD decomplexation 
that rapidly occurs when free complexes enter into contact with physiologic fluids [45] is slowed down due 
to the anchorage of γ-CD–NMA onto the dextran-MA chains (Scheme B. Dextran-MA–γ-CD–NMA links) and 
due to the entanglement of dextran-MA and γ-CD–NMA networks (Scheme 5.3 A. Dextran-MA–dextran-MA 
+ B. γ-CD–NMA–γ-CD–NMA). 
 
5.4.4. Cytotoxicity of the Hydrogel Particles 
A preliminary screening of the cytocompatibility of dexamethasone-loaded and non-loaded particle 
formulations was carried out against a human cell line of osteoblasts. The formulations were placed in 
direct contact with cells previously adhered to the bottom of the wells. The LDH released was evaluated 
and correlated with the percentage of live/dead cells (Figure 5.9). At 24 h, dexamethasone-loaded 
dextran-MA particles exhibited lower cell compatibility (one-way ANOVA, Tukey's multiple comparison test, 
p < 0.05) when compared with the same non-loaded formulations. However, such diﬀerences were not 
observed for the other formulations at this time point. At 72 h cell viability was close to 100% for all 
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formulations, which indicates that the materials and the drug released do not cause relevant cytotoxic 
effects. These findings are in agreement with the well-known biocompatibility of the starting materials 
(dextran and γ-CD), and also confirm that there is no leakage of unreacted monomers that could trigger 
unfavorable cell reactions. 
 
 
Figure 5.9. Viability of SaOs-2 cells after being in direct contact with dexamethasone loaded and non-loaded particles for 24 
and 72 h (n=4, error bars represent standard deviations). 
 
5.4.5. Eﬀect of Hydrogel Particles on hASCs 
5.4.5.1. In vitro Proliferation 
The hASCs were seeded on the well bottom and allowed to proliferate for 12 days under direct contact 
with particles loaded or not with dexamethasone (Figure 5.10). The proliferation was on average higher in 
the presence of dexamethasone, the differences being more accentuated at day 7 (p < 0.05). Previous 
studies demonstrated that dexamethasone either alone or in combination with β-GP + ascorbic acid 
stimulates the human bone marrow mesenchymal stem cell proliferation [46]. Such evidence can be 
correlated with the ability of glucocorticoids, at low concentrations, to stimulate the proliferation and/or 
differentiation of osteoprogenitor cells [46,31]. Moreover, ascorbic acid solely also demonstrated capability 
of stimulating the proliferation of mesenchymal stem cells and their derived cell types, namely osteoblasts, 
adipocytes, chondrocytes, etc., [47] while β-GP solely exerted the opposite effect [46]. The similar cell 
proliferation observed in the negative controls 1 and 2 revealed that the combination of β-GP and ascorbic 
acid does not alter cell proliferation (no significant statistic differences), probably due to their antagonic 
effect. On the other hand, the greater cell number recorded in positive control 2 compared to that 
obtained in negative control 2 (p < 0.05) at days 7 and 12 indicates that the presence of dexamethasone 
has a stimulating eﬀect on hASC proliferation. 
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Figure 5.10. Proliferation of hASCs cultured in direct contact with dexamethasone loaded and non-loaded particles and in the 
respective controls up to day 12. Cell number per well was calculated using a calibration curve of known cell numbers (n=3, 
bars represent standard deviations). 
 
5.4.5.2. In Vitro Osteogenic Differentiation 
The osteoinductive potential of the particles was evaluated by recording ALP activity. ALP is an enzyme 
present in the osteoblast membrane (early osteogenic marker) involved in ion phosphate hydrolysis 
stimulating the mineralization through the formation of hydroxyapatite crystals. As can be observed in 
Figure 5.11, the ALP activity increased over time. At day 3 the levels were similar for all formulations. At 
day 7 the dexamethasone-loaded formulations showed an early ALP activity peak with statistically 
significant differences (p < 0.05) when compared with the respective non-loaded formulations or the 
negative controls. For dexamethasone-loaded 10% dextran- MA and 10% dextran-MA + 20% γ-CD the 
results were similar to those obtained with the positive control (1 and 2). By contrast, the presence of γ-
CD–NMA in the particles induced a higher ALP activity (statistically different to positive control 1; p < 0.05) 
probably due to the increased capacity of the particles to load dexamethasone and release it in a 
sustained way during the period required to induce the cell differentiation. During the experiment, part of 
the cell culture medium was replaced with a fresh one in order to guarantee the feeding of the cells and 
the clearance of waste products. Such medium renovation may be advantageous because it should trigger 
the release of more drug from the particles in order to maintain a constant level of dexamethasone in the 
medium, as observed in the in vitro release studies. In all studied time points, the non-loaded particles 
presented an ALP activity similar to that of negative controls (undifferentiated cells), which means that the 
materials per se did not have osteoinductive properties. Moreover, the incorporation of β-GP + ascorbic 
acid to the culture medium without dexamethasone did not cause any effect on ALP activity (negative 
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control 2). Therefore, dexamethasone plays a key-role in osteogenesis induction being at the maximum 
between days 3 and 7. Previous studies demonstrated that hASCs stimulated by medium supplement with 
β-GP, ascorbic acid and 10 or 100 nM of dexamethasone also showed an ALP peak after 7 days in culture 
[27].  
 
 
Figure 5.11. ALP activity in hASCs induced by dexamethasone loaded and non-loaded particles and the respective positive 
and negative controls after 3, 7 and 12 days in culture. The results are expressed in mean±standard deviation within n=3 for 
each bar. 
 
The quantitative results about differentiation of the hASCs to osteoblasts were also visualized by means of 
ALP staining after 12 days of cell culture (Figure 5.12). Cells in contact with dexamethasone-loaded 
particles exhibited a more intense red color. Again, the drug-loaded 10% dextran-MA + 20% γ-CD–NMA 
particles caused the highest red staining (similar to those cells in positive control 2, which were 
supplemented with the maximum amount of dexamethasone that particles can release). This is explained 
by the increased capacity of such particles to load dexamethasone. The non-loaded formulations and the 
negative controls did not induce significant increase in ALP activity. Distinct polymeric systems 
encapsulating dexamethasone have been successfully reported for osteogenic diﬀerentiation, namely 
PLGA scaffolds [48,49], microparticles [23] and nanoparticles [50], 
carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles [25,51,52], polycaprolactone [53] and 
poly-(L-lactide-co-caprolactone)/collagen fibers [54]; however none studied the combination of polymers 
with cyclodextrins and their respective roles in loading and release of such a corticoid drug and the effect 
on osteogenic cell  differentiation. The particles developed in this work demonstrate high potential to be 
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applied in in situ bone regeneration avoiding the use of unstable proteins (e.g. growth factors) or even 
genetic manipulation of cells, and using a simple and cost effective method. 
 
 
Figure 5.12. ALP staining of hASCs in direct contact with non-loaded and loaded particles, and their respective controls at 12 
days. The scale bar is 100 µm. 
 
5.5. Conclusions 
Dextran-MA photocrosslinked spherical particles can be obtained using the superhydrophobic surface 
methodology and their performance to load hydrophobic drugs is improved via copolymerization with γ-
CDs. Copolymer networks of γ-CDs (γ-CD–NMA) and 10% dextran-MA are ca. 7 times more effective in 
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loading dexamethasone than the formulations with free γ-CDs and dextran-MA solely, meaning that the 
anchorage of CDs is advantageous. The in vitro release of dexamethasone from dextran-MA + 20% γ-CD–
NMA particles can be sustained for at least 10 days due to the hindered drug:CD decomplexation inside 
the network. These particles show an excellent cytocompatibility and are able to induce the osteogenic 
differentiation of hASCs after 3–7 days in culture. To summarize, the improved characteristics of the 
developed system could be useful for applications in bone regeneration. 
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Chapter 6  
Sequential Ionic and Thermogelation of Chitosan Spherical 
Hydrogels Prepared Using Superhydrophobic Surfaces to 
Immobilize Cells and Drugs 
 
6.1. Abstract 
Chitosan (CHI) is soluble in acidic media, which makes it incompatible for the encapsulation of cells 
and pH-sensitive molecules. In this work, a mild chitosan-based system with two sequential gelation 
steps is proposed, where the model drug dexamethasone and L929 cells are immobilized inside 
hydrogel beads. Superhydrophobic surfaces were used to produce the spherical hydrogel particles that 
provided favorable conditions to encapsulate cells or bioactive agents. First, the chitosan acidic solution 
was neutralized with β-glycerophosphate (β-GP) at room temperature to pH 6.2. Suspended cells (or 
dexamethasone) in the formulation were dispensed in controlled volumes onto biomimetic polystyrene 
superhydrophobic surfaces, to form spherical shapes. The addition of sodium tripolyphosphate (TPP) 
on the top of each sphere induced an ionic gelation process of the chitosan through electrostatic 
interactions. At 37 °C, the hydrophobicity of the chitosan-based formulations increased and a second 
gelation step occurred, which increased the elastic modulus. In addition, the pH-responsive behavior 
characteristic of chitosan was maintained. The softness and flexibility of the system can potentially be 
utilized to implant cells and therapeutic molecules using less invasive procedures. 
 
 
 
 
 
 
This chapter is based on the following publication:  
Lima A.C., Correia C. R., Oliveira M. B. and Mano J. F., Sequential ionic and thermogelation of chitosan spherical hydrogels prepared using 
superhydrophobic surfaces to imobilize cells and drugs, Journal of Bioactive and Compatible Polymers 2013, 29: 50-65. 
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6.2. Introduction 
CHI is a linear cationic polysaccharide derived by partial depolymerization and dea- cetylation of chitin 
extracted from the exoskeleton of crustaceans [1,2]. CHI has been used in preparation of hydrogels 
using the free amino groups as crosslinking sites. Due to its strong intermolecular hydrogen bonds, CHI 
can primarily be dissolved in acidic conditions, making the system aggressive to cells [3] and even to 
molecules that could lose their biological activity under such harsh environment. Few studies reported 
cell encapsulation utilizing water-soluble CHI [4-6]. A strategy to overcome this drawback was to add β-
GP to the acidic CHI solution [7], which can also make the CHI system thermoresponsive, forming gel 
at physiological temperatures [8-12]. Unlike materials such as gelatin, which are liquid at high 
temperatures and turn into a gel upon cooling, CHI/β-GP constitutes a reverse thermo-sensitive system 
for injectable applications due to a shift in attractive versus repulsive interchain forces during gelation 
[9,13]. Three mechanisms may be involved in this gelation process: (I) electrostatic attraction between 
CHI amino groups and the phosphate groups of β-GP (ionic crosslinking), (II) establishment of 
hydrogen bonds between CHI chains after reduction of electrostatic repulsive forces due to the CHI 
neutralization, and (III) CHI–CHI hydrophobic interactions. Later studies found that ionic crosslinking 
cannot be responsible for CHI/β-GP gelation and that the hydrophobic interactions caused the gelation 
at high temperatures [8]. More recently, Lavertu et al. [11] suggested that the gelation of CHI in the 
presence of β-GP occurred due to a proton transfer from the CHI to the phosphate moiety of β-GP upon 
heating. The precipitation of the CHI takes place when the amount of phosphates was sufficient to 
accept the released protons. There was no ionic crosslinking between the phosphates and the CHI 
chains, meaning that the phosphate salt was free to diffuse out of the gel. 
Due to the mild sol–gel transition at body temperature, CHI/β-GP has been explored to immobilize and 
retain in a specific site distinct types of cells, with potential use in tissue engineering, including 
mesenchymal stem cells [14], intervertebral disk cells [7], and chondrocytes [15]. However, the 
mechanical properties of the resulting gels may not be sufficient for several applications. Therefore, it 
would be desirable to combine the thermogelation ability of CHI/β-GP with other crosslinking processes 
to enhance the mechanical performance of the final biomaterial. 
The covalent crosslinkers commonly used to form CHI three-dimensional (3D) stable structures are 
formaldehyde [16] and glutaraldehyde [17-19], which present higher levels of toxicity [2,20] (especially 
if the unreacted molecules are not completely removed) when compared with ionic crosslinkers such 
as sodium sulfate [21] and sodium TPP [22,23]. We hypothesize that CHI/β-GP thermogelation could 
take place even if the CHI was previously crosslinked using non-toxic ions. Taking this into account, the 
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purpose of this study is to investigate whether CHI/β-GP hydrogels can be processed with a defined 
and manageable spherical shape, through a previous crosslinking step with TPP, in order to confer 
mild conditions to enable effective encapsulation of cells and therapeutic molecules. The methodology 
selected to produce spherical particles was the superhydrophobic surface technology due to its 
advantages to other conventional techniques [24]. This method is based on the rolling of water droplets 
onto natural superhydrophobic surfaces, as it is the case with lotus leaf [25], allowing the production of 
individual particles without contact with other liquid media and with a narrow particle size distribution. 
No organic solvents, mechanical forces, and extreme temperatures or pressures are required. This 
method was used to produce CHI microgels crosslinked within a glutaraldehyde atmosphere for oral 
and topical chemotherapy applications [26]. Mesenchymal stem cells and fibronectin were also 
immobilized in alginate (ALG) spheres using polystyrene (PS) superhydrophobic surfaces [27], and this 
technique provides adequate conditions to retain the viability of the cells during processing the 
particles. To the best of our knowledge, the proposed polymeric system (CHI/β-GP:TPP) combined with 
this production methodology has not been reported for applications in drug delivery [24] and tissue 
engineering [28]. 
 
6.3. Experimental Section 
6.3.1. Materials 
PS, an injection molding grade (Styrolution PS 158k), was purchased from UL IDES (USA), and used in 
a granular shape for the preparation of the superhydrophobic substrates. Tetrahydrofuran (THF; 99.9%) 
was purchased from Riedel de-Haen (Germany). 1H,1H,2H,2H-perfluorodecyltriethoxysilane (PFDTS; 
97%), phosphate-buffered saline (PBS), sodium ALG, dexamethasone (98%), CHI (medium molecular 
weight), sodium TPP, β-GP disodium salt, low-glucose Dulbecco’s modified Eagle’s medium (DMEM), 
and sodium bicarbonate were purchased from Sigma–Aldrich (USA). Fetal bovine serum (FBS), 
penicillin–streptomycin, and trypsin-ethylenediaminetetraacetic acid (EDTA) solution were purchased 
from Invitrogen (USA). Ethanol was purchased from Aga (Portugal). Calcium chloride (CaCl2) was 
purchased from Merck (Germany). Sodium hydroxide (NaOH) was obtained from JMGS (Portugal), and 
acetic acid was purchased from Pronalab (Spain). The immortalized mouse lung fibroblast cell line 
(L929) was purchased from the European Collection of Cell Cultures. Calcein-acetomethoxy (AM) and 
propidium iodide (PI) dyes were purchased from Molecular Probes (USA)—Invitrogen. CHI was purified 
using a reprecipitation method described elsewhere [29]. All the other chemicals were used as 
received. 
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6.3.2. Polystyrene Superhydrophobic Surfaces Preparation 
PS superhydrophobic surfaces were prepared using a phase separation method as described before 
[25,30]. Briefly, a PS solution in THF (70 mg/mL) was prepared and mixed with ethanol (2:1.3 v/v). 
The mixture was dispensed onto smooth PS commercial substrates, which were then immersed in 
ethanol for 1 min and dried under nitrogen flow. In order to increase the superhydrophobicity, the 
rough PS surfaces were modified with PFDTS (1% v/v in ethanol) after argon plasma treatment for 40 s 
at 30 W (Plasma Prep5; Gala Instruments, Germany). 
 
6.3.3. CHI/β-GP:TPP Particles 
A 2% (w/v) CHI solution was prepared by solubilizing CHI in 1% (v/v) acetic acid overnight. The CHI/β-
GP solution was prepared by adding the 2 M β-GP (in water) drop-wise into the stirring CHI solution 
until pH 6.2 was reached. L929 cells (1×106 cells/mL) or dexamethasone (15 mg/mL in ethanol, 
CHI:dexamethasone 25:1) were added to the neutralized CHI solution to produce the different 
formulations containing cells or the drug model, respectively. The spherical beads were produced by 
dispensing 4 µL of 4% (w/v) TPP solution on the top of 8 µL CHI/β-GP solution previously dispensed 
on the surface of the PS superhydrohobic platforms. The ionic crosslinking was allowed to occur during 
approximately 1–2 h at room temperature. Finally, the hydrogel beads were collected from the PS 
superhydrophobic surfaces. 
 
6.3.4. Mechanical Characterization: Dynamic Mechanical Analysis 
The viscoelastic properties of the CHI gels neutralized with β-GP and crosslinked with TPP were studied 
using a TRITEC8000B dynamic mechanical analysis (DMA) from Triton Technology (UK), equipped with 
the compressive mode. The gels used for this study were prepared using the same proportions of 
CHI/β-GP:TPP as described for the fabrication of the particles. However, in order to have a well-known 
geometry compatible with mechanical testing, hydrogels were produced in 96-well plates to obtain 
cylindrical specimens. The DMA spectra were obtained during a frequency scan between 0.1 and 15 
Hz, with the materials immersed in a PBS bath, either at 20°C or 37°C, in order to mimic both pre- 
and post-implantation situations, respectively. The experiments were performed under constant strain 
amplitude, corresponding to approximately 1% of the original height of the sample. A small preload was 
applied to each sample to ensure that the entire scaffold surface was in contact with the compression 
plates before testing. At least three samples were used for each condition. 
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6.3.5. Swelling Studies 
Non-loaded beads (five units), i.e., without cells or dexamethasone, were collected from the 
superhydrophobic surface, weighted, and immersed at 37 °C in: (I) water supplemented with 1 M HCl 
solution to reach pH 2, (II) phosphate buffer saline (pH 7.4), and (III) water supplemented with 1 M 
NaOH solution to reach pH 9. Beads were collected at given periods of time. After removing the excess 
of medium with a filter paper, samples were immediately weighted. The experiment was carried out in 
triplicate. 
The swelling degree was estimated as follows:  
 %Swelling = m! −m!m! ×100!!!!!!Eq. 1 
!
Where mi and m0 are the weights of the swollen and dry beads, respective. 
!
6.3.6. Particle Size 
The samples used for swelling studies were photographed using a stereo microscope (Zeiss–Stemi 
1000 PG-HITEC, Germany) at different time points. The diameters of the beads were measured using 
the ImageJ software (NIH, USA). 
 
6.3.7. In vitro Drug Release 
CHI/β-GP:TPP + dexamethasone beads (10 units) were placed in 4 mL (n=9) of distinct pH-dependent 
media: (I) water supplemented with 1 M HCl solution to reach pH 2, (II) phosphate buffer saline (pH 
7.4), and (III) water supplemented with 1 M NaOH solution to reach pH 9. The vials containing the 
particles were kept under agitation (ca. 60 rpm) at 37 °C. At pre-established periods of time, aliquots 
of 1 mL of the supernatant were taken out and replaced with equal volume of fresh medium to 
maintain the volume constant during the release study. The amount of dexamethasone was 
spectrophotometrically quantified, by measuring the UV absorbance at 242 nm (Synergie HT; Bio-Tek, 
USA). A calibration curve of dexamethasone solutions with pre-defined concentrations was constructed. 
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6.3.8. Release Kinetic Models 
In order to investigate the mechanism of dexamethasone release from CHI/β-GP:TPP particles at 
different pHs, the release data obtained were analyzed with different models including: zero-order 
(Eq.2), first-order (Eq.3), Higuchi (Eq.4), and Korsmeyer–Peppas (Eq.5) [31,32]. 
 M! = M! + k!t!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Eq. 2 !ogM! = logM! + k!2.303 t!!!!!!!!!!Eq. 3 M! = M! + k!t!/!!!!!!!!!!!!!!!!!!!!!!!!!Eq. 4 M! = k!"t!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Eq. 5 
 
where M0 is the initial amount of drug, Mt  is the cumulative amount of drug release at time t, k0 is the 
zero-order release constant, k1 is the first-order release constant, kH is the Higuchi constant, kKP is the 
Korsmeyer–Peppas constant, and n is an exponent characterizing the release mechanism. The model 
that best fits the experimental data was selected based on the highest correlation coefficient (R2) 
values. OriginPro8 was used to perform the data treatment. 
 
6.3.10. Cell Viability: Live/Dead Assay 
L929 cells were routinely cultured with low-glucose DMEM supplemented with 3.7 g/L sodium 
bicarbonate, 10% FBS, and 1% penicillin–streptomycin at pH 7.4. Cells were grown in 75 cm2 tissue 
culture flasks and incubated at 37 °C in a humidified air atmosphere of 5% CO2. At 90% of confluence, 
the cells were washed with PBS and detached by a chemical procedure using 0.05% trypsin–EDTA 
solution for 5 min at 37 °C in a humidified atmosphere of 5% CO2. After this period, cell culture 
medium was added to inactivate the trypsin effect. The obtained cell suspension was centrifuged at 
300 g and 25 °C. After discarding the supernatant, cells were suspended in CHI/β-GP or 1.5% (w/v) 
ALG (control) at cell density of 1 × 106 cells/mL. The resultant suspensions were used to produce 
particles onto PS superhydrophobic as previously described. The obtained particles were then 
maintained in culture similar to L929 cells before being encapsulated. Calcein-AM and PI dyes (1 
mg/mL) were used to evaluate the viability of the immobilized L929 cells inside CHI/β-GP:TPP and 
ALG particles. After 1, 3, and 7 days of culture, the cell culture medium was removed and 1 mL of PBS 
containing 2 µL of calcein-AM and 1 µL of PI was added to each well (n=3). The particles were then 
incubated at 37 °C for 10 min protected from light. After this period, samples were washed several 
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times with PBS to remove all traces of excessive dyes. Samples were immediately visualized in the dark 
by fluorescence microscopy (Axioimage RZ1M; Zeiss, Germany). 
 
6.4. Results and Discussion 
6.4.1. Superhydrophobic Surfaces Methodology 
The modification performed onto the PS smooth substrates, as described previously [30], created an 
ordered roughness composed of micro- and nanotopographic features. In addition, to improve the 
repellent properties of the PS, the roughness was conjugated with a chemical treatment. The obtained 
superhydrophobic surfaces presented an apparent water contact angle of 165° ± 4.9°. Aqueous-based 
solutions, when dispensed onto the superhydrophobic surfaces, assumed an almost spherical shape 
(Figure 6.1 (a)). The volume can control the sphere diameter [25]. A dispensing system, a 
superhydrophobic surface, and the precursor solutions are required to prepare particles, making this 
technique very cost-effective. Moreover, the use of significant amounts of solvents was avoided and no 
waste was produced. Unlike conventional techniques for particles production [24], this method allowed 
the individual solidification of the spherical hydrogels in a dry environment at room temperature. Such 
conditions were advantageous because the efficiency of the encapsulation process was very high as 
entrapped molecules had no possibility of being lost through migration to a surrounding medium. 
Moreover, the system was suitable for cell culture since encapsulated cells could maintain their viability 
(results discussed later).  
The CHI/β-GP:TPP particles are assumed to be produced from liquid precursors containing 
dexamethasone (Figure 6.1 (b)) or L929 cells (Figure 6.1 (c)) as generally shown in Figure 6.1. The 
superhydrophobic surfaces methodology allowed producing almost spherical hydrogel particles without 
mechanical stress, agitation, use of organic solvents, high temperatures, or pressures (Figure 6.1 (d)). 
Unlike other techniques/systems [33], CHI/β-GP:TPP hydrogels prepared on PS superhydrophobic 
surfaces do not require to be washed. 
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Figure 6.1. PS superhydrophobic surfaces were used as platforms to support aqueous-based droplets (A) for the 
preparation of CHI/β-GP:TPP spherical particles immobilizing (B) dexamethasone or (C) L929 cells. In any case, stable 
hydrogel beads were obtained upon ionic (D) crosslinking. 
 
6.4.2. CHI/β-GP:TPP Particles 
In the first step, the CHI/β-GP precursor solution was dispensed onto the PS superhydrophobic 
surfaces and the drops acquired a stable spherical shape. It is described in literature that β-GP 
neutralizes CHI allowing the incorporation of cells [7,34,35] as well as CHI gelation at physiological 
temperatures [9,10,36,37]. However, the CHI/β-GP gels obtained upon heating did not have a firm 
structure, and it was difficult to mold them in defined shapes such as spheres. In this context, an 
earlier crosslinking process of the CHI/β-GP solution may be an interesting strategy to obtain soft but 
manageable structures. A non-toxic polyanion crosslinker (TPP) was dispensed on the top of CHI/β-GP 
liquid droplets previously deposited on the PS superhydrophobic surfaces (first crosslinking mechanism 
in Figure 6.2). 
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Figure 6.2. Schematic representation of CHI/β-GP:TPP hydrogel networks derived from physical associations formed by 
ionic interactions (first crosslinking) and other attractive forces (second crosslinking). 
 
In the presence of water or acidic solutions, sodium TPP dissociates into OH! and P!O!"!! ions that 
interact with!−NH!! groups of CHI by deprotonation or ionic crosslinking [38]. The process of 
crosslinking started immediately after dispensing TPP. The diffusion of TPP through the CHI/β-GP 
droplets was very efficient as the ionic crosslinking occurred in less than 2 h. At physiological 
temperature, the presence of β-GP allowed the release of protons from the remaining CHI protonated 
amino group [11] and the subsequent appearance of attractive CHI–CHI forces that induced the 
reinforcement of the hydrogel physical structure (second crosslinking step in Figure 6.2). The proton 
receptor (β-GP) and the temperature increase turned the system kinetically unstable. Consequently, the 
reduction of the CHI charge decreased the repulsive chain–chain interactions and allowed the attractive 
forces (van der Walls, hydrogen bonding, and hydrophobic interactions) to predominate [11]. To 
determine whether any hardening effect had occurred after the thermogelation, DMA was performed on 
the CHI/β-GP:TPP hydrogels immersed in PBS at 20 °C and 37 °C. Both storage (elastic) modulus 
and loss (viscous) modulus are shown in Figure 6.3 (a) and (b), respectively. 
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Figure 6.3. (a) Storage modulus (E’), (b) loss modulus (E’’), and (c) loss factor (tan δ) of CHI/β-GP:TPP gels at 20 °C and 
37 °C, within the frequency range of 0.1–15 Hz. 
 
The storage modulus, E’, is a measurement of the sample stiffness, and the loss modulus, E’’, 
indicates the amount of mechanical energy lost during a cycle. At both temperatures, E’ increased with 
increasing frequency. For the same frequency, E’ was significantly higher at 37 °C as a result of the 
thermogelation effect. For example, at f =1 Hz, the storage modulus at 20 °C was 25.9 ± 3.4 kPa, 
which was significantly lower than the storage modulus of 78.9 ± 5.1 kPa at 37 °C. These results 
demonstrated that the stiffness of the formulated gels was increased when placed at simulated 
physiological conditions, meaning that the system could be hardened in situ upon implantation. The 
values of E’ in such conditions are within the range of values reported for hydrogels applied in cartilage 
regeneration strategies [39,40]. 
Regarding the E’’ values, the results were similar at both temperatures, which indicated that 
temperature does not affect the viscous component of the dynamic modulus. The damping capability of 
the gels can be evaluated by analyzing the tan δ (Figure 6.3 (c)), corresponding to E’’/E’ ratio. At 20 
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°C, the tan δ varied between 1 and 0.6. However, at 37 °C, it was significantly lower, varied between 
0.2 and 0.4. This means that the formulation under study exhibited a significant viscous component at 
20 °C, but displayed a much higher elastic nature at physiological temperature. Even in these 
conditions, the CHI/β-GP:TPP gels exhibited damping properties, showing the ability to partially 
dissipate the inputted mechanical energy, which might be advantageous in some biomedical 
applications.  
For the volume of the liquid precursor used, the diameter of the obtained particles was about 
2.70±0.29 mm. The low standard deviation value indicates that the superhydrophobic methodology 
allows producing particles with a narrow size distribution. However, such size can be easily 
manipulated by decreasing or increasing the volume of the dispensed solutions [25]. The size and 
water uptake of the particles should be dependent on the pH of the surrounding media. The pH 
sensitivity of the CHI/β-GP:TPP particles was verified through swelling studies under different pH 
conditions. The CHI network contains pH-ionizable groups that when immersed in acidic, neutral, or 
basic environments lead to distinct network electrical states, causing the structure to swell or shrink 
[41]. After preparation, CHI/β-GP:TPP particles were immediately soaked in phosphate buffer saline at 
pH 7.4, water supplemented with HCl at pH 2, or water supplemented with NaOH at pH 9 (at 37 °C). 
The swelling degree of the particles immersed in different solutions is shown in Figure 6.4. 
 
!  
Figure 6.4. Swelling of the CHI/β-GP:TPP particles after 2, 5, 7, and 14 days of immersion in pH 2, 7.4, and 9 media at 
37 °C. 
 
For 2 days, the particles shrunk in all three media. Probably, the increased attraction of CHI chains due 
to thermogelation caused by β-GP induced the release of water molecules that were in excess in the 
initially prepared particles (shrinking of the hydrogel structure). Comparing the swelling degree at this 
Chapter 6  Chitosan Spherical Hydrogels Loaded with Cells or Drugs  
!
! 246!
time point, the particles at low pH shrunk less than those immersed in neutral or basic medium. After 
this period, the CHI/β-GP:TPP particles immersed in pH 2 medium started to swell. After day 7, the 
structure was completely disintegrated, impairing further characterization. We can conclude that the 
system was not stable in acidic conditions. Similar results were obtained for CHI particles crosslinked 
with TPP using a spray-drying procedure [42]. However, a completely different effect occurred in the 
particles immersed in basic or neutral pH. From day 2 to day 5, the particles swollen slightly and 
started to shrink after 5 days. The protonation of amino groups in acidic conditions increased the 
electrical density and consequently increased the repulsive forces between the CHI crosslinked network 
[18]. This promoted the swelling of the CHI/β-GP:TPP structure until complete disintegration of the 
network. In neutral and basic medium, the protonation did not occur, and the particles kept their 
integrity for at least 14 days. The conservation of the 3D structure of particles during this time period 
indicated that the developed system remained stable. Shown in Figure 6.5 are aspects of the particles 
upon immersion in the solutions at different pH values. Essentially, the particles remained spherical. 
 
 
Figure 6.5. Stereomicroscope images of CHI/β-GP:TPP particles immediately after preparation (5 min) and after 
immersion in pH 2, 7.4, and 9 media for 5 and 7 days at 37 °C (scale bar: 1 mm). 
 
6.4.3. Drug Release 
To investigate the ability of the designed system to act as drug reservoirs, CHI/β-GP:TPP particles were 
loaded with dexamethasone, a synthetic glucocorticoid with efficient anti-inflammatory properties [43]. 
Dexamethasone has also been used combined with β-GP and ascorbic acid to support the osteogenic 
differentiation of mesenchymal stem cells [44]. During the preparation of the particles, the droplets 
Chapter 6  Chitosan Spherical Hydrogels Loaded with Cells or Drugs  
!
! 247!
were surrounded by air. Since the encapsulating molecules are not volatile, an encapsulation efficiency 
of virtually 100% could be expected. The amount of dexamethasone released was assessed by UV 
spectrophotometry. The respective release profiles for 5 h at different pH values are shown in Figure 
6.6. 
 
 
Figure 6.6. Dexamethasone release profiles from CHI/β-GP:TPP particles immersed in media with pH 2, 7.4, and 9 at 37 
°C. 
 
The profiles presented a relatively fast drug release, where almost 60%–70% of the encapsulated 
dexamethasone was released after 3 h. Despite their limited lifetime in physiological media, physical 
crosslinked systems have great advantages for short-term drug release applications [20]. The 
dexamethasone release profile observed at pH 2 was similar to the one at pH 7.4. However, at pH 9, 
the amount of dexamethasone released in each time point was slightly lower compared to the other 
cases. This may be due to the electrostatic attractive interactions between anions and CHI at basic pH 
[21], which may hinder the diffusion of dexamethasone to the release medium. The drug release 
kinetics was characterized by fitting the experimental data with the standard release equations (2)–(5). 
According to the R2 values in Table 6.1, the best fit was with the Higuchi model. This indicated that the 
release rate was significantly dependent on the rate of dexamethasone diffusion (Fickian diffusion) 
through the crosslinked CHI/β-GP:TPP networks. However, a good fitting was also observed in the 
Korsmeyer–Peppas model, which was applied as the mechanism of drug release and is used when 
more than one type of mechanism is involved. Based on the Korsmeyer–Peppas kinetic model, the 
dexamethasone release from CHI/β-GP followed an anomalous mode (0.43 < n < 0.85) [31]. This 
indicated that the release was controlled by diffusion as well as by the changes in the water uptake of 
the particles. 
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Table 6.1. Mathematical models and respective parameters obtained from the fitting of the experimental data 
corresponding to a dexamethasone release from CHI/β-GP:TPP particles at different pH values. The interval from 10% to 
60% of the amount of dexamethasone release was used in all fittings. 
Mathematical models Zero-order First-order Higuchi Korsmeyer-Peppas 
pH 
R2 
(±SD) 
K0 
(±SD) (µgh-1) 
R2 
(±SD) 
K1 
(±SD) 
(h-1) 
R2  
(±SD) 
KH 
(±SD) 
(h-0.5) 
R2  
(±SD) 
KKP 
(±SD) 
n 
(±SD) 
2 
0.947 
(±0.0833) 
9.43 
(±2.71) 
0.857 
(±0.109) 
0.548 
(±0.130) 
0.978 
(±0.0504) 
20.414 
(±5.795) 
0.976 
(±0.0477) 
16.41 
(±1.439) 
0.621 
(±0.148) 
7.4 
0.813 
(±0.129) 
7.76 
(±2.62) 
0.720 
(±0.147) 
0.486 
(±0.146) 
0.869 
(±0.118) 
17.157 
(±5.453) 
0.856 
(±0.152) 
16.61 
(±3.258) 
0.578 
(±0.185) 
9 
0.931 
(±0.0895) 
8.98 
(±1,00) 
0.808± 
(0.113) 
0.661 
(±0.103) 
0.967 
(±0.0508) 
19.471 
(±2.008) 
0.963 
(±0.0482) 
13.12 
(±1.491) 
0.751 
(±0.106) 
 
To tailor the release profiles to an appropriate efficiency for certain applications, it would be necessary 
to change the formulation of the liquid precursor (e.g. concentration of CHI or TPP) to modify the 
structure of the particles. As reported before [45], superhydrophobic surfaces’ technology can control 
drug release by increasing the structural complexity of the particles, namely, by the production of 
multilayer spherical systems where non-loaded layers may act as barriers to control the release of 
drugs immobilized in the inner layers. 
 
6.4.4. Cells Immobilization 
The cytocompatibility of the proposed system is an important property, especially due to its potential to 
immobilize cells inside the particles. The materials used should be noncytotoxic, and cell viability must 
be maintained during processing. Droplet deposition onto PS superhydrophobic surfaces has been 
validated as a mild technology to immobilize cells [25]. In this context, the viability and cell distribution 
inside CHI/β-GP:TPP particles were analyzed by Live/Dead staining. L929 cells were immobilized 
inside the spherical gels and then cultured under appropriated conditions for 7 days. Based on the 
fluorescent microscopy images in Figure 6.7, the cells were homogeneously distributed and viable 
(green spots) after 7 days. ALG (1.5% w/v) crosslinked with CaCl2 was used as control; such system 
could maintain viability of the mesenchymal stem cells for 21 days [27]. Compared with control (cells 
encapsulated in ALG using the same processing technique), the results were similar, and hence, the 
CHI/β-GP:TPP particles could provide a suitable system to encapsulate living cells without significant 
loss of viability. 
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Figure 6.7. Fluorescent microscopy images of Live/Dead assay at 1, 3, and 7 days of culture. ALG particles (control) and 
CHI/β-GP:TPP particles were analyzed. Living cells were stained in green by calcein-AM, and dead cells were stained in red 
by propidium iodide (scale bar: 500 µm). 
 
6.5. Conclusions 
Solid particles were prepared by crosslinking neutralized CHI/β-GP solutions with TPP. The use of 
biomimetic superhydrophobic surfaces as particle production methodology is advantageous since the 
particles are obtained in mild conditions conserving the viability of the encapsulated cells, with a 
narrow particle size distribution and without aggregation. Due to the particle–air interface, no 
dexamethasone was lost in our study; during the solidification of the drops, the encapsulation efficiency 
of the system was very high. The spherical systems were pH sensitive and transitioned from soft 
viscoelastic to a more elastic and stiff nature after being exposed to physiological conditions. The 
system maintains cells well distributed and viable up to 7 days. Dexamethasone was also encapsulated 
in the particles that sustained its release for 2–3 h. The fabrication and the particle features of the 
CHI/β-GP:TPP system have interesting properties that should be explored for more specific biomedical 
applications. 
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Chapter 7 
Fast and Mild Strategy, Using Superhydrophobic Surfaces, to 
Produce Collagen/Platelet Lysate Gel Beads for Skin Regeneration 
 
7.1. Abstract  
Platelet lysates (PL) were encapsulated in collagen (Coll) millimetric gel beads, on biomimetic 
superhydrophobic surfaces, under mild conditions, with the aim of obtaining easy-to-handle formulations 
able to provide sustained release of multiple growth factors (GFs) for skin ulcers treatment. The gel 
particles were prepared with various concentrations of PL incorporating or not stem cells, and tested as 
freshly prepared or after being freeze-dried or cryopreserved. Coll+PL particles were evaluated regarding 
degradation in collagenase-rich environment (simulating the aggressive environment of the chronic ulcers), 
sustained release of total protein, PDGF-BB and VEGF, cell proliferation (using particles as the only source 
of growth factors), scratch wound recovery and angiogenic capability. Compared to Coll solely particles, 
incorporation of PL notably enhanced cell proliferation (inside and outside gels) and favored scratch 
wound recovery and angiogenesis. Moreover, cell-laden gel particles containing PL notably improved cell 
proliferation and even migration of cells from one particle towards a neighbor one, which led to cell- cell 
contacts and the spontaneous formation of tissue layers in which the spherical gels were interconnected 
by the stem cells. 
 
 
 
 
 
 
This chapter is based on the following publication:  
Lima A.C., Mano J. F., Concheiro A. and Alvarez-Lorenzo C., Fast and mild strategy, using superhydrophobic surfaces, to produce collagen/platelet lysate gel 
beads for skin regeneration, Stem Cells Reviews and Reports 2014, DOI 10.1007/s12015-014-9548-6 (in press).  
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7.2. Introduction 
Skin ulcers caused by diabetes, peripheral vascular diseases, and disorders that hinder patient mobility 
can easily lead to severe states that are very difficult to treat [1]. Despite enormous efforts carried out to 
find efficient, standardized therapeutic strategies, until now this aim was not achieved. Moreover, the 
socio-economic costs associated to the treatments of chronic non-healing ulcers are still very relevant [1]. 
Normal wound healing process occurs sequentially and does not require any significant intervention. 
Platelets circulating in the blood stream reach the injured skin site and secrete growth factors (GFs). 
Macrophages recruitment and GFs release attract endothelial cells to migrate and proliferate in the wound 
site [2]. Angiogenesis and synthesis of Coll are also stimulated until skin reaches the anatomic and 
functional integrity [3]. Despite the different etiologies, chronic skin ulcers are characterized by failure in 
the healing process, requiring always intervention. A severe inflammatory process is triggered where large 
amounts of proteinases, such as plasmin and matrix metalloproteinases, and also reactive oxygen species 
are produced. Due to the presence of abnormal amount of proteinases, an excessive destruction of the 
extra-cellular matrix occurs, and the epidermis layer is disrupted causing cell dead [4]. Moreover, poor 
blood vessels formation is characteristic of chronic skin ulcers, meaning that therapeutic strategies are 
required to re-establish the normal vascular network. Three distinct mechanisms are involved in 
neovascularization process: the sprouting of preexisting resident endothelial cells, maturation and 
enlargement of the preexisting small vessels, and recruitment of bone marrow-derived endothelial 
progenitor cells [5]. Topical application of GFs that stimulate the formation of a neovascularized network 
constitutes an alternative, but human-recombinant GFs are expensive, have short shelf life, and repeated 
doses may be required to achieve therapeutic effects [5]. Strategies to avoid invasive procedures (such as 
skin grafts) while supplying efficiently the wound site with GFs and cells have been also a target of 
research [6]. 
Platelet derived products have been evaluated for regeneration of soft and hard tissues including ligament 
[7], bone [8], cartilage [9], skin wounds [10], and cornea [11]. In a safe and cost-effective manner, 
autologous platelets and fibrinogen are collected from blood and concentrated. After activation with 
thrombin, calcium, collagen or via mechanical destruction (freeze-thaw cycles), platelet cells release a 
large number of biologically active substances allowing obtaining a cocktail of GFs and cytokines that 
stimulate cell recruitment (chemotaxis), proliferation and differentiation [12], and also anti- inflammatory 
mediators such as lipoxins [13]. Platelet derived products are known as platelet lysates (PL), platelet-rich 
plasma (PRP), platelet-rich plasma releasates (PRPr) or plasma rich in growth factors (PRGF) [14]. Such 
products are topically applied or locally administered via injection in the damaged tissue. The main 
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drawbacks of this approach are the low retention in the injury site or the rapid access of the GFs to the 
blood stream, which in turn leads to a fast degradation of GFs and cytokines and failure of the therapy [5, 
15]. Therefore, easy-to-handle systems able to control the delivery of GFs and cytokines, and that also 
could eventually encapsulate stem cells, would be advantageous. 
Some natural-based hydrogels have been reported as candidates to release platelet-derived products [16]. 
Alginate beads loaded with PL have been shown to increase cell proliferation in vitro and to accelerate the 
healing of skin pressure ulcers in hospitalized patients [13]. Encapsulation of PL and vancomycin 
hydrochloride into alginate led to particles able to absorb wound exudates and to increase the cell number 
in proliferation phase [17]. Co-encapsulation of PL and adipose-derived stem cells into alginate 
microspheres revealed osteogenic and angiogenic potential [18]. Similarly, gelatin hydrogels encapsulating 
PL and bFGF behaved as multiple GFs release systems with angiogenic capability [19]. 
Alternatively to above described materials, Coll could constitute an interesting option to produce carriers of 
cells and bioactive agents for chronic ulcers treatment. Coll is the most abundant extracellular protein in 
tissues such as cartilage, ligaments, tendons, bone and skin. Its main function is to stabilize tissues and to 
maintain their structural integrity. In the case of skin, collagen is the base of dermal layer and it is 
secreted during the wound healing process [4, 20]. 
The purpose of this study was to develop millimetric gel particles composed by Coll and PL, using a fast 
and mild process, for application in chronic ulcers for skin regeneration. Employing superhydrophobic 
surface methodology [21], here is not waste of materials (100 % encapsulation efficiency) and cells may 
be even immobilized inside the gels without significant cell viability loss. Performance of the produced 
Coll+PL gel particles regarding cell proliferation was elucidated both as freshly prepared (in hydrated form) 
and after being freeze-dried, in order to identify adequate strategies for implantation and use of the 
obtained particles. To carry out the work, gel particles prepared with Coll and PL (as obtained or 
concentrated 2 and 3×) and exposed to cell medium without FBS, were compared with Coll solely particles 
cultured in medium with and without FBS. Encapsulation of human adipose-derived stem cells (hASCs) 
was also investigated to determine whether these gels could act as cell carriers to the ulcer sites and 
trigger the formation of tissue layers. Performance of cell-laden gel particles was evaluated before and 
after cryopreservation with the aim of elucidating the feasibility of preserve the obtained systems. 
 
7.3. Experimental Section 
7.3.1. Materials 
Polystyrene sheets (square Petri dishes, Bdbioscience, Enzifarma, Portugal) and polystyrene granules 
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(injection molding grade, Styrolution 158 k, UL Ides, Portugal) were used in the preparation of the 
superhydrophobic substrates. Tetrahydrofuran (THF, 99.9 %) was from Riedel de-Haen (Germany). 
1H,1H,2H,2H-perfluorodecyltriethoxysilane (PFDTS, 97 %), penicillin-streptomycin solution (10,000 units 
of penicillin and 10 mg streptomycin/mL), L-glutamine, trypsin-EDTA, cell counting kit-8 (CCK-8), calcein-
AM (17783), propidium iodide (PI, P4170), 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI, 32670) 
and phosphate buffer saline (PBS, 10×) were from Sigma-Aldrich (St. Louis, MO, USA). Rat tail collagen 
type I high concentration was from BD Biosciences (USA). Paraformaldehyde tablets were from Panreac 
(Spain). Ethanol was purchased from Merck (Germany). Triton X-100 was from Analema (Spain). 
Glutaraldehyde was from Scharlau (Spain). Mesenchymal stem cells StemPRO® human adipose-derived 
stem cells (hASCs), MesenPro RS basal Medium and MesenPro RS Growth sup- plement (fetal bovine 
serum, FBS) were from Gibco® (Life Technologies; USA). Bodipy 650/665 Phalloidin was from InvitrogenTM 
Molecular Probes® (Life Technologies; USA). Dimethyl sulfoxide (DMSO) was from Fisher Chemicals (UK). 
PierceTM BCA Protein Assay Kit was from Thermo Scientific (USA). Human VEGF and human PDGF-BB 
ELISA kits were from RayBiotech (USA). Purified water (resistivity >18 MΩ cm; MilliQ®, Millipore, Spain) 
was obtained by means of reverse osmosis. All the other chemicals were used as received. 
 
7.3.2. Polystyrene Superhydrophobic Surfaces 
A phase separation method was applied to make PS surface superhydrophobic [21, 22]. Briefly, a PS 
solution (70 mg/mL) in THF was prepared and then mixed with ethanol (2:1.3 v/v). The mixture was 
dispensed onto smooth PS commercial substrates, which were then immersed in ethanol for 1 min and 
dried under nitrogen flow. The rough PS surfaces were treated with PFDTS (1 % v/v in ethanol) after argon 
plasma exposure for 40 s at 30 W (Plasma Prep5, Gala Instruments, Germany). 
 
7.3.3. Platelet Lysates Preparation 
Platelet lysates were obtained from three different blood collections performed at Galicia Blood 
Transfusion Center (Spain). Blood samples were centrifuged at 1400 rpm, 25 °C for 15 min. The plasma 
was isolated and subjected to three repeated temperature cycles (frozen at −80 °C and heated at 37 °C). 
Remaining platelets and potential antigens were removed by means of centrifugation at 4 °C, 12000 rpm 
during 12 min. PL was frozen at −80 °C until use. Concentrated PL was prepared from liquid PL, which 
was divided in aliquots of 1 mL, frozen at −80 °C and then freeze-dried for 36 h. The mass of solids per 
volume unit of liquid PL was determined. After that, the freeze-dried PL was reconstituted in 500 µL or 
333.33 µL of PBS pH 7.4 to obtain PL concentrated 2 and 3×. 
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7.3.4. Gel Beads of Collagen Combined with Platelet Lysates 
Gel particles of Coll solely or combined with PL (Coll+PL) were prepared using the superhydrophobic 
surface methodology [21, 23–26]. Solutions of Coll and Coll+PL were placed on ice to prevent premature 
gelation. Coll solely formulation was prepared from a stock solution (5 mg/mL, neutralized according to 
the supplier instructions) that was diluted with PBS up of 2.5 mg/mL. Coll+PL was obtained mixing 
collagen stock solution and PL at 50:50 (v/v), as indicated in Table 7.1. 
 
Table 7.1. Composition of the solutions used to prepare the gel particles. 
Formulation 
Collagen neutralized 
(5 mg/mL) 
PL PBS 
Coll 500 µL  500 µL 
Coll+PL1x 500 µL 500 µL (PL1x)  
Coll+PL2x 500 µL 500 µL (PL2x)  
Coll+PL3x 500 µL 500 µL (PL3x)  
 
Hydrated gels were used or characterized immediately after hardening on the superhydrophobic surfaces 
(incubation at 37 °C for 10–15 min) or after being freeze-dried and re-hydrated into PBS pH 7.4. Freeze-
dried particles were obtained after fast frozen in liquid nitrogen of gels previously immersed in water (5 
gels/100 µL of water) to prevent the adhesion of gel beads to the walls of the containers. 
The size of hydrated, freeze-dried and re-hydrated gel particles was evaluated using an optical 
stereomicroscope (Olympus SZ-CTV; Tokyo, Japan) connected to a video camera (JCV TK-S350; Tokyo, 
Japan). Five particles of each formulation were sized using an analysis image software analysis (Image J, 
NIH, USA). The structure of the particles was visualized using Scanning Electron Microscopy (SEM). 
Immediately after hardening, some particles were collected, and fixed in glutaraldehyde (0.25 % v/v 
aqueous solution) overnight at 4 °C. The particles were then dehydrated in ethanol aqueous solutions of 
increasing concentration. Images of freeze-dried and dehydrated formulations were obtained using a Zeiss 
FESEM ULTRA Plus microscope (Zeiss, Oberkochen, Germany) after gold coating. 
 
7.3.5. Total Protein and Growth Factors Release 
In vitro release studies were performed in triplicate incubating 15 Coll+PL particles (Coll+PL2× in hydrated 
state) in 1 mL of PBS pH 7.4 at 37 °C inside Eppendorf LoBind tubes. At various time intervals, aliquots 
of 0.4 mL were withdrawn and replaced with the same volume of fresh PBS. Total protein released was 
quantified using a BCA protein detection kit (absorbance read at 595 nm), while PDGF-BB and VEGF 
released were quantified using specific ELISA kits (absorbance read at 440 nm; FLUOstar Optima 
microplate reader, BMG Labtech, Ortenberg, Germany). 
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7.3.6. Gel Beads of Collagen Combined with Platelet Lysates Encapsulating hASCs 
hASCs were cultured in MesenPro® RS medium supplemented with 2 % (v/v) growth supplement (FBS), 1 
% (v/v) L-glutamine solution (200 mM) and 1 % (v/v) penicillin/streptomycin in humid conditions at 37 °C 
with 5 % CO2. Then, cells were trypsinised and resuspended in Coll or Coll+PL solutions (formulations 
described in Table 7.1) with a density of 7.5×105 cells/mL. The cell suspensions were dispensed through 
pipetting on the superhydrohobic surfaces in volumes of 10 µL and incubated inside sterile Petri dishes at 
37 °C during 10–15 min for the gelling process. 
 
7.3.7. hASCs Viability, Proliferation and Morphology Inside Gel Beads 
Hardened gel particles were collected and cultured in 96 well plates for 1, 3 and 7 days (2 particles/well, 
200 µL of cell culture medium). Coll gels cultured in medium with or without FBS were used as controls. 
All the formulations containing PL were cultured in medium without FBS. The cells were routinely observed 
using inverted microscopy (x10) (Nikon Eclipse TS100, Nikon Corporation, Tokyo, Japan) in order to 
discard any contamination. hASCs proliferation was determined by quantification of metabolic activity 
following the CCK-8 kit supplier protocol. Briefly, part of the medium in each well was removed, and 
particles immersed in 100 µL of cell culture medium were incubated with 10 µL of CCK-8 solution at 37 
°C for 3 hours. Aliquots of the medium (80 µL) were transferred to 96 well plates and their absorbance 
measured at 450 nm using a microplate reader (BIORAD, Model 680, USA). Blank (100 µL of cell culture 
medium) and controls (gel particles without cells) were similarly processed. hASCs proliferation was 
determined from the measured absorbance values using a calibration curve prepared with known amount 
of cells seeded into the wells. In parallel, cell viability was assessed by means of live/dead test using 
Calcein-AM and propidium iodide staining. Briefly, at each time point, gel particles were washed with PBS 
and incubated at 37 °C for 10 min immersed in a PBS: Calcein-AM (1 mg/mL):propidium iodide (1 
mg/mL) 98.5:1:0.5 v/v/v solution. Afterwards the particles were washed with PBS to remove all traces of 
the dyes and then fixed with 4 % paraformaldehyde in PBS for 20 min at room temperature. Finally, the 
particles were again washed with PBS and visualized using confocal microscopy (LEICA TCS-SP2, Leica 
Microsystems GMbH, Mannheim, Germany). hASCs morphology inside Coll or Coll+PL gels was visualized 
using DAPI to stain cell nuclei (stock solution 1 mg/ml in H2O) and Phalloidin to stain the F-actin filaments 
in the cytoskeleton (stock solution 5 mg/1.5 mL in methanol). In brief, the cell-laden gels at 1, 3 and 7 
days of incubation in culture medium were immersed in 4 % paraformaldehyde in PBS for 20 min at room 
temperature to fix the cells. Then, the cells were permeabilized with 0.1 % Triton X-100 for 2 min at room 
temperature and subsequently washed with PBS several times. Afterwards, the cells were stained with 
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Phalloidin (3 µL of stock solution per 100 µL of PBS) for 45 min at room temperature. Then, they were 
washed with PBS and stained with DAPI (2.5 µL of stock solution per 1 mL of PBS) for 10 min also at 
room temperature protected from the light. After being washed again with PBS to remove all traces of the 
dyes, the particles were visualized using confocal microscopy (Leica Microsystems GMbH, Mannheim, 
Germany). 
 
7.3.8. Cryopreservation and Subsequent Viability and Proliferation Capacity 
After 24 h of culture, some cell-laden gel particles were cryopreserved. To do that, 10 particles of each 
type were suspended in 1 mL of FBS:DMSO 90:10 v/v. The particles were kept at −20 °C for 24 h and 
then stored at −80 °C. After 1 month of cryopreservation, the particles were removed from the −80 °C 
container and partially thawed at 37 °C. The medium was removed and the particles were washed several 
times with cell culture medium in order to remove traces of DMSO. The particles were cultured for 7 days 
(2 gels/well, 200 µL of cell culture medium) and then cell viability assessed using live/dead assay 
following the procedure described above. 
 
7.3.9. Gel Beads of Collagen Combined with Platelet Lysates as Growth Factors Release 
Systems 
Beads prepared as described above (without encapsulating cells) were also studied as possible reservoirs 
to release GFs in skin injuries. The tests performed are described below. 
 
7.3.10. In Vitro Degradation Assay 
Hydrated Coll and Coll+PL gels (5 particles per formulation) were incubated in 1 mL of collagenase 
solution (50 µg/mL) in tricine buffer pH 7.5 and incubated at 37 °C. Images of the gel particles were 
recorded at 30, 90, 150, 210, 270 min and 24 hours using an optical stereomicroscope (Olympus SZ- 
CTV; Tokyo, Japan) connected to a video camera (JCV TK- S350; Tokyo, Japan). 
 
7.3.11. Effect of the Released GFs on hASCs Proliferation 
hASCs were seeded (passage 7, 7500 cells/well, 100 µL of cell culture medium) in 48 well plates, and 
after 24 h the culture medium was replaced by 200 µL of fresh medium without FBS. Two particles of 
each formulation (hydrated or freeze-dried) were placed into direct contact with the cells. The plates were 
incubated at 37 °C in a humidified atmosphere with 5 % CO2 and the medium was replaced every 3 days. 
The cells were routinely observed using inverted microscopy (x10) (Nikon Eclipse TS100, Nikon 
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Corporation, Tokyo, Japan) in order to discard any contamination. Experiments were carried out in 
triplicate. Cell proliferation was evaluated using CCK-8 as described above. 
 
7.3.12. Scratch Wound Assay 
The scratch assay was performed as previously described [27, 28]. hASCs were seeded into cell culture 
dishes with culture inserts (µ-dishes 35 mm, Ibidi, Martinsried, Germany) and allowed to proliferate at 37 
°C, 5 % CO2 and humidified atmosphere until reach confluence. Such inserts were composed by two cell 
culture reservoirs which were separated by a 500 µm thick wall. The culture insert and the culture 
medium were then removed, and the cells were rinsed with phosphate buffer saline (PBS) and incubated 
with 1 mL of culture medium without FBS. 10 particles/mL where placed in direct contact with the cells. 
After 0, 2, 4, 8, 12, 24 and 48 h of incubation, pictures of the gap were taken using an inverted 
microscope (Nikon Eclipse TS100, Nikon Corporation, Tokyo, Japan). The percentage of the gap filled by 
hASCs was determined with respect to the initial cell-free gap, and used as an index of wound healing. 
 
7.3.13. Angiogenic Potential of the Gel Beads: Chick Chorioallantoic Membrane Test 
Fertilized eggs purchased from a local farm were placed horizontally in an incubator at 37 °C with 60 % 
humidity. After 3 days, the eggs were punctured and 2 mL of albumin was removed. A circular window 
was performed in the eggshell and covered with tape, and the eggs were returned to the incubator. On day 
7, two beads of Coll+PL (1 and 2×, in a hydrated state) were placed in contact with the Chorioallantoic 
Membrame (CAM) of each egg. Two controls were also performed with eggs to which Coll solely (2 
hydrated beads) or non-encapsulated PL (10 µL of PL1 and 10 µL of PL2×; equivalent to the same 
amount of PL encapsulated in the Coll+PL formulations) was directly dispensed on the CAM surface. All 
tests were carried out in triplicate. Three days after placing the gels in contact with CAM, images were 
collected to analyze vasculature development. To do that, the membranes were fixed with 10 % 
formaldehyde for at least 10 min at room temperature. The membranes were cut, disposed carefully on a 
glass slide, and visualized in a stereomicroscope (Olympus SZ-CTV, Tokyo, Japan). Images were captured 
using a connected JVC TK-S350 video camera (Tokyo, Japan) and used to quantify the blood vessels 
growth. 
 
7.3.14. Statistical Analysis 
All the experiments were performed with at least three replicates. Results are expressed as 
mean±standard deviation. Differences between experimental results were analyzed using one-way ANOVA 
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(Tukey’s multiple comparison test), with the limit for statistical significance being defined as p < 0.05. 
 
7.4. Results 
7.4.1. Preparation and Crosslinking of Gel Beads 
Superhydrophobic surface methodology allowed the production of almost spherical gels of Coll and PL 
with the optional simultaneous encapsulation of cells. Coll concentration was fixed to 2.5 mg/mL, 
according to previous studies [29]. PL concentration was varied in order to investigate its effect on cell 
proliferation inside and outside the gels, wound healing capacity and angiogenesis potential. The 
hardening of the gel beads was achieved by incubation of liquid droplets dispensed onto PS 
superhydrophobic surfaces at 37 °C during 10–15 min (Figure 7.1 A and B). The presence of hASCs did 
not affect the self-assembly hardening of collagen.  
 
 
Figure 7.1. Flow chart of the preparation and evaluation of Coll+PL gel particles. (A) A mixture of Coll and PL was dispensed 
onto PS superhydrophobic surfaces, as droplets of controlled volume. (B) The platform with liquid droplets was incubated at 37 
°C for 10–15 minutes and almost spherical gels in a hydrated state were obtained. Two main strategies were hypothesized in 
this work: (C.1) spherical particles encapsulating hASCs to be directly applied (I) or stored by cryopreservation and later thawing 
and use (II), (C.2) gels without cells which could act as bioactive agents release systems, also applied immediately after 
production (hydrated form) (I) or later, after being freeze-dried and stored (II). Each formulation could be then ingraft in a skin 
lesion (e.g. ulcer) (D) which in turn could be coated or not by a dressing (E and F). 
 
The obtained particles (1.5–2.5 mm in diameter) had gel appearance (Figure 7.2 A, D, G and J) with 
some sticky properties; the particles that contained PL were easier to handle (probably due to the 
formation of a fibrin mesh) than the ones made of collagen solely. Fibrillar Coll beads (hardened via the 
self- assembly process) contained large amounts of fluid in their matrix and thus showed soft consistency. 
Coll+PL spherical-shaped gels without cells had greater consistency and could be easily collected and 
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freeze-dried for storage (Figure 7.2 B, E, H and K). The dried beads recovered their gel appearance after 
immersion into PBS pH 7.4 (Figure 7.2 C, F, I and L), but were more fragile when compared with particles 
immersed into PBS immediately after production. SEM images confirmed the fibrillar structures 
characteristic of Coll (Figure 7.2 III). Significant differences were visualized between freeze-dried particles 
and the fixed ones. As expected, the freeze-dried particles were much more porous. In the freeze-dried Coll 
formulation a dense random mesh of nanofibers (<300 nm) was observed. Formulations with PL showed 
fibers with greater diameters. Fixed and dehydrated gel beads had a compact fibrillar nanostructure, 
without pores. 
 
 
Figure 7.2. I) Stereomicroscope images of Coll and Coll+PL (1, 2, and 3×) spherical gels prepared dispensing 10 µL of 
precursor solutions onto PS superhydrophobic surfaces and hardening at 37 °C for 10–15 min. Particles without cells were 
evaluated as hydrated gels obtained immediately after incubation (A, D, G and J), as freeze-dried particles (B, E, H and K) and 
as re-hydrated gels obtained after hydration of freeze-dried particles through immersion in PBS at pH 7.4 (C, F, I and L). Scale 
bar represents 1 mm. II) Diameter of hydrated, freeze-dried and re-hydrated gel beads (n=5). III) SEM images of the surface of 
freeze-dried spherical particles (M, N, O, P) and of the surface of the gels with PL without cells, fixed and dehydrated (Q, R, S). 
Two images with different magnifications of each gel formulation are shown. 
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The PL used was characterized in terms of mass of solids, total protein content and amount of VEGF and 
PDGF-BB before and after freeze-drying (Table 7.2). VEGF is known to be an angiogenic molecule [30], 
while PDGF promotes cell mitogenesis and migration of fibroblasts, smooth muscle cells and capillary 
endothelial cells [31]. Recombinant human PDGF-BB also shows beneficial effects when applied topically 
in skin wounds [32, 33]. Freeze drying of PL does not affect the cytokines role in wound healing [34, 35]. 
We observed that freeze-drying did not modify the contents in VEGF and PDGF-BB (Table 7.2). 
 
Table 7.2. Characterization of the PL before and after freeze-drying. 
PL Mass of solids Total protein content VEGF PDGF-BB 
Before freeze-
drying 
(PL1x) 
- 56.61±1.24 mg/mL 1.01±0.15 ng/mL 
Or 
17.9±2.6 pg/mg of 
total protein 
15.8±3.1 ng/mL 
Or 
462.4±54.0 pg/mg of 
total protein 
After freeze-
drying 
(resuspended in 
PBS) 
79.03±5.54 
mg/mL 
57.62±1.62 mg/mL 
Or 
0.73±0.02 mg/mg of 
freeze-dried PL 
0.96±0.19 ng/mL 
Or 
16.6±3.2 pg/mg of  
total protein 
22.1±2.5 ng/mL 
Or 
383.2±43.0 pg/mg of 
total protein 
 
PL has a complex composition, and firstly total protein released from the beads was quantified. Beads 
evaluated were prepared with PL concentrated 2× (Coll+PL2×). Each particle released 0.40–0.45 mg of 
protein within 8 h (nearly 90 % total protein) which indicated that the release was independent of the 
degradation of the bead structure (Figure 7.3 A). As expected, both VEGF and PDGF-BB were released in a 
sustained way for a relatively short time period (Figure 7.3 B). 
 
Figure 7.3. Total protein (A), VEGF and PDGF (B, C) released from Coll+PL2× particles over 72 h. Data are shown as 
percentage (A, B) and as amount released per bead (C). 
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7.4.2. Gel Beads of Collagen Combined with Platelet Lysates Encapsulating hASCs 
As described in the Figure 7.1 (C.1), gel beads with hASCS were obtained in a rapid and simple way after 
hardening onto the superhydrophobic surfaces under mild temperature. Firstly, the number of cells 
encapsulated inside the gels over 7 days in culture without FBS was assessed for three different Coll+PL 
formulations, varying the amount of PL (Figure 7.4). The comparison was performed against cells 
encapsulated in beads of Coll solely and cultured into a standard medium with FBS (Coll with FBS) and 
without FBS (Coll without FBS). Cell proliferation pattern was similar for Coll beads cultured in the 
presence or absence of FBS, but higher number of hASCS was found in the first case. Particles with PL 
behaved quite differently; for Coll+PL1 and Coll+PL2× the cell number increased from day 1 to day 7. The 
cells encapsulated in Coll+PL3× beads rapidly proliferated in the first day, but the number of cells was 
slightly lower than for Coll+PL1 and Coll+PL2× at days 3 and 7. 
 
 
Figure 7.4. A) hASCs growth within Coll and Coll+PL gel beads for 7 days. Gels without PL cultured in medium with and 
without FBS were used as controls. The effect of PL concentration on hASCs proliferation capability was evaluated.*p<0.05, 
significantly different from Coll with FBS. #p<0.05, significantly different from Coll without FBS. $p<0.05, significantly different 
from Coll+PL1×. &p<0.05, significantly different from Coll+PL2×. The comparisons were performed between data collected in 
the same time point. B) hASCS proliferation within Coll+PL1× prepared using freeze-dried or non freeze-dried (fresh) PL. The 
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influence of freeze drying process on effect of PL was evaluated. *p < 0.05, significantly different from Coll+PL1× when non 
freeze-dried PL was used, at day 7. 
 
In order to verify if freeze-drying may compromise the positive effect of PL on hASCs proliferation, a 
comparative study of the performance of Coll+PL1× formulations prepared using either liquid PL or freeze 
dried PL resuspended in PBS pH 7.4 was carried out. The results (Figure 7.4 B) did not show statistically 
significant differences in the first 3 days, and only a minor decrease in proliferation at day 7 was observed 
for freeze-dried PL. 
Fluorescence images of the live/dead assay confirmed the good cytocompatibility of the formulations 
studied. After 24 h, almost all encapsulated hASCs were alive, proving the mild conditions of the 
superhydrophobic surface methodology for cell encapsulation. Dead hASCs were not found in Coll gels 
cultured in medium with FBS after 3 (Figure 7.5 A.D3) and 7 (Figure 7.5 A.D7) days, but when the same 
beads were incubated in medium without FBS an important percentage of cells died (Figure 7.5 B.D3 and 
B.D7). Coll+PL beads were able to supply the needed GFs to the cells and most cells were alive after 7 
days of incubation. PL concentration (1, 2 and 3×) seemed not have significant effect on cell viability 
(Figure 7.5 C, D and E). 
 
Figure 7.5. Live/dead fluorescent assay at 1, 3 and 7 days of culture. Coll (cultured in medium with or without FBS, controls) 
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and Coll+PL particles with three different PL concentrations were tested. Living cells were stained green (calcein-AM) and dead 
cells were stained red (propidium iodide). Scale bar represents 100 µm. 
Although collagen has RGD domains that induce the cell spreading, after 24 h the actin cytoskeleton 
reorganization was much more visible in Coll+PL beads (Figure 7.6 C.D1, D.D1 and E.D1 versus A.D1 and 
B.D1). hASCs were protected by a dense meshwork of collagen fibrils and PL that allowed cell-matrix 
interactions and cell migration. Phalloidin/DAPI staining revealed a rapid hASCs migration from the 
Coll+PL gels (visible in Figure 7.6 C.D1), facilitating cell-cell direct contact among hASCs from different 
particles.  
 
Figure 7.6. Phalloidin/DAPI fluorescence assay at 1, 3 and 7 days of culture. Coll (cultured in medium with or without FBS, 
controls) and Coll+PL particles with three different PL concentrations were tested. Cells F-actin filaments in cytoplasm were 
stained red by Phalloidin, and nuclei were stained in blue by DAPI. Scale bar represents 100 µm. 
 
The images of optical microscopy (Figure 7.7) also evidenced the ability of hASCs to migrate out the 
particles, grow up at the bottom of the well plate and also act as bridges between gel beads. The release 
of PL components, such as fibrinogen which created a fibrin mesh, led to the formation of an organized 
membrane in which the spherical gels were interconnected by hASCs (Figure 7.7 V). The schematic 
representation of the successive events occurred in Coll+PL formulations is depicted in Figure 7.7 I-IV. 
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Interestingly, very few cells migrated from Coll particles cultured with and without FBS even after 3 and 7 
days in culture (Figure 7.7 A.D3, A.D7, B.D3, and B.D7). In agreement with previous works [4, 29], the 
Coll gels that encapsulated hASCs shrank over time, as revealed by the reduction of the volume of the 
particles (Figure 7.7 A.D3 and A.D7). Such shrinking was attenuated in the presence of PL.  
 
 
Figure 7.7. Optical microscope images of gel beads encapsulating hASCs and cultured for 3 and 7 days and the respective 
scheme representing the state of the cells when encapsulated in Coll+PL gels. Immediately after gels hardening, cells exhibited 
a round shape typical of non-adhered cells (I), over time, the cells started to extend their cytoplasmatic elongations (II), 
proliferated and established connections between adjacent particles (III). Finally, a membrane composed by gels unified by 
hASCs and gelified released PL was obtained (IV). Image V is the stereomicroscope image of a membrane composed by 
Coll+PL2× encapsulating hASCs and cultured for 7 days in a 12-well cell culture plate. Scale bar represents 1 mm. Coll 
formulations did not exhibit a significant hASCs proliferation neither cell established connections between adjacent particles 
after 3 (A.D3 and B.D3) and 7 (A.D7 and B.D7) days. Only in the formulations where PL was present the bond of adjacent 
particles was observed after 3 (C.D3, D.D3 and E.D3) and 7 days (C.D7, D.D7 and E.D7). Scale bar represents 100 µm. 
 
Beads containing hASCs were cryopreserved during 1 month and evaluated again as described above. 
Three days after thawing part of the cells remained viable (Figure 7.8). However, their capability to 
elongate inside Coll and Coll+PL gel beads was affected as well as their migration and proliferation. Even 
after 7 days, no cell migration or proliferation outside the gels was visible in the optical microscope 
observations. This means that although the cells withstood the freeze-thawing cycle, their normal 
performance was seriously affected. 
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Figure 7.8. Live/dead assay of the gels in culture for 3 and 7 days after being cryopreserved for 1 month. Sale bar represents 
100 µm. 
 
7.4.3. Gel Beads of Collagen Combined with Platelet Lysates as Growth Factors Release 
Systems 
In a second step, Coll+PL gels without encapsulating cells were evaluated (as freshly prepared and after 
freeze-drying) as GFs reservoirs able to promote cell proliferation and wound healing (Figure 7.1 C.2). 
Stability of the beads was tested in media of different composition. In tricine buffer pH 7.5 without 
collagenase no significant degradation was observed after 24 h. In PBS pH 7.4, without enzymes, Coll and 
Coll+PL beads maintained their integrity for more than 1 month (data not shown). Oppositely, in the 
presence of collagenase (50 µg/mL) beads degraded faster (Figure 7.9). Coll beads exhibited significant 
signals of erosion in collagenase medium after 30 min, and only small residues remained in the wells after 
90 min. Incorporation of PL increased resistance of the gel beads to collagenase degradation. Even after 
150 min some frag- ments of Coll+PL1 and Coll+PL2× beads were still visible. 
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Figure 7.9. Stereomicroscopeimages monitoring the enzymatic degradation of Coll and Coll+PL gel beads over time. High 
collagenase concentration (50 µg/mL, in tricine buffer pH 7.5) was used in order to mimic exudates of untreatable skin ulcers. 
Particles immersed in tricine buffer pH 7.5 were used as controls. Scale bar represents 3 mm. 
 
The effect of Coll+PL beads on hASCs proliferation was also evaluated using both hydrated and re-
hydrated freeze- dried particles. hASCs in contact with Coll solely (hydrated or re-hydrated) particles and 
cultured in cell culture medium without FBS did not proliferate over the 5 days of the study. PL was shown 
again essential for cell proliferation (Figure 7.10 A). hASCs proliferated well using either hydrated or re-
hydrated Coll+PL1× particles as the only source of GFs, as much as those incubated with culture medium 
to which non-capsulated PL was directly added (control tests). Comparing hydrated and re-hydrated beads, 
freeze-dried Coll+PL2 and Coll+PL3× beads led to lower number of cells at day 3, but the differences 
attenuated at day 7. No significant changes in cell proliferation were observed when particles prepared 
with fresh PL were replaced with the ones prepared with freeze- dried PL (Fig. 7.10 B), which means that 
using fresh (liquid) or freeze-dried (powder) PL in the preparation of the Coll+PL1× particles did not alter 
the bioactivity of the growth factors. 
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Figure 7.10. A) Effect of released PL from hydrated and re-hydrated particles on hASCs proliferation. hASCs cultured in the 
presence of PL without being encapsulated (PL1, PL2 and PL3×) and in medium with or without FBS were used as controls. 
*p<0.05, significantly different from Coll hydrated, re-hydrated and control (without FBS) at day 1, 3 and 5. #p<0.05, 
significantly different from Coll+PL1× re-hydrated (day 5). &p<0.05, significantly different from PL1× (day 5). $p<0.05, 
significantly different from control with FBS (day 5). B) Effect of PL released from Coll+PL1× hydrated particles prepared with 
freeze-dried or non freeze- dried (fresh) PL on hASCs proliferation. 
 
Scratch wound assay results are shown in Figure 7.11. After 48 h, hASCs cultured in medium without FBS 
and in direct contact with Coll gels were not able to migrate or proliferate to fill the gap between both cell 
groups. Beads with PL significantly accelerated the filling of the scratch and after 12 h, the gap was 
completely filled by cells. In addition, interaction of the cells with Coll+PL beads was observed. A number 
of hASCs were capable to migrate from the bottom of the cell culture plate and adhere onto the surface of 
the beads, as shown in detail in Figure 7.12. The cells formed long filopodia trying to connect adjacent 
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particles, also helped by a fibrin mesh formed outside the gels. This behavior was not observed in the 
absence of PL (Figure 7.12 A and E). 
 
 
Figure 7.11. Scratch test: hASCs were cultured physically separated by a distance of 500 µm. The presence of PL 
significantly accelerated cell migration and the filling of the scratch area. Scale bar represents 100 µm. 
 
 
Figure 7.12. Interaction of hydrated and re-hydrated gels with a monolayer of hASCs (cells adhered onto the bottom of cell 
culture plates). The particles were cultured in direct contact with a cell monolayer (I). After some days in culture, hASCs migrate 
to the particles surface (II). In the case of Coll gels (A, E), cells were not found on the gels surface, neither extending 
elongations to connect adjacent gels. Oppositely, hASCs adhered to the surface of Coll+PL gels (B-D and F-H) and tried to 
establish connections between the gel particles after 7 days in culture. Scale bar represents 100 µm. 
 
To gain a further insight into the benefits of encapsulating PL, the angiogenic potential of the beads was 
studied using the chick CAM model. The effect of Coll and Coll+PL spherical-shaped gels on direct blood 
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vessel growth was quantified by counting the total number of blood vessels that grew radially from the 
particles. No direct blood vessels growth was observed towards Coll gels. Oppositely, vascularization was 
clearly observed for Coll+PL1 and Coll+PL2× gel beads, with ca. 16 and 33 vessels respectively protruding 
from the area where the beads were implanted (Figure 7.13). Moreover, 3 days post-implantation Coll+PL 
gels were integrated in the CAM of the chicks, while Coll gels did not exhibit any signal of interaction. 
Similar experiments were carried out using non- encapsulating PL1 and PL2× fluid samples (positive 
controls), which coagulated immediately after being dispensed on the top of CAM. As occurred for Coll+PL 
gels, coagulated PL1 and PL2× were integrated by the membrane. No significant differences were 
observed between encapsulated and non-encapsulated PL, which confirm the release of active GFs from 
the beads. 
 
 
Figure 7.13. Representative stereomicroscope images of the excised chick CAMs after implantation of 2 particles of Coll (A), 
Coll+PL1x (B), Coll+PL2x (C), 10 µL of PL1x (D) and 10 µL of PL2× (E). (F) is a representative image of a normal CAM. Direct 
blood vessels growth was observed towards the Coll+PL formulations 3 days post-implantation, but no direct blood vessels 
growth was observed towards Coll solely. The Coll+PL beads were integrated in the chick CAM. Scale bar represents 1 mm. (G) 
Number of converging vessels at 3 days post- implantation. *p<0.05, significantly different from the Coll. #p<0.05, significantly 
different from Coll+PL1×. &p<0.05, significantly different from PL1×. 
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7.5. Discussion 
7.5.1. Preparation and Crosslinking of Gel Beads 
To the best of our knowledge, handleable spheres combining both fibrillar type I Coll and PL for cell 
encapsulation or bioactive agents release have not been previously reported. The sol–gel transition of Coll 
is a multi-hierarchical self-assembly process starting from a helical structure which winds around other 
and forms a super helical trimer (Coll triple helix). Then, the triple helix continues to pack forming nano 
fibrous structures (Coll fibrils), which in turn follow a self-assembly process forming an interconnected 
random hydrogel network [36]. Overall it is an entropy-driven process favored by the displacement of 
water from Coll molecules [37, 38]. Hydrophobic interactions between non-polar groups, hydrogen 
bonding be- tween polar residues and salt bridges (electrostatic interactions) are the main phenomena 
that cause the gelification of Coll type I under appropriate conditions [39]. The acidic Coll extraction 
process (applied to obtain the Coll used in this work) does not cleave the Coll terminal telopeptides, which 
are responsible for crosslinks formation between triple helices and then improvement of Coll stabilization 
[40]. Temperature, pH, collagen con- centration and ionic strength are the main factors that influence the 
formation of Coll fibers. Native type Coll fibrils are formed at pH range of 5.0–8.5, ionic strength between 
0.1 and 0.8 and temperatures varying from 15 to 37 °C [39]. In our case these variables were fixed at 37 
°C, pH 7.4 and collagen concentration of 2.5 mg/mL. The in vitro formed fibrils are expected to have 
similar morphologies to those found in vivo [40]. Compared to commercially available skin substitutes that 
use collagen solely at 0.66 mg/mL, an increase in Coll concentration may improve the mechanical 
properties, cell viability and biological stability and also increase the resistance to proteinases degradation 
[4]. 
Superhydrophobic surfaces methodology allowed the encapsulation of high amounts of bioactive 
molecules (PL) or mammalian cells without appreciable losses, because the particles hardened at the 
solid-air interface, in the absence of a surrounding liquid medium to which molecules/cells could escape 
via diffusion or migration (Figure 7.1) [21, 24]. Thus, the content can be known a priori and is only limited 
by the capacity of collagen to crosslink in the presence of the bioactive agents. In this work, we observed 
that the use of PL concentrated more than 3× did not allow collagen crosslinking. 
Platelets are generally activated by calcium, thrombin, collagen or freeze-thawing cycles, resulting in a 
cocktail of proteins, glycoproteins and other platelets cytoskeletal components; e.g. GFs, albumin, 
immunoglobulins, fibrinogen and transferrin. Activation of the platelets triggers clot formation in vivo. 
During this process, the fibrinogen existent in PL is transformed in a fibrin mesh causing the gelation of 
PL. However, this mechanism is usually not sufficient to obtain handleable spherical gels. For this reason, 
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Coll was used as a biomimetic support. Coll provides a stronger structure and also plays a role in 
stabilization of the clots against excessive retraction [41]. In the present work, PL was obtained via the 
activation of the platelets through freeze-thaw cycles, which was demonstrated to be more efficient than 
activation by thrombin and/or CaCl2 [13, 19]. This explains that the concentrations of both VEGF and 
PDGF-BB (Table 7.2) were higher than those reported in literature [35, 42]. 
Although superhydrophobic surfaces methodology allow to obtain particles sizes from micro [43, 44] to 
macro-scale [21, 24–26], in this work particles of 1.5–2.5 mm (10 µL) (Figure 7.2 II) were produced in 
order to facilitate their manage- ability during both the in vitro assays and also for in vivo applications 
(Figure 7.1 D). In skin ulcers such particle size may be easily applied as freshly prepared gel particles or 
as a dry powder for direct delivery of GFs or cells in the damaged region (Figure 7.1 C.1 and C.2 
strategies). After hardening, the gel beads can be used as wet, swollen particles or can be dried applying 
conventional methods for a more convenient storage. The dried beads were shown to swell again when 
enter into contact with aqueous medium (Figure 7.2). 
Sustained release of GFs from gel beads for several hours (Figure 7.3) is advantageous in comparison 
with direct PL application, which leads to a rapid clearance of GFs from the application site. Coll+PL2× 
particles could be used as ingraft release systems that remain in the application site and release GFs in a 
controlled way. 
 
7.5.2. Gel Beads of Collagen Combined with Platelet Lysates Encapsulating hASCs 
Direct injection of cells into skin ulcers may lead to loss of cells due to the blood-flow [29, 45] and dead of 
remaining ones due to the absence of a structured matrix where cells could adhere and proliferate, 
caused by the activity of the proteinases present in wound exudates. Injectable polymeric systems, which 
harden after being applied in the injured site, have been reported as cell supports conferring protection; 
however in most of the cases the polymer dispersions do not have sufficient viscosity and stiffness to 
retain the cells [46]. Moreover, the shear stress and turbulences generated during the injection may cause 
cell viability loss [29]. Having into account all these issues, the encapsulation of cells inside spherical 
particles may offer protection against aggressive environment while provide support for adhesion and 
proliferation. So far, alginate-based materials with immobilized cells have been explored for cell-based 
therapies applications [24], but alginate does not have anchorage points for adherent cells, requiring the 
incorporation of certain proteins or even the modification of the polymer backbone with RGD domains 
[47]. As a natural extracellular matrix, Coll provides anchorage points and acts as an excellent support for 
cell encapsulation due to the enhancement of adhesion and proliferation [29]. Although Coll is also an 
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interesting skin substitute for regeneration of dermis [48], its poor mechanical properties, weak shape 
stability and incompatibility with conventional encapsulation techniques [49] have so far prevented their 
use in cell- based strategies. In this work, hardening of Coll was carried out according to a previously 
developed method [29] with some improvements: cells were suspended in previously neutralized collagen 
solution and then incubated at 37 °C. The main innovations refer to the incorporation of PL as an 
additional source of GFs and the use of non-adhesive superhydrophobic surfaces to obtain almost perfect 
spherical gel particles. 
Our first strategy focused on hASCs encapsulation in Coll+PL gel beads to act as GFs and cell suppliers for 
skin ulcers treatment (Figure 7.1 C.1). Several studies have previously shown that hASCs exert beneficial 
effects on skin ulcer treatments [11, 50]. Adipose tissue is abundant in human body and can be easily 
accessed using low-invasive procedures. hASCs have extensive proliferation capacity and secret soluble 
factors that promote human dermal fibroblast proliferation and migration even when both cell types are 
physically separated, being such effect dose-dependent [51]. Mixtures of hACS and collagen have 
previously demonstrated synergic effects on wound healing rate [51]. As described in the Figure 7.1 (C.1) 
we hypothesized that gel beads with hASCS could be obtained in a fast way and applied immediately in 
the injured site or cryopreserved and stored to be used later or for subsequent applications to the patient. 
In a very simple way, particles hardened onto the superhydrophobic surfaces can be collected and applied 
directly in the injury site or previously adhered into a dressing which could be used to cover the ulcer. In 
this context, the application of spherical particles instead of continuous membranes could be 
advantageous since the interstitial spaces between the spheres may act as pores that allow O2 access, 
which also contributes to the healing process [52]. 
Encapsulated hASCs proliferated more in Coll+PL beads than in Coll solely gels (Figure 7.4). The presence 
of PL was advantageous in all cases and the cells number was significantly higher after 3 and 7 days 
incubation, disregarding the used PL had been freshly prepared or stored as a freeze-dried product before 
incorporation to the beads. Nevertheless, proliferation in the presence of PL1 or PL2× was more intense 
than with PL3×, which is in agreement with previous studies that have shown that very high 
concentrations of PL exert an inhibitory effect on proliferation and viability of several cell types [34, 53, 
54]. A healing retarded effect was observed in keratinocyte-based tissues when PL concentration higher 
than 2.5 times the physiological levels was used [55]. 
Importantly, Coll+PL beads were able to supply the needed GFs to the cells when incubated in medium 
without any other source of growth supplements, and most cells were alive after 7 days of incubation. 
Moreover, the bead network of collagen and PL created a physiologically relevant environment, which 
Chapter 7 Collagen/Platelet Lysate Gel Beads for Skin Regeneration 
!
! 278!
allowed cell-matrix interactions, cell migration and formation of cell layers interconnecting the cell-laden 
beads (as observed in Figures 7.6 and 7.7). These phenomena were not observed for Coll solely beads, 
demonstrating the role of PL in cell proliferation and tissue formation. Additionally, cell-laden Coll+PL 
beads did not shrink over time, which could be advantageous in the process of skin regeneration as a way 
to minimize the contraction of the new tissue. Studies performed in adult pig skin wounds demonstrated a 
direct correlation between tissue regeneration and delay of wound contraction [56, 57]. Therefore, Coll+PL 
beads provide an environment that may benefit integration in the host at cellular and molecular levels. 
Cryopreservation of cell-laden Coll+PL beads negatively affected the ability of hASCs to migrate and 
proliferate. Probably, the diffusion of the cryoprotectant into the gel particles was not completely achieved, 
and the cells were not efficiently protected. In addition, after thawing traces of DMSO may remain inside 
the Coll mesh creating a non-pleasant environment for the encapsulated cells. 
 
7.5.3. Gel Beads of Collagen Combined with Platelet Lysates as Growth Factors Release 
Systems 
The second strategy focused on the potential of the Coll+PL gels to act as reservoirs for sustained release 
of GFs able to promote efficient skin wound healing without encapsulating cells (Figure 7.1 C.2). Gel 
particles were tested both as freshly prepared and after freeze-drying. In a medium that mimicked the 
proteinase-rich environment in non-treatable skin ulcers (50 µg collagenase/mL) [58], Coll+PL beads 
maintained their integrity for more time than Coll solely beads (Figure 7.9). This finding can be explained 
by the presence of a fibrin mesh reinforced Coll structure, which in turn made the particles more 
biologically stable. Regarding hASCs proliferation, Coll+PL beads were shown able to provide the growth 
supplements required for proliferation. In fact, Coll+PL beads were as efficient as free PL as substitute of 
cell culture supplements (e.g. FBS) [59, 60]. Compared to freshly prepared beads, the slower cell 
proliferation observed when rehydrated freeze-dried beads were used (Figure 7.10) can be attributed to a 
certain slowdown of GFs release, as the drying procedure may favor hydrogen bonding of bioactive 
substances and collagen. In addition, the cells proliferated more in contact with Coll+PL1× than in the 
presence of PL2 and PL3×, which can be correlated to References supra-physiological GFs concentrations 
for the used cell-number. The beneficial effect of PL was confirmed in a scratch wound healing assay 
(Figure 7.11). The advantageous performance of Coll+PL beads indicates that the early controlled release 
of GFs (Figure 7.3 B) plays a very important role in cell migration for wound healing. In addition, cells 
favorably interacted with Coll+PL beads acting as bridges among adjacent particles (Figure 7.12). Overall, 
these findings suggest that acellular Coll+PL beads could also be easily integrated in the tissues by local 
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cells. Finally, one of the major problems of the skin substitutes is the failure in the vascularization process 
[61]. While Coll beads did not induce angiogenesis, Coll+PL1 and Coll+PL2× gel beads notably promoted 
vascularization (Figure 7.13). These results corroborate the crucial role of PL in bio integration and 
vascularization features of the Coll+PL beads. 
 
7.6. Conclusions 
Superhydrophobic surface methodology allows the preparation of handleable spherical-shaped Coll+PL 
gels in a fast way and under mild conditions that enable cell encapsulation. The developed gel beads act 
as scaffold suitable for cell adhesion and proliferation. hASCs can migrate from the particles and promote 
the connection between adjacent particles forming a membrane which can be easily handled to place in 
the target site. However, more efficient procedures to cryopreserve 3D cell-laden systems are required. 
Thus, so far the acellular approach seems to be more reliable. As an in situ release system, Coll+PL 
beads can act as depots of GFs that induce cell migration, proliferation and angiogenesis. The freeze-
drying process of Coll+PL beads did not affect the bioactivity of the encapsulated PL. The developed 
Coll+PL beads open the possibility of using an efficient autologous product, instead of expensive 
recombinant GFs, in an easy-to-handle way. 
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Chapter 8 
Novel Methodology Based on Biomimetic Superhydrophobic 
Substrates to Immobilize Cells and Proteins in Hydrogel Spheres for 
Applications in Bone Regeneration 
 
8.1. Abstract 
Cell-based therapies for regenerative medicine have been characterized by the low retention and 
integration of injected cells into host structures. Cell immobilization in hydrogels for target cell delivery has 
been developed to circumvent this issue. In this work mesenchymal stem cells isolated from Wistar rats 
bone marrow (rMSCs) were immobilized in alginate (ALG) beads fabricated using an innovative approach 
involving the gelification of the liquid precursor droplets onto biomimetic superhydrophobic surfaces 
without the need of any precipitation bath. The process occurred in mild conditions preventing the loss of 
cell viability. Furthermore, fibronectin (FN) was also immobilized inside alginate beads with high efficiency 
in order to mimic the composition of the extracellular matrix. This process occurred in a very fast way 
(around 5 min), at room temperature, without aggressive mechanical strengths or particle aggregation. The 
methodology employed allowed the production of alginate beads exhibiting a homogenous rMSCs and FN 
distribution. Encapsulated rMSCs remained viable and were released from the alginate for more than 20 
days. In vivo assays were also performed, by implanting these particles in a calvarial bone defect to 
evaluate their potential for bone tissue regeneration. Microcomputed tomography and histological analysis 
results showed that this hybrid system accelerated bone regeneration process. The methodology employed 
had a dual role by preventing cell and FN loss and avoiding any contamination of the beads or exchange of 
molecules with the surrounding environment. In principle, the method used for cell encapsulation could be 
extended to other systems aimed to be used in tissue regeneration strategies. 
 
 
 
This chapter is based on the following publication:  
Lima A.C., Batista P., Valente T. A. M., Silva A. S., Correia I. J. and Mano J. F., Novel methodology based on biomimetic superhydrophobic substrates to 
immobilize cells and proteins in hydrogel spheres for applications in bone regeneration, Tissue Engineering Part A 2013, 19: 1175-87. 
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8.2. Introduction 
Mesenchymal stem cells (MSCs) due to their multipotent properties and high rate of proliferation have 
been studied for regenerative medicine strategies [1,2]. When cultured under specific environments and 
appropriated supplemented culture media, MSCs can differentiate into lineages of mesenchymal tissues 
such as bone, cartilage, fat, muscle, tendon, and marrow stroma [3]. Hydrogels have been used as 
carrier’s materials to specifically deliver cells directly into damaged tissues, thus avoiding cell loss through 
the blood stream [1,4–6] The highly hydrated microenvironment and similar structure to the extracellular 
matrix (ECM) of these carriers provide good permeability for low molecular weight solutes, such as 
metabolites, nutrients, or other bioactive molecules that can present biochemical, cellular, and physical 
stimuli for cell differentiation, proliferation, and migration [7]. The cells immobilized inside hydrogels are 
physically isolated and consequently protected from the deleterious outside environment [8–11]. Although 
other shapes can be employed, spheres have been the most explored due to their large surface area, the 
ability to immobilize greater amount of biologically active molecules, or cells per unit volume [12] and due 
to the possibility of application in most complex systems such as cell-induced aggregates, cell carriers for 
cell expansion, and organ printing [13]. Several polysaccharides have been proposed as biomaterials for 
tissue engineering and regenerative medicine [14]. The vast majority of them, such as alginate, are 
currently used in the form of hydrogels to create structures with size features ranging between 0.1 and 10 
mm [15]. MSCs encapsulated in alginate hydrogels have been reported in the literature for different 
applications, such as bone [15] and cartilage regeneration [16], angiogenesis [17], and tumor treatment 
[18]. The easy gelling and biocompatible properties of alginate hydrogels, obtained by ionic crosslinking, 
have led to their study as cell transplantation vehicles for tissue regeneration [19]. However, since alginate 
based hydrogels poorly bind serum proteins, different ECM compounds such as fibronectin (FN) [20], 
collagen [16,21], or RGD sequences [22,23] have been added to these polysaccharides in order to offer 
adhesion sites to mammalian cells. So far, the techniques used for cell immobilization inside hydrogels 
required the mixing of gelling precursor with cells, followed by gelation through a physical, chemical, or 
ionic crosslinking. Several technologies have been proposed for cell immobilization in hydrogel particles, 
and some of them adopted from methodologies used in the pharmaceutical industry [24,25]: 
emulsification, photolithography, microfluidics, or coagulation baths using special dispensing systems of 
cell suspension in polymeric solutions. However, a significant part of these methodologies imply the 
contact of the gelling phase containing the cells or bioactive molecules with another liquid phase, which 
may be responsible for cells or molecules loss, due to their diffusion from the gel to the supporting liquid. 
The uncontrolled entrance of solvents may also lead to the contamination of the forming hydrogels, which 
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may compromise the viability of the cells entrapped inside the matrix. In this work an innovative 
methodology involving the use of superhydrophobic substrates [26] was employed to produce spherical 
hydrogels able to immobilize cells and bioactive compounds with high efficiency. The major advantages of 
this procedure include the use of mild processing conditions, high encapsulation loading, lower production 
costs, control of the particle size, and absence of mechanical forces during particles formation. This 
methodology has already been validated for production of controlled drug delivery systems [27]. We 
hypothesize that the method could be adapted to be used to encapsulate MSCs in hydrogel spheres 
containing bioactive molecules for posterior use in bone tissue engineering strategies. In vitro studies were 
performed to analyze the effect of the immobilization method on cell viability and also to evaluate cell 
differentiation over time. After that, in vivo studies were also performed to characterize the applicability of 
this system for bone tissue regeneration. 
 
8.3. Experimental Section 
8.3.1. Materials 
Polystyrene (PS) from a grade for injection molding was used in a granular shape for the preparation of the 
superhydrophobic substrates. Tetrahydrofuran (THF, 99.9%) was purchased from Riedel de-Haen. 
1H,1H,2H,2Hperfluorodecyltriethoxysilane (PFDTS, 97%), low-viscosity sodium alginate (ALG), FN from 
human plasma, Dulbecco’s modified Eagle’s medium (DMEM-F12), trypsin, albumin bovine serum (BSA, 
96%), 4,6-diamidino-2-phenyindole, dilactate (DAPI), tetramethylrhodamine B isothiocyanate (Phalloidin), 
and in vitro toxicology assay kit (lactate dehydrogenase [LDH] quantification) were purchased from Sigma-
Aldrich. Ethanol was purchased from Panreac. Calcium chloride (CaCl2) was purchased from Merck. Fetal 
bovine serum (FBS) was purchased from Biochrom AG. 3-[4,5-dimethylthiazol-2-yl]-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and electron coupling reagent 
(phenazine methosulfate; PMS) were purchased from Promega. FN was labeled using Molecular Probes’ 
Alexa Fluor 555 Protein Labeling kit and cells were labeled with Hoechst 33342 and calcein acetoxymethyl 
ester (calcein-AM) purchased from Invitrogen. Propidium iodide (PI) was purchased from VWR. 
Hydrochloric acid solution was purchased from Surgipath. All chemicals were used as received. 
 
8.3.2. Polystyrene Superhydrophobic Surfaces 
PS superhydrophobic surfaces were prepared using a phase separation method as described elsewhere 
[26,27]. Briefly, a PS solution (70 mg/mL) in THF was prepared and then mixed with ethanol (2:1.3 v/v). 
The mixture was dispensed onto smooth PS commercial substrate, which was then immersed in ethanol 
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for 1 min and dried with nitrogen flow. In order to increase the superhydrophobicity of obtained surfaces, 
the rough PS surfaces were modified with PFDTS (1% v/v in ethanol) after argon plasma treatment for 40 s 
at 30 W (Plasma Prep5; Gala Instruments). 
 
8.3.3. Preparation of the Hydrogel Particles 
The beads were produced using different ALG concentrations: 1%, 1.5%, and 2% (w/v). Five microliters of 
ALG solution were dispensed on the PS superhydrophobic surface. The alginate hydrogel beads were 
obtained on the surface after addition of 2 mL of 5% (w/v) CaCl2 solution on the top of each liquid sphere. 
 
8.3.4. Stability of the Alginate Particles in Culture Medium 
The stability of the produced beads was analyzed through quantification of calcium released from 
crosslinked alginate beads immersed in cell culture medium. Five alginate beads of each concentration 
were placed in 5 mL of cell culture medium (n = 3): DMEM-F12 supplemented with FBS (10%, v/v), 
penicillin G (100 U/cm3), streptomycin (100 µg/cm3), and amphotericin B (0.25 µg/cm3). The vials 
containing the beads were kept at 37 °C. At pre-established periods of time, aliquots of 1 mL of the 
supernatant were taken out and replaced with equal volume of fresh cell culture medium to maintain the 
volume constant during the release study. The calcium concentration of the collected samples was 
measured using Coupled Plasma Spectrometry (ICP, JY 2000-2; Horiba Jobin Yvon), after diluted 10x in 
1% HNO3 (v/v) solution. 
 
8.3.5. Cell Culture and Immobilization in Alginate Beads 
MSCs from Wistar rats femoral bone marrow [28,29] were isolated as previously described [30]. Then, 
cells were seeded in T-flasks with DMEM-F12 supplemented with FBS (10% v/v), penicillin G (100 U/cm3), 
streptomycin (100 µg/cm3), and amphotericin B (0.25 µg/cm3). rMSCs were kept in culture inside an 
incubator at 37 °C with a 5% CO2 humidified atmosphere. After reached confluence, rMSCs were 
subcultivated by a 3–5 min incubation in 0.18% trypsin (1:250) and 5 mM ethylenediaminetetraacetic acid. 
Subsequently, the rMSCs were centrifuged, resuspended in culture medium, and then encapsulated in 
alginate beads. Cells were added to 1, 1.5, and 2 wt% alginate solutions in order to obtain ≈10,000 
cells/bead. Some studies were carried out in the presence of FN. In those cases, FN with a concentration 
of 250 µg/mL [31] was added to alginate cell suspension. Five microliters of cell suspension with or 
without FN was dispensed on the PS superhydrophobic surface (Figure 8.1 A). The alginate hydrogel beads 
were obtained on the surface after addition of 2 µL of 5% (w/v) CaCl2 solution on the top of each sphere 
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(Figure 8.1 B). After that, the spheres were kept in culture with 150 µL of cell culture medium (Figure 8.1 
C). The distribution of FN in alginate beads was observed by fluorescent microscopy (Zeiss) using 250 
µg/mL of FN labeled with Alexa Fluor 555 dye following the protocol of Molecular Probe’s Alexa Fluor 555 
Protein Labeling kit. Phalloidin and DAPI staining to visualize actin cytoskeleton and to label the DNA, 
respectively, were conducted as outlined by the supplier’s protocol. Briefly, the particles were washed with 
0.15 M of NaCl supplemented with 10 mM of CaCl2, fixed in freshly prepared 4% (v/v) of formaldehyde in 
phosphate-buffered saline for 15 min at room temperature (RT), and washed extensively to remove all 
traces of the fixative. The cells were then stained with 50 µg/mL fluorescent phalloidin for 45 min at RT. 
DAPI labeling solution (0.5 µg/mL) was incubated for 3 min at RT. The particles were washed again to 
remove remaining staining solutions and visualized using a Zeiss LSM 710 confocal microscope equipped 
with a 10x/0.5 dry Fluor objective (Carl Zeiss SMT, Inc.). Beads distribution size was investigated using a 
stereo microscope (Stemi 1000 PG-HITECH; Zeiss). After being prepared, alginate beads were immersed in 
cell culture media and observed under stereomicroscope immediately. The mean particle size was 
calculated by analyzing the images using the ImageJ software.  
 
8.3.6. In Vitro Live/Dead Assay 
rMSCs immobilized in alginate beads were kept in culture, in a 96-well plate, with 150 µL of DMEM-F12 
supplemented with FBS (10%, v/v), penicillin G (100 U/cm3), streptomycin (100 µg/cm3), and 
amphotericin B (0.25 µg/cm3) and incubated at 37 °C, with a 5% CO2 humidified atmosphere. After an 
incubation period of 24, 48, and 72 h, cells viability was assessed through the reduction of the MTS into a 
water-soluble formazan product [32]. Briefly, the medium of each well was removed and replaced with a 
mixture of 100 µL of fresh culture medium and 20 µL of MTS/PMS reagent solution. Then, the beads were 
incubated for 4 h at 37 °C. The absorbance was measured at 492 nm using a microplate reader (Sanofi; 
Diagnostics Pauster). Wells containing cells in the culture medium without being immobilized in alginate 
were used as negative controls (K-). EtOH (96%) was added to wells with cells, to be used as a positive 
control (K+) [32]. Moreover, the amount of dead cells was also quantified by the LDH assay, in 2% ALG+FN 
particles due to the higher beads stability. LDH is released to the medium through the damaged cell 
membrane and convert a yellow tetrazolium salt into a red formazan dye, which is quantified by reading its 
absorbance at 492 nm using a microplate reader. The optical density is proportional to the number of 
lysed cells [33]. After 24, 48, and 72 h the well plates containing the beads in culture were shaken briefly 
to homogenize the released LDH into the cell culture medium. Then, 50 µL of the cell culture medium was 
transferred into a fresh 96-well plate and 100 µL of LDH assay mixture was added to each well [34]. After 
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30–45 min the enzymatic activity was stopped by adding 7.5 µL of HCl and the absorbance was 
measured. Wells containing cells in the culture without being immobilized in alginate were used as negative 
control and lysis solution was added to wells containing cells as a positive control. The results obtained 
were expressed as the mean – the standard error of the mean for at least three independent experiments. 
Live/dead staining was also performed on 2% ALG+FN particles. The beads were incubated for 15 min at 
37 °C and immersed in 0.15 M of NaCl complemented with 10 mM of CaCl2 where 2 µL of Calcein AM (1 
mg/mL) and 1 µL of PI (1 mg/mL) were added. After incubation, the Calcein AM/PI solution was removed 
and the beads were washed and finally visualized in a Zeiss LSM 710 confocal microscope with 
appropriated filters to detect green (live cells) and red (dead cells). 
 
8.3.7. Cell Morphology: Optical Microscopy, Scanning Electron Microscopy, and Fluorescent 
Microscopy.  
rMSC morphology, adhesion, and proliferation were firstly visualized using an Olympus CX41 inverted light 
microscope, equipped with an Olympus SP-500 UZ digital camera. Scanning electron microscopy (SEM) 
was also used to observe the morphology of the rMSCs immobilized in the alginate particles. To do so, 
samples were fixed overnight using 2.5% glutaraldehyde in water, at 4 °C. After that, they were rinsed with 
distilled water and dehydrated in graded ethanol of 70%, 80%, 90%, and 100% for 10 min each. Finally, the 
samples were mounted in supports using double-size adhesive tape and coated with gold by using Emitech 
K550 sputter coater. Samples were analyzed using a Hitachi S-2700 SEM. Moreover, to visualize the 
rMSCs immobilized in alginate, a Hoechst dye (H1399) was used to label cell nucleus. A trihydrochloride 
trihydrate solution (2 µg/mL) was added to a cell pellet obtained by centrifugation and then resuspended 
in culture media. After 30 min in contact with Hoechst solution, rMSCs were encapsulated in alginate in 
the same conditions as previously described. rMSCs were visualized after 0, 24, 48, and 72 h of 
incubation in a Zeiss AX10 microscope and analyzed with the Axio Vision Real 4.6 software (Carl Zeiss 
SMT, Inc.). 
 
8.3.8. Osteogenic Induction 
To induce osteogenic differentiation, rMSCs immobilized in alginate beads were cultured in osteogenic 
medium, which consisted on DMEM-F12 containing FBS (10%, v/v), penicillin G (100 U/cm3), streptomycin 
(100 µg/cm3), amphotericin B (0.25 µg/cm3), and supplemented with 0.1 mM l-ascorbic acid 2-
phosphate, 10 mM beta-glycerol phosphate (β-GP), and 100 nM dexamethasone [35]. At 1, 7, 14, and 21 
days postinduction, alginate beadswere fixed overnight in 2.5% glutaraldehyde in water, at 4 °C, 
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dehydrated in graded ethanol solutions, and finally embedded in paraffin blocks. Sections of 4–5 µm were 
stained with alizarin red dye for the detection of calcium deposits. Microscope images were acquired with 
Zeiss Imager A.1.  
 
8.3.9. In Vivo Assays 
The in vivo experiments were performed using 12 Wistar rats with an average weight of 200 g. Such 
studies were done accordingly to the guidelines set forth in the National Institutes of Health Guide for the 
care and use of laboratory animals. Animals were anesthetized by intraperitoneal injection of ketamine (40 
mg/kg) and xylazine (5 mg/kg). Bone defects with ≈5 mm diameter were made on calvarial bone and four 
beads with ≈10 000 rMSCs and FN (250 µg/mL) were implanted inside it. The alginate concentration with 
best results in vitro was selected to be tested in animals (2% ALG). For that, three groups (n = 4) were 
created: (1) controls with empty defects; (2) alginate beads just with FN were implanted; and (3) an 
experimental group where alginate beads with FN and immobilized rMSCs were implanted. After its 
implantation into bone defects, animals were maintained in individual cages with free access to 
commercial rat food and water ad libitum. Then, animals were euthanized after 4 weeks with an overdose 
of anesthetic.  
 
8.2.10. MicroComputed Tomography 
Cranial bone samples obtained at week 4 by necropsy were fixed in formaldehyde. After dehydration, the 
samples were analyzed using a high resolution microcomputed tomography (µCT) Skyscan 1072 scanner 
(Skyscan). Scannings were performed in high resolution mode using a pixel size of 14.7 µm and 
integration time of 1.7 s. The X-ray source was set at 51 kV of energy and 195 mA of current. For all 
samples, representative data sets were transformed into binary using a dynamic threshold of 42–255. This 
data was used for morphometric analysis (CT Analyzer v1.5.1.5; SkyScan). Three-dimensional (3D) virtual 
models of calvarial bones were created, visualized, and registered using the image-processing software 
(ANT 3D creator v2.4; SkyScan). 
 
8.3.11. Histology 
Cranial bones samples used for µCT analysis were then decalcified in a hydrochloric acid solution and 
embedded in paraffin blocks. Furthermore, sample organs (brain, heart, lung, liver, spleen, and kidney) 
were also collected, fixed in formaldehyde, and embedded in paraffin blocks for routine histological 
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processing in order to check for any morphological alteration. Sections of 4–5 µm were stained with 
hematoxylin and eosin and finally visualized using a light microscope (Zeiss Imager A.1). 
 
8.3.12. Statistical Analysis 
Statistical analysis (GraphPad Prism; GraphPad Software) concerning MTS and LDH assays was performed 
using one-way analysis of variance following the Tukey’s post-hoc test with a significant set at p < 0.05. All 
the results are presented as the mean ± standard deviation. 
 
8.4. Results and Discussion 
8.4.1. rMSC and FN Immobilization in Alginate Beads 
Cell encapsulation is an important strategy to prevent the escape and the elimination of the entrapped cells 
when implanted in damaged tissue sites [18]. The most important objective of this work was the evaluation 
of the applicability of superhydrophobic surfaces as a method to immobilize cells (rMSCs previously 
isolated from Wistar rats) and unstable molecules (as it is the case of proteins and glycoproteins, such as 
FN) inside spherical hydrogels to be used in tissue engineering purposes (see Figure 8.1).  
 
 
Figure 8.1. Schematic representation of cell and protein immobilization in alginate hydrogels using polystyrene (PS) super- 
hydrophobic substrates: 5 µL drops of mesenchymal stem cells isolated from Wistar rats bone marrow (rMSCs) + fibronectin (FN) 
suspension in a sodium alginate (ALG) solution were dispensed on PS superhydrophobic substrates (A). After, 2 µL of CaCl
2 was 
dispensed on the top of each drop to crosslink alginate (B). After 5 min the spheres with rMSCs + FN immobilized were 
collected (C) and in vitro (D) and in vivo (E) tests were performed. A bone defect was created in calvarial bone (E1) and filled in 
with  particles  (E2) in order  to  evaluate  the  regeneration of the  bone. 
 
The water-repellent properties of PS superhydrophobic surfaces allowed the production of nearly spherical 
shape hydrophilic particles (Figure 8.1 D). Different concentrations of alginate in the liquid precursors were 
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used (1%, 1.5%, and 2% w/v). The final diameter of the obtained beads tended to increase with increasing 
alginate concentration, despite the same volume of the precursor solution was used (see Table 8.1).  
 
Table 8.1. Mean size of the produced beads (n=6) obtained using different alginate concentrations. 
Beads Formulation Beads Size (µm) 
1% ALG 1930 ±160 
2% ALG 2030 ±190 
3% ALG 2180 ±160 
 
As an innovative methodology capable to immobilize mammalian cells and proteins, superhydrophobic 
surfaces show several advantages when compared with traditional techniques. For example, some of those 
methodologies to produce polymeric particles have a spread particle size distribution [36], which 
constitutes a problem when a narrow range of sizes is required. As it is possible to verify in the obtained 
results, the particles produced using superhydrophobic surfaces own a narrow size distribution, highly 
controlled by the volume of the liquid precursors dispensed over the substrates. This volume control could 
be interesting to produce particles with a specific required size. In addition, the small range of particle size 
obtained avoids additional steps for particle selection, saving production time and costs. The absence of 
mechanical forces that are sometimes responsible for cell damage and loss of biological activity of 
molecules constitutes another advantage of this methodology. 
The dry environment where droplets harden into hydrogels avoids the particle aggregation and provide very 
high encapsulation efficiency (almost 100%) because cells or bioactive molecules are not in contact with 
surrounding fluid media and they cannot migrate or diffuse outside the volume of the spherical objects. 
This is particularly useful because FN molecules are water soluble [37], which is a bottleneck of the 
encapsulation procedures previously described in literature [24], since water-soluble molecules are easily 
lost to the wet media commonly used in those techniques. Moreover, this characteristic is particularly 
important when expensive molecules such as growth factors, or even genes, are desired to be 
encapsulated. Compared with other immobilization techniques, superhydrophobic surfaces allowed a very 
fast particle production because the particles became completely solid within the time of the cross-linking 
reaction, usually a fast chemical or physical process. The results obtained show (Figure 8.2 A, B) that FN 
molecules and cells were homogenously distributed on the beads, in agreement to our previous work, 
where BSA labeled with fluorescein isothiocyanate was encapsulated in dextran/poly(N-isopropylacrylomide 
(PNIPAAm) beads as a model drug [27]. The three studied formulations exhibited similar FN and rMSC 
distribution (data not showed). To our knowledge, the co-encapsulation of FN and rMSCs in alginate 
hydrogels for bone regeneration applications was never studied before. 
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Figure 8.2. Fluorescent microscopy images of FN (250 µg/mL) labeled with Alexa Fluor 555 (A) and rMCSs labeled with 
Phalloidin/ DAPI (B) inside 2% ALG beads.  
!
8.4.2. In Vitro Alginate Cytotoxicity and rMSC Morphology Studies 
The synergistic effect of FN in cell viability was first explored quantitatively through cytotoxicity evaluation. 
Figure 8.3 shows MTS assay results and a significant difference between encapsulated cells and positive 
controls (dead cells), both in the presence and in the absence of FN, for 24, 48, and 72 h was observed. 
This means that the material is noncytotoxic and the rMSCs maintain their viability for at least 3 days. The 
general decrease in cell viability observed between 24 and 48 h for all alginate formulations may be 
explained by the need of an accommodation period by the rMSCs to adapt to new conditions. After this 
period the cell viability remains constant [38]. 
When compared the amount of viable cells immobilized in the presence or absence of FN, it is possible to 
observe that in the first 48 h of culture, there is a significant difference between both conditions. This 
difference was attenuated after 72 h, indicating that the effect of FN was more relevant in the initial 
anchorage of the cells in the hydrogel structure. The fraction of viable cells was higher in the presence of 
FN for all alginate formulations (1%, 1.5%, and 2% ALG) (Figure 8.3). It is well known that FN is an ECM 
constituent with a relevant role in regulation of cell adhesion, proliferation, and differentiation [39], which 
are very important factors for osteogenesis of human MSCs [21], as also that FN presence in the plasma 
modulates the response of the body against new implanted biomaterials constituting a good strategy to 
improve the performance of biomedical devices [40]. Having this into account, the entrapment of FN in 
alginate beads, beyond contributing to increase cell viability should also improve the acceptance of the 
studied system in vivo. To further characterize the carrier’s biocompatibility and corroborate the MTS 
results, LDH assay was also performed in the particles with FN and the corresponding fraction of dead 
cells is shown in Figure 8.4. LDH is a stable cytoplasmatic enzyme that is released to the extracellular 
media when the cytoplasmatic membrane is damaged being directly proportional to the percentage of dead 
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cells [33]. Figure 8.4 shows that during at least 72 h the percentage of dead rMSCs encapsulated in 
alginate were maintained around 20%–25%, which is similar to the value obtained for the negative control 
(normal cell culture). 
 
 
Figure 8.3. Cellular activity quantified by MTS assay: (K-), negative control where cells were cultivated in wells; (K+), positive 
control where the cells were dead and rMSCs immobilized in three different alginate concentrations with and without FN. Each 
result is the mean and respective standard error of at least three independent experiments. 
 
 
Figure 8.4. LDH quantification of rMSCs immobilized in alginate beads with FN in culture after 24, 48, and 72 h: (K-) is the 
negative control where cells were cultivated in wells; (K+) is the positive control where the cells were dead.  
 
Finally, the distribution of the live and dead rMSCs inside the 2% ALG+FN (the most stable formulation) 
particles was accessed by calcein-AM/PI staining for 21 days of culture. As it is possible observe in Figure 
8.5, the majority of the cells were green which means that were live and significant differences were not 
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observed over time. The beads provided good conditions for rMCS survival and representative confocal 
microscopy images are observed in Figure 8.5.  
 
 
Figure 8.5. Live/dead staining of rMSCs immobilized into 2% ALG + FN beads over 21 days in culture. 
 
Regarding the fraction of viable cells inside our alginate beads, similar results were previously obtained by 
Zhao et al. [41] for human umbilical cord stem cell encapsulated in alginate, where the percentage of 
viable cells ranged from ≈90% to 70%, after 7 days of culture. Figure 8.6 presents optical microscopy 
images of beads with different alginate concentrations in the presence and absence of FN after 72 h in 
culture. After 1 day the cells were seen well confined in the volume of the beads. Over 3 days in culture, 
rMSCs remained with their typically round shape and were homogeneously distributed inside the alginate 
beads. However, at this time point, it was possible to detect a slight particle disintegration and the 
consequently cell release (white arrows in Figure 8.6) principally in weaker beads corresponding to the 
ones prepared with lower alginate concentrations. The released rMSCs migrated from the particle core to 
the surface, adhered in the wells, and probably the proliferation started. The referred continuous cell 
release and proliferation was accessed and followed by optical microscopy for more 18 days in all alginate 
concentrations even after beads transferring to new well plates (see images in Figure 8.7). The 1% ALG 
beads released a higher number of rMSCs when compared to that of 1.5% and 2% ALG, for the same 
period. Such finding can be explained by the alginate particle disintegration, which occurred at higher rate 
for low concentration alginate beads. Similar results were earlier reported by Hunt et al. [42] They studied 
the degradation of 2% and 5% w/v alginate matrix with immobilized fibroblasts under normal cell culture 
conditions where it was shown that the alginate degradation process was not influenced by the presence of 
fibroblasts and that lowering the alginate concentration from 5% to 1% increased the rate of disintegration.  
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Figure 8.6. Optical microscopy images of alginate particles loaded with rMSCs. Group A were beads composed by 1% ALG 
after 72 h in culture in presence (A1) and absence (A2) of FN. The same order of images disposition was followed for the other 
alginate beads concentration: in group B was 1.5% ALG and group C 2% ALG. The white arrows show the cells released due to 
the slight particle disintegration. 
 
Figure 8.7. Part I. The alginate particles with rMSCs+FN were cultured in a well plate for 9 days and the rMSC morphology 
was accessed by optical microscopy: (A) correspond to 1% ALG, (B) to 1.5% ALG, and (C) to 2% ALG after 5 days (A1, B1, C1) 
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and 7 days (A2, B2, C2) in culture. Part II. When the released rMSCs reach the confluence in the surface of the well plate, the 
particles were transferred for a new plate. 1% ALG beads were not transferred because were completely disintegrated before day 
9. The other alginate formulations were cultured for more days and the continuous rMSC release was observed at day 14 (B3, 
C3) and 21 (B4, C4). Scale bar 20 µm. 
 
The degradation of the alginate beads structure could be explained by crosslinked chain disintegration 
caused by the replacement of calcium cations (responsible for the crosslinking) by monovalent cations 
such as sodium or potassium present in cell culture medium [43,44]. This was confirmed by the release 
calcium studies, in which calcium was released from alginate beads for 24 h (Figure 8.8). Moreover, it was 
hypothesized by Drury et al. [45] that ion exchange and the reordering of the alginate chain occur within 
the first 7 days and stabilize thereafter. In our study the 1% ALG beads disintegrates completely after 7 
days in culture medium, while 1.5% and 2% ALG beads (or fragments) remained stable for more than 21 
days. However, there was no significant effect on the concentration of alginate and the quantity of calcium 
ions released within this time period. 
 
 
Figure 8.8. Cumulative release of calcium ions from alginate beads (1%, 1.5%, and 2% ALG) crosslinked with CaCl2 after 
immersion in cell culture medium. The calcium at 0h corresponds to the amount content in cell culture medium. 
 
Calcium is an essential element and plays a key role in skeletal mineralization. During the bone formation, 
osteoblasts capture calcium from bloodstream (that has been absorbed previously in the intestine or 
resulted from osteoclasts activity) and deposit it in an appropriate site in the form of calcium phosphate 
complexes [46]. Regarding this, it is possible that the in situ calcium delivered may help the mineralization 
process during bone defect regeneration. Another important parameter is the number of the cells 
immobilized inside the beads because studies reported that cell density must be sufficiently high to provide 
cell contact and consequently the proliferation [38]. Based on that, about 10 000 cells were encapsulated 
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in beads with ≈2 mm. Other studies reported the use of particles containing cells with similar dimensions. 
Alginate beads with 3.6, 2.2, and 1 mm were produced for cell encapsulation and used as components of 
calcium phosphate cements and polymer pastes [41]. The purpose of these beads is that they could 
quickly degrade and release the cells throughout the entire scaffolds. However, a considerable part of 
alginate beads produced so far did not present fast degradable properties and cell release was not 
observed. Zhou and Xu [47] reported that it is desirable to have beads with a fast degradation profile in 
order to promote a quick stem cells release, differentiation, and consequently enhance production of new 
tissue. Having this into account, it was expected that the fast release of the rMSCs over time and their 
adhesion into a defect site allowed a continuous and faster regeneration of the damaged tissue. Due to the 
higher stability of 2% ALG+FN beads, this formulation was selected to pursue the studies. The SEM 
analysis revealed that 2% ALG beads without cells (Figure 8.9 A) present a smooth surface structure. The 
alginate beads loaded with cells exhibit several protuberances with almost 10 µm diameter, which may be 
caused by the presence of rMSCs immobilized inside the hydrogel (Figure 8.9 B). To complement this 
assay, the rMSC nuclei were stained and the immobilized cells were observed through a fluorescent 
microscope (Figure 8.9 C). The images showed that cells were inside alginate hydrogels and even on 
surface having a typical round shape. These results corroborate those obtained by SEM analysis.  
 
Figure 8.9.  Scanning electron microscopy micrographs of 2% ALG+FN without rMSCs (A) and with rMSCs immobilized (B), 
after 48 h in culture. (C) Corresponds to fluorescent microscopy images of rMSCs stained with Hoechst 33342 immediately 
after immobilization in 2% ALG+FN. 
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8.4.3. Osteogenic Differentiation Assay  
Bone regeneration is a complex physiologic process that includes cell recruitment and proliferation of 
progenitor cells followed by its differentiation along osteoblastic lineage, osteoid formation (deposition of 
ECM components), and finally mineralization [48]. The matrix mineralization consists in calcium deposits 
[49]. Alizarin red staining (Figure 8.10), which is a specific dye for calcium detection [50], showed a 
staining increase in 2% ALG+FN+rMSCs from day 1 to 14 (Figure 8.10 A2, C2) and especially between day 
14 and 21 (Figure 8.10 C2, D2), when the beads were cultured under osteogenic conditions. The same 
beads formulation maintained under basal conditions did not show any difference in the color of the 
staining over time (Figure 8.10 A1, B1, C1, D1). The high permeability of alginate beads allowed the 
creation of an enabling in vitro environment for differentiation of encapsulated rMSCs. Similar results were 
previously obtained by Abbah et al. [51] using murine-derived adipose-tissue stromal cells encapsulated in 
alginate for 21 days. These results also demonstrate that the produced alginate beads had appropriated 
diffusion characteristics to allow the entrance of nutrients or other molecules that play an important role in 
rMSC viability and differentiation. 
 
Figure 8.10. Alizarin red staining of 2% ALG+FN+rMSCs after 1 (A1, A2), 7 (B1, B2), 14 (C1, C2), and 21 days (D1, D2) in 
culture under basal and osteogenic conditions. 
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8.4.4. In Vivo Bone Regeneration 
Wistar rats were used to perform the in vivo studies in order to evaluate the biocompatibility of the carriers 
with immobilized rMSCs and also their capability in stimulating the regeneration of a bone defect not 
affected by high mechanical stresses. In all studied groups, no specific inflammation or reactive 
granulomas were observed in tissues surrounded the site where alginate beads were implanted. 
Furthermore, no pathological abnormalities were observed in the brain, lung, liver, spleen, heart, and 
kidney samples. Representative µCT reconstructions of ex vivo bone explants around the defect regions are 
shown in Figure 8.11, 4 weeks postimplantation. In the defects of the control group, where no beads were 
implanted, is not observed bone tissue growth (see Figure 8.11 I). Otherwise, in the group II (Figure 8.11 
II) where alginate beads loaded with FN were implanted, the 3D reconstructions show a lower level of bone 
infiltration compared with group III (Figure 8.11 III), where alginate beads loaded with FN and rMSCs were 
implanted.  
 
 
Figure 8.11. MicroComputed Tomography analysis of calvaria defects in Wistar rats. Images show the endpoint result after 4 
weeks of bone regeneration of empty defects (I) and upon implantation of 2% ALG beads (II) loaded with FN and (III) loaded with 
FN and rMSCs. 
 
Histological analysis was performed in order to confirm the previous described results and also to obtain 
complementary information related to host response and tissue/cellular organization (see Figure 8.12). 
The light microscopic examination of decalcified sections showed that in control (group I) and group II, new 
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bone tissue formation inside of the defect was not observed; only fragments of periosteum were present. 
However, neo bone tissue was formed circumferentially along the defects of group III and a significant 
amount of new bone tissue was visualized in the central areas. In addition, the histology results show an 
active periosteum and osteoblasts deposition which formed circular structures that give rise to circular 
pieces of bone tissue (black arrows in Figure 8.12 III) without connection to the border of the defect. The 
presence of osteoclastic-like cells was not visualized as also reactive or granulomatous inflammatory 
reactions in the surround tissue and fibrous connective tissue in the local where beads were implanted. 
This supports the local and systemic histocompatibility of these beads. These last results showed that the 
presence of cells induced the growth of higher amount of new bone tissue after 4 weeks. Furthermore, the 
visualized deposition of osteoblasts (black arrows in Figure 8.12 III) could be correlated with the release of 
rMSCs by alginate beads, which in turn had the appropriated diffusion properties to allow the differentiation 
of rMSCs under osteogenic conditions. On the other hand, the differentiated cells released or even the 
ones remained inside the particles could have delivered key proteins (e.g., growth factors) [52,53] which 
recruited other cells to the damaged site and consequently accelerate the tissue regeneration. Lee et al. 
[54] demonstrated that calcium crosslinked alginate beads mineralized when injected subcutaneously or 
implanted intramuscularly after 1–6 months during which bone-like apatite deposits were found throughout 
the microparticles. This information reinforce that alginate is a very interesting material to induce 
biomineralization and also confirms its application for regeneration of bone damaged tissue. Taking into 
account these results, the immobilization of rMSCs with a component of ECM, namely FN, in alginate 
hydrogels using superhydrophobic surfaces constitute an interesting strategy to obtain particles for cell 
encapsulation and delivery and to improve tissue regeneration in a cheap, fast, and efficient way. 
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Figure 8.12. Hematoxylin and eosin stained histological images of calvaria defects at 4 weeks: empty control group (I), defects 
filled with beads loaded with FN (II), and beads loaded with FN and rMSCs (III). The black arrows represent the deposition of 
osteoblasts and formation of circular bone pieces. CB, compact bone; NB, new bone; P, periosteum. Scale bar 200 µm. 
 
8.5. Conclusions 
The present work evaluated the efficiency of an innovative methodology for the encapsulation of unstable 
bioactive molecules and cell immobilization in hydrogel spheres to be used in tissue engineering strategies. 
The use of superhydrophobic PS substrates allowed the production of biocompatible calcium crosslinked 
alginate beads with viable rMSCs entrapped. This methodology avoided important disadvantages exhibited 
by conventional encapsulation techniques, such as mechanical forces, particles aggregation, cell and 
bioactive molecules loss, and wet conditions. The application of the hybrid alginate beads for bone 
regeneration was evaluated under in vitro and in vivo conditions, and the results showed that the synergy 
effect between FN and rMSCs was crucial for bone regeneration. The ALG beads have good permeability 
for nutrients and O2, which provides to the cells optimal conditions to survive for at least 21 days. In 
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addition, the encapsulation of the cells allowed their fixation in a proper site of the damaged tissue, 
avoiding the possibility of cells being removed by the blood stream. Moreover, the rMSCs were released at 
the same time of alginate degradation, constituting an advantage since it allowed the continuous bone 
regeneration without cell loss. 
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Chapter 9 
Biomimetic Methodology to Produce Polymeric Multilayered Particles 
for Biotechnological and Biomedical Applications 
 
9.1. Introduction 
Polymeric particles can serve as versatile carriers/containers of a variety of active substances and even 
cells for a wealth of applications, including drug therapy, tissue engineering and biotechnology [1-4]. 
Strategies to optimize their performance for a specific application are mostly based on adjusting the 
chemistry and the structural architecture by means of increasingly sophisticated designs, which in the 
particular case of drug release try to overcome the short diffusion path [5-7]. Multi-compartmentalized 
particles are envisioned to offer simultaneous release of various bioactive agents at different kinetics that 
can fulfill the therapeutic demands of multifactor diseases and regenerative processes [8-10]. Specifically, 
multilayered particles exhibiting predefined diameter and layers thickness may offer high drug loading, 
improved drug stability, and programmable drug release schedules, such as delayed or pulsate, avoiding 
burst phenomena [3,11]. They can also incorporate diverse bioactive agents isolated from each others in 
every single particle. However, most methodologies suitable to produce multilayered particles, namely 
emulsion solvent evaporation [8,12], dip coating (including capsules obtained by layer-by-layer technique) 
[5], spray-drying [13,14], coaxial ultrasonic atomization [15], multi-step interrupted gelation [16], and 
precision particle fabrication [6], involve the production/hardening of the particles in a liquid or aggressive 
environments, with the inherent risk of that a relevant fraction of the bioactive molecules to be loaded may 
be lost [1]. Moreover, these methods employ harsh conditions (organic solvents, extreme temperatures, 
mechanical stress, pressures) that prevent their use for the encapsulation of cells, proteins or other 
unstable molecules [13,17]. Even in the mentioned particle fabrication technologies, the production of 
triple or more layered systems is challenging and until now a very few applications of such complex 
particles were reported. 
 
 
This chapter is based on the following publication:  
Lima A.C., Custódio C. A., Alvarez-Lorenzo C. and Mano J. F., Biomimetic methodology to produce polymeric multilayered particles for biotechnological and 
applications, Small 2013, 9: 2487-92. 
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The absence of a simple methodology capable to produce multilayered particles under mild conditions, 
where cells and/or multiple molecules can be independently encapsulated with very high efficiency, was 
the main motivation of the present work. 
 
9.2. Experimental Section 
9.2.1. Materials 
The copper (Cu) substrates were from a local hardware store; hydrochloric acid (HCl, 37%) was from 
Laborspirit; and ammonium hydroxide solution, 1H,1H,2H,2H-perfluorodecyltriethoxysilane (PFDTS), 
phosphate-buffered saline (PBS), dextran from Leuconostoc mesenteroides (MW 100–200 kDa), 
rhodamine B isothiocyanate (RhoB), fluorescein-5(6)-isothiocyanate (FITC), 4,6-diamidino-2-phenyindole 
dilactate (DAPI), Dulbecco’s modified Eagle’s medium (DMEM), sodium alginate were from Sigma- Aldrich 
Co. Calcein AM was from Invitrogen; propidium iodide (PI) from Alfagene; MTS and calcium chloride (CaCl2) 
from VWR. All chemicals were used as received. 
 
9.2.2. Fabrication of Copper Superhydrophobic Surfaces  
Cu superhydrophobic surfaces were prepared by a chemical-base deposition method [18,19]. Briefly, Cu 
commercial substrates previously cleaned with 1 M HCl were immersed in ammonium hydroxide aqueous 
solution (0.03M, pH 9–10) at 4 °C. After 5 days the surfaces were collected, washed with water and 
completely dried in air. Finally, the Cu plates were immersed in a PFDTS solution (1% v/v) in ethanol during at 
least 24 h, and then dried in air. 
 
9.2.3. Dextran Modification 
Dextran (DEX) was modified as previously described [19]. Briefly, DEX (25 g) was dissolved in DMSO 
(225 mL) under nitrogen atmosphere to prevent oxidation. After dissolution of 4-(N,N-dimethylamino)pyridine 
(5 g), glycidyl methacrylate (20.5 mL) was added. The solution was stirred at room temperature for 48 h, and 
then the reaction was stopped by adding an equimolar amount of concentrated HCl (37% w/w) solution to 
neutralize 4-(N,N-dimethylamino)pyridine. The reaction mixture was transferred to a dialysis tube (MWCO 
12400 Da) and dialyzed during 1 month against deionized water. Finally, DEX-MA was lyophilized (Manifold 
freeze-drier, Telstar cryodos, Spain). 
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9.2.4. Fabrication of Bi- and Tri-Layered Particles for Drug Release Applications 
Particles were produced following the scheme shown in Figure 9.1 (A1, B1 and C1). 15% (w/v) DEX-MA was 
dissolved in distilled water containing 0.5% (w/v) of Irgacure 2959. For each layer a specific dye was added 
to the solution: DAPI, RhoB, and FITC (50 µg/mL). For the internal layer (core), 2 µL of DEX-MA+DAPI 
solution was dispensed onto the Cu superhydrophobic surface and irradiated with UV light (15 W/cm2) for 30 s 
(Omnicure series 2000 EXFO S2000-XLA). After, 4 μL of DEX-MA+RhoB solution was dispensed in the top of 
each previously prepared sphere and again irradiated with UV light for 30 s under the conditions reported 
above. For the third layer, 6 µL of DEX-MA+FITC was dispensed and one more time the particles where irradiated 
with UV light. In each processing step, particles were visualized in fluorescent microscope (Stemi 1000 PG-
HITEC Zeiss) with blue, green and red filters. 
 
9.2.5. Drug Release Experiments 
RhoB was used as a model of low molecular weight drug. Two groups of particles were prepared with: (i) RhoB 
immobilized in the most external layer of the particles and (ii) RhoB immobilized in the core of the particles. 
After being crosslinked, 4 particles were suspended in 1mL of PBS, pH 7.4, at 37 °C and the system kept 
under oscillatory stirring at 60 rpm for 6 h. Aliquots of 200 µL were collected at predetermined time 
intervals, and the same volume of fresh medium was added to the solution in order to maintain the initial 
volume. Three independent experiments were performed. The fluorescence of the samples was analyzed 
(λexc = 540 nm; λem = 573 nm) in a microplate reader (Bio-Tek, USA). Calculations of the amount of drug 
released took into account the replacement of aliquots with fresh medium. The release profiles were fitted to 
the square-root kinetics in the 10 to 60% amount released interval, taking into account the lag time [31]: 
 M! M! = k(t− t!"#)!.!    Eq.1 
 
where M! and M! represent the amount of RhoB released at time t and the initial content in the particles, and 
t
lag 
the lag time between the start of the experiment and the detection of drug released. 
 
9.2.6. Fabrication of Bi-layered Particles for Cell Immobilization 
Cores were prepared using a 2% (w/v) DEX-MA solution in water containing 5% (w/v) of CaCl2 and 0.5% 
(w/v) of VA-086 or 0.25% (w/v) of Irgacure 2959. 2 µL of this solution was dispensed on Cu 
superhydrophobic surface and irradiated with UV light (15 W/cm2) for 60 s. An immortalized mouse lung 
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fibroblast cell line (L929) purchased from European Collection of Cells Cultures (ECACC) was suspended 
in 2% (w/v) sodium alginate solution, and 6 µL of this suspension were dispensed on the top of DEX-MA 
cores in order to have a density of 2000–3000 cells/particle. The diffusion of CaCl2 from the core of the 
particle allowed the gelation of the alginate external layer. After 10 min the particles were immersed in 1 
mL of PBS for 10 min to remove the surplus of CaCl2 and the free radicals resultant of the non reacted 
photoinitiator. Particles were incubated at 37 °C for 3 days in complete DMEM in a humidified 
atmosphere of 5% CO2. 
 
9.2.7. Alizarin Red Staining 
The release of Ca2+ from DEX-MA particles crosslinked using VA-086 photoinitiator was analyzed in order to 
gain an insight into the crosslinking of the alginate external layer. Freshly prepared DEX-MA particles as well 
as washed (20 min in water) DEX-MA particles were stained with a 40 mM alizarin red solution at pH 4.3. 
The particles were then observed using a stereomicroscope (Stemi 1000 PG-HITECH, Zeiss). 
 
9.2.8. Cell Viability, Morphology and Distribution 
The viability of the cells encapsulated in cell-loaded bi-layered particles was evaluated at various times by 
means of the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) 
assay. Briefly, after each time period, fresh culture media without phenol red was added to the particles with 
cells. MTS was used in a 5:1 ratio to the culture medium and incubated with the particles for 3 h (37 °C, 5% 
CO2). After the incubation period, the optical density (OD) was read at 490 nm in a microplate reader (Bio-
Tek, USA). Particles without cells were used as controls in order to verify that the materials do not react 
with MTS. Common 2D control (cells not exposed to particles) was not carried out since cells 
encapsulated in a 3D system are known to proliferate at different rate, leading to non comparable MTS results. 
After each period of culturing in standard conditions, cell viability was also assessed by staining the cell-
loaded bi-layered particles with Calcein AM/PI solution. Particles were incubated at 37 °C with 2 µL of 
Calcein AM (1 mg/mL) diluted in DMEM without phenol red. After 10 min, the Calcein AM solution was 
removed and the particles were washed with PBS. 1 µL of PI (1 mg/mL) diluted in PBS was added to the 
particles and incubated for 5 min at room temperature protected from the light. The particles were collected, 
washed with PBS and visualized in fluorescence microscope (Stemi 1000 PG-HITEC Zeiss) with appropriate 
filters to detect green (live) and red (dead) stained cells. Phalloidin and DAPI staining to visualize actin 
cytoskeleton and to label the DNA, respectively, were conducted as outlined by the supplier’s protocol (Sigma, 
Germany). Briefly, the particles were washed with PBS, fixed in freshly pre- pared 4% (v/v) of formaldehyde 
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in PBS for 15 min at room temperature and washed extensively in PBS to remove traces of the fixative. The 
cells were then stained with 50 µg/mL fluorescent phalloidin-conjugate solution in PBS for 45 min at room 
temperature. DAPI labelling solution (0.5 µg/mL) was incubated for 3 min at room temperature. The particles 
were washed in PBS to remove remaining staining solutions, and imaged using Olympus FluoView FV 1000 
confocal laser microscope in order to visualize cell morphology and distribution inside the particles outside 
layers. 
 
9.2.9. Statistical Analysis 
All data are presented as mean ± s.d. for at least three independent measurements. Assessment of nor- 
mality distribution of the population was performed by Shapiro-Wilk test. Groups were compared using one-
way ANOVA (Tukey’s multiple comparison test), with p < 0.05 indicating statistical significance. 
 
9.3. Results and Discussion 
Here we report the development of a simple biomimetic strategy, inspired by the rolling of water droplets 
onto the superhydrophobic surfaces of some plant leaves, to prepare compartmentalized multilayered 
polymeric spherical particles. Mimicking the micro and nano hierarchical structure and the low surface 
free energy of Lotus leaf, superhydrophobic surfaces were obtained by a chemical-based deposition 
method using copper substrates [18]. These surfaces were already characterized in a previous work [19]. 
Droplets of aqueous solutions of polymeric precursors containing bioactive agents (drugs, enzymes, 
pesticides, flavors, odors, or other type of molecules) or cells (eukaryotic and prokaryotic) can be 
dispensed onto such superhydrophobic surfaces with well-defined volumes, maintaining a close spherical 
geometry and a negligible contact area with the substrate due to the surface roughness. The size of the 
particles can be finely tuned by the volume of polymeric precursor solution dispensed [20]. Crosslinking 
and/or solvent evaporation under mild conditions renders spherical particles. The use of a fast liquid 
dispensing system and well-known crosslinking routes should permit the scale-up production of particles. 
Subsequent deposition of liquid droplets onto the preformed spherical particles followed by crosslinking 
with a suitable agent renders the first coating layer. Repetition of this process (with the same/different 
volume/composition of the droplets) leads to multilayer structures. The number of layers is limited by the 
particle deformation when the size increases and the effect of the gravity is stronger than the 
superhydrophobic capacity of the surface [21]. A remarkable advantage of the proposed technique is that 
high encapsulation efficiencies (≈100%) of non-volatile molecules can be achieved under mild conditions 
because each particle layer solidifies surrounded by air (not by a liquid solvent), avoiding the possibility of 
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molecules migration from the inner of the particle to the surrounding environment. Moreover, these 
particles can be concomitantly loaded with a sequence of different cell types or molecules confined in 
individual layers that can be tailor-crosslinked in order to endow the resultant particles with a notable 
physical stability. For drug delivery applications, non-loaded polymeric layers may be added with the aim 
to act as a barrier to control the release of drugs immobilized in the previous layers. 
Two main approaches were explored in this work: (i) the preparation of multilayered hydrogel particles 
(onion-like structure) for sequential release of multiple molecules, and (ii) the preparation of bilayered 
particles composed by different hydrogels to immobilize living animal cells in the outer layer and bioactive 
molecules in the core for possible applications in cell therapies. The resultant particles in the micro- to 
milli-meter range could be suitable for topical and oral drug delivery, wound healing and for a variety of 
other biomedical applications, including tissue engineering scaffolds, cell reservoirs to implant inside 
damaged tissues and organ printing [11,22-27]. 
For the proof-of-concept dextran-based multilayered particles were prepared containing three different 
fluorophores (DAPI, RhoB and FITC; simulating low molecular weight drugs) in the different concentric 
layers. Dextran was modified previously by adding methacrylic groups in the polymer structure (DEX-MA) 
to enable the crosslinking under UV exposure for the minimum time and the lowest power, in order to 
avoid the fluorophores photobleaching phenomena. Through the proposed bottom-up procedure, 
multilayered hydrophilic particles (with a narrow particle size distribution) were obtained (Figure 9.1 A1, 
B1 and C1). Fluorescent microscope images of mono- (Figure 9.1 A2), bi- (Figure 9.1 B2, B3 and B4) and 
tri-layered (Figure 9.1 C2) DEX-MA based particles evidenced the separate distribution of the different 
dyes. The simultaneous emission of fluorophores spectra confirmed the successful immobilization of up to 
3 dyes in independent compartments in the same particle (Figure 9.1 C2). The thickness of one specific 
layer was finely tuned by controlling the volume of the polymeric solution dispensed (Figure 9.1 B2, B3 
and B4). Depositing droplets of 2, 4 or 6 µL onto preformed cores (first layer of 2 µL rendered core 
diameter=1355±41 µm; n=3) resulted in particles of increasing sizes (Figure 9.1 B5). The layer thickness 
could be also kept almost constant by progressively increasing the volume of the deposited droplets, due 
to the crescent particle surface area. Measurements of the thickness of each layer in four distinct points 
rendered similar values (small standard deviation), which means that the distribution of the polymeric 
precursor solution around each previously crosslinked layer occurred homogeneously. In addition, the low 
standard deviation values corresponding to the core particle size indicates that this methodology is 
capable to produce particles with a narrow size distribution. Dual and triple-layered DEX-MA particles 
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showed high stability and did not evidence layer separation after 6 h in the release medium under 
oscillatory stirring. 
 
 
Figure 9.1. Biomimetic approach using copper superhydrophobic surfaces to produce multilayered particles: (A1) the core 
(Layer 1) is produced dispensing 2 µL of DEX-MA+DAPI solution onto the superhydrophobic surface and then crosslinking by 
UV light exposure; (B1) the follow layer (Layer 2) is obtained dispensing µL of DEX-MA+Rhodamine B solution around the 
previous obtained particle and again crosslinking by UV light exposure; and (C1) the third layer (Layer 3) is obtained following 
the same procedure but using 6 µL DEX-MA+FITC solution. Fluorescent microscopic images (A2, B2, B3, B4 and C2) of the 
particles obtained in each step of the procedure; and (B5) thickness of the particle layers that where obtained by dispensing 
different volumes of polymeric precursor solutions in the second layer: 2 µL (B2), 4 µL (B3) and 6 µL (B4). 
 
The loading efficiency of those particles is limited by the solubility of the bioactive agents in the polymer 
aqueous solution as also by the thickness of each layer. During the preparation process of polymeric 
particles using superhydrophobic surfaces, the loss of molecules that are desired encapsulate is not 
significant, as verified in a previous work [20] and we may say that this process have an encapsulation 
efficiency of 100%. The versatility of the process to permute the order of layers containing different 
molecules is shown in Figure 9.2 A. This could allow for a distinct release profile of the two sub- stances 
with an expectable delay of the one located in the inner side. This last statement was confirmed by 
combining non-loaded and RhoB-loaded layers in a single particle and monitoring the release for 6 h: 
Figure 9.2 B. This experimental design avoided the interferences that came up when simultaneous  
monitoring  of  the  release  of  several  fluorescent molecules was tried. The release of RhoB molecules 
was controlled varying the relative location of the layers; namely RhoB encapsulated in the outside layer of 
DEX-MA particles exhibited a relatively rapid release (k=7.6 min-0.5; s.d. 1.2, n=3), while the molecules 
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encapsulated in the core of the particles showed a lag time of 45 min and were released at much slower 
rate (k=2.1 min-0.5; s.d. 0.1, n=3). Thus, the outside layer acts as a barrier allowing the control of the 
molecules release. In addition, these release profiles show that it is possible to encapsulate molecules in 
different particle compartments and their delivery may be time-programmed. 
 
 
Figure 9.2. (A1 and A2) Bi-layered DEX-MA particles with red and green dyes immobilized in opposite positions; (B) In vitro 
release of Rhodamine B from 15% (w/v) bi-layered DEX-MA particles, where Rhodamine B was encapsulated on the external layer 
(triangles) and in the internal layer/core (squares). 
 
The second approach explored dealt with the ability of these concentric multilayered systems to 
immobilize living animal cells in the external layers for possible applications in biomedical field, namely 
cell therapies through implantation. Such configuration may be useful in devices where the inner regions 
of the particles could act as reservoirs for bioactive or therapeutic substances that, after being released, 
could influence the behavior of the cells in the periphery or even of those in the surrounded tissues. In 
addition, the presence of the cells in the external layer of the particle facilitates the access to nutrients and 
O2 and the clearance of cell metabolites. To demonstrate the potential of these particles, a bi-layered 
system was designed in which the core regions delivered calcium ions that crosslinked the outer alginate- 
based layer containing cells.  In conventional processing methodologies, alginate beads may be obtained 
by external gelation (dipping of sodium alginate drops in CaCl2 solution), internal gelation (water-insoluble 
calcium salt dispersed in the sodium alginate solution is triggered to act as crosslinker when the pH 
drops) or their combination [28]. These procedures are quite aggressive for cell encapsulation and could 
cause the loss of cell viability. Moreover, if drugs or proteins have to be concomitantly encapsulated, the 
wet environment may not ensure high encapsulation efficiency. Then, starting the polymer crosslinking 
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from the center of the particle to the surface, not requiring the acidification of the environment where the 
particles are being produced, represents an innovative engineered strategy to crosslink an alginate layer. 
CaCl2 was encapsulated in DEX-MA cores and when a L929 cell suspension in sodium alginate was 
dispensed on the cores, the alginate solidified immediately creating the second layer: see Figure 8.3 
(scheme A1 and A2). The surface of the DEX-MA core became hydrated due to the sodium alginate 
solution and the Ca2+  ions diffused immediately from the core to the layer 2 allowing the alginate 
crosslinking. As observed in Figure 8.3, our strategy is a mild procedure that allows the cell immobilization 
in alginate in an air environment and in a very fast way. The cell viability assays (Figures 8.3 B and C) 
showed that the cells remained viable for 3 days and were homogenously distributed on the external layer 
of the particle (Figure 8.3 D). To complete this study, two different photoinitiators were used to produce 
the solid DEX-MA core particles and their effect on cell viability was evaluated. As reported in the literature, 
chemical photoinitiators may be cytotoxic both in precursor and radical forms, and organic solvents maybe 
required to dissolve them in the polymer precursor solution [29]. In this work Irgacure 2959 (a well-known 
cytocompatible initiator) [29] and VA-086 were tested avoiding the use of organic solvents. Although 
Irgacure 2959 is described as a non water soluble photoinitiator, it could be dissolved up to 5 mg/mL 
(under stirring at 37 °C during 24 h). The minimal concentrations able to crosslink DEX-MA were used to 
prepare the core particles. MTS assays showed that the cells inside the particles produced using VA-086 
had higher viability after 72 h in culture than those encapsulated over core particles crosslinked using 
Irgacure 2959. This means that for the same UV light exposure conditions, Irgacure 2959 probably 
generates more photodissociated radical species that diffused from the core of the particles to the shell 
where the cells were immobilized [29]. Moreover, in both conditions, cell viability decayed between 4 h 
and 24 h, probably, due to the cells needing a period of accommodation for new conditions within the 
hydrogel shell. After that time, their metabolic activity backs to normal [30].  
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Figure 9.3. Bi-layered particles where cells were immobilized in the external layer: (A1) 2 µL of DEX-MA solution containing a 
photoinitiator and CaCl2 was dispensed onto the superhydrophobic surface and then crosslinked under UV light; (A2) the 
external layer was obtained dispensing a L929 cell suspension in sodium alginate over the previously obtained particles. The 
release of the calcium immobilized in the cores allowed the crosslinking of the alginate layer; (B) MTS viability assay of bi-
layered particles where the core was crosslinked with two different photoinitiators (Irgacure 2959 and VA-086) after 4 h, 24 h 
and 72 h of cell culture (mean values with standard deviations, n = 3; *** indicate significant differences between testing 
conditions as a function of time); (C) Fluorescent microscopy image of loaded particles where cells were stained with Calcein-
AM and propidium iodide and cultured for 4 h; (D) confocal microscopy image of a quarter-circle of a bi-layered particles where 
cells were stained with DAPI (nucleus) and phalloidin (cytoskeletons) cultured for 4 h; (E1) and (E2) stereo microscope images 
of core particles stained with Alizarin red immediately after being produced and after being immersed in water for 20 min, 
respectively. 
 
In order to confirm the release of CaCl2 from the DEX-MA particles, alizarin red staining - a well-established 
test to identify calcium deposits - was applied to the core particles immediately after being produced and 
after immersion in water for 20 min (Figure 8.3 E1 and E2). The red color characteristic of calcium 
deposits was not observed in the particles after being immersed in water, meaning that calcium ions were 
rapidly released under wet conditions. This fast diffusion of calcium allowed the crosslinking of alginate. 
Minimal quantities of CaCl2 were used and their release did not affect the cell viability after 72 h in culture. 
In principle, the developed methodology would allow the encapsulation of bioactive molecules, with 
important roles in cell behavior, to be released when implanted, avoiding the additional supplying of 
bioactive agents. This compartmentalized particle design allows the immobilization of different cell types 
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(co-cultures) or bioactive factors in distinct layers which may be particularly useful for complex tissues 
regeneration.  
 
9.4. Conclusions 
In sum, this work proposes a new methodology based on the use of superhydrophobic surfaces and the 
dispensing of controlled volumes of polymeric solutions to produce, under mild conditions, micro- to milli-
meter multilayered particles that could incorporate molecules or living cells with high efficiency, and with 
the potential to be used in a wide range of applications including cosmetics, pharmacy, agriculture, food 
technology and biomedicine. This simple procedure permits to obtain multilayered particles with controlled 
size and layer thicknesses of distinct materials which allow tailoring molecules release profiles and gathers 
appropriate conditions to support viable cells. If a particular application would require smaller particles, 
these hierarchical structures could be pre- pared using a dosing system to deliver smaller droplets. 
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Biomimetic superhydrophobic surfaces inspired in the behavior and properties of lotus leaf demonstrated 
to be an adequate methodology to produce a variety of spherical-based hydrogel particles for biomedical 
applications. Simple homogeneous matrices and compartmentalized spherical systems were obtained in a 
fast way.  This versatile technique allowed the production of particles with different diameters ranging from 
ca. 700 µm to ca. 3 mm. The volume dispensed on the top of the surfaces defined the size of the 
particles. Four different natural-based polymers crosslinked through adequate mild procures were used in 
the production of manageable particles. In each proposed system we were able to encapsulate cells, 
bioactive agents or a combination of both. The efficiency of encapsulation was very high (except in the 
chapter 5 where the particles were loaded after being produced) because the particles hardened in dry 
environments, avoiding the diffusion of the bioactive agents from the particles to the surrounded medium. 
The conditions to produce the particles were mild and did not compromise the viability of the cells and the 
activity of labile bioactive agents.  In addition, the particles were obtained individually, no aggregation 
occurred during the processing and no mechanical forces (e.g. stirring) were applied to the particles. All 
the obtained systems under the scope of this thesis exhibited an almost spherical shape.  
The first system proposed was successfully obtained by UV light exposure of a surface containing liquid 
droplets of a modified dextran and CDs. It was observed that the use of monomers of CDs (γ-CD-NMA) 
improved the general performance of the system, when compared with dextran solely particles and 
systems where the γ-CDs were free inside the dextran gels. The copolymerization of γ-CD-NMA increased 
the loading capacity of the particles in approximately 7 folds to a hydrophobic drug (dexamethasone), and 
sustained its release for at least 10 days. This strategy demonstrates that the difficulties associated to 
hydrophilic systems, as the case of hydrogel-based particles, in encapsulation of hydrophobic drugs may 
be overcome by integrating anchored CDs in the polymer network. This particulate system showed good 
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cytocompatibility and was effective in inducing the osteogenic differentiation of hASCs after 3-7 days, 
demonstrating potential to be used in bone regeneration strategies.  
Another proposed system was based on chitosan. The mild conditions were obtained increasing the pH of 
the chitosan acidic solution by adding β-GP. The particles were successfully hardened following two steps: 
ionic crosslinking and temperature exposure. The obtained particles were pH sensitive and easy-to-handle 
after ionic crosslinking. In addition, under physiological temperatures the structure of the network was 
reinforced at mechanical level due to the attractive forces between chitosan chains caused by β-GP. 
Entrapped L929 cells in this hydrogel remained viable for 7 days. The dexamethasone-loaded particles 
released almost 70% of the total content into 2-3 h. For effective biomedical applications several 
improvements would be required, namely, a better control of the drugs release as well as the inclusion of 
anchorage sites in the hydrogel network for adherent cells. In this context, a third system was developed in 
this thesis by combining collagen as a structural support, PLs as a GFs source and hASCs. The application 
envisaged for this system was skin regeneration because in the particular case of ulcers, the new collagen 
formed during the healing process is immediately destroyed due to the high concentration of proteases, the 
cells died due to the absence of a support to adhere and proliferate, and angiogenesis is an issue due to a 
fast degradation of GFs. The presence of PLs in the proposed particulate system was crucial for the 
biological performance of the system in both explored cellular and acellular strategies. The particles 
obtained provided mild conditions for cell encapsulation and stimulated the hASCs adhesion and 
proliferation.  A very interesting event occurred in the cell-laden gels: the cells were capable to migrate and 
establish cell-cell communications; consequently, a membrane composed by particles connected by cells 
was formed. Such membranes were easy-to-handle and could be straightforwardly implanted in the skin 
damaged sites. In the case of particles without cells the system was tested as in situ GFs release 
demonstrating great capacity to stimulate the hASCs proliferation and migration, and to induce the 
angiogenesis.  The use of superhydrophobic surfaces and physiological temperatures to produce those 
particles constituted a very fast and mild strategy to obtain multifunctional systems without compromise 
the viability of the cells and the bioactivity of GFs, as well as without risk of lose GFs due to the dry 
environment where the particles hardened.  
The last monocompartmentalized spherical system proposed was obtained by encapsulating a cell 
adhesive protein (FN) and MSCs. Alginate particles were prepared by ionic gelation, under a gaseous 
environment; both in vitro and in vivo tests were performed, namely the implantation in a bone defect 
created in the calvaria of rats. The FN entrapped into the particles increased the percentage of viable cells 
inside the particles. In addition, the results obtained, when the particles were implanted in vivo, 
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demonstrated that the presence of the cells was crucial for a more efficient regeneration of bone tissue. 
Similarly to the Coll+PL gels, alginate particles were hardened into 10-15 min, in mild conditions for cells 
and for the protein.  
The versatility of the superhydrophobic surfaces methodology was extended to produce 
multicompartmentalized particles, through a bottom-up approach. Core/shell and multilayered particles 
were successfully obtained using photocrosslinkable dextran and alginate. Cells and bioactive agents were 
encapsulated into individual compartments in different proposed strategies. It was showed that such 
complex architectures were suitable for control temporally the release of a model drugs. The cells 
encapsulated in the external layer were maintained viable for at least 3 days.  
The work developed herein showed that multiple systems, ranging from homogeneous 
monocompartmented matrices to multicompartmented architectures, might be produced using the 
superhydrophobic surfaces methodology. In addition, different materials to obtain the solid particles 
(dextran, chitosan, collagen, alginate) were used as well as different hardening processes (UV light 
irradiation, ionic crosslinking and temperature exposure). Regarding the content of the particles, also a 
variability of bioactive agents (small synthetic drugs, proteins and GFS) and cell types (cell lines and 
primary cells) were successfully entrapped in the hydrogel spherical matrices.  
Although superhydrophobic surfaces had several abovementioned advantages when compared with 
conventional methodologies, this procedure also has some limitations that in the future have to be 
surpassed. The most obvious is the limitation to repeal just aqueous solutions; superhydrophobic surfaces 
are not capable to repeal organic solvents preventing the production of synthetic-based particles. The use 
of superamphiphobic surfaces instead of superhydrophobic may be a reasonable alternative. Other 
limitation refers to the minimal volume dispensed to produce the particles. Using a micropipette, volumes 
lower than 2 µL are not possible to be dispensed. In this sense, accurate and automatic systems to 
dispense droplets to prepare particles in the micro scale range are required and should be accompanied 
with the engineering of surfaces with lower-scale roughness. This technology demonstrate potential to be 
scaled up by a continuous mass production, for example by developing an automatic system capable 
dispense the liquid particles precursors in a belt conveyor with repellent properties on the surface. Then, 
the droplets could harden into solid particles along of the route of the belt conveyor and be collected in the 
end.  
In the future, it is expected the preparation of more sophisticated and complex systems in order to mimic 
closely the complex biological events occurred during the regeneration of damaged tissues, as well as to 
produce systems for other biomedical and biotechnological applications.  
